Carbohydrate–protein ingestion during recovery from prolonged exercise in man by James A. Betts (3218589)
" I ( 
~, 
i ., 
l 
.,. 
" 
., 
University Library 
•• Loughborough 
., University 
~ AuthorlFiling Title ....... B..E::r1.$ .. , ..... :J .. : ................. .. 
'I 
! ~;~~~.~~~~.:::::::::::::::::::::::::::r.::::::::::::::::::::::::::::::::::::::. 
Please note that fines are charged on ALL 
overdue items. 
0403270421 
~'~I """" "' " 1111' 
. 
~ ~{., ,tl " 
.. ' 
CARBOHYDRATE-PROTEIN INGESTION 
DURING RECOVERY FROM PROLONGED 
EXERCISE IN MAN 
by 
James A. Betts 
A Doctoral Thesis 
. Submitted in partial fulfilment of the requirements for the award of 
Doctor of Philosophy of Loughborough University 
, 200~ 
- , 
- , - I 
, .. © 1. A. Betts'(2005): 
I 
. . ..... 
U Loughborough 
Uni\'cl"Sity 
Pilkingl"" Library 
Dale SR.,fl 2.00(, 
Class \ • 
Ace 
No. 011-032."10'+-2\ 
Abstract 
Evidence supports that the ingestion of carbohydrate solutions in the post-exercise period 
can facilitate the restoration of exercise capacity both through providing the fluid 
necessary for rehydration and through stimulating carbohydrate storage. The accrual of 
this evidence has now established many components of the optimal carbohydrate feeding 
strategy during recovery and further progress has been sought through investigating the 
potential influence of other macronutrients. Specifically, combined ingestion of protein 
and carbohydrate may promote a more rapid resynthesis of endogenous glycogen stores 
than when either nutrient is ingested in isolation. This possibility has lead to speculation 
that ingestion of a mixed carbohydrate-protein solution (CHO-PRO) might restore the 
capacity for physical exercise more completely during a short-term recovery than when a 
matched quantity of carbohydrate alone is ingested. However, evidence in support of this 
hypothesis is not yet available and the present series of studies will therefore attempt to 
directly examine the effects of CHO-PRO ingestion on recovery of exercise capacity. It 
was established in the first of these studies that restoration of exercise capacity at 85% 
VO, max was not enhanced when protein was added to a recovery solution providing 
quantities of carbohydrate likely to optimise carbohydrate storage when ingested alone 
(i.e. l.l g CHO·kg-1·h-1)_ The second study then repeated this protocol using a lower 
quantity of carbohydrate which would not be expected to maximise the rate of 
carbohydrate storage during recovery (i.e. 0.8 g CHO·kg-1·h-1). Nonetheless, despite 
confirming that the addition of protein produces a more conducive hom10nal milieu for 
the resynthesis of muscle glycogen, exercise capacity following recovery remained 
unaffected. In addition, the metabolic data taken from these initial studies indicated that a 
lower intensity exercise capacity test might provide more valid reflection of changes in 
carbohydrate status during recovery. It was subsequently demonstrated in Study 3 that 
the addition of 0.3 g·kg-1·h-1 of either protein or carbohydrate to a solution providing 0.8 g 
CHO·kg-1-h-1 can improve the recovery of exercise capacity when assessed at 70% 
VO, max_ The precise mechanism underlying the ergogenic benefit of CHO-PRO 
ingestion remains unclear, although the data gathered in the final study of this thesis 
negates the possibility that this effect was related to an increased availability of muscle 
glycogen. 
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Chapter I Introduction 
Introduction 
Many athletes are required to train or compete on multiple occasions within a 
single day and therefore strive to maximise their recovery in the relatively short 
interval between each exercise session. Similarly, individuals undertaking less 
intensive training regimens might also benefit from an effective and rapid recovery as 
this would be likely to increase the frequency of their participation while also 
improving adherence to the exercise program. Taking part in prolonged physical 
exercise of moderate to high intensity places a high demand on the body's limited 
carbohydrate stores to provide energy for continued muscular contraction (Gollnick et 
al., 1972; Hermansen et aI., 1967). Endogenous sources of carbohydrate, such as 
muscle glycogen, are therefore progressively depleted during exercise of this intensity 
and fatigue has been found to occur when the availability of such sources reaches 
critically low levels (Ahlborg et aI., 1967). A logical extension of this finding 
consequently dictates that the capacity to perform physical exercise for extended 
periods will be detennined by the availability of muscle glycogen at the onset of 
exercise (Bergstrom et aI., 1967). 
Given the relationship described above, it is reasonable to suggest that the 
replenishment of depleted carbohydrate stores will constitute a crucial component of 
an effective recovery. The resynthesis of muscle glycogen is perhaps most important 
and will be initiated immediately following exercise as a direct result of prior 
muscular contraction (Bergstrom and Hultman, 1966; Ivy and Holloszy, 1981). 
However, a sustained rate of muscle glycogen accumulation over a more extended 
period will require nutritional intervention to maintain high concentrations of 
circulating glucose and insulin (Costill et aI., 1981; Piehl, 1974). When recovery time 
, ' 
is not restricted, it appears that simply ingesting carbohydrate in quantities sufficient 
to replace losses can completely restore the capacity for physical exercise within 24 h 
(Nicholas et aI., 1997). Conversely, neither muscle glycogen concentrations nor 
exercise capacity are likely to be entirely restored within 8 h of prior exercise, which 
has placed great emphasis on identifying the optimal nutritional strategy for a short-
term recovery. 
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In contrast to more prolonged recovery periods, it has become increasingly 
evident that subtle differences in post-exercise nutrition can have a profound 
influence on the efficacy of a given supplement during a more short-tenn recovery. 
The rate of muscle glycogen resynthesis immediately following exercise is mediated 
to a large extent by the precise feeding schedule which is employed along with 
considerations regarding the specific type of carbohydrate that is ingested (Ivy, 200 I, 
1998; Jentjens and Jeukendrup, 2003). In fact, it is likely that variations in the 
frequency and form of carbohydrate intake across different studies has been primarily 
responsible for the difficulty in determining the optimal amount of carbohydrate that 
should be ingested during a short-term recovery. Nonetheless, when all available 
evidence is considered, a dose-response relationship does appear to exist between 
carbohydrate intake and the rate of muscle glycogen resynthesis over the first 6 h 
following exercise. More important, however, is the finding that muscle glycogen 
resynthesis with carbohydrate feeding appears to plateau at a rate of ",45 mmol 
glucosyl units·kg dry mass·l·h· l, a rate that can be achieved through ingestion of 1.2 
g.kg-l.h· l of carbohydrate at 30 min intervals during a 5 h recovery (van Loon et aI., 
2000a). 
A large amount of research has attempted to elucidate the precIse factors 
which might limit the rate of muscle glycogen storage following exercise. Of 
particular relevance have been the findings that intravenous infusion of glucose and 
insulin but not glucose alone can increase the rate of muscle glycogen resynthesis 
above that attainable through oral carbohydrate intake (Hansen et aI., 1999; Reed et 
aI., 1989). These observations have led to the suggestion that insulin concentration 
may limit the rate of carbohydrate storage when glucose availability is adequate, with 
the implication that augmentation of the insulinaemic response to a standard 
carbohydrate solution may further enhance the rate of muscle glycogen storage during 
recovery (Ivy, 2001). It is therefore noteworthy that the combined ingestion of 
protein with carbohydrate can stimulate pancreatic insulin secretion to a greater extent 
than ingestion of either macronutrient alone (Rabinowitz et aI., 1966), a finding which 
introduces the interesting possibility that muscle glycogen storage might also be 
facilitated when a mixed carbohydrate-protein solution is ingested during recovery. 
Indeed, early evidence appeared to support this hypothesis as Zawadzki et al. (\ 992) 
observed a 38% increase in muscle glycogen storage over a 4 h recovery when ",0.3 
3 
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g·kg-1·h-1 of protein was added to a solution already providing ",,0.8 g·kg-1h-1 of 
carbohydrate. However, subsequent attempts to exceed the proposed maximal rate of 
muscle glycogen storage through adding a similar amount of protein to 1.2 g·kg-1·h-1 
of carbohydrate have not been successful, despite the synergistic effect of 
carbohydrate and protein on insulin release (Jentjens et al., 2001; Van Hall et al., 
2000b). The authors of these latter studies postulated that insulin stimulated glycogen 
resynthesis may be maximal following ingestion of 1.2 g·kg-1h-1 of carbohydrate 
alone, which would explain why further increases in insulin release following the 
addition of protein provided no additional benefit. It might therefore be deduced from 
this evidence that the presence of protein in a carbohydrate recovery solution may 
only be of benefit in terms of muscle glycogen storage when added to more moderate 
quantities of carbohydrate. 
In terms of recovery of exercise capacity, however, current understanding is 
far less developed regarding the effect of nutritional intervention. Even without the 
additional variable of added protein to consider, it remains uncertain whether exercise 
capacity will be enhanced in a dose-response relationship with increasing 
carbohydrate intake. The study of Fallowfield et al. (1995) certainly supports that 
exercise capacity can be restored more effectively when carbohydrate rather than 
placebo is ingested during a short-term recovery, yet manipulating the carbohydrate 
dose has not been found to produce any graded effect on exercise capacity 
concomitant with the expected rate of muscle glycogen resynthesis (Fallowfield and 
Williams, 1997; Wong and Williams, 2000). Contrary to these findings, a more 
recent study from Williams et al. (2003) examined the influence of simultaneously 
increasing carbohydrate intake and providing additional protein on the resynthesis of 
muscle glycogen and restoration of exercise capacity over a 4 h recovery. These 
authors reported a 128% increase in the rate of muscle glycogen resynthesis during 
recovery and a 55% increase in exercise capacity subsequent to recovery when 
carbohydrate ingestion was increased from 0.15-0040 g·kg-1·h-1 while also adding 0.10 
g.kg-1·h-1 of protein (Williams et aI., 2003). However, it cannot be established from 
these data whether the observed benefits of the carbohydrate-protein mixture were 
primarily the result of the increased carbohydrate availability or the inclusion of 
protein. It would therefore be of interest to further consider the potential benefits of 
ingesting carbohydrate-protein mixtures during recovery from exercise. 
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The studies described in this thesis attempt to resolve some of the outstanding 
issues regarding the efficacy of ingesting a mixed carbohydrate-protein supplement 
during recovery from prolonged exercise. This series of investigations begins with an 
examination of whether the addition of a small amount of amino acids to a high-
carbohydrate recovery solution can improve the restoration of treadmill running 
capacity at 85% VO, max within 4 h of prior exercise (Chapter 4). This recovery 
duration and exercise intensity are identical to those applied by Williams et al. (2003) 
in their previous examination of recovery solutions. To gain greater insight into the 
specific influence of carbohydrate availability on recovery of exercise capacity, a 
second investigation was conducted to repeat the protocol from Study I but involving 
a more moderate quantity of carbohydrate (Chapter 5). Following Chapters 4 and 5 it 
was necessary to detemline whether any influences of the carbohydrate- protein 
mixture had been a product of the additional protein per se or simply a result of the 
increased energy content. As such, Study 3 was designed to evaluate a carbohydrate-
protein solution in comparison both with a solution matched for carbohydrate content 
and a solution matched for available energy. Notably, the relative intensity of the 
exercise capacity test was reduced to 70% VO, max for this study (Chapter 6). In the 
final investigation of this thesis, the carbohydrate matched solutions that were 
examined during Study 3 were assessed both in terms of the rate of muscle glycogen 
resynthesis during recovery and the rate of muscle glycogen degradation during 
exercise subsequent to recovery (Chapter 7). Finally, the General Discussion reviews 
how the cumulative information gathered across all the above studies might progress 
scientific understanding regarding the potential role of carbohydrate-protein ingestion 
during recovery from exercise. 
5 
CHAPTER 2 
Chapter 2 Review of Literature 
Review of Literature 
2.1 Energy Metabolism During Exercise 
2.l.1 Metabolism of Muscle Glycogen 
At sub-maximal exercise intensities, a linear relationship exists between 
exercise intensity and oxygen uptake. Once oxygen demand exceeds approximately 
65% of an individual's VO,max, the preferred fuel source to support muscle 
metabolism will be carbohydrate since this substrate exists in an already partially 
oxidised form and can therefore be metabolised most efficiently (Wasserman and 
Cherrington, 1991). The majority of endogenous carbohydrate (",79%) is stored 
within muscle in the form of glycogen, which provides an essential source of fuel 
during exercise of moderate to high intensity (Sherman, 1995). Basal concentrations 
of muscle glycogen have been reported in the region of 300-400 mmol glucosyl 
units·kg dry mass·] (Bergstrom et al., 1972) and it has been demonstrated that 
manipulation of both exercise and diet has the capacity to elevate this concentration 
closer to 900 mmol glucosyl units·kg dry mass·] (Sherman et ai., 1981). Muscle 
glycogen is comprised of 2 physiologically distinct SUb-glycogen pools: proglycogen 
and macroglycogen (Jentjens and Jeukendrup, 2003). This heterogeneous structure is 
known to originate from a self-glucosylating protein (glycogenin) which acts as a 
primer for muscle glycogen synthesis through the actions of branching enzyme and 
glycogen synthase (Alonso et al., 1995; Pitcher et ai., 1988; Smythe and Cohen, 
1991). Following the transcription of glycogen in in muscle (Shearer et ai., 2005), the 
initial rapid addition of glucosyl units to glycogen in forms proglycogen, while a more 
gradual accumulation over an extended period results in the formation of 
macroglycogen (Adamo et al., 1998). 
The importance of muscle glycogen as a substrate during moderate to high 
intensity exercise is clearly demonstrated by the large quantity of this fuel that is used 
during such activity (Ahlborg et ai., 1967; Bergstrom et al., 1967; Hermansen et al., 
1967) and also by the severe exercise intolerance that is present in patients with 
McArdle's disease (Nielsen et ai., 2002), a condition characterised by the inability to 
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breakdown glycogen due to phosphorylase deficiency (McArdle, 1951). The rate at 
which muscle glycogen is degraded during exercise is influenced by a number of 
factors and, as indicated above, the intensity of exercise is a crucial determinant of 
substrate selection (Brooks and Mercier, 1994; Romijn et aI., 1993). In fact, an 
exponential increase in the rate of muscle glycogen utilisation can be observed in 
response to a linear increase in exercise intensity (Hawley et aI., I 997b; Sherman, 
1995; van Loon et aI., 2001). In addition to the relative oxygen efficiency of 
carbohydrate metabolism, it is likely that the particular increase in muscle glycogen 
oxidation with increasing exercise intensity is also mediated by the catecholamine 
stimulated suppression of insulin secretion (Hunt and Ivy, 2002), thus limiting the 
availability of extracellular carbohydrate sources (Tsintzas and Williams, 1998). 
Furthermore, Gollnick et al. (1974) have demonstrated that an increase in exercise 
intensity also alters the glycogen depletion pattern across different muscle fibres. In 
this study it was identified that muscle glycogen metabolism during sub-maximal 
endurance exercise occurs primarily in those muscle fibres with a high oxidative 
capacity (type I) and only once these fibres are depleted will those fibres with a high 
glycolytic capacity (type II) be substantially recruited (Gollnick et aI., 1974). Indeed, 
more recent evidence has confirmed that, following a treadmill run to exhaustion at 
70% VO, max, a selective depletion of muscle glycogen in the type I rather than type 
II fibres is apparent (Tsintzas et aI., 1996a). 
Another important factor which dictates the rate of muscle glycogen utilisation 
during exercise is the availability of the substrate itself (Gollnick et al., 1972; 
Sherman et aI., 1981; Weltan et aI., 1998a). Specifically, low muscle glycogen 
concentrations result in an increased contribution of lipid towards energy production 
and therefore reduce the reliance on muscle glycogen as a substrate (Weltan et aI., 
1998a, 1998b). This finding is clearly important regarding carbohydrate loading 
strategies but is also inexorably linked to exercise duration since the progressive 
decline in muscle glycogen content during exercise at 65-70% VO, max has been 
associated with a progressive decline in the rate of muscle glycogen utilisation (Coyle 
et al., 1986; Hargreaves et aI., 1995; Romijn et aI., 1993). 
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While relative exercise intensity and substrate availability have been 
suggested as the major determinants of muscle glycogen utilisation rate (Arkinstall et 
al., 2004), the specific type of exercise being undertaken along with the presence or 
absence of exogenous carbohydrate provision also exert an influence (Tsintzas and 
Williams, 1998). The interaction of these 2 variables appears to be important in that 
ingestion of exogenous carbohydrate may provide perfomlance benefits through 
different mechanisms depending on exercise mode. When exogenous carbohydrate is 
provided during prolonged constant pace running, the rate of blood glucose oxidation 
increases such that total carbohydrate oxidation can be maintained while the rate of 
muscle glycogen utilisation is reduced (Tsintzas et aI., 1995; Tsintzas et al., 1996b). 
In contrast, ingestion of carbohydrate during prolonged constant pace cycling 
produces no such muscle glycogen sparing effect, although an improved maintenance 
ofeuglycaemia late in exercise has been reported (Coyle et aI., 1986; Hargreaves and 
Briggs, 1988; Mitchell et al., 1989). The mechanism through which an enhanced rate 
of blood glucose oxidation might delay fatigue is not immediately apparent but recent 
evidence suggests that this effect is independent of changes in total carbohydrate 
oxidation and unrelated to the avoidance of hypoglycaemia (Claassen et aI., 2005). A 
further consideration regarding exercise type is whether that exercise is of constant 
pace (as discussed above) or is more intermittent in nature. When exercise of 
moderate to high intensity is interspersed with periods of lower intensity work or 
complete rest, there may be a greater opportunity for exogenous carbohydrate 
ingestion to postpone muscle glycogen depletion (Tsintzas and Williams, 1998). One 
reason for the increased effectiveness of ingested carbohydrate during intermittent 
exercise is that, unlike during higher intensity activity, plasma insulin is able to 
elevate transiently during the lower intensity periods (Ivy et aI., 2003). In addition, it 
has been suggested that resynthesis of muscle glycogen may occur in non-exercising 
muscle fibres during these rest periods (Kuipers et aI., 1987; McKenzie et aI., 2005). 
Overall, evidence supports a glycogen sparing effect of carbohydrate ingestion both 
during intermittent cycling (Yaspelkis et al., 1993) and during an intermittent shuttle 
running protocol (Nicholas et al., 1999). 
There are clearly a myriad of factors which govern the rate at which muscle 
glycogen will be degraded during physical exercise and the relative influence of each 
will be mediated by other elements that are specific to each individual. Endurance 
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training is one such factor that has been suggested to modify the metabolic response 
across varying exercise intensities and durations (Holloszy and Coyle, 1984). As 
detailed by Brooks and Mercier (1994), substrate selection will be the product of 
intensity induced increases in carbohydrate oxidation coupled with a training induced 
promotion of lipid oxidation. It has been clearly demonstrated that endurance training 
can enhance lipid oxidation and thus reduce carbohydrate oxidation, but only when 
the exercise intensity remains relatively low (i.e. <40% VO, max) and when that 
activity is performed following an overnight fast (Bergman and Brooks, 1999). The 
significance of the overnight fast appears to be related to the finding that physical 
training will also increase both the sensitivity and responsiveness of insulin-mediated 
glucose uptake (Dela et aI., 1992; Mikines et aI., 1989), which may account for why 
exogenous carbohydrate ingestion has been reported to negate the carbohydrate 
sparing influence of prior training by some (Helge et aI., 1996; Jeukendrup et aI., 
1997) but not all authors (van Loon et al., 1999). One final factor which may 
contribute to the inter-individual differences in carbohydrate utilisation during 
exercise is gender (Tarnopolsky et aI., 1990). Firstly, it has been reported that 
females may be less able to supercompensate their muscle glycogen stores through 
chronic exercise-diet manipulation than males (Tarnopolsky et aI., 1995) although the 
possibility remains that a more acute dietary manipulation in the immediate post-
exercise period may reveal the capacity to rapidly synthesise muscle glycogen in 
females (Tarnopolsky et aI., 1997). Furthermore, female athletes have been shown to 
oxidise comparatively less carbohydrate and more lipid during exercise of moderate 
to high intensity than do males of matched training status (Tarnopolsky et al., 1995). 
These authors attribute their observed differences in substrate selection to the lower 
insulin release in males during exercise (Tarnopolsky et al., 1990) although more 
recent evidence does not appear to support this hypothesis (Leelayuwat et al., 2005). 
Alternatively, others have suggested that females may display a blunted sympathetic 
response to exercise which would restrain their transfer towards a predominance of 
carbohydrate metabolism at moderate exercise intensities (Brooks and Mercier, 1994). 
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2.1.2 Metabolism of Other Carbohydrate Sources 
As described in the previous section, carbohydrate is the preferred fuel source 
during exercise of moderate to high intensity but the readily available store of 
carbohydrate within the working muscle is finite. In addition to the carbohydrate 
stored within muscle, alternative sources are found in the liver and in the blood. Liver 
glycogen comprises approximately 14% of total stored carbohydrate while 
approximately 7% of available carbohydrate circulates as blood glucose (Sherman, 
1995). However, these 2 sources are inherently linked since the increase in blood 
glucose uptake by muscle during exercise is closely matched by an increased rate of 
hepatic glycogenolysis and gluconeogenesis (Wasserrnan and Cherrington, 1991). 
During the early stages of exercise, hepatic glucose production is known to be 
suppOlied almost entirely by an increased rate of hepatic glycogenolysis (Wahren et 
al., 1971). This maintenance of euglycaemia through hepatic glycogenolysis results 
in a progressive decline in liver glycogen concentrations, thus necessitating an 
increasing reliance on gluconeogenesis such that, after approximately 2 h of moderate 
exercise, up to 20% of total hepatic glucose output can be derived from other carbon-
based compounds (Ahlborg et al., 1974; Decombaz et aI., 1979; Wasserrnan et al., 
1988). However, while an increased contribution of gluconeogenesis to hepatic 
glucose output can undoubtedly delay both muscle and liver glycogen depletion 
(Turcotte et aI., 1990), it cannot entirely compensate for any major decrease in hepatic 
glycogenesis once liver glycogen depletion eventually occurs (Ahlborg and Felig, 
1982). Regulation of gluconeogenic flux during prolonged exercise appears to be 
principally under hormonal control since a reduction in insulin and/or an increase in 
glucagon have been shown to be essential for effective maintenance of glucose 
homeostasis in such situations (Barthel and Schmoll, 2003; Wolfe et al., 1986). 
Interestingly, this finding may explain why ingestion of exogenous carbohydrate 
during exercise has been shown to completely suppress endogenous glucose 
production (Jeukendrup et aI., 1999). In addition, recent evidence also suggests that 
interleukin-6 (IL-6) exert a major influence in mediating endogenous glucose 
production during exercise, but not at rest (Febbriao et al., 2004). Further information 
relating to this cytokine is provided in section 2.3 .2.2a. 
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Whether arising from the liver or from an exogenous source, there are many 
factors which influence the rate at which blood glucose will be oxidised during 
exercise (Jeukendrup and Jentjens, 2000). Similar to muscle glycogen oxidation, the 
rate of plasma glucose oxidation can be expected to rise exponentially in response to a 
linear increase in exercise intensity (Romijn et al., 1993; van Loon et al., 200 I). In 
the transition from low to moderate intensity exercise (i.e. up to 60% VO, max), it is 
likely that the exponential increase in total carbohydrate oxidation will be met through 
a concomitant increase both in endogenous and exogenous carbohydrate oxidation 
rates (Pimay et aI., 1982), although this effect may only be detectable when 
monitoring the transition upwards of very low intensities when non-oxidative glucose 
disposal would initially be possible (Jeukendrup and Jentjens, 2000). In contrast, for 
any increase in exercise intensity beyond approximately 60% VO, max, increases in 
overall carbohydrate oxidation will predominantly originate from a greater oxidation 
of muscle glycogen rather than exogenously provided substrate (van Loon et al., 
2001 ). 
The rate of blood glucose oxidation at any given exercise intensity does not 
appear to be determined by muscle glycogen availability (Arkinstall et aI., 2004) but 
instead is controlled primarily by the availability of blood glucose (Weltan et aI., 
1998a, 1998b). The availability of blood glucose for oxidation during exercise will 
depend on how quickly ingested carbohydrate sources can be emptied from the 
stomach and absorbed through the intestine, the degree of hepatic glucose output and 
the capacity of active muscle to absorb blood glucose (Angus et al., 2002; Jentjens 
and Jeukendrup, 2003). When ingesting glucose alone, maximal rates of glucose 
oxidation have been reported in the region of 1.1 g·min'l (Jeukendrup and Jentjens, 
2000; Wagenmakers et aI., 1993). The rate of gastric emptying is not believed to 
dictate the maximal rate of glucose oxidation since the rate of glucose appearance 
·from the stomach exceeds the maximal glucose oxidation rate =o3-fold (Moodley et 
aI., 1992; Rehrer et al., 1992). Conversely, evidence does support a limit to the rate 
of glucose oxidation located at the level of the intestine. When glucose has been 
infused into the bloodstream, thus bypassing the proposed intestinal limitation, rates 
of glucose oxidation have been recorded far in excess of 1.1 g.min'l (Hawley et aI., 
1994). Furthermore, Jentjens et al. (2004) proposed that this limit to intestinal 
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absorption may occur due to saturation of the sodium-dependent glucose transporters 
which carry glucose across the brush-border membrane from the intestine into the 
bloodstream. These authors have subsequently demonstrated rates of exogenous 
carbohydrate oxidation as high as 1.75 g·min- 1 following ingestion of mixed glucose 
and fructose (Jentjens and Jeukendrup, 2005; Jentjens et aI., 2004) and have attributed 
this effect to the fact that fructose can be absorbed separately to glucose via sodium-
independent facilitative transporters (Ferraris, 2001). Despite this identification of 
intestinal absorption as a rate limiting factor for blood glucose oxidation, it cannot be 
ruled out that the liver may also perform a role under certain circumstances to limit 
the quantity of glucose which is made available for metabolism (Jeukendrup and 
Jentjens, 2000). 
In addition to blood glucose, it has been suggested that blood lactate may 
provide another particularly mobile source of fuel for aerobic metabolism (Brooks, 
2002b). While the proposal that lactate released by an active muscle can either be 
oxidised by other muscles or used as a gluconeogenic precursor is widely accepted, 
the extension of this concept to describe intracellular shuttling of lactate has not been 
as well received (Brooks, 2002a). The key tenets of this theory which have been 
challenged by other authors are that it would firstly involve transport of lactate into 
the mitochondria, before subsequently necessitating the presence of lactate 
dehydrogenase (LDH) to catalyse conversion of lactate into pyruvate for further 
oxidation to take place (Gladden, 2004). This scepticism stems from evidence that 
mitochondria may be unable to oxidise lactate due to the absence of intra-
mitochondrial LDH (Rasmussen et aI., 2002; Sahlin et al., 2002). In contrast, other 
data have verified the existence of an LDH pool within mitochondria and, more 
recently, specific lactate transporters have been identified which would facilitate the 
function of a lactate shuttle (Brooks et aI., 1999; Hashimoto et aI., 2005). Brooks 
(2002a) speculates that the discrepancy in these findings may be due to LDH loss 
during the mitochondrial isolation procedures which were applied by Rasmussen et al. 
(2002) and Sahlin et al. (2002). Despite these inconsistent findings, there is now 
good evidence both for inter- and intra-cellular lactate shuttling mechanisms, thus 
providing a clear link between the aerobic and anaerobic routes of glycolysis 
(Gladden, 2004). It is essential, therefore, that any discussion of metabolism during 
exercise must recognise the contribution of this emerging substrate towards overall 
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carbohydrate metabolism. Furthemlore, evidence also supports that lactate can easily 
be converted into muscle glycogen during recovery from exercise (Astrand et aI., 
1986; Bendall and Taylor, 1970; Hemlansen and Vaage, 1977), particularly in type II 
muscle fibres (McLane and Holloszy, 1979). 
2.1.3 Metabolism of Lipid 
While sections 2.1.1 and 2.1.2 clearly demonstrate the importance of 
carbohydrate as an energy source during exercise, if it were the sole energy substrate 
then total depletion of endogenous carbohydrate reserves would occur within ",2 h of 
physical activity (Sherman, 1995). Fortunately, the body's endogenous 
triacylglycerol (TAG) stores represent an energy source over 60 times larger than that 
of glycogen and, once hydrolysed (i.e. lipolysis), these TAG can provide the 
mitochondria with sufficient free fatty acids (FFA) to sustain physical activity over 
longer periods of exercise (Horowitz and Klein, 2000). Most of this TAG is stored as 
sub-cutaneous or deep visceral adipose tissue, although other sites of storage are 
located within muscle fibres and in the circulation as either FFA or Iipoproteins (van 
Loon, 2004). Initial escalation from low to moderate exercise intensity elevates the 
absolute rate of lipid oxidation (Romijn et al., 1993) and evidence indicates that this 
increase is predominantly achieved through an accelerated oxidation of IMTG and 
circulating lipoprotein, although the greatest contribution is still derived from FFA 
(van Loon et al., 2001). Further increments in exercise intensity (i.e. >70% 
VO, max) result in decreased oxidation of all lipid based substrates (Romijn et aI., 
1993; van Loon et aI., 2001), partly due to a reduced mobilisation of FFA from 
adipose tissue (Romijn et al., 1995). In addition, however, these relatively low rates 
of lipid oxidation during intense exercise have also been associated with an increased 
accumulation-of intramuscular fatty acids, which may suggest that the rate of lipid 
utilisation is limited by transport of lipid sources into the mitochondria rather than 
their availability in the circulation (Kiens et aI., 1999). Importantly, recent evidence 
has now demonstrated that inhibition of adipose tissue lipolysis can dramatically 
increase the rate of muscle glycogen degradation during exercise (van Loon et aI., 
2005), which confirms earlier support for the existence of a glucose-FFA cycle 
whereby FFA availability exerts a central mediating role in substrate selection 
(Randle et aI., 1963; Randle et al., 1964; Rennie and Holloszy, 1977). 
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In terms of exercise duration, it has been well documented that metabolism of 
lipid displays an overall increase as time progresses (Ahlborg et al., 1974; Romijn et 
al., \993; van Loon et al., 2003b), largely due to an amplified catecholaminergic 
stimulation oflipolysis (Horowitz and Klein, 2000). An earlier report from Romijn et 
al. (1993) suggesting that this gradual elevation in lipid oxidation over time is mainly 
supported by an increased oxidation of FFA has more recently been confimled (van 
Loon et al., 2003b). Furthermore, direct measurement of IMTG from muscle biopsy 
samples has now indicated that utilisation of this lipid source may actually decline 
with increasing exercise duration (Watt et al., 2002a). Taken together, these findings 
have been interpreted to suggest that an increased availability of FF A may suppress 
IMTG oxidation during the latter stages of prolonged exercise (van Loon, 2004). It is 
also known that the rate of lipid oxidation will remain elevated in the post-exercise 
period to allow a more rapid replenishment of endogenous carbohydrate stores (Kuo 
et al., 2005). 
Endurance training is known to modify the metabolic response to exercIse 
such that relatively more lipid will be oxidised at low to moderate exercise intensities 
following training (Bergman and Brooks, \999). Regarding the effect of training on 
the different endogenous sources of lipid, one proposed training adaptation is an 
enhanced myocellular capacity to uptake and oxidise FF A rather than IMTG (Turcotte 
et aI., 1992). However, other studies attribute most of the increased propensity for 
lipid oxidation when in the trained state to an increased lipolysis of IMTG (Hurley et 
al., 1986). At least some of the controversy regarding training adaptations in terms of 
IMTG use during exercise may arise from methodological differences between certain 
studies and a recent review has identified many of the difficulties in attaining reliable 
IMTG data using muscle biopsies, especially when untrained individuals have been 
recruited (Watt et al., 2002b). Specifically, it has been suggested that measuring 
IMTG in muscle biopsy samples taken before and after exercise may not be a valid 
method due to the simultaneous utilisation and reesterification of IMTG over the 
intervening period (Guo, 2004). Overall, data using techniques other than muscle 
biopsies to quantify IMTG utilisation during exercise (e.g. stable isotope methodology 
and/or IH-MRS) support the contention that IMTG does indeed represent a valuable 
source of energy for muscular contraction during exercise (van Loon, 2004; Watt et 
al., 2002b). Interestingly, recent evidence has also clarified that males may in fact 
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oxidise more intramuscular triacylglycerol (IMTG) than females during prolonged 
sub-maximal exercise (Zehnder et al., 2005), although it remains to be fully 
established whether these differences were a direct consequence of gender or an 
indirect consequence of gender related training habits. 
In summary, the oxidation of lipid during prolonged exercise is essential to 
supplement the body's primary reliance upon relatively limited endogenous 
carbohydrate stores for energy production. Recent evidence has clarified the specific 
contributions of the various lipid sources that are used during exercise and further 
research is warranted regarding the potential need to replace IMTG stores during 
recovery (Decombaz et aI., 2000). 
2.1.4 Metabolism of Protein 
Protein can support metabolism both through direct oxidation within muscle 
and also through providing gluconeogenic precursors for hepatic glucose production 
(Butterfield, 1990). Only the branched chain amino acids (BCAA) along with 
asparagine, aspartate, and glutamate are available for oxidation within muscle (Rennie 
and Tipton, 2000). All other amino acids must be transaminated into either glutamate 
or alanine before subsequent deamination in the liver, at which point the resultant 
carbon can be oxidised and the amino group disposed of as urea (FeJig and Wahren, 
1971). Importantly, a dynamic endogenous amino acid pool exists such that the 
ammo acids required for hepatic glucose production during exercise do not 
necessarily require catabolism of muscle protein (Decombaz et aI., 1979). 
Early evidence using [U- 14C]alanine and [U- 14C]leucine tracers reported that 
the metabolism of these 2 amino acids can increase during exercise (White and 
Brooks, 1981) and this finding has been generalised to the other amino acids for 
estimations that as much as 5-10% of total energy production may be derived from 
protein during exercise (Butterfield, 1990). However, data from other authors using 
[15N2]urea as a tracer do not support the contention that exercise elicits an increased 
rate of amino acid catabolism (Carraro et al., 1993). These apparently discrepant 
findings may be resolved through the suggestion that the rate of leucine oxidation 
may not necessarily represent the fate of all other amino acids (Wolfe et aI., 1984). 
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This hypothesis has been confirmed more recently using a multiple-tracer approach 
(L-[1-13C]leucine, L-[2Hs]phenylalanine and eSN2]urea) to demonstrate not only the 
disproportionate oxidation of leucine during exercise, but also the absence of any 
increase in net protein oxidation above basal levels even during very prolonged 
activity (Koopman et al., 2004). 
More recent estimations regarding the capacity for protein oxidation in 
humans now assert that amino acids can only ever account for a very minor 
proportion (i.e. <5%) of overall energy production (Gibala, 2002). Nonetheless, 
amino acids clearly play an important role in facilitating carbohydrate oxidation 
through the provision of precursors for gluconeogenesis and possibly also through 
anaplerotic replenishment of the tricarboxylic acid (TCA) cycle (Ivy et aI., 2003; 
Sahlin et aI., 1990). A more comprehensive discussion with respect to this latter 
possibility is provided in section 2.2.1. 
2.2 Mechanisms of Fatigue During Exercise 
2.2.1 Muscle Glycogen Depletion 
The interaction between exercise intensity and duration will impact 
profoundly on the precise causes of fatigue during physical exercise. Evidence is 
available demonstrating that elevated pre-exercise muscle glycogen concentrations 
can delay fatigue during high intensity exercise lasting less than 10 min (Maughan 
and Poole, 1981) and it appears that a prior bout of sub-maximal exercise augments 
this enhancing influence of glycogen availability (Pizza et aI., 1995; Tamopolsky et 
aI., 1995). However, even when preceded by sub-maximal exercise, the effects of 
glycogen loading regimens on high intensity exercise have typically been small and it 
is unlikely that absolute muscle glycogen availability was compromised within such 
short durations (Hawley et aI., 1 997b). It is more likely, therefore, that the ergogenic 
benefit of an increased muscle glycogen concentration during maximal or supra-
maximal exercise operates through a mechanism other than delaying the point of 
glycogen depletion, possibly involving some enhancement of fibre excitability 
(Rock well et al., 2003; Stephenson et al., 1999). 
17 
Chapter 2 Review of Literature 
Similar to the very short duration exercise described above, the availability of 
muscle glycogen does not appear to be a primary determinant of exercise capacity 
during a single bout of exercise lasting less than 90 min (Hawley et al., 1997b). 
Research involving time-trial performance tests have demonstrated that well trained 
athletes are able to exert themselves at relatively high intensities (i.e. ",85% VO, max) 
over such durations without perfomlance being limited by glycogen availability 
(Hawley et al., 1997a; Sherman et aI., 1981). Correspondingly, when exercise 
capacity tests following carbohydrate supercompensation are set at an intensity such 
that run time to fatigue does not exceed 90 min, substantial quantities of muscle 
glycogen can remain in the active muscles at the point of exhaustion (Madsen et al., 
1990). From these data, it seems reasonable to conclude that pre-exercise muscle 
glycogen availability does not influence exercise capacity during an isolated exercise 
session lasting less than 90 min because exercise of this duration is not sufficiently 
prolonged to induce a substantial degree of carbohydrate depletion. 
In contrast, when the intensity of exhaustive exercise is reduced to 65-75% 
VO, max, thus permitting sustained physical activity for longer than 90 min, the point 
of fatigue will often coincide with critically low concentrations of muscle glycogen 
(Bosch et al., 1993; Sherman, 1995). Compelling evidence in support of this 
contention has demonstrated a strong positive correlation (r = 0.92) between initial 
muscle glycogen content and subsequent work time to fatigue at 75% VO, max 
(Bergstrom et aI., 1967). Furthermore, at the point of exhaustion during exercise of 
such intensity and duration it has been a common observation for mixed muscle 
glycogen concentrations to be depleted below 100 mmol glucosyl units·kg dry mass' 1 
(Ahlborg et al., 1967; Bergstrom et aI., 1967; Hermansen et aI., 1967). It has been 
reported that sub-maximal exercise requires a greater rate of glycogen utilisation in 
type I as opposed to type Il muscle fibres (Costill et aI., 1973; Gollnick et aI., 1974; 
Tsintzas et al., 1995) and subsequent work appears to suggest that the onset of fatigue 
may be associated with the depletion of glycogen specifically in those fibres with a 
high oxidative capacity (Tsintzas et aI., 1996a). 
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The association described by Bergstrom et al. (1967) between pre-exerclse 
muscle glycogen content and exercise capacity permits those studies investigating the 
effect of carbohydrate supplementation on exercise metabolism to provide indirect 
evidence for a role of low muscle glycogen availability in the fatigue process. In 
particular, the study of Tsintzas et al. (1996a) investigated the influence of 
carbohydrate ingestion during exercise on concomitant rates of muscle glycogen 
utilisation. The increased time to exhaustion in association with carbohydrate 
ingestion was attributed by these authors to the 24% reduction in muscle glycogen 
utilisation in comparison with placebo ingestion. Coupled with the finding that mixed 
muscle glycogen at the point of fatigue was depleted to a similar extent in both the 
carbohydrate and placebo trials (",55 mmol glucosyl units·kg dry mass· I), this study 
provides clear support for the contention that fatigue during prolonged exercise can 
coincide with depletion of muscle glycogen (Tsintzas et aI., 1996a). In addition, other 
evidence has revealed that this ergogenic benefit of an improved muscle glycogen 
availability is not only manifested during exercise capacity tests. Studies have shown 
that using high carbohydrate diets to increase pre-exercise muscle glycogen 
availability can reduce the time taken to complete a 30 km time trial, due primarily to 
an improved maintenance of running speed over the finalS km (Karlsson and Saltin, 
1971; Williams et al., 1992). However, other findings showing that the provision of 
exogenous carbohydrate late in exercise can reverse the occurrence of fatigue, without 
any sparing of muscle glycogen, appear to suggest that fatigue arises as a consequence 
of compromised overall carbohydrate oxidation rather than limited muscle glycogen 
availability per se (Coggan and Coyle, 1989, 1987; Coyle et al., 1986; Marcil et aI., 
2005; Widrick et al., 1993). This concept is discussed further in section 2.2.2. 
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The precise reasons why an adequate supply of muscle glycogen is so essential 
during moderate to high intensity exercise remain to be fully elucidated. One 
possibility is that continued muscular contraction may require a steady balance of 
glycogenolysis and glycogenesis such that a limited availability of intramuscular 
glucose would necessitate the presence of sufficient muscle glycogen to meet 
immediate cellular energy demand (Shulman, 2005; Shulman and Rothman, 2001). 
However, it has also been suggested that glycogen may act as a carbon chain 
precursor for anaplerosis of certain intermediates in the TCA cycle during exercise 
(Wagenmakers et aI., 1990). Evidence certainly supports that intermediates such as 
2-oxoglutarate, succinate, fumarate, malate and oxaloacetate are reduced below 
normal exercising levels at the point of exhaustion (Gibala et al., 1997) and it has 
been shown that carbohydrate ingestion might offset this effect (Spencer et aI., 1991). 
Nonetheless, while some authors have affirmed that this consequence of reduced 
glycogen availability might compromIse mitochondrial respiration (Sahlin et al., 
1990; Wagenmakers et aI., 1991), data from other authors have indicated that 
manipulation of TCA pool size does not causally effect either aerobic energy 
production or exercise perfom1ance (Dawson et al., 2005; Gibala et aI., 1998), 
possibly indicating that an enriched pool of TCA cycle intermediates is not necessary 
to maintain cycle flux (Gibala, 2003). 
2.2.2 Liver Glycogen Depletion and Hypoglycaemia 
While the availability of muscle glycogen at the onset of exercIse IS 
undoubtedly an important determinant of exercise capacity and the intensity of 
exercise must necessarily be reduced once this substrate is depleted (Ahlborg et al., 
1967; Bergstrom et aI., 1967; Hermansen et al., 1967), there are clearly other 
mechanisms of fatigue which can be initiated before a muscle glycogen availability 
reaches critically low levels (Costill et aI., 1971 b). Evidence for such mechanisms 
arises from the studies referred to earlier in which provision of exogenous 
carbohydrate was shown to postpone fatigue without reducing the rate of muscle 
glycogen utilisation (Coggan and Coyle, 1989, 1987; Coyle et aI., 1986; Marcil et aI., 
2005; Widrick et al., 1993). In the study by Coyle et al. (1986), endurance trained 
participants were required to cycle to the point of exhaustion at approximately 70% 
\rO, max while ingesting either a placebo or a glucose polymer solution. As might be 
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expected, time to fatigue was significantly enhanced through ingestion of the 
carbohydrate solution rather than the placebo solution (242 versus 182 min, 
respectively). Of greater interest was the fact that the additional hour of exercise 
performed with carbohydrate supplementation was supported almost entirely through 
blood glucose oxidation, despite approximately 170 mmol glucosyl units·kg dry mass-
I of muscle glycogen still available for metabolism in the active muscles at the point 
of fatigue. It was concluded from these results that the muscle glycogen 
concentrations after 3 h of cycling were sufficiently reduced to stimulate an increased 
rate of muscle glucose uptake and that eventual fatigue therefore coincided with the 
development of hypoglycaemia (Coyle et al., 1986). 
However, as discussed in section 2.1.2, it has subsequently been discovered 
that the rate of glucose disposal during exercise is regulated by blood glucose 
availability and not muscle glycogen availability (Arkinstall et aI., 2004; Weltan et 
al., 1998a, 1998b). Furthermore, Claassen et al. (2005) recently applied a 
euglycaemic clamp to demonstrate that the ergogenic influence of glucose 
administration late in exercise is unrelated to changes in carbohydrate oxidation and 
that fatigue under such circumstances is not a direct consequence of hypoglycaemia. 
These authors propose that fatigue during prolonged exercise might instead be the 
result of a combined depletion of both intramuscular and intrahepatic carbohydrate, 
which in turn acts as a feed-forward signal to mediate cerebral sensitivity to 
reductions in blood glucose concentration (Claassen et aI., 2005). This suggestion is 
in agreement with evidence using l3C MRS to simultaneously quantify muscle and 
liver glycogen concentrations during continuous cycling to exhaustion at 70% 
VO, max following prior depletion (Casey et aI., 2000). This evidence demonstrated 
that, under certain conditions, the relationship between pre-exercise muscle glycogen 
content and subsequent exercise capacity, first described by Bergstrom et al. (1967), 
may not be as strong as when pre-exercise availability of both muscle and liver 
glycogen are considered in unison. 
The apparently increased influence of liver glycogen on exercise capacity in 
the study of Casey et al. (2000) might be a consequence of the prior bout of prolonged 
exercise that was performed just 4 h before the capacity test. A study in rats from 
Terjung et al. (1974) verifies that hypoglycaemia secondary to depletion of liver 
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glycogen will occur before depletion of muscle glycogen when these animals exercise 
to fatigue in the fasted state. Furthermore, this data also maintains that preferential 
restoration of liver glycogen is initiated following such exercise because complete 
recovery of hepatic carbohydrate status takes longer than in muscle and may therefore 
limit recovery of functional capacity (Terjung et aI., 1974). However, due to the 
relatively small amount of muscle glycogen that is stored in rodent muscle, it may be 
that this particular animal model might overestimate the importance of blood glucose 
availability when generalised to humans (Pederson et aI., 2005). On the other hand, 
repeated exercise bouts performed with a limited recovery interval may sensitise the 
human system to the effects of compromised glucose availability (Casey et aI., 2000; 
Tsintzas et al., 2003), at least in certain individuals (Claassen et al., 2005; Sherman, 
1995), thus making the human and rodent models more comparable in this specific 
situation. The importance of liver glycogen availability during exercise is further 
highlighted by studies which have demonstrated that the ability to increase hepatic 
glucose output at the onset of exercise may be essential for maintenance of glucose 
homeostasis (Jentjens et aI., 2003; Moseley et aI., 2003). 
In summary, the reliance on carbohydrate as an energy substrate during 
moderate to high intensity exercise dictates that fatigue during such activity will often 
coincide with reduced carbohydrate availability. However, despite the primary 
importance of muscle glycogen as a carbohydrate source during exercise, depletion of 
this particular substrate is not necessarily the central cause of fatigue in all 
circumstances. Instead, it is apparent that a complex interaction between muscle 
glycogen utilisation, blood glucose disposal and hepatic glucose output operates to 
maintain carbohydrate oxidation during exercise. The precise cause of fatigue will 
therefore depend upon the availability of both muscle and liver glycogen while also 
taking into account the relative sensitivity of the central nervous system (eNS) to 
depletion of each respective carbohydrate store. 
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2.2.3 Dehydration 
The clear importance of substrate availability to maintain energy delivery 
during exercise has been documented in previous sections. However, in some 
situations increases in body temperature and associated fluid losses can compromise 
physiological function long before substrate depletion occurs (Nadel et al., 1980). To 
prevent undue increases in body temperature, the heat which is produced by 
exercising tissue must be transported to the periphery by the blood and dissipated via 
the evaporation of sweat from the skin surface (Murray, 1995). This process results 
losses of body fluid, as evidenced by the strong positive correlation (r = 0.98) 
between increases in oesophageal temperature and body mass losses during exercise 
when performed at an ambient temperature of 33°C (Montain and Coyle, 1992b). 
These losses in body fluid have been shown to reduce blood volume such that 
increases in heart rate are unable to compensate for the resultant decrease in stroke 
volume, thus reducing cardiac output (Hamilton et aI., 1991). Ultimately, this 
cardiovascular drift is manifested as a reduced peripheral blood flow and, as a result, 
subsequent thermoregulation is compromised (Montain and Coyle, 1992a, I 992b). 
The negative influence of dehydration on fatigue is known to be more 
profound when exercise is perfornled in warmer environments. Graded increments in 
ambient temperature from 11 to 31°C have been reported to exert a progressively 
detrimental influence on exercise capacity (Galloway and Maughan, 1997). However, 
it is difficult to establish from the above data whether fatigue at each temperature was 
in fact a direct consequence of dehydration and resultant hyperthermia. Given that the 
catecholaminergic response to exercise would be augmented with increasing heat load 
(Parkin et aI., 1999) and that this in turn would be expected to accelerate the rate of 
muscle glycogen utilisation (Febbraio et aI., 1994; Hunt and Ivy, 2002; Jentjens et aI., 
2002), the data of Galloway and Maughan (1997) cannot refute the possibility that 
depletion of endogenous carbohydrate may have occurred earlier as environmental 
temperature approached 31°C. To investigate this hypothesis, the subsequent 
investigation has now quantified muscle glycogen directly during 135 min of cycling 
and confirmed that the reduced ability to exercise under heat stress when dehydrated 
is in fact due to hyperthermia rather than depletion of metabolic substrate (Gonzalez-
Alonso et aI., 1999). Nonetheless, the majority of evidence implicating fluid 
23 
Chapter 2 Review of Literature 
availability as a limiting factor for physical performance has tended to focus on 
exercise performed under conditions of heat stress. If a euhydrated individual were to 
perform similar exercise in a thermoneutral environment and with sufficient 
opportunity for fluid consumption then it is more likely that exercise capacity will 
depend on carbohydrate rather than fluid availability (Murray, 1995). 
2.2.4 Accumulation of Metabolic By-Products 
During the performance of dynamic exercise at close to maximal intensity, 
energy production through anaerobic glycolysis results in the formation of lactic acid 
which quickly dissociates to yield lactate salts and hydrogen ions, thus contributing to 
reductions in muscle pH as low as ",6.6 (Sahlin et aI., 1976). Reductions in 
intramuscular pH of similar magnitude have been shown to inhibit further glycolysis 
in vitro (Sutton et aI., 1981), with evidence suggesting that this limitation occurs 
primarily through inhibition of the respective rate-limiting enzymes for 
glycogenolysis and glycolysis: namely phosphorylase (Chasiotis et aI., 1983a) and 
phosphofructokinase (Trivedi and Danforth, 1966). In addition to a reduced 
glycolytic rate, an accumulation of hydrogen ions during exercise can also limit 
muscle contraction more directly through inhibiting both the release of calcium from 
the sarcoplasmic reticulum (SR) and its subsequent binding to troponin (Metzger and 
Fitts, 1987; Nakamaru and Schwartz, 1972). As alluded to in section 2.2.1, this 
inhibition of calcium release may be even more profound in situations where muscle 
glycogen availability is also compromised (Rockwell et aI., 2003; Stephenson et aI., 
1999). 
However, in reviewing this topic, other authors have challenged the notion 
that metabolic acidosis is the principal cause of fatigue during high intensity exercise 
(Westerblad et al., 2002). This view stems from findings indicating that the negative 
impact of elevated intracellular pH on force production is absent when acidosis is 
induced in intact skeletal muscle at temperatures within the physiological range 
(Wiseman et al., 1996). Evidence from skeletal muscle in vivo certainly supports that 
elevated muscle acidity does not diminish muscle glycogenolysis or glycolysis and 
therefore cannot be the sole cause of fatigue during intense exercise (Bangsbo et al., 
1996). An alternative cause of fatigue to the more traditional metabolic acidosis 
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explanati9n has been suggested following reports of deteriorated muscle fibre 
con tractility following exposure to high physiological concentrations of lactate 
(Andrews et al., 1996). However, subsequent investigations attempting to verify this 
potential influence of lactate on muscular fatigue have only identified a modest 
detrimental effect of lactate on excitation-contraction coupling (Posterino and Fryer, 
2000). Some evidence even supports a protective effect of lactic acidosis against 
fatigue, supposedly related to a reversal of the negative influence exerted by elevated 
potassium concentrations (Nielsen et aI., 200 I). 
Inorganic phosphate is another by-product of anaerobic metabolism for which 
evidence in support of a potential role in depressed contractile function is more 
convincing (Alien and Westerblad, 2001; Westerblad et al., 2002). The concentration 
of inorganic phosphate in skeletal muscle increases rapidly with the onset of exercise 
as creatine kinase (CK) catalyses the breakdown of phosphocreatine to maintain an 
adequate supply of adenosine triphosphate (Sahlin et aI., 1997). Support for the role 
of inorganic phosphate in the fatigue process comes from research showing that 
repeated tetanic stimulation of isolated muscle fibres in CK-deficient mice neither 
increases inorganic phosphate concentration nor produces a decline in maximal force 
production over time (Dahlstedt et aI., 2000). One mechanism through which 
inorganic phosphate accumulation is believed to inhibit contractile function involves 
an inhibition of calcium uptake by the SR, although this effect is not straightforward 
since inorganic phosphate would simultaneously facilitate opening of SR calcium 
release channels (Ba log et aI., 2000; Duke and Steele, 2000). 
While inorganic phosphate accumulation clearly provides a credible 
alternative to the current paradigm implicating metabolic acidosis as the primary 
cause of fatigue during dynamic exercise of high intensity, certain issues remain to be 
resolved concerning the specific relationship between increases in inorganic 
phosphate concentration and the time-course of fatigue across various muscle groups 
(Gladden, 2004). Even once the precise role of inorganic phosphate has been 
clarified, the more traditional perspective regarding reduced intramuscular pH should 
not be entirely discounted since evidence strongly supports a beneficial role of 
induced alkalosis on physical performance (Bird et al., 1995; WiIkes et al., 1983). 
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2.2.5 Reduced Central Drive 
The causes of fatigue described so far have tended to involve peripheral 
factors which might impede or at least result in dysfunction of contraction in the 
working muscles during exercise. Intuitively, however, the CNS can be expected to 
play a major role in terms of deciphering the many peripheral signals during exercise 
and ultimately initiating fatigue (Blomstrand, 200 I). This process is likely to be 
highly complex and potential mediating factors may involve either efferent 
stimulation from the corticospinal tract or afferent signals from active tissue (Davis 
and Bailey, 1997). Regarding this latter possibility, it has been suggested that the 
synthesis of certain neurotransmitters from amino acid precursors may dictate the 
central drive for exercise and, although perhaps overly reductionist, efforts have been 
made to identify the specific neurotransmitters which might induce fatigue (Davis, 
1995). One such neurotransmitter, 5-hydroxytryptamine (5-HT), has been implicated 
in the development of fatigue since it has been found to be released from the 
hippocampus of rats following exercise (Meeusen et al., 1996). Causal evidence, 
again in the rat model, supporting a role of 5-HT in the fatigue process arises from the 
finding that exercise capacity can either be deteriorated or enhanced by approximately 
30% through administration of 5-HT agonists or antagonists, respectively (Bailey et 
aI., 1993). 
The study referenced above from Meeusen et al. (1996) also demonstrated that 
the release of 5-HT in the brain is stimulated by treatment with its amino acid 
precursor tryptophan. However, for 5-HT to be synthesised without tryptophan 
administration, circulating tryptophan must first be displaced by FF A from its binding 
site on albumin (Yamamoto et aI., 1997) before subsequently competing with the 
other large neutral amino acids (LNAA) for transport across the blood-brain barrier 
(Blomstrand et al., 2005; Pardridge, 1983). Therefore, the increased mobilisation of 
FFA during exercise (see section 2.1.3) and preferential oxidation of certain LNAA 
(namely leucine, see section 2.1.4) might be expected to favour the synthesis of 5-HT 
and thus reduce the central drive to exercise (Blomstrand, 2001; Davis and Bailey, 
1997). 
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While manipulations of 5-HT or its amInO acid precursor have been 
consistently shown to influence fatigue in rodents, evidence relating this and other 
isolated neurotransmitters to fatigue in humans has been less conclusive (Chinevere et 
al., 2002). Research in this area using humans has typically involved BCAA 
supplementation during exercise, under the rationale that increased plasma 
concentrations of these particular amino acids might inhibit the transport of free 
tryptophan into the brain and therefore alleviate sensations of fatigue. Blomstrand 
and colleagues have demonstrated a reduction in the free tryptophan:BCAA ratio 
using such supplements, which has been associated both with a reduced rating of 
perceived exertion at a given work rate (Blomstrand et aI., 1997) and with an 
improved performance during a competitive marathon in non-elite individuals 
(Blomstrand et aI., 1991). Attempts to replicate this latter finding under laboratory 
conditions have tended to involve exercise in warm environments to increase the 
central component of fatigue and, while some authors have corroborated the 
enhancing effect of BCAA on performance (Mittleman et al., 1998), others have not 
(Watson et al., 2004a). However, in the study ofWatson et al. (2004), a large inter-
individual response to BCAA supplementation was noted and therefore the possibility 
remains that BCAA supplementation might improve the central drive for exercise in 
certain individuals. The question has also been raised as to whether co ingestion of 
carbohydrate along with BCAA during exercise may further ameliorate the central 
component of fatigue through simultaneously reducing the circulating concentrations 
of both free tryptophan and FFA (Davis et aI., 1992). The available evidence does not 
appear to support this hypothesis during continuous exercise (Madsen et al., 1996) 
and it is not clear whether the improved performance of intermittent exercise with 
carbohydrate-protein ingestion is the result of central or peripheral mechanisms (Ivy 
et al., 2003). 
As stated earlier, it is likely that overall CNS control of exercise motivation is 
a highly complex process and attempts to determine the cause of fatigue in terms of a 
single neurotransmitter may be an Qverly reductionist approach (Noakes et aI., 2005). 
In this sense, many peripheral factors contributing to fatigue are likely to exert a 
direct influence on the brain in addition to any indirect neurotranmitter mediated 
signalling pathways. For instance, brain carbohydrate metabolism is known to 
increase in the transition from rest to exercise (Ide et aI., 2000) and it may be that 
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hypoglycaemia as a consequence of increases in peripheral glucose uptake during 
exercise might reduce CNS activation (Bequet et aI., 2002; Nybo, 2003), possibly in 
conjunction with a depletion of glycogen within the type 2 astrocytes of the brain 
(Kong et aI., 2002). In summary, it must be accepted that fatigue in any circumstance 
in which an individual exercises to the point of voluntary exhaustion will necessarily 
be dictated to some extent by the CNS (Noakes and SI. Clair Gibson, 2004). 
2.3 Short-Term Recovery from Prolonged Exercise 
As described in the previous sections, prolonged exercise can deplete the 
body's limited stores of endogenous carbohydrate while also eliciting some degree of 
dehydration. An effective recovery therefore requires the replacement of these 
essential resources as rapidly as possible in preparation for subsequent performance. 
If the interval between exercise sessions is 24 h or longer, then simply ingesting a 
carbohydrate-rich diet along with sufficient fluid can often completely restore both 
carbohydrate and fluid status (Casey et aI., 1995; Costill et aI., 1981; Piehl, 1974) 
such that exercise capacity can also be entirely recovered within this time (Nicholas et 
aI., 1997). Furthermore, provided that adequate quantities of carbohydrate and fluid 
are consumed over a 24 h recovery, it appears that no further considerations are 
necessary regarding the specific type of diet that is consumed (Burke et aI., 1995; 
Kiens et al., 1990; Reed et al., 1989) or indeed the time-course over which it is 
provided (Ivy et aI., 1988a; Parkin et aI., 1997). In contrast, many athletes are 
required to train or compete on multiple occasions within a single 24 h period, in 
which case considerations regarding the timing, type and amount of carbohydrate 
ingested during recovery become quantitatively more important (Ivy, 2001, 1998; 
Jentjens and Jeukendrup, 2003; Sherman, 1995). The following sections will address 
the physiological mechanisms that are involved during recovery, with specific 
reference to those nutritional strategies which might be implemented to accelerate 
these processes when recovery time is limited (i.e. <8 h). 
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2.3.1 Rehydration 
The degree to which an individual will be rehydrated following exercise is 
dependent upon how much fluid they consume along with the specific composition of 
that fluid. These 2 factors are inextricably linked since factors relating to the 
composition of a solution can also directly influence both the palatability of that 
solution and the subsequent effect of ingestion on the thirst mechanism, thus dictating 
the volume which will be voluntarily consumed (Shirreffs et al., 2004). The inclusion 
of certain electrolytes can improve the palatability of rehydration solutions following 
exercise induced dehydration. One such electrolyte is sodium, which has been 
demonstrated to encourage fluid consumption while also improving the absorption 
and retention of fluid (Shirreffs and Maughan, 1998b). Evidence also exists 
supporting the inclusion of potassium in rehydration solutions, although it is thought 
to be less effective than sodium in terms of recovering extracellular fluid volume 
following exercise (Yawata, 1990). 
It is known that the amount of fluid evacuated from the stomach in a given 
unit of time will correlate positively with the volume of gastric contents (Murray, 
1995), which suggests that fluid should be consumed at regular intervals during 
recovery to maintain a high gastric volume and therefore maximise fluid delivery. In 
addition to gastric volume, other factors such as the pH, osmolality, energy content 
and macronutrient composition of gastric contents are also known to influence gastric 
emptying rate with varying effect (Costill and Saltin, 1974; Piehl Aulin et aI., 2000). 
For example, when the carbohydrate content of a solution is elevated, the rate of 
gastric emptying will be delayed more as a consequence of the increase in energy 
density than as a result of increased osmolality (Vist and Maughan, 1995, 1994). 
Regarding macro nutrient content, it has long been known that carbohydrate empties 
from the stomach much more rapidly than fat and somewhat faster than intact protein 
(Thomas, 1957). However, a more recent investigation has reported no difference in 
the rate of gastric emptying and intestinal fluid flux following ingestion of iso-
energetic glucose and soy protein hydrolysate solutions (Maughan et al., 2004). In 
addition, certain amino acids are known to have physiologically distinct mechanisms 
for transport across the intestinal brush-border (Taylor et al., 1989) and it has been 
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suggested that the inclusion of such amInO acids in a recovery solution might 
therefore actually facilitate net fluid absorption (Bowtell et aI., 1999). 
2.3.2 Repletion of Endogenous Carbohydrate 
2.3.2.1 Autoregulation of Glycogen Concentration 
The rate at which muscle glycogen will be resynthesised following prolonged 
exercise is determined both by the rate of glucose transport into muscle and by the 
conversion of this glucose into glycogen (Fisher et aI., 2002b). The literature supports 
that the degree of carbohydrate depletion may play an important role in mediating 
both these processes (Jentjens and Jeukendrup, 2003). Specifically, Zachwieja et al. 
(1991) have demonstrated that the rate of muscle glycogen resynthesis following 
exercise will become more rapid with an increasing magnitude of glycogen depletion 
and this finding has been attributed both to a stimulation of glucose uptake (Fell et al., 
1982; Ivy and Holloszy, 1981; Ploug et aI., 1984) and an increase in glycogen 
synthase activity (Mikines et aI., 1988; Zachwieja et aI., 1991). Notably, this 
stimulus for rapid carbohydrate storage in the immediate post-exercise period operates 
primarily to increase the concentrations of muscle glycogen rather than hepatic 
carbohydrate stores (Fell et aI., 1980), possibly linked to the ability of skeletal muscle 
to increase IMTG utilisation during recovery to allow maximal utilisation of glucose 
for glycogenesis (Kiens and Richter, 1998; van Loon et aI., 2003b). In an attempt to 
clarify whether the observed increase in muscle glycogen storage following exercise 
was related to the high glycogen utilisation rate during that exercise or due to the 
amount of muscle glycogen remaining afterwards, Price et al. (2000) compared the 
glycogen resynthesis rate between nomlal and glycogen loaded muscles following a 
similarly demanding exercise regimen. It was concluded from this study that it is low 
muscle glycogen content per se which stimulates post-exercise increases in 
carbohydrate storage, rather than the amount by which initial glycogen levels were 
previously reduced (Price et aI., 2000). 
Interestingly, it has been demonstrated that this stimulatory influence of low 
muscle glycogen availability on glycogen resynthesis is not dependent on insulin 
(Price et aI., 1994) and that the factors which are responsible appear to become less 
influential over time following exerCIse, even if muscle glycogen concentrations 
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remain low (Ploug et aI., 1987). Indeed, the biphasic nature of glycogen resynthesis 
has previously been identified to involve an initial rapid insulin-independent phase 
followed by a more gradual accumulation of glucosyl units which is dependent on 
insulin (Piehl, 1974). This effect may be related to the 2 distinct pools of muscle 
glycogen that were described in section 2.1.1 since proglycogen has been shown to be 
resynthesised more rapidly than macroglycogen (Adamo et al., 1998). More 
importantly, a large body of literature now provides compelling evidence in support 
of an additive effect of exercise and insulin on the rate of muscle glycogen synthesis, 
which indicates that glycogen resynthesis is stimulated by different mechanisms at 
various stages in recovery (Gao et aI., 1994; Lund et al., 1995; Ploug et al., 1984; 
Ploug et al., 1987; Ploug et al., 1993; Price et al., 1996; Thorell et al., 1999; 
Wallberg-Henriksson et aI., 1988; Wallberg-Henriksson and Holloszy, 1984; Zorzano 
et aI., 1986). The processes of glucose uptake and subsequent conversion of glucose 
into glycogen are described in the following sections 2.3.2.2 and 2.3.2.3, respectively, 
with particular reference to the independent influences of exercise and insulin on each 
process (sub-sections a and b, respectively). 
2.3.2.2 Glucose Uptake 
2.3.2.2a Exercise Induced Glucose Uptake 
In addition to the references cited in the prevIOus section regarding the 
additive effect of exercise and insulin on glucose uptake, further support for the 
existence of specific exercise induced mechanisms comes from the finding that 
translocation of glucose transporter 4 (GLUT4) becomes normal in type 2 diabetic 
subjects following exercise (Kennedy et aI., 1999). GLUT4 is thought to be the 
primary glucose carrier in skeletal muscle (Bell et aI., 1993; Fushiki et al., 1989) and 
pham1acological inhibition of this transporter has been shown to reduce overall 
glucose uptake by 70-80% (Rudich et aI., 2003). Both exercise and insulin are 
believed to increase glucose uptake through translocation of GLUT4 from an 
intracellular storage vesicle onto the plasma membrane (Hirshman et aI., 1990; Lund 
et al., 1995; Rodnick et al., 1992; Thorell et al., 1999; Wardzala and Jeanrenaud, 
1981) and data demonstrating the additive effects of these stimuli have lead to the 
suggestion that 2 separate pools ofGLUT4 transporters may exist (Douen et aI., 1990; 
Goodyear and Kahn, 1998; Hayashi et aI., 1997; Holman et aI., 1994; Ploug et aI., 
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1998) which are likely to be stimulated via distinct signaling pathways (Brozinick et 
aI., 1994; Stemlicht et al., 1989). Further suggestions that the intrinsic activity of this 
glucose transporter might also be increased are less convincing since increases in 
glucose uptake can often be completely accounted for by the increased number of 
GLUT4 carrier proteins at the cell surface (Hansen et aI., 1998; King et aI., 1989; 
Lund et aI., 1995; Nesher et aI., 1985). 
The availability of glucose is clearly an essential requirement for muscle 
glycogen resynthesis to take place and a direct relationship (r = 0.63) has been 
identified between the concentration of GLUT4 carrier proteins on the plasma 
membrane and the rate of post-exercise glycogen storage (McCoy et al., 1996). 
Furthermore, it has been suggested that it is glucose transport rather than subsequent 
conversion of glucose into glycogen which may ultimately limit the rate of muscle 
glycogen synthesis (Holloszy, 2003). This suggestion is based on findings from 
transgenic mice showing that increased glucose transport can produce large 
increments in the rate of glycogen storage despite a 50% reduction in the active form 
(I foml) of glycogen synthase (Ren et aI., 1993). In fact, the activity of glycogen 
synthase is only thought to impose a limit on the rate of muscle glycogen storage 
when the percent of glycogen synthase in the I form is below fasted values (Fisher et 
al., 2002b). 
There are a number of mechanisms through which exercise might operate to 
stimulate the increments in the rate of glucose uptake, primarily involving a direct 
influence of increased availability of interstitial glucose as a result of exercise induced 
increases in blood flow (MacLean et al., 1999). An increased cytoplasmic 
concentration of calcium (Ca2+) has also been reported to contribute to the increased 
rates of glucose transport during exercise (Holloszy and Narahara, 1967). However, it 
has been difficult to determine whether Ca2+ acts directly to translocate GLUT4 or if 
it is Ca2+ induced contraction which provides the principle stimulus for glucose uptake 
(Holloszy, 2003; Zorzano et al., 2005). The direct signalling pathways downstream 
of Ca2+ are thought to involve protein kinase C (PKC) and calmodulin-dependent 
protein kinase (CAMK) since inhibition of these protein kinases has been shown to 
inhibit exercise induced glucose uptake (Ihlemann et al., 1999a). Evidence 
supporting this direct influence of calcium per se originates from the finding that 
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glucose uptake can be stimulated by levels of calcium release that are insufficient to 
induce muscular contraction (Youn et aI., 1991). In support for an effect of Ca2+ 
stimulated contraction on glucose uptake, Holloszy and Narahara (1965) have 
described a good correlation between the permeability of isolated frog muscle to 
glucose and the frequency to which that muscle is stimulated to contract, although 
more recent evidence has clarified that stimulation frequency is not the sole 
determinant of contraction induced glucose uptake since force development is also a 
mediating factor (Holloszy and Narahara, 1965; Ihlemann et aI., 1999b). A 
subsequent investigation to determine the relative impact of stimulation frequency and 
force development on glucose uptake found that the influence of both these factors 
was in fact dependent on other metabolic consequences of exercise (Ihlemann et aI., 
2000). 
In summarising the available evidence regarding exercise induced glucose 
uptake, Richter et al. (2001) have stated that "If glucose transport were only activated 
by a feed-forward Ca2+-sensitive mechanism, the regulatory and adaptive capacity of 
the system would be limited" (Richter et aI., 2001, p. 314). This statement arises 
primarily from the findings of Ihleman et al. (2000) and concisely describes the 
necessity for some feed-back mechanism through which fuel depletion might maintain 
the stimulus for glucose uptake even once muscle contraction ceases (i.e. the 
persistent increase in glucose uptake during recovery). The reductions in muscle 
glycogen content that occur during exercise are known to increase glucose uptake and 
a negative correlation (r = -0.53) has been observed between glycogen content and the 
expression of GLUT4 on the cell membrane (Derave et aI., 1999). This finding has 
led some authors to speculate that glycogen may be structurally attached to GLUT4 
(Coderre et al., 1995; Richter et al., 2001), although direct biochemical evidence to 
support such an association has not been published to date. 
All the factors which are discussed above in relation to glucose uptake are 
illustrated in Figure 2.1. However, the lower portion of this figure also depicts the 
interaction of these factors with the activation of adenosine monophosphate-activated 
protein kinase (AMPK). This particular enzyme has received great interest in recent 
years and has been proposed to be the contraction-activated kinase responsible for 
increasing glucose transport (Richter et aI., 2003). As presented in Figure 2.1, even if 
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muscle glycogen is structurally attached to GLUT4, it is likely that a secondary 
function of reduced muscle glycogen availability is to activate AMPK during the 
insulin independent phase of glycogen resynthesis. Evidence clearly shows that low 
muscle glycogen concentrations are associated with an increased AMPK activity both 
at rest and during exercise (Wojtaszewski et aI., 2002; Wojtaszewski et aI., 2003b). 
However, patients suffering from McArdle's disease appear to have hyper-activated 
AMPK despite high muscle glycogen concentrations (Nielsen et al., 2002), which 
leads to the conclusion that it may be a low capability to oxidise glycogen rather than 
a low glycogen content per se which causes AMPK activation (Hardie, 2004). In 
addition, the dephosphorylation of A TP and PCr during exercise is known to result in 
allosteric activation of AMPK (Kemp et aI., 1999) and, when exercise is of sufficient 
intensity, hypoxia has been found to be entirely dependent on the presence of AMPK 
to stimulate increased glucose transport (Mu et aI., 2001). 
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Figure 2.1: Regulation of glucose uptake during/following exercise. Open arrows represent 
feed-forward mechanisms and closed arrows represent feed-back mechanisms. 
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Once activated, the specific process through which AMPK ultimately 
stimulates the translocation of GLUT4 onto the plasma membrane remains unclear 
(Musi and Goodyear, 2003). It has been suggested that nitric oxide synthase (NOS) 
may perform an intermediary role (Balon and Nadler, 1997; Fryer et at., 2000) since 
evidence has reported the phosphorylation of endothelial NOS (eNOS) by AMPK 
(Chen et al., 1999). Alternatively, AMPK might target the p38 mitogen-activated 
protein kinase (MAPK). In support of this, the increase in glucose uptake that is 
usually observed following activation of AMPK using 5-aminoimidazole-4-
carboxarnide ribonucleoside (AI CAR) can be substantially blunted without 
simultaneous activation ofMAPK (Xi et at., 2001). Another potential AMPK related 
pathway has been identified through the positive correlation (r = 0.86) between the 
activity of AMPK and the release of IL-6 from skeletal muscle during exercise 
(MacDonald et al., 2003), although the possibility that IL-6 release might also be 
directly stimulated by low muscle glycogen availability precludes the establishment of 
a causal relationship (Pedersen and Febbraio, 2005). Indeed, it is unlikely that AMPK 
is the only contraction induced stimulus for glucose uptake following exercise (Jessen 
and Goodyear, 2005). Nonetheless, given that IL-6 has been implicated in both the 
regulation of hepatic glucose production (Febbriao et al., 2004) and signalling 
peripheral fuel status to the CNS (Gleeson, 2000), any potential interaction with 
AMPK is likely to be a central component of metabolic regulation during exercise. 
Establishing the precise signalling pathways through which AMPK and IL-6 stimulate 
glucose uptake during and after exercise will therefore be crucial for further 
progression of understanding in this area. 
Regardless of the mechanism of action, it is clear that AMPK plays an 
essential role in the regulation of glucose transport during exercise, acting as an 
intracellular fuel gauge to stimulate glucose uptake in the early stage of recovery. 
However, it is also evident that AMPK can only account for a portion of the increase 
in glucose transport following muscular contraction (Mu et at., 2001). This suggests 
that overall control of glucose uptake during and after exercise is the net product of an 
integrated intracellular system whereby Ca2+ release and fuel depletion can both 
stimulate glucose uptake either directly or indirectly via AMPK (Holloszy, 2003; 
Richter et al., 2001). Recent evidence seems to suggest that the relative influence of 
Ca2+ and AMPK dependent mechanisms on glucose transport may be determined 
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primarily by muscle fibre type. Specifically, it has been suggested that exercIse 
stimulated glucose uptake into type 1I muscle fibres may involve both Ca2+ and 
AMPK mediated mechanisms (Wright et aI., 2004), while glucose uptake into type I 
fibres may be entirely dependent on the former (Wright et aI., 2005). Importantly, the 
effect of exercise on glucose uptake is sustained during recovery and manifested as 
the insulin independent rapid phase of glycogen resynthesis (Goodyear et al., 1990b). 
Despite being independent of insulin, this early stage of recovery is also associated 
with a period of insulin sensitivity (Cartee et al., 1989; Holloszy, 2005; Wojtaszewski 
et al., 2003a) which has emerged as yet another factor that may be mediated by the 
activation of AMPK (Fisher et al., 2002a; Musi and Goodyear, 2003). Insulin 
sensitivity during the early hours of recovery allows for elevations in insulin and 
glucose arising from carbohydrate supplementation to further mcrease the 
translocation of GLUT4 over this period (Kuo et aI., 1999). This separate influence 
of insulin on the rate of glucose uptake in the post-exercise period is addressed in sub-
section b. 
2.3.2.2b Insulin Induced Glucose Uptake 
Similar to contraction induced glucose uptake, insulin also stimulates glucose 
transport through evoking translocation of GLUT4 from its intracellular storage site 
onto the plasma membrane (Rodnick et al., 1992; Thorell et al., 1999; Wardzala and 
Jeanrenaud, 1981). Also similar to the glucose uptake initiated by muscular 
contraction is the belief that GLUT4 translocation can entirely account for increases 
in glucose uptake, therefore negating any role for an increased intrinsic activity of 
these transporters (Hansen et al., 1998; Lund et aI., 1995; Nesher et aI., 1985). 
However, it has recently been proposed that intrinsic activation of GLUT4 subsequent 
to translocation may be necessary for glucose transport to be stimulated maximally, at 
least in relation to insulin induced glucose uptake (Furtado et aI., 2003). This 
proposal arises from a series of studies in which a myc tagged GLUT4 carrier protein 
was used to detect the effects of insulin on GLUT 4 translocation and glucose uptake 
independently; this novel methodology made it possible to identify a temporal 
divergence between the translocation of GLUT4 and increases in glucose uptake 
(Somwar et al., 200 I). 
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The above mentioned study by Somwar et al. (200 I) also highlighted some 
integration between the glucose uptake pathways that are initiated by insulin and 
exercise respectively, since insulin was shown to stimulate GLUT4 activity via the 
same MAPK (p38) that is responsible for exercise induced increases in glucose 
transport (Somwar et aI., 2001). In their review, Rudich and Klip (2003) neatly 
describe the combined operation of 2 other factors which are known to play a major 
role in the stimulation of glucose transport by insulin, these are phosphatidylinositol 
3-kinase (PI3K) and protein kinase B (PKB). At rest without insulin stimulation, 
PI3K and PKB (along with the PI3K sub-units p85a and p II 0) are distributed 
throughout the cytosol and 90% of GLUT4 remains within its intracellular storage 
vesicle (Li et aI., 200 I), as can be seen in Figure 2.2a. Upon stimulation with insulin, 
certain insulin receptor substrates (IRS) will be phosphorylated which, through the 
p85a and p 11 0 sub-units of PI3K, will generate phosphatidylinositol-3,4,5-
triphosphate (PIP3) on the cell surface (Zorzano et aI., 2005). The essential role of the 
IRS for insulin mediated glucose transport is evidenced by the finding of impaired 
glucose disposal in mice that are deficient in IRS (Withers et al., 1998). The initial 
role of PIP3 is to encourage the remodelling of filamentous actin, thus drawing the 
plasma membrane closer to GLUT4 containing vesicles (Rudich and Klip, 2003). 
This 'ruffling' of the plasma membrane is illustrated in Figure 2.2b. In addition to 
this effect, Figure 2.2c shows how PIP3 simultaneously functions to facilitate PKB in 
accelerating the transport of GLUT4 through its intracellular recycling endosome 
compartment (Foster et aI., 2001; Watson et aI., 2004b). Finally, GLUT4 must be 
transported from its intracellular recycling endosome to the cell surface (Figure 2.2d) 
and vesicle-associated membrane-2 (VAMP2) has been suggested as the 'specialised 
GLUT4 vesicle compartment' responsible for this transportation across the actin mesh 
(Rudich and Klip, 2003). This suggestion is supported by evidence showing that 
inhibition of V AMP2 results in a markedly reduced insulin stimulated incorporation 
of GLUT4 into the cell surface (Randhawa et aI., 2000). 
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While the process through which insulin stimulates glucose uptake is 
undoubtedly complex, what is clear is that increasing glucose and insulin 
concentrations in the immediate post-exercise period can result in large increases in 
glucose transport (Kuo et aI., 1999). As stated earlier, the stimulatory effect of insulin 
is even more potent following prolonged exercise due to the relative insulin sensitivity 
which occurs in the post-exercise period (Holloszy, 2005; Wojtaszewski et al., 
2003a). Notably, in the absence of carbohydrate ingestion, this elevated insulin 
sensitivity has been observed to persist in rats for at least 48 h following exercise 
(Cartee et aI., 1989). The finding that glucose uptake in the exercised leg following 
single-legged cycling is far greater than in the unexercised leg suggests that this 
enhanced influence of insulin on glucose uptake following exercise is primarily due to 
local factors (Richter et al., 1984; Richter et aI., 1989). One such factor is muscle 
glycogen depletion and evidence has demonstrated that low muscle glycogen 
concentrations can stimulate an enhanced sensitivity of insulin induced glucose 
transport through activation of the PKB signalling pathway (Derave et aI., 2000). In 
addition, the possibility that GLUT4 might be structurally attached to glycogen could 
also explain the progressive increase in the rate of glucose uptake as glycogen 
concentrations fall (Coderre et al., 1995; Richter et aI., 2001). Aside from these 
direct influences of muscle glycogen on insulin induced glucose uptake, the reports 
that post-exercise insulin sensitivity may be mediated by AMPK activation suggest 
that muscle glycogen depletion (among other exercise associated factors, see Figure 
2.1) may also exert an indirect effect on insulin action (Fisher et aI., 2002a; Holloszy, 
2005; Musi and Goodyear, 2003; Olsen and Hansen, 2002; Wojtaszewski et aI., 
2003a). 
The magnitude of insulin sensitivity following exercise is also mediated by 
other more applied factors relating to the specific nature of the exercise session which 
preceded recovery. In particular, evidence suggests that a period of relative insulin 
resistance can occur following eccentric or unaccustomed exercise (Asp and Richter, 
1996; Asp et al., 1997b; King et al., 1993; Kirwan et al., 1992). Such physical 
activity can potentially induce a substantial degree of muscle damage and it seems 
reasonable to suggest that this tissue injury might inhibit GLUT4 translocation due to 
disruption of the plasma membrane, with evidence also supporting a potential role for 
reduced insulin signalling via MAPK under conditions of oxidative stress (Blair et aI., 
1999). This reduced capacity to develop insulin sensitivity following damaging 
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exercise can ultimately result in a reduced rate of muscle glycogen resynthesis during 
recovery (Costill et ai., 1990; Doyle et ai., 1993; O'Reilly et al., 1987) or even a net 
degradation of muscle glycogen in the first 2 h following exercise (Zehnder et al., 
2004), although it has been suggested that impaired carbohydrate storage following 
muscle damage probably involves more than reduced GLUT4 translocation alone 
(Asp et ai., 1997a). Further to the negative impact during recovery of prior eccentric 
contractions, it would also be expected that muscle glycogen utilisation during 
subsequent exercise would be higher in damaged muscle groups (Asp et al., 1998). A 
final consideration is whether the prior exercise bout was an isolated episode or was 
part of a continued program of training. Similar to the effects of eccentric or 
unaccustomed exercise, repeated depletion of muscle glycogen over a series of days 
may also compromise the stimulatory influence of prior exercise on the rate of 
glycogen resynthesis (McInerney et al., 2005), although such repeated depletion 
would also be expected to reduce the rate of muscle glycogen degradation during each 
sequential exercise session (Costill et ai., 1971 a). 
Replenishment of muscle glycogen following prolonged exercise is a critical 
component of recovery and it appears that the rate at which this substrate will be 
replaced is limited to a large extent by the rate at which glucose can be transported 
into muscle (Fisher et al., 2002b; Holloszy, 2003; Ren et ai., 1993), which in turn will 
vary according to fibre type (Henriksen et ai., 1990; James et ai., 1985). The 
respective mechanisms through which exercise and insulin independently promote 
glucose uptake have been discussed. However, to be stored within muscle as an 
available fuel source, the absorbed glucose must first be synthesised into muscle 
glycogen. The rate limiting enzyme for this process is glycogen synthase (GS) and 
the relative influences of exercise and insulin on GS activity will be reviewed in the 
following sub-sections. 
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2.3.2.3 Conversion of Glucose to Glycogen 
2.3 .2.3a Exercise Induced Activation of Glycogen Synthase 
While glucose transport is believed to be the rate limiting factor for glycogen 
resynthesis under most circumstances (Ren et al., 1993), it has been shown that GS 
activity also has the potential to limit the rate of muscle glycogen resynthesis when 
insufficiently activated (Conlee et aI., 1978; Fisher et aI., 2002b), even when the rate 
of glucose uptake is also sub-maximal (Ryder et al., 1999). The potential for this 
occurrence is further supported by findings that transgenic over-expression of GS can 
result in at least a 2-fold increase in glycogen synthetic rate across all types of skeletal 
muscle (Azpiazu et aI., 2000). However, it should be acknowledged that the 
processes of glucose uptake and glycogen synthesis in vivo are not mutually exclusive 
since the glucose that is transported into muscle is immediately converted by 
hexokinase into glucose-6-phosphate (G-6-P) which is known to be a powerful 
allosteric effector of all forms of GS (Shulman et aI., 1995). Following this 
conversion, G-6-P is subsequently converted into G-I-P by phosphoglucomutase 
before merging with uridine triphosphate via the action of G-I-P uridtransferase to 
yeild uridine diphosphate (U-D-P)-glucose (Ivy, 1991). The rate limiting reaction in 
the formation of muscle glycogen occurs next as U-D-P is released and the glucose 
residue is attached to a pre-existing branch of glycogen, it is this final incorporation of 
glucose into glycogen which is catalysed by GS (Jentjens and Jeukendrup, 2003). 
GS is known to exist in 2 enzymatically interconvertible forms, of which the I 
form is thought to be most active because, unlike the D form, it can operate even in 
the absence of G-6-P (Danforth, 1965). Exercise is known to stimulate increases in 
GS-I through dephosphorylation of GS-D, which would explain why increments in G-
6-P are not essential for exercise induced GS activation (Montell et aI., 1999). In fact, 
consistent with so many factors relating to muscle glycogen resynthesis, it appears 
that the most potent regulator of GS activity is a reduced availability of muscle 
glycogen (Laurent et aI., 2000; Montell et al., 1999; Nielsen and Richter, 2003; 
Zachwieja et aI., 1991). Muscle glycogen content remains high following exercise in 
patients with McArdle's disease and it has been noted that these individuals are also 
unable to activate GS in the post-exercise period (Nielsen et al., 2002). In such 
situations where muscle glycogen is readily available, GS would be located on the 
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outer branches of macroglycogen and it has been suggested that a high level of GS 
activation can only occur when GS is positioned within the inner core of glycogen, 
bound to glycogenin (Pitcher et aI., 1988; Smythe and Cohen, 1991). A further 
explanation for the inverse relationship between muscle glycogen content and GS 
activity is that glycogen might cause allosteric inhibition of both GS phosphatase 
(GSP) and indeed GS itself (Fischer et aI., 1971). In this scenario, the depletion of 
muscle glycogen during exercise would therefore release both enzymes and GS would 
then be converted into its active form by GSP (Ivy and Kuo, 1998). 
Contrary to the above findings, it is also likely that compromised muscle 
glycogen availability, and indeed exercise per se, will also stimulate a number of 
inhibitory regulators of GS activity (Nielsen and Richter, 2003). As discussed in 
section 2.3.2.2a, AMPK is emerging as an important exercise induced factor 
regulating metabolic responses both during and following exercise (Hardie, 2004) and 
it appears that this particular kinase operates not only to increase glucose uptake (see 
Figure 2.1) but also to inhibit GS activity (Halse et al., 2003; Nielsen et aI., 2002; 
Wojtaszewski et al., 2002). Furthermore, sympathetic stimulation from the CNS 
during exercise results in increased circulating levels of adrenaline which have also 
been associated with a decrease in the ratio of GS-I:GS-D (Chasiotis et aI., 1983b). 
This effect of adrenaline is thought to operate through protein kinase A (PKA) and 
evidence supports that this pathway is distinct to that of contraction mediated GS 
inhibition (Sakamoto et al., 2002). Notably, while not essential to stimulate GS 
activation, increases in G-6-P concentration following exercise are known to attenuate 
the inhibitory effects of kinases such as AMPK and PKA while at the same time 
increasing the susceptibility of GS-D to dephosphorylation by GSP (Nielsen and 
Richter, 2003). In addition, it has been shown in rodents that exercise increases GS 
activity through deactivating other inhibitory kinases such as glycogen synthase 
kinase (GSK)-3 (Markuns et aI., 1999; Sakamoto et al., 2002). However, this 
negative influence of exercise on GSK-3 activity has not been consistently 
demonstrated in human muscle (Sakamoto et al., 2004; Wojtaszewski et aI., 2001), 
possibly because the stimulation of AMPK activity during exercise can potentiate the 
ability ofGSK-3 to phoshorylate GS (Zhang et al., 1993). Figure 2.3 summarises the 
regulation of GS activity following exercise and clearly illustrates that the activation 
status of GS at any given time will be determined by the relative intensity of a number 
43 
Chapter 2 Review of Literature 
of opposing stimuli. It can be seen that the balance of these stimuli will favour the 
activation of GS during recovery from prolonged exercise since both muscle glycogen 
depletion and the increase in G-6-P availability will exert a positive influence, while 
the latter would also act to inhibit those kinases which would otherwise deactivate 
GS. 
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Figure 2.3: Regulation of glycogen synthase (GS) activity following exercise. Open arrows 
represent signalling pathways culminating in GS activation and closed arrows represent 
signalling pathways culminating in GS deactivation. GS is often activated following prolonged 
exercise since many positive influences will be initiated, while increments in G·6·P also serve to 
inhibit the negative influences of AMPK and PKA (N.B: it remains unclear whether a similar 
inhibition ofGSK·3 occurs following exercise in human skeletal muscle). 
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2.3.2.3b Insulin Induced Activation of Glycogen Synthase 
In contrast to exercise induced GS activation, the precise mechanisms through 
which insulin stimulates conversion of glucose into glycogen are far less well 
understood (Wojtaszewski et aI., 2003a). The fact that combined exercise and insulin 
stimulation do not always produce an additive effect on OS activation suggests that 
that the signalling pathways of these 2 stimuli converge at some point (Nielsen and 
Richter, 2003; Wojtaszewski et al., 1999). This convergence may occur quite late in 
the respective signalling pathways of exercise and insulin since both processes must 
ultimately dephosphorylate GS at the same C-terminal residues (Lawrence and Roach, 
1997). However, it is thought that the more distal factors leading up to this eventual 
activation of GS are likely to differ between the exercise and insulin stimulated 
pathways. For instance, insulin stimulated GS activation appears to involve IRS, 
PI3K, 3-phosphoinositide dependent protein kinase (PDK)-I and PKB (Cross et aI., 
1997; Mora et al., 2005), yet muscular contraction can maintain GS activity even 
when this signalling network is inhibited (Sakamoto et al., 2002; Wojtaszewski et al., 
1999). In parallel to this finding that certain pathways may be exclusive to insulin 
signalling, it has also been identified that the dephosphorylation of GS by GSP that 
occurs in response to exercise is not necessary when GS is activated by insulin 
(Suzuki et aI., 2001). 
A signalling mechanism which may potentially be common to both insulin and 
exercise stimulated GS activation is that of GSK-3 (Nielsen and Richter, 2003). This 
kinase operates to phosphorylate and therefore deactivate GS and it is thought that 
this process may be inhibited by insulin (Lawrence and Roach, 1997). However, as 
illustrated in Figure 2.3, it has not yet been fully established whether a similar 
deactivation of GSK-3 also occurs following exercise in humans (Sakamoto et al., 
2004; Wojtaszewski et al., 2001). Even if exercise is assumed to down-regulate 
GSK-3 activity, evidence suggests that the mechanism through which this is achieved 
does not involve the PKB pathway that is initiated by insulin (Markuns et al., 1999). 
Nonetheless, the possibility that GSK-3 might be involved in GS activation both by 
exercise and insulin stimulation has led some authors to implicate this particular 
signalling pathway in the enhanced action of insulin on GS in the post-exercise period 
(Christ-Roberts et al., 2003). Indeed, more recent evidence has now established that 
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exerCIse induced IL-6 release can increase insulin sensitivity by facilitating the 
phosphorylation of GSK-3 by insulin (Weigert et aI., 2005). However, this effect is 
likely to operate in combination with an increased insulin delivery to muscle during 
exercise due to elevated blood flow (Clark et aI., 2003). 
This section (2.3.2) has described the specific signalling mechanisms through 
which exercise and insulin promote the uptake and storage of glucose during 
recovery. The fact that insulin promotes muscle glycogen resynthesis through a 
mechanism that is distinct from that of exercise is important when considering various 
nutritional strategies which might facilitate carbohydrate storage following exercise, 
especially since factors initiated by prior exercise have been shown to increase insulin 
sensitivity during the early hours of recovery (Wojtaszewski et al., 2003a). 
Specifically, any nutritional strategy which rapidly increases both glucose and insulin 
concentrations during recovery will augment the rate of muscle glycogen storage 
since the exercise and insulin mediated signalling pathways will operate 
synergistically during the initial rapid phase of resynthesis (Narahara and Ozand, 
1963). In addition, increasing the availability of blood glucose in the immediate post-
exercise period may also be important in terms of decreasing the influence of factors 
such as adrenaline release that would otherwise oppose the rapid resynthesis of 
muscle glycogen (Galbo et al., 1977). The benefit of hyperglycaemia and 
hyperinsulinaemia becomes even more important later in recovery when the residual 
influence of exercise related factors has diminished and muscle glycogen resynthesis 
progresses into the insulin dependent phase (Young et aI., 1987). The ingestion of 
carbohydrate following prolonged exercise has the potential to promote muscle 
glycogen storage through the mechanism described above and what follows is an 
account of the various studies that have demonstrated such an effect. 
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2.4 Carbohydrate Ingestion 
The belief that muscle glycogen should be resynthesised as rapidly as possible 
during recovery stems from the initial findings of Bergstrom et al. (1967) which 
demonstrated a direct association between pre-exercise muscle glycogen content and 
exercise capacity. Many studies certainly support that physical performance can be 
improved over a range of exercise intensities through glycogen loading prior to 
exercise (Brewer et aI., 1988; Karlsson and Saltin, 1971; Maughan and Poole, 1981; 
Pizza et aI., 1995; Simonsen et al., 1991; Starling et aI., 1997; Tamopolsky et al., 
1995; Williams et aI., 1992), although it appears that acute carbohydrate loading 
regimens may be more effective in terms of performance enhancement than more 
chronic dietary manipulation (Jacobs and Sherman, 1999). However, when the 
primary focus of nutritional supplementation is to restore exercise capacity within a 
matter of hours following prolonged exercise, these carbohydrate loading regimens 
will need to be condensed to maximise the rate of muscle glycogen storage during 
recovery while also minimising any potential metabolic disturbance during 
subsequent exercise. In this sense, nutritional interventions during a short-term 
recovery necessitate a combined appreciation of pre- and post-exercise nutrition since 
the most effective feeding strategy will be required to maximise muscle glycogen 
availability following recovery while simultaneously reducing the rate of muscle 
glycogen utilisation during a repeated performance (Chryssanthopoulos et al., 1994b; 
Wright et al., 1991). 
It has been consistently demonstrated that carbohydrate ingestion over a short-
term recovery period can increase the rate of carbohydrate storage above that of a 
placebo (Casey et al., 2000; Tamopolsky et aI., 1997; Van Hall et al., 2000b). 
However, attempts to identify the most effective carbohydrate feeding strategy have 
shown that the rate of muscle glycogen resynthesis can vary greatly depending on the 
relative timing, type and amount of carbohydrate that is ingested during recovery (Ivy, 
2001, 1998; Jentjens and Jeukendrup, 2003; Sherman, 1995). In terms of exercise 
capacity, while some authors have reported an improved exercise time to exhaustion 
at 70% VO, max when carbohydrate rather than flavoured water was ingested during 
a preceding 4 h recovery (Fallowfield et aI., 1995), other authors have observed no 
such effect (Casey et aI., 2000). The following sections will address considerations 
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relating to the timing, type and amount of carbohydrate that should be ingested during 
a short-term recovery with particular reference to the impact of these varying feeding 
regimens on muscle glycogen resynthesis and the restoration of exercise capacity. 
2.4.1 Considerations Regarding Timing of Carbohydrate Ingested 
There are 3 considerations in terms of supplement timing during recovery: 
how soon after the initial exercise session should supplementation begin; how 
frequently during the recovery period should supplements be ingested; and how soon 
before subsequent exercise should supplementation be terminated? In answer to the 
first of these considerations, it is thought that the rate of muscle glycogen resynthesis 
will be most rapid during a short-term recovery if carbohydrate is consumed 
immediately following prior exercise rather than delayed by several hours (Ivy, 2001). 
This might be expected since the exercise induced increase in insulin sensitivity is 
greatest in the early hours of recovery and the capacity to translocate and activate 
GLUT4 through carbohydrate ingestion will therefore gradually diminish over time 
(Cartee et aI., 1989; Goodyear et aI., 1990a; Young et al., 1987). It has been 
demonstrated that delaying the intake of a mixed macronutrient supplement by 3 h 
rather than feeding immediately post-exercise can reduce net leg glucose uptake 
during recovery by approximately 65% (Levenhagen et aI., 2001). Furthermore, a 
study by Ivy et al. (1988a) demonstrated a rate of muscle glycogen resynthesis of ",25 
mmol glucosyl units·kg dry mass·]·h·] over a 4 h recovery when carbohydrate was 
provided immediately following exercise. Importantly, this rate of resynthesis was 
reduced by almost half to ",14 mmol glucosyl units· kg dry mass·]·h·] when 
carbohydrate provision was delayed by just 2 h (Ivy et al., 1988a). Contrary to this 
finding, Parkin et al. (1997) monitored the effects of delayed carbohydrate feeding, 
again by 2 h, on the resynthesis of glycogen over an 8 h recovery and reported that the 
rate of muscle glycogen resynthesis was similar between treatments (Parkin et aI., 
1997). While at first glance it appears that these studies are in direct opposition, it 
may be that the rate of muscle glycogen resynthesis is greater with immediate feeding 
over the first 4 h of recovery but slows thereafter due to a greater feedback inhibition 
of GS activity (Laurent et aI., 2000) .. This pattern of resynthesis is shown in Figure 
2.4 and would suggest that prompt ingestion of carbohydrate following exercise 
becomes of increasing importance when recovery time is more restricted. Of course, 
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aside from issues relating to the development of insulin resistance later in recovery, it 
would be prudent to begin carbohydrate feeding as early as possible following 
exercise to maximise the time available for the resynthesis of muscle glycogen to 
occur (Ivy, 2001). 
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Figure 2.4: Expected time-course of muscle glycogen resynthesis when carbohydrate 
is provided either immediately following exercise or after a 2 h delay. Based on the 
combined findings ofIvy et al. (1988a) and Parkin et al. (1997), this figure illustrates 
that shorter recovery periods increase the necessity for carbohydrate feeding 
immediately following exercise. 
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In relation to the issue regarding how frequently carbohydrate should be 
consumed following exercise, studies from Blom et al. (1987) and Ivy et al. (1988b) 
have both provided carbohydrate at 2 h intervals during recovery and subsequently 
reported muscle glycogen resynthesis rates in the region of 22-25 mmol glucosyl 
units·kg dry mass'lh'l. Notably, these rates of muscle glycogen resynthesis ~re 
achieved using relatively moderate carbohydrate intakes (i.e. 0.35-0.75 g CHO·kg ,l·h' 
I) but doubling the amount of carbohydrate did not increase the rate of muscle 
glycogen storage any further (Blom et ai., 1987; Ivy et ai., 1988b). It has been 
suggested that providing carbohydrate at 2 h intervals during recovery may not sustain 
elevations in circulating insulin sufficiently between feedings, resulting in sub-
optimal activation of GLUT4 and GS (Ivy, 1998). This suggestion has subsequently 
been upheld by evidence showing that, when carbohydrate is ingested at 15-30 min 
intervals during a short-term recovery, the rate of muscle glycogen resynthesis can be 
elevated to 30-45 mmol glucosyl units·kg dry mass'l'h'l (Doyle et ai., 1993; Jentjens 
et ai., 2001; Piehl Aulin et ai., 2000; van Loon et ai., 2000a). However, more applied 
evidence has shown that more frequent feeding during a short-term recovery can also 
increase the reliance on carbohydrate oxidation during subsequent exercise, although 
this effect was not found to be detrimental in terms of exercise capacity (Siu et al., 
2004). 
The final consideration regarding the timing of carbohydrate ingestion during 
a short-term recovery is whether feeding should cease at least I h prior to subsequent 
performance to prevent metabolic disturbances during that activity. Specifically, 
ingesting 75 g of carbohydrate 45 min prior to a 30 min treadmill run can potentially 
increase the rate of muscle glycogen utilisation during that exercise by 17% as a result 
of hyperinsulinaemia and hypoglycaemia (Costill et ai., 1977). On the basis of this 
finding, these authors hypothesised that exercise capacity might be compromised if 
carbohydrate is ingested within 1 h of performance and they consequently repeated 
their protocol with a cycling capacity test following feeding. This follow-up study 
confirmed the hypothesis in that time to exhaustion at 80% VO 1 max was reduced by 
19% when carbohydrate rather than plain water was ingested prior to exercise (Foster 
et ai., 1979). While these hyperinsulinaemic and hypoglycaemic influences of pre-
exercise carbohydrate feeding have now been demonstrated at a range of exercise 
intensities (Achten and Jeukendrup, 2003), the negative effect on performance shown 
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during cycling to has yet to be replicated usmg a treadmill runnmg protocol 
(Chryssanthopoulos et al., I 994a), possibly because maintenance of euglycaemia 
during exercise is less important during running than during cycling (see section 
2.1.1). More recent evidence has now established that, although hypoglycaemia can 
occur during exercise if large quantities of carbohydrate are consumed within 1 h of 
perfonnance, this effect is often a transient response (i.e. 'rebound' hypoglycaemia) 
and would not therefore be expected to contribute to eventual fatigue (Jentjens et al., 
2003; Moseley et aI., 2003). However, all the above studies relate specifically to pre-
exercise feeding, which may not necessarily reflect the metabolic response to 
carbohydrate ingestion when exercise is perfomled following recovery from an earlier 
exercise session. The specific question as to whether continuous ingestion of 
carbohydrate during recovery would influence subsequent glycogen metabolism was 
addressed in the study of Tsintzas et al. (2003). This study demonstrated that 
ingesting moderate (",0.5 g CHO·kg'l·h'l) rather than low (",0.2 g CHO·kg,l·h,l) 
amounts of carbohydrate at frequent intervals during recovery can significantly 
increase glycogen storage prior to subsequent exercise without affecting glycogen 
utilisation during the ensuing activity (Tsintzas et aI., 2003). Nonetheless, even if 
carbohydrate ingestion late in recovery does not influence subsequent exercise 
metabolism, from a practical perspective it seems reasonable to suggest that feeding 
should cease at least 15-30 min prior to exercise in order to minimise the risk of 
gastrointestinal discomfort. 
2.4.2 Considerations Regarding Type of Carbohydrate Ingested 
There are a number of considerations regarding the type or form of 
carbohydrate that should be ingested during a short-tenn recovery (Williams, 2004). 
One issue which has received much attention in recent years is the issue of glycaemic 
index (GI). The GI is a measure of the glucose response to a given carbohydrate 
source (expressed as incremental area under curve; see Appendix F) in relation to the 
maximal response observed following ingestion of a matched quantity of pure glucose 
(Wolever, 2004). Given the influential role of insulin in the promotion of 
carbohydrate storage following exercise, it has been suggested that the increased 
insulin response following ingestion of a mixed high GI meal might result in a greater 
rate of muscle glycogen resynthesis than following ingestion of a mixed low GI meal 
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(Burke et al., 1998). A study from Kiens et al. (1990) investigated the influence of 
high versus low GI carbohydrate feeding during recovery from prolonged cycling and 
confirmed that the almost doubled insulin response with high GI as opposed to low GI 
was associated with a significantly higher muscle glycogen concentration 6 h later. 
Notably, as with the delayed carbohydrate feeding discussed above (Ivy et aI., 1988a; 
Parkin et al., 1997), the issue of glycaemic index seems to become of greater 
importance in the early stages of recovery since the differences in muscle glycogen 
content that have been reported at 6 h have been found to be normalised 14 h later 
(Kiens et aI., 1990). Conversely, however, other authors have found differences in 
muscle glycogen resynthesis in favour of high GI to persist for up to 24 h following 
exercise (Burke et aI., 1993). 
Despite the positive effect of high GI meals on glycogen storage during 
recovery, it is important to consider whether ingesting these highly insulinotropic 
foods prior to exercise may exacerbate the proposed metabolic disturbances which 
can occur during subsequent exercise (Costill et aI., 1977; Foster et al., 1979). It has 
therefore been suggested that ingestion of low GI carbohydrates during recovery may 
result in muscle glycogen sparing during subsequent exercise and a study from 
Thomas et al. (1991) has demonstrated that this reduction in carbohydrate oxidation 
with low GI can prolong exercise capacity (Thomas et aI., 1991). However, while 
subsequent investigations have verified the proposed metabolic benefits of low GI 
ingestion, the earlier reports of performance enhancement from Thomas et al. (1991) 
have not yet been confirmed (Febbraio et aI., 2000; Sparks et al., 1998; Wee et al., 
1999; Wee et aI., 2005). 
Studies that have investigated the influence of ingesting varIOUS forms of 
sugar during recovery provide some insight into the specific fate of high and low GI 
carbohydrates following mixed meals. In particular, fructose has a lower GI than 
glucose and consequently also results in a lower rate of muscle glycogen resynthesis 
during recovery (Blom et al., 1987). It is thought that the rate of muscle glycogen 
synthesis when fructose is ingested may be limited by the conversion of fructose into 
glucose by the liver and it is therefore possible that liver glycogen resynthesis may be 
greater in this situation (Nilsson and Hultman, 1974). This possibility was assessed in 
the study of Casey et al. (2000) which examined the effect of ingesting either glucose 
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or sucrose (i.e. equimolar fractions of glucose and fructose) during recovery on the 
combined resynthesis of both muscle and liver glycogen. A trend was apparent in 
favour of greater liver glycogen resynthesis following ingestion of sucrose and, 
similar to the findings of others (Blom et aI., 1987), there were no differences in 
muscle glycogen resynthesis between the glucose and sucrose treatments (Casey et 
al., 2000). It has been hypothesised that the fructose component of sucrose may 
decrease liver glucose uptake and therefore render a greater fraction of the glucose 
component available for muscle glycogen synthesis (Blom et aI., 1987), although 
subsequent investigations have demonstrated that fructose can actually increase 
hepatic glucose uptake (Shiota et aI., 2005). Contrary to evidence promoting the use 
of sucrose over glucose, another study has reported reduced whole body and skeletal 
muscle glycogen storage with sucrose ingestion as opposed to glucose ingestion 
(Bowtell et aI., 2000). However, the data gathered during this latter study are 
questionable because the acid extraction method used to assess muscle glycogen 
would have disregarded the acid soluble fraction of glycogen (Jansson, 1981). 
Therefore, it cannot be discounted that this soluble fraction of glycogen (i.e. 
proglycogen) may have responded differently to the respective glucose and sucrose 
treatments since it is known to be highly sensitive to dietary intervention and would 
be expected to account for the majority of muscle glycogen resynthesis during a short-
term recovery (Adamo et aI., 1998). On balance, especially given the suggestion that 
restoration of exercise capacity may require the rapid resynthesis of both muscle and 
liver glycogen stores (Casey et aI., 2000; Claassen et aI., 2005; Terjung et aI., 1974), 
it appears reasonable to conclude that sucrose ingestion represents the most effective 
method of carbohydrate supplementation during recovery. 
Whether carbohydrate is ingested in solid or liquid form is another important 
consideration when attempting to enhance the rate of post-exercise carbohydrate 
storage. Early evidence suggested that ingestion of a mixed macronutrient meal or a 
carbohydrate-rich liquid can achieve a similar rate of muscle glycogen resynthesis 
over aSh recovery period, although the carbohydrate content of the solid meal in this 
particular study was greater than that of the carbohydrate solution (Keizer et aI., 
1987). A subsequent investigation by Reed et al. (1989) compared the effects of solid 
versus liquid feedings during a 4 h recovery when the carbohydrate content of the 2 
supplements was matched (0.75 g CHO·kg-l·h- I ). This investigation confirmed earlier 
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findings in that rates of muscle glycogen resynthesis were not different between 
treatments and a further comparison of these oral feedings against intravenous glucose 
infusion suggested that the rate of gastric emptying did not limit the rate of muscle 
glycogen resynthesis following either feeding method (Reed et aI., 1989). Successive 
investigations have now supported the contention that the gastric emptying rate of 
ingested carbohydrate is not likely to limit the rate of muscle glycogen resysnthesis 
following exercise (Moodley et al., 1992; Rehrer et aI., 1992), although the possibility 
remains that gastric emptying may begin to limit carbohydrate storage when the rate 
of carbohydrate intake is in excess of 0.75 g CHO·kg,l·h'l (Jentjens and Jeukendrup, 
2003). From a practical perspective, even if solid and liquid carbohydrate sources can 
be assumed to stimulate muscle glycogen resynthesis with equal effect, fluid 
supplements will achieve this aim while also encouraging rehydration and are 
therefore recommended (Coleman, 1994). Of course, plain water can be ingested 
alongside solid meals to satisfy both objectives but care should be taken because 
many solid foods do not contain carbohydrate in isolation and the presence of other 
macronutrients can compromise the gastric emptying rate of the liquid component 
(Berry et aI., 2002). One final consideration which warrants attention is whether the 
osmolality of a given carbohydrate solution will influence the rate of glycogenesis 
during recovery. Indeed, recent evidence from Piehl Aulin et al. (2000) has 
demonstrated a notably higher rate of muscle glycogen resynthesis over the initial 2 h 
of recovery when a glucose polymer solution (low osmolality) was ingested as 
opposed to a glucose monomer solution (high osmolality), with this effect attributed 
to a more rapid rate of gastric emptying together with an increase in exercise induced 
glucose uptake (Piehl Aulin et aI., 2000). However, a subsequent study has reported 
that carbohydrate oxidation rates during exercise may be unaffected by the osmolality 
of a given carbohydrate solution (Row lands et aI., 2005). 
2.4.3 Considerations Regarding Amount of Carbohydrate Ingested 
While the above considerations regarding the timing and type of carbohydrate 
ingested during recovery are undoubtedly of importance, it is perhaps of most 
practical value to establish the optimal amount of carbohydrate to ingest during 
recovery. The finding that carbohydrate supplementation of any substantial 
magnitude during recovery can stimulate far greater rates of muscle glycogen 
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resynthesis than when no carbohydrate at all is ingested has been well established 
(Casey et aI., 2000; Ivy et aI., 1988b; Tamopolsky et al., 1997; Van Hall et al., 
2000b). What is less clear is the precise effect of increasing carbohydrate intake on 
subsequent glycogen storage rates, particularly with reference to the factors which 
may limit the rate of muscle glycogen resynthesis when large quantities of 
carbohydrate are ingested. However, it is likely that the difficulty in ascertaining the 
smallest quantity of carbohydrate necessary to maximise muscle glycogen resynthesis 
is at least partially due to the confounding influence of the many factors discussed 
above regarding the timing and type of carbohydrate ingested and, most importantly, 
the degree of prior depletion. 
It was initially suggested by Blom et al. (1987) that ingesting 0.35 g CHO·ki 
I·h- I might be sufficient to maximise the rate of muscle glycogen resynthesis 
following exhaustive cycling. This opinion was based on these authors' finding that 
doubling the rate of carbohydrate ingestion from ",0.18-0.35 g CHO·kg-l·h- 1 resulted 
in a linear increase in muscle glycogen resynthesis during recovery (r = 0.99) but with 
no further elevation in glycogen storage when carbohydrate intake was increased to 
0.7 g CHO·kg-l·h-1 (Blom et al., 1987). Even when the carbohydrate ingestion rate 
has been further raised from 0.75-1.5 g CHO·kg-l·h- l, glycogen synthetic rate has been 
unaffected (Ivy et aI., 1988b). In retrospect, however, the rate of glycogen resynthesis 
reported by Blom et al. (1987) in response to 0.35 g CHO·kg-l·h- 1 was rather high 
(",25 mmol glucosyl units·kg dry mass-1h-\ possibly as a result of lower absolute 
glycogen concentrations at the beginning of recovery in this trial. As discussed in 
section 2.3.2.1, the degree of glycogen depletion is thought to be the most powerful 
determinant of glycogen resynthesis (Price et aI., 2000). Furthermore, it is likely that 
the plateau in muscle glycogen resynthesis with increasing carbohydrate intake in the 
studies of Blom et al. (1987) and Ivy et al. (1988) was also due to the relative 
infrequency of feedings in these studies (i.e. 2 h intervals) rather than attainment of 
the optimal carbohydrate ingestion rate (see section 2.4.1). 
In support of this contention, subsequent research has demonstrated that 
ingesting ~I g CHO·kg-l·h- 1 at more frequent intervals (i.e. 15-30 min) during a short-
term recovery can elevate the rate of muscle glycogen resynthesis above that 
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previously proposed to be maximal following lower carbohydrate ingestion rates 
(Doyle et aI., 1993; Jentjens et aI., 2001; Piehl Aulin et aI., 2000; van Loon et aI., 
2000a). A prime example of such evidence is the investigation of van Loon et al. 
(2000a), which showed that an increase in carbohydrate ingestion rate from 0.8-1.2 g 
CHO·kg·lh- 1 can in fact increase the rate of muscle glycogen resynthesis from ",17 
mmol glucosyl units·kg dry mass-I·h- I up to ",45 mmol glucosyl units·kg dry mass-lh- I 
when supplements are provided every 30 min during recovery. On the basis of this 
finding, it has been suggested that the carbohydrate ingestion rate implemented by 
these authors (i.e. 1.2 g CHO·kg-l·h- l) may have achieved the maximal possible rate of 
muscle glycogen synthesis in response to oral carbohydrate intake (Jentjens and 
Jeukendrup,2003). 
The above suggestion from Jentjens and Jeukendrup (2003) is supported when 
the majority of available literature regarding carbohydrate ingestion and muscle 
glycogen resynthesis during short-term recovery is examined collectively (Figure 
2.5). All the studies presented in Figure 2.5 involve supplementation of carbohydrate 
in isolation over recovery durations ranging from 2-6 h and a positive correlation is 
clearly apparent between the 2 variables (r = 0.65; P<O.Ol). The protocols adopted 
across this range of studies varied greatly with respect to a number of factors that are 
koown to impact upon muscle glycogen resynthesis, in particular, the muscle 
glycogen concentrations at the start of recovery ranged from "'16-260 mmol glucosyl 
units·kg dry mass' I (Price et aI., 2000; Tsintzas et aI., 2003). Given the effective 
autoregulation of muscle glycogen that was described in section 2.3.2.1, it is highly 
likely that the large variation in terms of glycogen resynthesis at any given rate of 
carbohydrate ingestion is mainly the result of these differences at the beginning of 
recovery. Interestingly, when the studies displayed in Figure 2.5 are streamed 
according to the absolute degree of depletion prior to recovery (see trendlines), it is 
apparent that the capacity of glycogen availability to mediate the glycogen storage 
may be eradicated at higher rates of ca'rbohydrate intake (i.e. > 1.4 g CHO·kg-lh- I). 
Of primary importance, however, is that the general dose-response relationship 
between carbohydrate intake and glycogen resynthesis appears to be limited at a 
maximal rate of ",45 mmol glucosyl units·kg dry mass-I·h- I, a rate which can be 
accomplished by ingesting 1.2 g CHO·kg-lh-1 (van Loon et aI., 2000a). 
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Figure 2.5: Reported rates of muscle glycogen resynthesis during 2-6 h recoveries 
across 25 different studies involving varying rates of carbohydrate intake. The solid 
trendline denotes the correlation coefficient (r = 0.76; P<O.OI) for the 22 data points 
which represent the upper 50% of muscle glycogen concentrations prior to recovery 
(Blom et aI., 1987; Carrithers et al., 2000; Doyle et aI., 1993; Ivy et al., 1988a; Ivy et 
al., 1988b; McCoy et aI., 1996; Reed et aI., 1989; Roy and Tamopolsky, 1998; 
Tamopolsky et al., 1997; Tsintzas et aI., 2003; Van Hall et aI., 2000a; van Loon et aI., 
2000a; Yaspelkis and Ivy, 1999; Zawadzki et aI., 1992), while the broken trendline 
denotes the correlation coefficient (r = 0.69; P<O.OI) for the 22 data points which 
represent the lower 50% of muscle glycogen concentrations prior to recovery (Blom, 
1989; Blom et al., 1987; Bowtell et aI., 2000, 1999; Casey et aI., 2000; Casey et aI., 
1995; Jentjens et aI., 2001; Maehlum et al., 1978; Piehl Aulin et al., 2000; Price et al., 
2000; Reed et aI., 1989; Van Hall et al., 2000b). The study of Zachweija et al. (1991) 
is represented as data points but does not contribute to either trendline since no 
absolute muscle glycogen concentrations were reported in this study (Zachwieja et aI., 
1991 ). 
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The relationship shown in Figure 2.5 together with the proposed association 
between pre-exercise muscle glycogen availability and exercise capacity (Bergstrom 
et aI., 1967) may account for the enhanced recovery of endurance running capacity 
when 0.5 g CHO·kg-1·h-1 is ingested during a 4 h recovery in comparison with 
ingestion of a placebo (Fallowfield et aI., 1995). Given these same correlations, 
however, it is puzzling why increasing the carbohydrate dose from 0.5-1.5 g CHO·kg-
Ih-1 did not result in a further enhancement of exercise capacity (Fallowfield and 
Williams, 1997). It is possible that the rate of muscle glycogen resynthesis may have 
been limited by the frequency of ingestion as in the earlier studies of Blom et al. 
(1987) and Ivy et al. (I 988b ) since the carbohydrate solutions in the studies of 
Fallowfield et al. were only provided at 2 h intervals during recovery. However, 
ensuing investigations have fed carbohydrate at 30 min intervals during recovery and 
supported the findings of Fallowfield et al. (1997) in that subsequent endurance 
capacity at 70% VO, max was not different between solutions providing either 0.2 or 
0.6 g CHO·kg-1·h-1 (Wong and Williams, 2000). These findings remain somewhat 
surprising since muscle glycogen resynthesis has been shown to be different between 
treatments when this experiment has been repeated using muscle biopsies to quantify 
glycogen content directly (Tsintzas et al., 2003). The fact that restoration of exercise 
capacity has not been found to reflect muscle glycogen availability following 
recovery suggests either that factors other than muscle glycogen depletion contributed 
to fatigue or that the exercise capacity tests employed in these studies were not 
sufficiently sensitive to detect less substantial differences in muscle glycogen 
concentration (Fallowfield and Williams, 1997; Fallowfield et aI., 1995; Wong and 
Williams, 2000). Therefore, it remains to be established whether a more complete 
recovery of exercise capacity can be accomplished through increasing the amount of 
carbohydrate that is ingested during recovery. 
The rate of muscle glycogen resynthesis can be limited to the proposed 
maximal rate of ",45 mmol glucosyl units·kg dry mass-1h-1 by a number of factors 
between the moment a large volume of exogenous carbohydrate is ingested to the 
eventual conversion of the glucose into glycogen within muscle. As was discussed in 
relation to solid versus liquid carbohydrate feedings in section 2.4.2, while 
consumption of large quantities of carbohydrate can delay carbohydrate storage when 
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ingested in conjunction with solid non-carbohydrate sources (Berry el al., 2002; 
Jentjens and Jeukendrup, 2003), it is not thought that gastric emptying is likely to 
limit the rate of muscle glycogen resynthesis under most circumstances (Moodley et 
ai., 1992; Reed et ai., 1989; Rehrer et ai., 1992). In contrast, the rate of intestinal 
absorption may well impose a limitation to the maximal rate of muscle glycogen 
storage since infusion of a glucose solution directly into the duodenum has revealed 
intestinal absorption of glucose to be almost maximal at a rate of just ",1.3 g·min- I 
(Duchman et ai., 1997). However, more recent findings showing that rate of 
exogenous carbohydrate oxidation can approach 1.75 g·min- I during exercise argues 
that intestinal absorption of glucose can in fact exceed 1.3 g·min- I (Jentjens and 
Jeukendrup, 2005), but possibly only when mixed glucose and fructose are ingested 
(Ferraris, 2001; Jentjens et al., 2004) or when supplements are provided immediately 
following exercise (Rose et ai., 2001). Overall, it is likely that muscle glycogen 
resynthesis is at least partly limited at some stage of gastrointestinal transit since 
arterial infusion of glucose and insulin over an 8 h recovery from exercise has been 
found to elicit extremely high muscle glycogen storage rates (",98 mmol glucosyl 
units·kg dry mass-1-h"1) in comparison with carbohydrate ingestion (Hansen et ai., 
1999). 
Interestingly, the above study from Hansen et al. (1999) also indicated that, in 
addition to the restriction imposed by intestinal transport, the rate of muscle glycogen 
accumulation may be further limited by the transport capacity of exercised muscle. 
This is because only ",30% of the glucose infused during recovery was actually taken 
up by muscle, despite glucose and insulin concentrations being elevated to ",22 
mmol·r l and ",11.4 nmol-r l , respectively (Hansen et al., 1999). In agreement, a study 
from Bowtell et al. (2000) assessed the proportion of ingested carbohydrate that is 
directed towards muscle glycogen synthesis and concluded that storage of glucose 
within previously exercised muscles accounted for less than one-third of total 
carbohydrate storage (Bowtell et al., 2000). Given that the maximal rate of muscle 
glycogen storage from oral glucose intake during recovery is thought to be only ",0.3 
g·min- I , the remaining glucose that appears from the gastrointestinal tract would be 
taken up by other tissues and either oxidised or stored (Jentjens and Jeukendrup, 
2003). This latter possibility is certainly supported by the studies cited earlier from 
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Casey et al. (2000) and Terjung et al. (1974) in which the predominant route for 
carbohydrate disposal during recovery was storage in the form of liver glycogen 
(Casey et aI., 2000). 
The finding that transport capacity of previously exercised muscle can restrict 
the rate of muscle glycogen resynthesis during recovery raises a number of interesting 
possibilities in terms of nutritional intervention following exercise. Specifically, in 
the study of Reed et al. (1989) there were no differences in the rate of muscle 
glycogen storage when glucose was infused intravenously rather than being ingested 
during recovery. This was surprising since the peak blood glucose concentrations 
during recovery were almost twice as high following infusion as opposed to ingestion, 
although perhaps most relevant is the fact that insulin concentrations were not 
different between treatments (Reed et aI., 1989). In contrast, the remarkably high 
rates of glycogen resynthesis observed by Hansen et al. (1999) were achieved through 
the application of both hyperglycaemic and hyperinsulinaemic clamps (Hansen et al., 
1999). Taken together, these observations have led to the suggestion that insulin 
concentration may limit the rate of carbohydrate storage in situations where glucose 
availability is adequate (Ivy, 2001). As discussed at length in sub-sections 2.3.2.2b 
and 2.3.2.3b, insulin functions to facilitate both the uptake of glucose into muscle and 
its subsequent conversion into glycogen. Moreover, evidence has demonstrated that 
the latter of these processes may require insulin concentrations >340 pmol·r l before 
the glucose that is transported into muscle is stored rather than oxidised (Young et al., 
1988). Given these findings it becomes understandable why a number of 
investigators have explored the possibility that increasing the insulinaemic response to 
a carbohydrate solution may promote a greater rate of muscle glycogen resynthesis 
during recovery. 
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2.5 Influence of Carbohydrate-Protein Mixtures on Recovery 
2.5.1 Insu1inaemic Response to Amino Acid Ingestion 
It has been known for a relatively long time that pancreatic insulin secretion 
can be induced both through intravenous infusion or ingestion of certain amino acids 
(Floyd et aI., 1966; Rabinowitz et aI., 1966). More importantly, it has been shown 
that when amino acids or proteins are provided in conjuction with carbohydrate, a 
synergistic influence on insulin release can occur (Floyd et al., 1970a, 1970b; 
Rabinowitz et al., 1966). More recent research by van Loon et al. (2000b) has 
examined the specific magnitude of insulinaemic responses following ingestion of 10 
different amino acid/protein mixtures when ingested alongside carbohydrate. The 
results obtained from this investigation suggested that the insulinaemic response to a 
carbohydrate-protein (CHO-PRO) mixture will be strongly dependent on the amounts 
of leucine, phenylalanine and tyrosine that are included in the medium (van Loon et 
aI., 2000b). Interestingly, despite the fact that arginine is known to be highly 
insulinotropic when infused intravenously (Floyd et aI., 1966), evidence contests that 
arginine may not be an effective means of elevating circulating insulin when provided 
orally (Gannon et aI., 2002; Robinson et aI., 2003), especially in light of the 
gastrointestinal discomfort that is associated with ingestion of this amino acid (van 
Loon et aI., 2000b). Finally, the study of van Loon et al. (2000b) has also indicated 
that ingestion of protein hydrolysates may increase circulating amino acid 
concentrations more effectively than ingestion of intact casein. Indeed, subsequent 
research by these authors has now confirmed that coingestion of carbohydrate, protein 
hydrolysate, leucine and phenylalanine provides an effective means of increasing 
plasma insulin concentrations during a 3 h recovery (van Loon et al., 2000c). 
In addition to findings regarding the most effective mixture of amino acids to 
ingest during recovery, the latter study cited above from van Loon et al. also found 
that a greater insulinaemic response can be achieved through increasing the amount of 
protein in a given CHO-PRO mixture from 0.2-0.4 g·kg-1·h-1 (van Loon et aI., 2000c). 
While no significant dose-response relationship between protein intake and insulin 
release was reported in an earlier study which assessed a range of protein intakes 
alongside carbohydrate, an inverse relationship between elevations in plasma glucose 
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and protein intake was apparent (Spiller et aI., 1987). However, it cannot be 
established from this data whether the lower blood glucose concentrations at higher 
rates of protein intake were the result of increased glucose uptake or to a reduced 
appearance of glucose due to a delayed rate of gastric emptying (Thomas, 1957). 
Nonetheless, the likelihood is that CHO-PRO ingestion will be most effective in 
elevating circulating insulin when the protein component is ingested at rates in excess 
of ",0.3 g·kg-1·h-1. When the available evidence reporting insulinaemic responses to 
CHO-PRO ingestion is compiled, it is apparent that those studies reporting insulin 
concentrations to be enhanced following the addition of protein to a carbohydrate 
solution have all included between 0.3-0.5 g PRO·kg-1·h-1 (Jentjens et al., 2001; Van 
Hall et al., 2000a; Van Hall et al., 2000b; van Loon et aI., 2000a; van Loon et aI., 
2000c; Zawadzki et aI., 1992). Conversely, those studies that have not reported a 
significant enhancement of insulinaemic response following ingestion of CHO-PRO 
rather than carbohydrate alone have tended to provide protein in quantities closer to 
0.1 g·kg-1·h-1 (Carrithers et aI., 2000; Ivy et aI., 2002; Ivy et al., 2003; Tamopolsky et 
al., 1997). Furthermore, similar to the findings of Spiller et al. (1987), 7 out of the 10 
investigations cited above have reported significantly lower blood glucose 
concentrations following ingestion of CHO-PRO rather than carbohydrate alone 
(Carrithers et aI., 2000; Ivy et al., 2002; Ivy et aI., 2003; Van Hall et al., 2000a; Van 
Hall et al., 2000b; van Loon et aI., 2000a; Zawadzki et aI., 1992). It should also be 
noted that 2 of the 3 remaining studies also observed a reduced glycaemic response 
when protein was added but that this difference did not reach statistical significance 
(Tamopolsky et al., 1997; van Loon et al., 2000c), probably due to the diminished 
statistical power associated with the multi-factorial designs that were applied in these 
experiments (Atkinson, 2002). Again, however, it is difficult to determine whether 
these attenuated elevations in blood glucose concentration are the consequence of 
decreased glucose appearance or increased glucose uptake, although the study of Van 
Hall et al. (2000b) appears to support the former explanation (Van Hall et al., 2000b). 
This evidence notwithstanding, it cannot be entirely discounted that the synergistic 
influence of carbohydrate and protein on insulin secretion might increase glucose 
uptake and thus facilitate muscle glycogen storage during recovery, a possibility that 
is addressed in section 2.5.3. 
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2.5.2 Carbohydrate-Protein Mixtures and Protein Synthesis 
Before moving on to discuss the potential influence of CHO-PRO mixtures on 
muscle glycogen resynthesis, it is appropriate at this juncture to consider the influence 
of such solutions on protein balance in the post-exercise period. Evidence gathered 
using rats has demonstrated that prolonged treadmill running can reduce post-exercise 
muscle protein synthesis by 18% (Anthony et aI., 1999) and increase non-myofibrillar 
protein degradation by 37% (Kasperek and Snider, 1989) in comparison with resting 
levels. As a result, it has been suggested that a transient period of negative protein 
balance occurs during recovery from such exercise (Rennie and Tipton, 2000). 
Importantly, it has now been well established that ingestion of amino acids following 
exercise can encourage a transition from net protein breakdown to net protein 
synthesis (Biolo et al., 1997; Borsheim et al., 2002; Tipton et aI., 2004; Tipton et aI., 
1999). It is of further relevance that this effect has also been observed when 
carbohydrate and protein are ingested together either during or following various 
forms of exercise (Koopman et al., 2004; Koopman et al., 2005; Rasmussen et aI., 
2000). Amino acid ingestion will promote anabolism both via direct stimulation of 
net protein synthesis by amino acids such as leucine (Anthony et aI., 1999; Anthony 
et al., 2002; Rennie, 2005) and through stimulating the release of anabolic hormones 
such as insulin, insulin-like growth factor (IGF)-I and growth hormone (Balon et aI., 
1990; Chromiak and Antonio, 2002; Fryburg et aI., 1995). The insulin independent 
pathways involving leucine, IGF-I and growth hormone are thought to be responsible 
for stimulation of protein synthesis, while the insulin dependent pathway improves 
protein balance solely by inhibition of proteolysis (Fryburg et al., 1995; Vary et al., 
2005). This synergism between insulin and amino acids advocates the combined 
ingestion of carbohydrate plus protein during recovery to induce a more favourable 
influence on muscle protein synthesis than when either nutrient is consumed in 
isolation (Roy et aI., 1997; Tipton and Wolfe, 2004). 
The considerations regarding how much protein is necessary to achieve this 
benefit are relatively uncomplicated in comparison with the earlier discussion 
regarding carbohydrate ingestion during recovery. No dose dependent effect was 
apparent regarding the extent of protein synthesis when the rate of essential amino 
acid ingestion has been doubled from ~0.07-0.14 g.kg,lh,1 during a 4,5 h recovery 
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(Tipton et al., 1999) and considerable increments in muscle protein synthesis have 
been achieved with ingestion of far smaller quantities of essential amino acids (",0.04 
g·kg-I·h- I) over a similar duration of recovery (Borsheim et aI., 2002). It is known 
that this sensitivity is at least partially due to the fact that the insulin mediated 
suppression of proteolysis is maximal even with relatively low doses of amino acids 
(Louard et al., 1992). The finding that protein synthesis is highly sensitive to insulin 
may explain why, similar to muscle glycogen storage, a more rapid accretion of 
muscle protein occurs if CHO-PRO supplements are provided immediately after 
exercise rather than being delayed by 3 h when insulin sensitivity would have 
diminished (Levenhagen et aI., 200 I). However, this effect was not evident in an 
earlier study in which CHO-PRO solutions were ingested at either I h or 3 h post-
exercise and no difference in net muscle protein balance was identified (Rasmussen et 
al., 2000). Perhaps more relevant in terms of supplement timing in relation to amino 
acid ingestion is the actual sequence of exercise and ingestion. To be precise, it has 
been established that a superior rate of net muscle protein synthesis occurs when a 
CHO-PRO mixture is consumed before as opposed to after resistance exercise, with 
this effect being attributed to an increased delivery of amino acids to exercising tissue 
during muscular contraction (Tipton et aI., 2001). It is therefore reasonable to suggest 
that an additional benefit of ingesting CHO-PRO during recovery could be to prime 
the musculo-skeletal system with an increased availability of amino acids in 
preparation for the succeeding recovery from a repeated performance or even just to 
maintain a higher habitual intake of protein to facilitate training adaptation (Bolster et 
al., 2005). 
Aside from the obvious positive influence of protein accretion in terms of 
muscular hypertrophy, the anabolic stimulus provided by ingestion of amino acids 
also has the potential to impart a number of associated benefits. For example, if the 
exercise bout that was performed prior to recovery involved a large component of 
eccentric muscle contractions, then it is likely that a substantial amount of damage to 
muscle fibres will have occurred as a consequence (Armstrong et aI., 1983; Cleak and 
Eston, 1992; Eston et aI., 1995). This mechanical tissue injury is often associated 
with the appearance of intracellular proteins and enzymes in the circulation due to 
membrane disruption (Armstrong, 1984; Friden and Lieber, 2001) which 
subsequently leads to secondary oxidative stress, as evidenced by increased 
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concentrations of thiobarbituric acid reactive substrates (T-BARS), malondialdehyde 
and lipid hydroperoxide (Alessio, 1993; Dekkers et aI., 1996; Pyne, 1994). In relation 
to CHO-PRO ingestion, it has been suggested by some authors that the ingestion of 
carbohydrate coincident with protein may maintain cell membrane integrity more 
effectively than ingestion of either a placebo (Seifert et al., 2005) or just carbohydrate 
in isolation (Ready et aI., 1999). This suggestion is supported by studies in which the 
post-exercise concentration of plasma creatine kinase (an ordinarily intracellular 
enzyme) has been attenuated when protein was included in a standard carbohydrate 
solution (Ready et aI., 1999; Saunders et al., 2004). Further support comes from a 
study in which the ingestion of CHO-PRO resulted in a decreased appearance of 
certain biomarkers that are associated with oxidative stress (Williams et aI., 1999). 
On the other hand, another study from Wojcik et al. (2001) reported that markers of 
muscle damage and inflammation following exercise were not alleviated any more 
effectively when CHO-PRO was ingested following exercise than when carbohydrate 
alone was ingested. It is possible, however, that the prior exercise bout in this latter 
study did not induce a sufficient degree of muscle damage to identify the beneficial 
effects of the additional protein (Wojcik et al., 2001). From a practical perspective, it 
has been demonstrated that this potential impact of post-exercise CHO-PRO ingestion 
in terms of muscle damage may be translated into reduced sensations of muscular 
soreness when consumed daily over ",8 weeks of basic training in a large cohort of 
marine recruits (Flakoll et al., 2004). 
It was also observed in the above study involving marine recruits that those 
individuals who consumed the CHO-PRO mixture required 33% fewer visits to the 
medical clinic than those individuals who consumed either placebo or carbohydrate 
alone (Flakoll et aI., 2004). Prolonged exercise is known to depress immune cell 
function (Gleeson et aI., 2004) and proteolysis of the gastrointestinal tract following 
exercise may compound this effect through an increased translocation of gut bacteria 
(Flakoll et aI., 2004; Halseth et aI., 1997). It is therefore possible that the reduced 
incidence of bacterial/viral infections reported by Flakoll et al. (2004) was a direct 
result of decreased gut catabolism arising from the ingestion of amino acids (Hamada 
et al., 1999). 
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The studies presented throughout this section provide clear evidence that 
including amino acids in a post-exercise carbohydrate supplement may provide a 
number of benefits associated with the stimulation of protein synthesis. However, it 
is unlikely that any of these benefits would be of value when the primary focus of 
nutritional supplementation is to restore functional capacity as rapidly as possible 
following prolonged exercise. In such circumstances, a more desirable outcome 
would be to accelerate the rate at which carbohydrate is stored during recovery and 
the following section will discuss how effectively CHO-PRO supplements might 
achieve this aim. 
2.5.3 Carbohydrate-Protein Mixtures and Carbohydrate Storage 
As was addressed in section 2.5.1, it is thought that the greatest insulinaemic 
response will be achieved when the protein fraction of a CHO-PRO mixture is 
composed of protein hydrolysate along with certain essential amino acids (van Loon 
et aI., 2000b). The addition of individual amino acids such as leucine, glutamine or 
arginine to a carbohydrate supplement has not be found to substantially increase 
circulating insulin concentrations and, while adding leucine to carbohydrate has been 
shown to enhance muscle glycogen storage in rats (Anthony et aI., 1999), ingestion of 
either glutamine or arginine has failed to accelerate muscle glycogen accumulation 
during recovery in humans (Van Hall et aI., 2000a; Yaspelkis and Ivy, 1999). It 
cannot be ruled out, however, that amino acids such as glutamine might be 
deaminated and converted into muscle glycogen directly rather than promoting 
glycogenesis from glucose (Vamier et al., 1995). In contrast, a number of studies 
have reported that the augmented insulin concentrations when mixed amino acids 
have been added to carbohydrate recovery solution can in fact increase the rate of 
muscle glycogen resynthesis following exercise (Fogt and Ivy, 2000; van Loon et aI., 
2000a; Williams et al., 2003; Zawadzki et al., 1992). However, in 2 of these studies 
the CHO-PRO mixture was assessed in relation to a carbohydrate solution which was 
not matched for carbohydrate content, which makes it difficult to determine if the 
glycogenic effect of the CHO-PRO solution was due to the amino acids or to the 
additional carbohydrate (Fogt and Ivy, 2000; Williams et al., 2003). Of the other 
studies cited above, the study from Zawadzki et al. (1992) examined whether 
ingesting ",0.8 g CHO·kg·l·h,1 plus an additional ",OJ g·kg'lh'l of protein at 2 h 
68 
Chapter 2 Review of Literature 
intervals during a 4 h recovery from prolonged exercise would result in a faster rate of 
muscle glycogen storage than when ingesting the carbohydrate fraction alone. 
Although the absolute concentrations of muscle glycogen were not different between 
trials by the end of recovery in this study, the rate at which glycogen was stored was 
38% greater when protein was included in the recovery solution (Zawadzki et aI., 
1992). Again, however, it cannot be established whether the enhanced rate of 
glycogenesis reported by Zawadzki et al. (1992) was purely a result of the increased 
insulin response to the CHO-PRO solution or a consequence of the 43% increase in 
energy provision when protein was added. Other authors have subsequently 
~ demonstrated that the energy content of a supplement can enhance the rate of muscle 
glycogen storage irrespective of macronutrient composition (Roy and Tamopolsky, 
1998). Therefore, the only remaining study to show an increase in the rate of muscle 
glycogen resynthesis following amino acid induced hyperinsulinaemia is that of van 
Loon et al. (2000a). In this study a CHO-PRO solution providing 0.8 g·kg·1 h-! of 
carbohydrate and 0.4 g·kg-!·h-! of protein was ingested at 30 min intervals during a 4 h 
recovery from exhaustive cycling. Fortunately, the effectiveness of the CHO-PRO 
solution was evaluated in comparison with 2 separate carbohydrate solutions: I 
matched for carbohydrate content and the other for total energy content. In this way it 
was possible to determine that the rate of muscle glycogen accumulation can be 
increased equally effectively when either amino acids or additional carbohydrate are 
added to an existing recovery solution that provides carbohydrate in sub-optimal 
quantities (van Loon et aI., 2000a). 
There are also a similar number of investigations that have observed the 
increase in insulinaemic response when mixed amino acids have been added to a 
standard carbohydrate solution but have reported no concomitant increase in the rate 
of muscle glycogen storage during recovery (Jentjens et al., 2001; Van Hall et al., 
2000a; Van Hall et al., 2000b). The studies of Jentjens et al. (2001) and Van Hall et 
al. (2000b) assessed whether the proposed 'maximal' rate of muscle glycogen 
resynthesis in response to ingesting ",1.2 g·kg-!·h-! of carbohydrate could be exceeded 
if additional protein, rather than additional carbohydrate, was ingested during a 3-4 h 
recovery. It was concluded by both authors that the additional protein did not further 
increase the rate of carbohydrate storage during recovery despite a significant 
enhancement of insulin release (Jentjens et al., 2001; Van Hall et al., 2000b). It 
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appears that the important distinction between these studies and those cited 
previously, in which muscle glycogen resynthesis was accelerated, is the precise 
quantity of carbohydrate to which the protein was added. When plotted graphically 
(Figure 2.6), it becomes apparent that those studies which have provided 21 g 
CHO·kg·1h-1 have not observed any increase in muscle glycogen resynthesis when 
amino acids were added (Jentjens et aI., 2001; Van Hall et aI., 2000b). Conversely, 
muscle glycogen resynthesis has more commonly been accelerated when amino acids 
have been added to matched quantities of carbohydrate providing sO.8 g CHO·kg-1h-1 
(Ivy et al., 2002; van Loon et al., 2000a; Zawadzki et al., 1992). The only study 
which does not conform with this explanation is that of Van Hall et al. (2000a), who 
concluded that adding protein to 0.8 g CHO·kg-1·h-1 did not significantly increase the 
rate of muscle glycogen resynthesis over the course of a 3 h recovery. However, it is 
clearly illustrated in Figure 2.6 that the differences in muscle glycogen resynthesis 
reported by these authors (represented as circular data points) are meaningful even if 
not statistically significant (Van Hall et ai., 2000a). 
In combination with the fact that the rate of muscle glycogen resynthesis 
appears to be maximal following ingestion of 1.2 g CHO·kg-J.h- J alone (see Figure 
2.5), the above findings have led some authors to suggest that regular ingestion of 
relatively high doses of carbohydrate during recovery will maxim ally stimulate 
glucose uptake such that further increases in insulin concentration as a result of added 
amino acids are obsolete (Carrithers et al., 2000; Jentjens et al., 2001; van Loon et aI., 
2000a). Nonetheless, the addition of protein to a carbohydrate solution can 
potentially increase the rate of muscle glycogen storage in circumstances where 
insulin is likely to limit the rate of muscle glycogen re synthesis, i.e. when insufficient 
carbohydrate is consumed to maximise glucose transport. 
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Figure 2.6: Reported rates of muscle glycogen resynthesis during 3-5 h recoveries 
across 6 different studies involving varying rates of carbohydrate intake both with and 
without mixed amino acids. Each study is represented by a different symbol with 
filled data points representing carbohydrate alone and open data points representing 
carbohydrate plus protein (Ivy et aI., 2002; Jentjens et aI., 2001; Van Hall et aI., 
2000a; Van Hall et al., 2000b; van Loon et al., 2000a; Zawadzki et al., 1992). The 
trendlines denote the suggested patterns of muscle glycogen resynthesis with each 
treatment based on all 6 studies (N.B: the apparent treatment effect in the study of 
Jentjens et al. (2001), represented as squares, is a product of large inter-individual 
variation during the exercise induced component of glycogen resynthesis and is not 
statistically significant). 
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As discussed in section 2.5.\, it is likely that ingestion of <:0.3 g.kg-1.h-1 of 
protein is necessary to achieve the synergistic effect of combined CHO-PRO 
ingestion on insulin secretion (van Loon et al., 2000c). This finding would explain 
why some other investigators have failed to increase glycogen storage when adding 
less than this critical amount of protein to carbohydrate recovery solutions, since 
insulin stimulated glucose transport would not be expected to differ between trials 
(Carrithers et al., 2000; Tamopolsky et al., 1997). However, a study by Ivy et al. 
(2002) has demonstrated that ingestion of just ~0.2 g PRO·kg-1·h-1 in combination 
with ~0.5 g CHO·kg-1h-1 can increase the rate of muscle glycogen storage above that 
of either ~0.5 g CHO·kg-1·h-1 alone or even an isoenergetic carbohydrate feeding of 
",0.7 g CHO·kg-1·h-1. Perhaps of most interest is the fact that this effect was not 
associated with any significant increase in insulin concentration (Ivy et aI., 2002), 
thus presenting the interesting possibility that enhanced insulin mediated glucose 
uptake may not be the only mechanism through which CHO-PRO ingestion can 
operate to increase carbohydrate storage. Indeed, it is highly possible that the protein 
fraction of a CHO-PRO solution might also be used as gluconeogenic substrate during 
recovery to provide additional glucose both for liver and muscle glycogen resynthesis 
(Butterfield, \990). 
In summary, it appears that the rate of muscle glycogen resynthesis during 
short-term recovery can be maximised either through ingesting <: I g CHO·kg-1·h-1 or 
through the ingestion of smaller quantities of carbohydrate in combination with mixed 
amino acids. The primary mechanism through which additional amino acids increase 
muscle glycogen storage is likely to be related to the synergistic influence of 
carbohydrate and protein on insulin secretion, especially when <:0.3 g.kg-1·h-1 of 
amino acids are ingested. However, the possibility remains that the ingested amino 
acids may also provide an indirect substrate for synthesis of muscle glycogen through 
conversion into glucose by the liver. Regardless of the mechanism, the potential for 
amino acids to accelerate glycogen resynthesis when ingested alongside carbohydrate 
during recovery introduces the possibility that subsequent physical performance might 
also be enhanced. The final section of this chapter will present those studies which 
have examined the effectiveness of CHO-PRO ingestion in terms of restoring the 
capacity for physical exercise within 8 h of prior activity. 
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2.5.4 Carbohydrate-Protein Mixtures and Physical Performance 
If the addition of amino acids to a carbohydrate recovery solution does in fact 
increase the rate of muscle glycogen resynthesis above that achieved through 
ingestion of carbohydrate alone, then it would seem reasonable to suggest that 
subsequent exercise capacity might also be improved given the proposed association 
between pre-exercise muscle glycogen availability and exercise capacity (Bergstrom 
et al., 1967). Furthermore, the potential interaction of ingested amino acids with the 
liver might also be relevant in terms of short-term recovery since it has been 
suggested that resynthesis of liver glycogen might be another crucial element 
dictating subsequent performance (Casey et al., 2000; Terjung et aI., 1974). Despite 
the above possibilities, however, there is a relative dearth of information relating to 
the influence of CHO-PRO mixtures on recovery of exercise capacity. 
Tentative evidence supporting the efficacy of CHO-PRO ingestion during 
recovery can be derived from the recent study of Saunders et al. (2004). This study 
involved the ingestion of carbohydrate either with or without additional whey protein 
both during and after a prolonged bout of cycling to exhaustion at 75% V0 2 max, 
followed 12-15 h later by another exercise capacity test at 85% V0 2 max. Including 
protein in the solution was reported to increase cycle time to exhaustion by 29% 
during the first exercise test and by 40% during the second exercise test. However, 
while the 2 solutions provided in this study were matched for carbohydrate content, 
the inclusion of protein resulted in a 20% increment in total energy provision 
(Saunders et al., 2004). Therefore, similar to much of the research on muscle 
glycogen resynthesis, it cannot be established whether the ergogenic benefit of the 
CHO-PRO solution was due to the increase in available energy or the additional 
protein per se. Regardless of this limitation, the above study clearly demonstrates that 
recovery over a more extended period can benefit from CHO-PRO ingestion and 
Saunders et al. (2004) suggest that this performance enhancing effect may be the 
result of improved protein synthesis and consequent repair of damaged tissue during 
recovery. Therefore, since muscular contraction during cycling is exclusively 
concentric, it is possible that even greater performance benefits might arise from 
CHO-PRO ingestion when other more damaging forms of exercise are performed. 
Nonetheless, it is less likely that any substantial repair of muscle tissue will occur 
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during a more short-term recovery, at least not sufficiently to impact upon physical 
perfornlance within 8 h. 
The study of Saunders et al. (2004) also warrants further discussion in relation 
to the observation that exercise capacity during the first exercise session was 
increased from 82.3 min up to 106.3 min when CHO-PRO rather than carbohydrate 
alone was consumed. The fact that physical performance was enhanced without any 
prior manipulation of muscle glycogen availability leads to the possibility that CHO-
PRO might positively affect metabolism through other mechanisms. Further support 
for this contention comes from a study by Ivy et al. (2003) in which either CHO-PRO 
or a supplement matched for carbohydrate content was ingested during 3 h of variable 
intensity cycling (45-75% \IO,max), following which the exercise intensity was 
increased to 85% \102 max until the point of fatigue. In agreement with Saunders et 
al. (2004), it was identified in the study of Ivy et al. (2003) that the CHO-PRO 
mixture improved time to fatigue above that of the carbohydrate matched solution by 
7.2 min (36%). Importantly, there were no significant differences in insulin 
concentrations during the exercise performed in this study, despite the intermittent 
periods oflow intensity activity, which would tend to argue against the possibility that 
muscle glycogen was spared in the CHO-PRO trial (Ivy et aI., 2003). Alternative 
explanations for the differences in exercise capacity between trials may therefore 
involve specific protein mediated mechanisms such as an increased central drive for 
exercise (Oavis, 1995) or anaplerotic replenishment of TCA cycle intermediates (Ivy 
et al., 2003; Wagenmakers et aI., 1990). The former of these hypotheses was 
addressed earlier in section 2.2.5 where it was concluded that the coingestion of 
glucose along with branched-chain amino acids was unlikely to improve performance 
through attenuated sensations of fatigue (Madsen et aI., 1996). Likewise, recent 
evidence (Dawson et a/., 2005; Gibala, 2003) has also challenged the latter hypothesis 
that amino acids might maintain TCA cycle flux during prolonged exercise (see 
section 2.2.1). However, even if these mechanisms can be discounted, the findings of 
Saunders et al. (2004) and Ivy et al. (2003) remain in their contention that an 
enhanced rate of muscle glycogen resynthesis during recovery might not be the only 
factor contributing to improved performance with CHO-PRO ingestion. 
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There is actually very little evidence to support the proposal that an enhanced 
rate of muscle glycogen resynthesis during recovery will result in an improved 
recovery of exercise capacity. It is known that the rate of muscle glycogen 
resynthesis will be very low if no carbohydrate is consumed during recovery (Ivy et 
al., 1988b; Tamopolsky et al., 1997; Van Hall et al., 2000b), yet increasing the rate of 
muscle glycogen storage through the provision of carbohydrate has not been 
consistently found to enhance subsequent exercise capacity (Casey et al., 2000; 
Fallowfield et al., 1995). However, it is possible that one of the above studies may 
not have provided sufficient carbohydrate to reveal an effect of carbohydrate 
ingestion on physical performance (Casey et aI., 2000). In summary, the apparent 
dose-response relationship between carbohydrate intake and muscle glycogen 
resynthesis has not yet been reflected in a similar relationship between carbohydrate 
intake and exercise capacity (Fallowfield and Williams, 1997; Wong and Williams, 
2000). 
However, there is an investigation which has demonstrated that an increased 
rate of muscle glycogen resynthesis during a short-term recovery will also improve 
exercise capacity during subsequent exercise (Williams et aI., 2003). The 
investigation of Williams et al. (2003) is also of particular relevance given that it is 
presently the only study to date which has investigated the effect of CHO-PRO 
ingestion during recovery on the capacity to exercise within 8 h of prior exertion. 
Specifically, in this investigation participants were required to cycle at 65-75% 
VO, max for> I 05 min in order to deplete muscle glycogen stores and reduce blood 
glucose concentrations below 4.0 mmol·r 1 Once glucose homeostasis had been 
sufficiently challenged, participants began a 4 h recovery during which they 
consumed either carbohydrate alone (0.15 g·kg,l·h,l) or a mixture of carbohydrate 
(0.40 g.kg'lh'l) plus additional protein (0.10 g.kg,l·h,l). Perhaps unsurprisingly given 
the large differences in carbohydrate content, the CHO-PRO mixture resulted in a 
92% greater insulinaemic response and 128% greater rate of muscle glycogen 
resynthesis than the solution which provided less carbohydrate with no amino acids. 
Of primary importance, however, was that participants were able to exercise for 55% 
longer (i.e. 20.0 versus 31.1 min) during a subsequent exercise capacity test at 85% 
VO, max when CHO-PRO rather than carbohydrate alone was ingested during 
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recovery (Williams et al., 2003). Despite the obvious bias towards the CHO-PRO 
solution both in terms of carbohydrate and total energy provision, this study provides 
convincing evidence that elevations in muscle glycogen resynthesis during recovery 
above that induced by a standard carbohydrate solution can actually be translated into 
an enhancement of exercise capacity. 
What remainS to be established is whether this enhancement of exercise 
capacity subsequent to recovery would also occur if a CHO-PRO solution was 
evaluated in comparison with a solution that was matched for either total carbohydrate 
or total energy content. Such a comparison would not be expected to induce 
differences in muscle glycogen resynthesis of the magnitude reported by Williams et 
al. (2003) but, in combination with the other potential mechanisms which might also 
facilitate performance, it remains a possibility that ingestion of carbohydrate along 
with amino acids during short-term recovery might restore exercise capacity more 
effectively than ingestion of carbohydrate alone. What follows is an account of a 
series of studies in which this possibility is explored and the potential mechanisms 
underlying any differences in physical performance are considered. 
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Chapter 3 General Methods 
General Methods 
3.1 Introduction 
This chapter provides an account of the genenc methodologies that were 
implemented during the various studies which compose this thesis. Each of these 
investigations was conducted in the Exercise Physiology Laboratories of 
Loughborough University and received approval from the University Ethics 
Committee prior to participant recruitment. The target population for recruitment 
were male, non-smokers who included running as part of their habitual training. 
These participants were recruited via advertisements located around the university 
campus and tended to be undergraduate students aged between 18 & 25 years. After 
volunteering for any study, participants were fully briefed both verbally and in writing 
regarding what would be required of them for that particular study. Any volunteers 
who felt they could adequately fulfil these requirements were asked to give written 
informed consent and were made aware that they could withdraw from the procedures 
at any time without giving a reason. Participants completed a compulsory health 
screen questionnaire (Appendix Ai) and were excluded from the study if they reported 
any medical condition that either posed an undue personal risk or introduced bias into 
the investigation. Further health questionnaires were completed by each participant 
upon every visit to the laboratory to ensure that no deterioration in either well-being 
or commitment to the study had occurred over the course of testing (Appendix Aii). 
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3.2 Anthropometry 
Post-void nude body mass was recorded as part of each participant's initial 
visit to the laboratory so that carbohydrate provision during subsequent main trials 
could be calculated relative to body mass. Body mass was also recorded before and 
after any exercise session to assess hydration status through percentage change in 
mass, this measurement was again made nude and only after participants had used a 
towel to remove excess moisture from the skin surface. All body mass measurements 
were made using a balance scale (Avery Ltd., UK) that had a capacity of 120 kg and 
was accurate to ± 0.05 kg. 
Height was measured using a wall mounted stadiometer (Holtain Ltd., UK) 
that had a maximum range of 200 cm and was accurate to ± 0.0 I cm. Each 
participant's height was recorded barefoot, with heels together and resting against the 
stadiometer. The moveable indicator was lowered until in contact with the superior 
point of the head while each participant inspired deeply. Both height and mass were 
then used to calculate body mass index (BM I = kg/m2). 
3.3 Preliminary Measurements 
Prior to main trials, all participants were required to make 2 visits to the 
laboratory for preliminary testing. The first of these visits was used to assess each 
participant's sub-maximal and maximal oxygen uptakes (Taylor et al., 1955) while 
the second was designed to familiarise participants with the experimental procedures. 
Exercise during all preliminary tests, along with main trials, was performed on a 
motorised treadmill (Technogym HC1200, Italy) that had been calibrated prior to each 
testing period to confirm the validity of the analogue speedometer and gradient 
display. 
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3.3.1 Sub-maximal and Maximal Oxygen Uptake 
Participants' preliminary visit to the laboratory comprised 2 exercIse tests. 
The first of these tests detemlined each participant's oxygen uptake (VO,) at a 
variety of sub-maximal running speeds. Typically this test was completed within 16 
min, with the treadmill speed increasing at 4 min intervals such that a range of at least 
4 intensities could be monitored. For most participants, treadmill speeds of 11, 12, 13 
and 14 km· h·' were sufficient to encompass all the relative exercise intensities 
employed during subsequent main trials. During the final minute of each 4 min stage, 
expired gas samples along with ratings of perceived exertion (Borg, 1973) and heart 
rates were recorded. Heart rates were recorded throughout all these investigations via 
short range telemetry (Polar 8810, Finland). 
Approximately 30 mm following the sub-maximal oxygen uptake test 
participants completed a second test to assess their maximal oxygen uptake 
(VO, max). This test involved incremental continuous treadmill running until the 
point of volitional exhaustion. The speed at which this test was conducted was 
dictated by the data recorded during the sub-maximal test and a speed eliciting 
approximately 85% of maximum heart rate was selected. Participants ran at this 
speed against a 3.5% gradient which was increased by 2.5% after every 3 min stage. 
One minute expired air samples, ratings of perceived exertion (Borg, 1973) and heart 
rates were measured in the final minute of each stage and also at the point of 
volitional exhaustion, defined as when the participant indicated that only I minute 
remained until fatigue. A number of criteria were applied to determine whether this 
endpoint was reflective of a valid VO,max value, these were: attainment of age 
predicted maximal heart rate (± 10 beats· min·'); a respiratory exchange ratio (RER) in 
excess of 1.15; and an increase in V0 2 :<;;5 ml.kg·1min·' in response to an increased 
gradient. While progressive incline protocols may be less likely to fulfill all 3 of 
these criteria in comparison with level running protocols, the resultant VO,max value 
is not thought to differ significantly between the 2 methods (St. Clair Gibson et al., 
1999). 
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3.3.2 Familiarisation 
The sub-maximal and maximal oxygen uptake data obtained from the first 
preliminary tests were subjected to a simple linear regression against running speed to 
detennine what speed would be required to elicit given relative exercise intensities. 
Participants' second visit to the laboratory was scheduled within 2 weeks of the first 
main trial and involved running at speeds eliciting 70% V0 2 max for at least 60 min 
(an additional 15 min at 85% VO, max was included in Chapters 4 and 5 due to the 
intensity of exercise perfonned during these investigations). This test provided 
confirmation that the calculated speeds corresponded to the proper relative exercise 
intensities (± 2-3%). An additional purpose of this visit was to familiarise all 
participants with the experimental procedures and apparatus. 
3.4 Experimental Design 
All studies reported in this thesis involved a cross over design that was fully 
randomised and counterbalanced. All main trials were separated by at least 1 week to 
avoid any carry-over effects and the interventions were applied in a double blind 
manner. Common to all these investigations was an overall main trial fonnat 
involving a 90 min treadmill run at 70% VO, max (RI) followed by a 4 h recovery 
period, during which 8 experimental solutions were consumed at 30 min intervals 
beginning immediately after the initial run. The precise intensity and nature of the 
exercise session (R,) which proceeded this recovery period was manipulated 
specifically according to the aims of each study and details of these protocols are 
included in the methods sections of each respective experimental chapter. 
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3.5 Physiological Measurements 
3.5.1 Expired Gas Analysis 
Participants were provided with a nose clip and a respiratory valve 45 s prior 
to any expired gas collection to clear all atmospheric air from the apparatus prior to 
sampling. The respiratory valve was attached via falconia tubing (Baxter, 
Woodhouse and Taylor, UK) to a 200 I Douglas bag (Harvard Apparatus, UK) for 
collection of expired gases (Williams and Nute, 1983). The relative gas fractions of 
oxygen and carbon dioxide were measured usmg paramagnetic and infra-red 
analysers, respectively (Servomex 1440, UK). These analysers were calibrated on the 
morning of each trial with a two point calibration using gas cylinders of known 
composition within the physiological range (0, 0-16%; CO, 0-4%) which had been 
previously checked for accuracy via gravimetric analysis (British Oxygen Company, 
UK). Each analyser was then validated against atmospheric air and was recalibratcd 
at 4 h intervals during main trials. Expired gas volumes (V £) were determined while 
each Douglas bag was evacuated using a dry gas meter (Harvard Apparatus, UK) 
which was routinely checked against a precision 3 I calibration syringe (5530 Hans 
Rudolph Inc., USA). The temperature of expired gases was recorded during 
evacuation using a thermistor probe (Edale type 2984, Model C, UK) and all values 
were converted to the standard temperature and pressure for a dry gas (i.e. O°C and 
760 mmHg). The assumptions of the Haldane transformation (Wilmore and Costill, 
1973) were applied to establish inspired gas volumes (V,) in order that rates of 
oxygen utilisation (VO 2) and carbon dioxide production (V CO,) could be 
calculated (Appendix Di). Using these data, it was then possible to estimate both the 
RER ( V CO, / VO 2) and the relative contributions of carbohydrate and lipid towards 
overall energy expenditure via indirect calorimetry (Appendix Dii). In addition, 
during the study described in Chapter 7, the predicted VO, and VC 0, for protein 
was incorporated into subsequent equations (Appendix Diii) such that non-protein 
respiratory exchange ratios (NPRER) and corrected rates of substrate utilisation could 
be detemlined for the recovery period (Frayn, 1983; Jequier et al., 1987; Weir, 1949). 
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3.5.2 Urine Collection and Analysis 
Urine samples were collected before all mall1 trials and analysed for 
osmolality by freezing point depression using a cryoscopic osmometer (Gonometer 
030, Gonotec, Germany) to assess whether participants were euhydrated upon arrival 
in the laboratory. Adequate hydration was assumed for urine osmolality values below 
900 mosmol·kg- I (Shirreffs and Maughan, 1998a). During the study described in 
Chapter 7, each participant's urine was collected throughout the 4 h recovery period 
and was stored in a vessel containing 5 ml of 10% thymol-isopropanol as a 
preservative. In this study, the total volume of urine produced during recovery was 
recorded and a mixed 5 ml sample of this total volume was stored at -80 QC. As an 
estimate of total urine nitrogen excretion, the urea concentration of this sample was 
determined spectrophotometrically using procedures identical to those applied during 
analysis for plasma urea concentrations (see section 3.5.4.3). Plasma urea 
concentrations were then used to correct urinary urea excretion for changes in the 
total body urea pool (Jequier et al., 1987) and NPRER was calculated according to the 
estimated protein oxidation rate (Frayn, 1983; Weir, 1949). The precise methods and 
equations used in this process are detailed in Appendix Diii .. 
3.5.3 Blood Sampling 
Blood samples were drawn during main trials through an indwelling cannula 
(Venflon, 18G, BOC Ohmeda, Sweden). This cannula was inserted into an 
antecubital vein under local anaesthetic (I % lignocaine, Antigen Pharmaceuticals 
Ltd., Ireland) and was kept patent throughout each trial by frequent flushing with non-
heparinised isotonic saline (0.9% Sodium Chloride, Steripak Ltd., UK). Participants 
were required to stand for 15 min prior to all resting blood samples to reduce the 
effect of body position on localised haemoconcentration and those blood samples 
taken during recovery were drawn prior to each feeding. Of the 10 ml whole blood 
drawn at each sampling point, 5 ml was dispensed into a non-anticoagulant blood 
collection tube (Sarstedt Ltd., UK) where it was left to clot for "A5 min at room 
temperature and centrifuged at 2000 xg for 10 min at 4 QC (Beckman-Coulter Allegra 
X-22R, Germany) before the serum fraction was removed and stored at -80 QC. The 
other 5 ml of whole blood was transferred into another blood collection tube (Sarstedt 
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Ltd., UK) containing the anti-coagulant ethylenediaminetetraacetic acid (EDTA) from 
which 4 x 20 ~I along with 3 x 50 ~I aliquots of blood were removed using 
micropipette tubes and non-heparinised microhaematocrit tubes, respectively 
(Blaubrand, Germany). Two of the 20 ~tl samples of whole blood were deproteinised 
in 2.5% perchloric acid (200 ~I) and centrifuged at 7000 xg for 3 min (Eppendorf 
Centrifuge 5415c, Germany) prior to storage at -80°C, the other 5 aliquotes were 
analysed immediately to determine plasma volume (see section 3.5.4.1). The 
remaining EDT A treated blood was centrifuged at 2000 xg for 10 min at 4 °C 
(Beckman-Coulter Allegra X-22R, Germany) before plasma was abstracted and stored 
at -80°C. 
3.5.4 Blood Analysis 
3.5.4.1 Plasma Volume 
Duplicate 20 ~tl aliquots of EDTA treated whole blood were mixed with 5 ml 
of Drabkin's Reagent (GmbH Diagnostica, Boehringer Mannheim, Germany) and 
haemoglobin concentration was calculated using a standard cyanomethaemoglobin 
method and a spectrophotometer (Shimadzu 1240, Japan) to measure light 
absorbency. Haematocrit was then determined from 3 further 50 ~I aliquots of EDT A 
treated whole blood using a micro-haematocrit centrifuge and reader (Hawksley Ltd., 
UK) to assess packed cell volume. Equations were subsequently applied to these 
haemoglobin and haematocrit values to monitor changes in plasma volume during 
main trials (Dill and Costill, 1974). 
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3.5.4.2 Blood Lactate 
Blood lactate concentrations were detennined Via fluorimetric analysis 
(Locarte 8.9, UK) using 20 ~tl of perchloric acid extract derived from the previously 
deproteinised whole blood samples (Maughan, 1982). The fluorescence of each 
sample was then converted into a blood lactate concentration using a standard linear 
regression programme. The lactate standards used to construct this regression line 
ranged from 0.65 - 13.2 mmol·r' (ABX diagnostics, France), a range which was 
sufficient to encompass all values recorded in this thesis. 
3.5.4.3 Plasma Glucose, Free Fatty Acids, Glycerol, Myoglobin and Urea 
An automated spectrophotometer (COBAS Mira Plus, Roche Diagnostic 
Systems, Switzerland) was used to analyse the absorbency of all plasma samples at 37 
QC using commercially available techniques: glucose (Randox, Ireland); free fatty 
acids (Wako NEFA C, Gemmny); glycerol (Randox, Ireland); myoglobin (Randox, 
Ireland); and urea (Randox Ireland). The principle of this method is that the amount 
oflight absorbed by any sample will be proportional to the concentration of analyte in 
that sample. Prior to each assay, this automated analyser was calibrated against a 
number of commercially available standards (Randox, Ireland; Wako, Gennany) and 
checked against quality controls (Preciset, Boehringer Mannheim, Germany) in both 
the physiological and pathological range. 
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3.5.4.4 Serum Insulin. Cortisol and Growth Hormone 
Commercially available radioimmunoassays (MP Biomedicals Ltd., USA) 
were used to analyse sera for insulin (Coat-Count Insulin), cortisol (Corti-Cote) and 
growth hormone (hGH) using an automated gamma counter (Cobra 5000, Packard 
Instruments, USA). All these assays operate on the principle that the sample antigen 
will compete for a limited number of specific antibody binding sites with the 
radioactive form of that antigen (Iodine-125). The result is an inverse relationship 
between radioactivity and hormone concentration that, when plotted graphically using 
standards (MP Biomedicals Ltd., USA), allows the precise quantification of analyte 
concentration in each sample. These radioimmunoassays were conducted either in the 
Radiochemistry Laboratories at Loughborough University or in the School of 
Biomedical Sciences, Queen's Medical Centre, Nottingham, UK. 
3.5.5 Muscle Biopsy Sampling and Storage 
During the study described in Chapter 7, biopsy samples were taken from the 
vastus lateralis muscle on 3 occasions during each trial. This specific site was 
selected for muscle biopsy sampling because the quadriceps can be assumed to 
contribute substantially during treadmill running. Early evidence suggested that the 
lateral portion of the quadriceps femoris, the gastrocnemius and the lateral gluteals 
contribute equally to running activity (Karlsson and Saltin, 1971). However, while 
total depletion of glycogen in the vastus lateralis has commonly been reported 
following prolonged exhaustive cycling (Hermansen et aI., 1967), it has been 
questioned whether long-distance running focuses a comparable emphasis on the 
quadriceps (Costill et aI., 1974). Indeed, a more recent study has confirmed that 
treadmill running actually elicits a greater rate of muscle glycogen utilisation in the 
triceps surae than in the vastus lateralis (Krssak et al., 2000). Nonetheless, previous 
findings do support the contention that prolonged treadmill running exerts a 
substantial, even if not principal, demand on the quadriceps (Tsintzas et aI., 1996a). 
In concordance with these latter findings, when calculating the total contribution of 
muscle glycogen towards overall metabolism it was assumed that the dry muscle mass 
of both legs was 5% of body mass and that the average glycogen utilisation for these 
limbs was reflected by that observed in the vastus lateralis (Tsintzas et aI., 1996a). 
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Upon completion of RI in the relevant investigation, participants rested in a 
supine position while a 3-5 mm skin incision was made under local anaesthetic (2-3 
ml of 1 % lignocaine, Antigen Pharmaceuticals Ltd., Ireland) using a surgical blade. 
The percutaneous needle biopsy technique (Bergstrom, 1962) was then used to obtain 
between 30 and 100 mg of wet muscle tissue from this site. In a similar manner, a 
further 2 skin incisions were made to the same leg approximately 3 h 45 min later 
such that subsequent biopsies could be acquired after precisely 4 h of recovery and 
then again immediately following R2. During participants first trials, the times 
elapsed between: completion of RI and the first muscle biopsy; the second muscle 
biopsy and the onset of R2; and completion of R2 and the final biopsy, were recorded 
and then matched in each participant's second trial (904 ± 314 s; 548 ± 94 s; and 339 
± 48 s, respectively; mean ± SD). In addition, muscle biopsies were taken from each 
participant's opposite leg during trial 2 and the use of dominant/non-dominant limbs 
was counterbalanced. 
Once removed from the leg, muscle samples were immediately placed in a 
ventilated eppendorf tube and snap-frozen in liquid nitrogen where they were stored 
for ",8 weeks. Upon removal from storage but while still immersed in liquid nitrogen, 
each sample was dissected to remove a 15-20 mg fragment of muscle which was 
placed in a freeze-dryer (Pirani 10, Edwards, UK) for 24 h at -50°C and between -10- 1 
and _10-2 mmHg. Following freeze-drying, the muscle fragments were placed in 
plastic eppendorf tubes and washed with I ml of petroleum ether to remove any 
excess fat before being left to dry In a fume cupboard. All visible blood and 
connective tissue was removed from each fragment using a surgical blade and an 
agate pestle and mortar was used to reduce each sample into a fine powder. The 
resultant powder obtained from each fragment was divided equally between 2 new 
eppendorf tubes and the precise quantity in each was assessed using an electrical 
balance (Mettler AE240, Switzerland). These powdered samples were then stored at -
80°C along with silica gel pending analysis for mixed muscle metabolites. 
87 
Chapter 3 General Methods 
3.5.6 Muscle Biopsy Analysis 
On the first day of analysis, mixed muscle metabolites were extracted by 
adding to each powder sample 100 ,..tl.mg· i of 0.5 mmol.r i perchloric acid (HCI04) 
which also contained I mmol.r i ethylenediaminetatraacetic sodium salt (EDT A.Na2)' 
All samples were then kept on ice for 10 minutes while being agitated regularly using 
a vortex (Stuart Scientific, UK), before centrifugation at 20000 xg for 10 min at 0-4 
°C (Hawk 15/05, Sanyo, USA). A known quantity (>150 /-ll) of sup em at ant (extract) 
was transferred to a new eppendorf tube and the remaining precipitate stored at -80°C 
pending later analysis for insoluble glycogen (i.e. proglycogen). The extracted 
fraction was then quickly neutralised by adding 25 ,..tl of 2.2 mmoJ.r i potassium 
hydrogen carbonate (KHCOJ ) per 100 /-ll of extract. Each sample was then vortexed 
(Stuart Scientific, UK) and left on ice for 5 minutes with lids fitted loosely to pennit 
the liberated CO2 to escape. Litmus paper was used to verify that the reaction had 
completed before samples were centrifuged once again at 20000 xg for 10 min at 0-4 
°C (Hawk 15/05, Sanyo, USA). Finally, the clear supematant (neutralised extract) 
was transferred into a new eppendorf tube and stored at -80°C pending analysis for 
mixed muscle metabolites, based on the calculation that I ml of this neutralised 
extract was equivalent to 8 mg of powdered muscle tissue (Harris et al., 1974). 
All assays were performed within 96 h of extraction. A fraction of the 
neutralised extract was diluted for glucose-6-phosphate (G-6-P), adenosine 
triphosphate (A TP) and phosphocreatine (PCr) analysis in the first 24 h following 
extraction, with analysis for remaining creatine (Cr) being performed a further 24 h 
later. On the third day of analysis, muscle lactate concentrations were measured using 
the undiluted extracts and samples to be used for glycogen analyses were hydrolysed. 
Acid hydrolysis of the soluble fraction of glycogen (i.e. macroglycogen) required the 
addition of 100 /-ll of I mmol·r i hydrochloric acid (HCI) to a 20 ,..tl volume of each 
neutralised extract. Similarly, the insoluble fraction of glycogen (i.e. proglycogen) 
involved adding 100 /-ll of I mmol·r i HCI for every I mg of powder originally 
weighed. These mixtures were then incubated at 100°C in a dry bath (Grant BTS, 
UK) for 2 h, before centrifugation (Eppendorf minispin plus, Germany) for I min at 
I 1000 xg. Following incubation, the soluble fraction was then neutralised with 15 /-ll 
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of sodium hydroxide (NaOH). On the day following acid hydrolysis, the hydrolysed 
extracts and powder pellets were diluted as necessary and total glycogen content was 
determined as the combined glucose concentrations recorded in each (Jansson, 1981). 
Furthermore, the glucose concentration in the condensed neutralised extracts was also 
assessed in order that the soluble glycogen concentrations could be corrected for any 
free glucose within muscle. 
The relative concentrations of all the metabolites cited above were determined 
according to the methods described by Harris et al. (1974) using a spectrophotometric 
plate reader (SpectraMax 190, Molecular Devices, USA). These methods are based 
on enzyme catalysed reactions with the coenzymes NAD+ and NADP+ being 
simultaneously reduced to NADH and NADPH, respectively (or vice versa in the case 
of the creatine assay). Using the coefficient of extinction of NADH and NADPH, 
metabolite concentrations can therefore be calculated from the change in sample 
absorbency in relation to double-distilled water blanks (Rnase free H20, Sigma-
Aldrich Ltd., UK) using the equations presented in Appendix E. All buffers, co-
factors, standards and enzymes were prepared immediately prior to each assay using 
Grade-! chemicals and all samples were analysed at least in duplicate (both glycogen 
assays in triplicate). Standards were prepared to a speci tied molarity and, where 
necessary, metabolite concentrations were adjusted according to the calculated result. 
Finally, to account for any contamination of the muscle samples with blood, fat or 
connective tissue, all metabolites other than lactate were normalised in relation to 
each participant's mean total creatine (PCr + Cr) across both trials. All muscle 
metabolite data are reported as units·kg dry mass'! to avoid changes in concentration 
due to fluid shift during exercise. A more detailed account of all muscle analysis 
procedures including relevant stochiometry, calculations and corrections is provided 
in Appendix E. 
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3.5.7 Subjective Data 
Participants' sensations of fatigue were monitored during all exercise sessions 
using a rating of perceived exertion (RPE) scale as described by Borg (1973). The 
RPE scale is graded from 6-20, with these numbers being anchored by expressions 
ranging from 7 being 'Very, very light' to 20 which infers 'Maximum' effort 
(Appendix Bi). Both heart rate and relative exercise intensity have been found to 
correlate positively with the RPE (Borg, 1973). Furthermore, to assess each 
participant's perceptions of gut fullness and thirst, 2 adapted versions of the 
conventional RPE scale were constructed such that the anchor terms ranged from' not 
full' and 'not thirsty' to 'very very full' and 'very very thirsty', respectively 
(Appendices Bii and Biii). 
3.6 Intra-Assay Variation 
Coefficients of variation (CV = SD/mean x I 00) were calculated to evaluate 
the error variation present in each assay. The CV for each analyte that was measured 
during the current series of studies is presented in Table 3.1, with these calculations 
arising from the results of at least 10 separate analyses of a given sample. However, 
due to the limited availability of muscle tissue, the CV for muscle glycogen represents 
the variance across triplicate absorbencies when averaged for all participants. 
Table 3.1: Coefficient of variation for each assay. 
Analyte Method CV (%) 
Lactate Fluorometry 2.0 
Haemaglobin Spectrophotometry 0.6 
Glucose Spectrophotometry 1.2 
Free Fatty Acids Spectrophotometry 0.5 
Glycerol Spectrophotometry 1.0 
Urea Spectrophotometry 1.8 
Myoglobin Spectrophotometry 1.3 
Insulin Radioimmunoassay 7.4 
Cortisol Radioimmunoassay 4.8 
Growth Hormone Radioimmunoassay 4.4 
Urine Osmolality Osmometry 0.4 
Proglycogen Spectrophotometry 1.5 
Macroglycogen Spectrophotometry 1.4 
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3.7 Standardisation Procedures 
3.7.1 Ambient Conditions 
The ambient temperature and humidity in the laboratory were controlled 
where possible such that all main trials were performed under simi lar conditions 
between treatments. A whirling hygrometer (Zeal, UK) was operated in close 
proximity to the treadmill every 30 min to measure the wet and dry bulb temperatures 
in this area of the laboratory. Relative humidity was then calculated from the 
difference between these 2 readings. A wall mounted barometer (Griffin and George 
BHL-340-X, UK) was used to monitor atmospheric pressure at regular intervals 
during trials so that expired gases could be corrected to standard volumes at 760 
mmHg. 
3.7.2 Dietary Control 
To ensure that each participant's nutritional status was standardised between 
experimental conditions, each participant was provided with a dietary record book 
(Appendix C) and weighing scales (Salter 3007, UK) with which to record their 
dietary intake over the 48 h prior to their first main trial. This diet was then strictly 
adhered to over the 48 h prior to subsequent main trials. Each dietary record was 
assessed using a nutritional software package (COMP-EA T 4.0, Nutritional Systems, 
UK) to calculate both total energy intake and a profile of various macronutrients, 
vitamins and minerals. In addition, participants were required to abstain from 
consuming both alcoholic and caffeinated drinks over the 48 h prior to main trials. 
All food intake ceased at 10 pm on the night before main trials and participants fasted 
overnight, consuming only water in order to remain adequately hydrated. 
91 
Chapter 3 General Methods 
3.7.3 Habitual Training 
While participants were permitted to continue the majority of their habitual 
training throughout the testing period, strenuous exercise was avoided in the week 
leading up to each main trial. Participants were asked to record any low-intensity 
training that was performed during this period prior to trial 1 and then repeat this 
activity pattern in preparation for ensuing trials. However, due to the demanding 
nature of the investigations described in this thesis, all physical exertion was entirely 
prohibited during the 48 h prior to any visit to the laboratory. 
3.8 Statistical Analyses 
Any data in this thesis which required a single comparison of 2 level 
measurements was tested for normality of distribution using a Shapiro-Wilk test to 
examine the respective mean and median of each respective trial. A paired t-test with 
a 1 sided significance level was then applied to those data sets deemed to be normally 
distributed, while any data requiring a non-parametric statistical method was assessed 
using a Wilcoxon test. Where multiple comparisons were necessary, a 2 way general 
linear model for repeated measures (Drink x Time) was used to identify differences 
between experimental conditions, regardless of normality, since the type 1 error rate 
of this model is usually close to the nominal value even when data are non-normally 
distributed (Maxwell and Delaney, 1990, p. 109). The degrees of freedom for all 
significant F values were Greenhouse-Geisser corrected for epsilon <0.75, while the 
Huynh-Feldt correction was adopted for less severe asphericity (Atkinson, 2001); the 
F values quoted in the text reflect interaction effects unless main/time effects are 
specifically stated. Where a significant interaction effect was identified, comparisons 
between the level means of interest were made using multiple paired t-tests to 
determine the location of variance. The Holm-Bonferroni step-wise method was then 
used to prevent these multiple comparisons inflating the type 1 error rate (Atkinson, 
2002; Ludbrook, 1998). 
A Priori statistical power tests were conducted to determine the number of 
participants required in each study to provide at least an 80% power of correctly 
rejecting the null hypothesis and every effort was made to attain the necessary sample 
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sIze. No order effects were detected between trials for any variable. All statistical 
analyses were perfonned using commercially available software (SPSS 11.0, USA) 
and significance was accepted at the P :;; 0.05 level. Unless otherwise stated, all data 
are expressed in text as mean ± SEM. Specifically, descriptive data are expressed as 
mean ± SD because no inference to the target population is intended, while non-
nonnally distributed data are expressed as median and range. 
The error bars displayed on figures are confidence intervals (Cl) that have 
been corrected for the repeated measures design to remove between subject variance 
(Masson and Loftus, 2003). These normalised confidence intervals' are computed 
using an equation (Appendix G) that incorporates the same error term as was involved 
during statistical testing. The magnitude of these confidence intervals therefore 
directly infers the difference between means in the target population (i.e. statistical 
significance) and not the variance of individual values around the mean. Due to the 3 
trial study design described in Chapter 6, the confidence intervals included in this 
chapter were corrected for violations of sphericity. This correction was made as 
described above using either Greenhouse-Geisser or Huynh-Feldt epsilons to reduce 
the relevant degrees of freedom for the omnibus error tenn, thus maintaining a valid 
reflection of the overall pattern across all 3 means. However, regarding the run times 
observed in Chapter 6, it was of particular theoretical interest to illustrate the 
comparisons between the CHO-PRO trial and each other trial independently. Thus, 
on this figure (6.3, p. 158) the specific error tenns from each contrast were used to 
calculate separate pairs of confidence intervals for each comparison (Loftus and 
Masson, 1994). 
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CHAPTER 4 
Chapter 4 Study I 
The Influence of Carbohydrate-Protein Mixtures on 
Recovery of Running Capacity. 
4.1 Introduction 
It has been established that exercise capacity during exercise of moderate to 
high intensity is closely related to the magnitude of pre-exercise muscle glycogen 
stores and that fatigue during such exercise often coincides with muscle glycogen 
depletion (Ahlborg et al., 1967; Bergstrom et aI., 1967). These findings have placed 
great focus on the detem1ination of nutritional strategies to maximise pre-exercise 
muscle glycogen concentrations (Ivy, 1991; Tsintzas and Williams, 1998). 
While exhaustive exercIse has been shown to stimulate muscle glycogen 
resynthesis independent of nutritional interventions (Bergstrom and Hultman, 1966; 
Zachwieja et aI., 1991), ingesting carbohydrate during recovery is known to enhance 
the rate of post-exercise muscle glycogen resynthesis (Bergstrom et al., 1967). More 
recent experimental data has now revealed the optimum amount (Ivy et aI., 1988b; 
Wong and Williams, 2000), timing (Ivy et aI., 1988a; Parkin et aI., 1997) and type 
(Blom et al., 1987; Burke et aI., 1993; Reed et al., 1989) of carbohydrate intake 
required to effectively promote recovery. The most rapid rates of muscle glycogen 
resynthesis for a 4-6 h recovery have now been reported slightly in excess of 40 
mmol·kg dry mass,l·h,1 following ingestion of 1.2 g CHO·kg,l·h,1 at 30 min intervals 
(van Loon et aI., 2000a). However, it has been suggested that a 'glycogen synthesis 
threshold' may occur at this optimal level- of carbohydrate intake (Jentjens and 
Jeukendrup, 2003) and attention has subsequently focused on the possibility that 
ingesting a mixed macronutrient supplement may accelerate the rate of muscle 
glycogen resynthesis beyond this threshold (Zawadzki et al., 1992). 
Early evidence revealed that the ingestion of carbohydrate plus protein can 
stimulate pancreatic insulin secretion to a greater extent than ingestion of either 
substrate alone (Rabinowitz et aI., 1966). These initial findings have now been 
extended and the precise mixtures of various amino acids and proteins with the 
greatest insulinotropic properties have been identified (van Loon et al., 2000b; van 
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Loon et al., 2000c). There are 2 mechanisms through which these elevated insulin 
concentrations may increase the rate of muscle glycogen synthesis. Firstly, insulin 
can stimulate an increased rate of glucose uptake into the muscle cell both through 
translocating glucose transporters (GLUT4) to the cell membrane (McCoy et al., 
1996; Rudich and Klip, 2003) and potentially also through increasing the intrinsic 
activity of these glucose transporters (Furtado et al., 2003; Somwar et al., 2001). 
Secondly, insulin is known to convert the rate limiting enzyme for glycogenesis 
(glycogen synthase) into its active form, thus facilitating the conversion of glucose-6-
phosphate into glycogen (Danforth, 1965; Markuns et al., 1999). 
The study of Zawadzki et al. (1992) demonstrated both an elevated insulin 
concentration and a 38% greater rate of muscle glycogen resynthesis when a 
carbohydrate-protein (CHO-PRO) mixture was ingested during a 4 h recovery rather 
than carbohydrate (CHO) alone (Zawadzki et aI., 1992). However, the CHO-PRO 
supplement provided in this study contained 43% more energy than the CHO 
supplement; the energy content of a supplement has since been found to enhance 
muscle glycogen storage irrespective of macronutrient composition (Roy and 
Tamopolsky, 1998). Nonetheless, these early findings suggesting a beneficial effect 
of adding protein to carbohydrate recovery solutions have been corroborated by some 
more recent studies (Fogt and Ivy, 2000; Ivy et al., 2002; van Loon et al., 2000a), 
although other studies have found similar rates of muscle glycogen resynthesis 
following either CHO or CHO-PRO ingestion (Jentjens et aI., 2001; Van Hall et aI., 
2000a; Van Hall et al., 2000b). Furthermore, other authors have reported that CHO-
PRO mixtures fail even to elevate insulin release to a greater extent than solutions 
containing CHO alone (Carrithers et al., 2000; Ivy et al., 2002; Tamopolsky et al., 
1997; Wojcik et al., 2001). 
Given the previously described correlation between exercise capacity and pre-
exercise muscle glycogen content (Ahlborg et aI., 1967; Bergstrom et aI., 1967), it is 
reasonable to assume that any supplement increasing the rate of glycogen resynthesis 
during recovery might also restore the capacity for aerobic exercise more rapidly. 
While information on this topic is certainly limited, evidence from Williams et al. 
(2003) has supported that the addition of protein to a carbohydrate solution can 
enhance recovery of exercise capacity during continuous cycling. However, the 55% 
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greater time to exhaustion at an intensity of 85% VO,max reported in this study may 
be attributable to the quantity of carbohydrate included in each supplement. 
Specifically, the CHO-PRO solution provided in this study contained more 
carbohydrate than the solution containing CHO alone (Williams et al., 2003). 
Therefore, the malll aIm of this first study was to determine whether the 
ingestion of a CHO-PRO solution results in a more rapid recovery of running capacity 
at 85% VO,max than a solution containing a matched quantity of CHO (1.2 g 
CHO·kg-l·h- l) without any additional protein. 
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4.2 Methods 
4.2.1 Participants 
Nine healthy male participants volunteered to take part in this study. These 
individuals participated in a wide range of sporting activities but all reported running 
to represent a substantial component of their habitual training. The physiological 
characteristics of these participants are presented in Table 4.1. 
Table 4.1: Participant details. 
Characteristic 
Age (yr) 
Height (m) 
Mass (kg) 
V0 2 max (ml·kg,l·min,l) 
4.2.2 Experimental Design 
Mean± SD 
21 ± I 
1.81±0.1 
79.6 ± 11.2 
60±4 
Participants performed 2 main trials in a randomised, counterbalanced design 
that were separated by at least I week and applied in a double blind manner. A 2 day 
dietary record was completed over the 48 h prior to trial I and then the same diet was 
consumed prior to trial 2 (2458 ± 670 kcal·day'l, 53 ± 9% CHO, 25 ± 6% fat, 19 ± 5% 
protein: mean ± SD), Each main trial involved a 90 min run at 70% V0 2 max (RI) 
followed by a 4 h recovery. During the recovery period, participants rested while 
consuming either CHO alone or a CHO-PRO mixture before a treadmill run to 
exhaustion was performed at an intensity of 85% VO, max (R2). 
4.2.3 Experimental Protocol 
A schematic representation of the experimental protocol is included in Figure 
4.1. All participants arrived in the laboratory between 8-8.30 am following a 10 h 
overnight fast and completed a pre-trial consent form (Appendix Aii). After 
providing a urine sample, each participant's post-void nude body mass was recorded 
(A very Ltd., UK) before a cannula was inserted into an antecubital vein and a 10 ml 
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resting venous blood sample obtained. The cannula was kept patent throughout each 
trial by frequent flushing with isotonic saline. Prior to exercise, the Douglas bag 
technique was used to collect a 5 min resting expired gas sample (Williams and Nute, 
1983). Participants were required to stand for 15 min prior to the collection of all 
resting gas and blood samples. A 5 min run at 60% VO 2 max was used as a 
standardised warm-up prior to running at a speed equivalent to 70% VO, max for 90 
min (RI). One minute expired gas samples, heart rates (Polar 8810, Finland) and RPE 
(Borg, 1973) followed by 10 ml venous blood samples were taken at 30 min intervals 
throughout RI. Water intake was permitted ad Iibitlllll during trial I and matched in 
trial 2 (0.46 ± 0.15 I; mean ± SO). Nude body mass was recorded immediately 
following RI to assess hydration status through percentage change in mass. 
The first volume of prescribed solution was provided as soon as post RI nude 
body mass had been recorded. The remaining 7 volumes were provided at 30 min 
intervals during the 4 h recovery such that the last solution was ingested 30 min prior 
to R2, participants were permitted 15 min to consume each volume. Expired gas 
samples and venous blood samples, along with ratings of gut fullness and thirst (6-20 
scale; Appendices Bii and Biii), were taken during the recovery period every hour 
prior to feedings. Nude body mass was again recorded and, after the standard warm-
up, participants began the run to exhaustion at 85% VO 2 max (R2) with any 
background music and verbal encouragement being standardised between trials 
(Atkinson et aI., 2004). As in RI, water intake was ad Iibitlll1l during trial I and 
matched in trial 2 (0.12 ± 0.05 I; mean ± SO). Physiological measurements were 
obtained at regular intervals (10 min) and at the point of volitional fatigue. Nude 
body mass was recorded immediately after R2, again to assess hydration status 
through changes in body mass. Ambient temperature and humidity were recorded at 
30 min intervals throughout all testing periods using a hygrometer (Zeal, UK) and 
were not different between trials. Average values recorded across both trials were 
22.6 ± 1.9 DC and 42.3 ± 6.7% (mean ± SO). Full details of all sampling and analysis 
are included in the General Methods section 3.5. 
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Figure 4.1: A schematic representation of the experimental protocol. Key: * = 
solution provision, # = expired gas sample/blood sample & RPE, t = body mass, 
hatched area = warm-up (5 min at 60% VO, max), open area = RI (90 min at 70% 
VO, max) and closed area = R2 (85% VO, max until volitional exhaustion). 
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4.2.4 Solution Composition 
The CHO and CHO-PRO supplements were both 9.3% carbohydrate solutions 
composed of 6.2% glucose and 3.1% fructose (GlaxoSmithKline, UK). These 
solutions were provided in matched volumes between trials (1031 ± 144 ml·h·1; mean 
± SO) relative to each participant's body mass such that both solutions provided a 
matched quantity of carbohydrate (1.2 g CHO·kg·1·h·1). Participants in this study 
therefore ingested a total of 382 ± 54 g CHO during recovery (mean ± SO). The 
CHO-PRO solution included an additional 1.5% (0.2 g PRO·kg·1·h·1) of wheat protein 
hydrolysate (Hyprol 4107, Quest International, The Netherlands), rich in peptide 
bound glutamine (i.e. ~6: I carbohydrate-protein ratio). Thus, 64 ± 9 g PRO (mean ± 
SO) was ingested during recovery, which made approximately 16.7% more energy 
available for metabolism in the CHO-PRO trial (4.8 versus 5.6 kcal·kg·1·h·1). The 
specific amino acid profile of the wheat protein hydrolysate is included in Figure 4.2. 
These solutions were taste matched (orange and passion fruit flavour). 
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Figure 4.2: Amino acid profile of the wheat protein hydrolysate added to CHO 
solutions during CHO·PRO trials. (N.B: approximately 90% of the glutamic acid and 
aspartic acid fraction comprise glutamine and asparagine). 
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4.2.5 Statistical Analyses 
The exercise capacity data of Williams et af. (2003) were utilised to estimate 
that a sample size of 9 has a 94% power to detect a difference in means of 11.1 min, 
assuming a SO of differences of approximately 9.4, using a paired t-test with a I sided 
significance level. The exercise capacity data recorded during R2 were found to be 
non-normally distributed and a Wilcoxon test was therefore applied to compare the 
median run times between trials, along with any other ordinal/discrete variables (i.e. 
RPE, gut fullness and thirst) requiring non-parametric statistical analysis. Paired t-
tests were used to analyse the incremental area under curve data that was calculated to 
assess the glycaemic and insulinaemic responses to each solution during recovery 
(Wolever, 2004). A 2 way general linear model for repeated measures (Drink x 
Time) was used to identify differences between experimental conditions. The 
Greenhouse-Geisser correction was utilised for epsilon <0.75, while the Huynh-Feldt 
correction was adopted for less severe asphericity. Where significant F values were 
found, the Holm-Bonferroni step-wise correction was applied to determine the 
location of variance where necessary (Atkinson, 2002; Ludbrook, 1998). Unless 
otherwise stated, all data are expressed in text as mean ± SEM and the error bars 
included on figures are confidence intervals (Cl) that have been corrected to remove 
between subject variance (Masson and Loftus, 2003). Specific details of, and 
justification for, these statistical methods are included in the General Methods section 
3.8. 
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4.3 Results 
4.3.1 Exercise Capacity 
The recovery of exercise capacity was not different following ingestion of the 
CHO-PRO solution than following ingestion of CHO alone (Effect size = 0.3) and 
was highly variable between participants. Median run times to exhaustion at 85% 
VO, max (R2) were 14.5 (7-57) min during the CHO trial and 18 (7-72) min during 
the CHO-PRO trial (Figure 4.3). 
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Figure 4.3: Run times to exhaustion for each individual during R2 following 
ingestion of either CHO or CHO-PRO during recovery (n = 9). 
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4.3.2 Serum Insulin 
Serum insulin concentrations were higher during the CHO-PRO trial than 
during the CHO trial (main effect: F = 6.8, P = 0.03; Figure 4.4). The values 
observed during recovery were then converted into an insulinaemic response 
(Appendix F), expressed as incremental area under the curve. In concordance with 
the observed main effect, this insulinaemic response was also higher in the CHO-PRO 
trial than in the CHO trial (P = 0.02; Figure 4.5). 
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Figure 4.4: Serum insulin concentrations during R}, recovery and R2• Participants (n 
= 9) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 
min R2 n = 4). Values are means ± Cl and are different between trials (P = 0.03). To 
convert from SI units into ~IU·mrl divide by 6.95. 
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Figure 4.5: Insulinaemic responses during 4 h recovery (n = 9). Values are means ± 
cr and * denotes values different between trials (P = 0.02). To convert from SI units 
into mJU·mr 1 divide by 6.95. 
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4.3.3 Plasma Glucose 
Plasma glucose concentrations were not statistically different between the 
CHO and CHO-PRO treatments at any time point (Figure 4.6) although a slightly 
lower peak concentration after 1 h of recovery was apparent when ingesting the CHO-
PRO mixture. In both trials, the blood samples taken 10 min into R2 revealed glucose 
concentrations to be below 3.5 mmol·r l for most participants and there was an 
insignificant trend for this hypoglycaemia to be more severe during the CHO trial 
than during the CHO-PRO trial. When the incremental area under the curve during 
recovery was calculated for this glucose data, the resultant glycaemic response did not 
identify any differences between the experimental treatments (Figure 4.7). 
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Figure 4.6: Plasma glucose concentrations during RI, recovery and R2. Participants 
(n = 9) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 
min R2 n = 4). Values are means ± Cl. 
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Figure 4.7: Glycaemic responses during 4 h recovery (n = 9). Values are means ± Cl. 
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4.3.4 Plasma Urea 
Plasma urea concentrations began to dissociate between trials after 
approximately 1 h of recovery and were significantly greater (F = 6.7, P = 0.01) 
during R2 following ingestion ofCHO-PRO rather than CHO (Figure 4.8). 
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Figure 4.8: Plasma urea concentrations during RI, recovery and R2. Participants (n = 
9) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 min 
Rz n = 3). Values are means ± Cl and * denotes values different between trials (P ~ 
0.02). 
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4.3.5 Plasma Free Fatty Acids and Glycerol 
Ingestion of either the CHO or the CHO-PRO solutions did not effect free 
fatty acid or glycerol concentrations differently between trials. Concentrations of 
both metabolites increased gradually during RI before decreasing sharply upon 
ingestion of the first carbohydrate mixture, thereafter remaining close to zero 
throughout the recovery period (Figures 4.9 and 4.10). 
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Figure 4.9: Plasma free fatty acid concentrations during RI, recovery and R2. 
Participants (n = 9) received either CHO or CHO-PRO supplements during recovery. 
(N.B: at 10 min R2 n = 4). Values are means ± Cl. 
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Figure 4.10: Plasma glycerol concentrations during RI, recovery and R2. Participants 
(n = 9) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 
min R2 n = 4). Values are means ± Cl. 
III 
-------------
Chapter 4 Study I 
4.3.6 Blood Lactate 
Blood lactate concentrations increased slightly upon commencement of RI and were 
maintained at approximately 1.5 mmol·r l throughout this exercise session and the 
subsequent recovery period. These values increased during R2 such that samples 
taken immediately post-exercise had reached concentrations of 5.0 ± 0.3 mmol.r l 
during the CHO trial and 4.4 ± 0.4 mmoJ.r 1 during the CHO-PRO trial. However, 
there were no statistical differences between the CHO and CHO-PRO treatments 
(Figure 4.11). 
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Figure 4.11: Blood lactate concentrations during RI, recovery and R2. Participants (n 
= 9) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 
min R2 n = 4). Values are means ± Cl. 
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4.3.7 Substrate Metabolism 
The estimated contributions of lipid and carbohydrate oxidation towards 
overall energy expenditure were not different between the CHO and CHO-PRO trials 
(Table 4.2). However, the respiratory exchange ratio (RER) tended to be lower 
during the CHO-PRO trial than during the CHO trial, although this difference could 
not be detected statistically (main effect: F = 4.7, P = 0.06). 
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Table 4.2: Substrate metabolism and respiratory exchange ratios during RI, recovery and R2• Participants (n = 9) received either CHO or CHO-PRO 
supplements during recovery (N.B: at 10 min R2 n = 4). Values arc means ± SEM. 
Carbohydrate 
oxidation (g.min- I ) 
CHO 
CHO-PRO 
Lipid oxidation (g.min- I ) 
CHO 
CHO-PRO 
RER 
CHO 
CHO-PRO 
Prc 
0.3±0.1 
0.3±0.1 
0.1±0.02 
0.1±0.02 
30 min 
3.0±0.4 
2.9±0.3 
0.4±0.1 
O.S±O.I 
Run I 
60 min 90 min I hr 
2.7±0.4 2.8±0.3 0.4±0.1 
2.6±0.3 2.S±0.3 0.4±0.1 
0.6±0.1 0.6±0.1 0.l±0.02 
0.6±0.1 0.7±0.1 0.1±0.02 
Recovery Run 2 
2 hr 3 hr 4 hr 10 min Last min 
0.4±0.1 0.S±0.04 0.S±0.04 4.3±0.3 4.8±0.4 
0.4±0.1 O.S±O.I O.S±O.I 4.2±0.6 4.6±0.4 
0.1±0.01 0.04±0.01 0.03±0.01 0.0 l±0.0 1 0.l±0.03 
0.l±0.01 0.l±0.02 0.1±0.0 1 0.l±0.04 0.2±0.1 
O.88±004 O.90±O.OI O.89±O.02 O.89±O.OI O.94±O.03 O.95±O.03 O.97±O.02 O.98±O.02 I.02±O.02 I.Ol±O.OI 
0.87±0.03 0.90±0.01 0.89±0.01 0.88±0.01 0.90±0.02 0.90±0.02 0.93±0.02 0.9S±0.02 0.99±0.02 0.98±0.01 
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4.3.8 Serum Cortisol 
Serum cortisol concentrations were not different between the CHO and CHO· 
PRO treatments. Levels of this hormone increased during RI before decreasing in the 
latter stages of recovery and then, primarily in the CHO trial, elevating once again at 
the end of R2 (Figure 4.12). 
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Figure 4.12: Serum cortisol concentrations during Rh recovery and R2• Participants 
(n = 9) received either CHO or CHO·PRO supplements during recovery. (N.B: at 10 
min R2 n = 4). Values are means ± Cl. 
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4.3.9 Plasma Myoglobin 
Concentrations of myoglobin increased with both exercise sessions (RI and 
Rz) and decreased slightly during recovery. This profile was unifonn between the 
CHO and CHO·PRO treatments (Figure 4.13). 
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Figure 4,13: Plasma myoglobin concentrations during RI, recovery and R2. 
Participants (n = 8) received either CHO or CHO·PRO supplements during recovery. 
(N.B: insufficient degrees of freedom to construct Cl at 10 min Rz, n = 4). Values are 
means ± Cl. 
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4.3.10 Indices of Hydration Status 
Urine osmolality was 747 ± 344 mosmol·kg· 1 prior to CHO trials and 797 ± 
319 mosmol·kgol prior to CHO-PRO trials (mean ± SO), this difference was not 
statistically significant. Changes in each participant's body mass (BM) revealed 
losses in the CHO trial of -1.7 ± 0.2% BM in RI and -0.8 ± 0.2% BM in R2. Similar 
shifts in hydration status were recorded during the CHO-PRO trials: -1.7 ± 0.2% BM 
(RI) and -1.0 ± 0.3% BM (R2). Fluctuations in plasma volume during main trials 
were not different between the CHO and CHO-PRO treatments (Figure 4.14) but an 
effect of time was established (F = 5.4, P = 0.004). 
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Figure 4.14: Changes in plasma volume during RI, recovery and R2. Participants (n 
= 9) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 
min R2 n = 4). Values are means ± Cl and t denotes values different from baseline (P 
~ 0.02). 
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4.3.11 Subjective Data 
The RPE indicated by participants (scale 6-20) during both RI and R2 were not 
different between the CHO and CHO-PRO trials. Likewise, thirst ratings during the 
recovery and R2 were unaffected by the independent variable. However, the 
cumulative rating for gut fullness throughout each trial was greater following 
ingestion ofCHO-PRO as opposed to ingesting CHO alone (P = 0.02; Table 4.3). 
Table 4.3: Subjective ratings of gut fullness during recovery and R2. Participants 
(n = 9) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 
min R2 n = 4). Values are means ± SEM and are different between trials (P = 0.02). 
Gut Fullness (scale 6-20) 
CHO 
CHO-PRO 
4.3.12 Control Data 
I h 
9±1 
9±1 
Recovery Run 2 
2h 3h 4h 10 min Last min 
II±I II±I 12±1 12±1 12 ± I 
13 ± I 13±1 14±1 15±1 12±2 
The intensity of exercise performed in the CHO and CHO-PRO trials was controlled 
and kept consistent between each participant's first and second trial. Ouring RI the 
average relative exercise intensity was 71.0 ± 4% VO,max in the CHO trial and 71.3 
± 3% VO, max in the CHO-PRO trial (mean ± SO). This intensity was increased for 
R2 but remained similar between trials: CHO = 84.0 ± 5.7% VO, max and CHO-PRO 
= 85.6 ± 2.8% VO, max (mean ± SO). Accordingly, mean heart rates were very 
similar between trials and were 169 ± 10 beats·min-I overall during RI and 182 ± 6 
beats·min- I overall during R2 (mean ± SO). 
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4.4 Discussion 
The main finding of this study was that exercise capacity following 4 h of 
recovery from prolonged exercise was similar following ingestion of either a CHO 
solution or an identical solution with added protein. However, the addition of protein 
did result in a higher insulinaemic response during recovery, although no associated 
effect on plasma glucose concentrations was apparent. 
A higher rate of glycogen resynthesis during recovery will result in a larger 
pre-exercise glycogen availability, therefore it is reasonable to assume that this may 
be reflected in an enhanced capacity to perform subsequent exercise (Ahlborg et al., 
1967; Bergstrom et al., 1967). The improved cycling capacity following CHO-PRO 
rather than CHO ingestion observed by Williams et al. (2003) was attributed to the 
increased rate of muscle glycogen storage during recovery. Given the similarity of 
run times in the present study it might be concluded that glycogen accumulation 
occurred at similar rates in the CHO and CHO-PRO trials. However, since glycogen 
concentrations were not directly measured in this investigation, it cannot be ruled out 
that factors other than muscle glycogen depletion may have contributed to eventual 
fatigue. Indeed, recent evidence using IlC magnetic resonance spectroscopy to 
quantify both muscle and liver glycogen has indicated that, when individuals perform 
(\ 
repeated exercise sessions with a limited (i.e. 4 h) recovery, the depletion of liver 
glycogen may be the principle factor initiating fatigue (Casey et aI., 2000). 
While the data presented in section 4.3.10 negates the suggestion that 
dehydration directly influenced time to exhaustion during R2, it remains a possibility 
that an accumulation of metabolic by-products may have contributed to fatigue. 
Blood lactate values immediately following R2 were 5.0 ± 0.3 mmoJ.r 1 (CHO) and 
4.4 ± 0.4 mmol·r l (CHO-PRO), which may suggest significant intramuscular 
accumulation of metabolic by-products that are associated with high-intensity activity 
(e.g. hydrogen ions, lactate, inorganic phosphate and adenosine diphosphate). These 
metabolites can potentially induce fatigue both through an inhibition of key glycolytic 
enzymes (Chasiotis et aI., 1983a; Sulton et aI., 1981; Trivedi and Danforth, 1966) and 
through interference with excitation-contraction coupling (Allen and Westerblad, 
2001; Nakamaru and Schwartz, 1972). The present results may therefore suggest that 
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factors other than carbohydrate availability contributed to fatigue during the treadmill 
run to exhaustion (R2)' Clearly, if fatigue during this second run was primarily the 
consequence of increased anaerobic metabolism rather than compromised substrate 
availability, then this may question the validity of a capacity test at 85% V0 2 max as 
a proxy measure for muscle glycogen availability. However, there is evidence that 
increased pre-exercise muscle glycogen availability can improve exercise capacity 
even at maximal and supra-maximal workloads (Maughan and Poole, 1981; Pizza et 
aI., 1995), possibly due to an enhancing effect of muscle glycogen either on H+ 
buffering capacity or fibre excitability (Stephenson et aI., 1999). 
If the run times recorded during R2 were in fact dictated by pre-exercise 
muscle glycogen content, then it is important to elucidate why the rate of muscle 
glycogen resynthesis would be similar between the CHO and CHO-PRO trials when 
the insulinaemic responses were different. It would be expected that the higher 
insulin concentrations following CHO-PRO ingestion should increase glucose uptake 
into muscle and also the conversion of this glucose into glycogen. However, plasma 
glucose concentrations were not di fferent between trials which may suggest that 
glucose uptake occurred at a similar rate under both experimental conditions. One 
possibility is that the rate of glucose uptake was already maximal following ingestion 
of 1.2 g CHO·kg-1h- 1 (Carrithers et aI., 2000; Jentjens et al., 2001; van Loon et aI., 
2000a). If this were the case then it becomes understandable why the additional 
protein might fail to increase both glucose uptake and glycogen resynthesis, since 
insulin would no longer be a rate limiting factor for these processes (Jentjens et al., 
200 I). 
The sharp fall in plasma glucose concentrations upon commencement of R2 
was interpreted as 'rebound' hypoglycaemia in response to the combination of high 
carbohydrate intake and the commencement of exercise. In agreement with the 
literature (Jentjens et al., 2003; Moseley et aI., 2003), this challenge to glucose 
homeostasis was quickly compensated for and would therefore not be expected to 
contribute to eventual fatigue. However, the observed trend for higher glucose values 
at 10 min R2 following ingestion of CHO-PRO rather than ingestion of CHO (3.8 ± 
0.5 versus 2.9 ± 0.4 010101·]"1, respectively) may be of physiological relevance in 
terms of skilled performance since many participants were noticeably less alert at this 
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stage of the CHO trial. The mechanism underlying this improved maintenance of 
plasma glucose availability in the CHO-PRO trial may be an increased hepatic 
glucose output. In support of this, the elevated plasma urea concentrations following 
CHO-PRO ingestion could indicate an increased deamination of the exogenously 
provided amino acids in the liver, thus supplying carbon for synthesis of glucose 
through gluconeogenesis (Wahren et a/., 1973). 
r 
The observed increase in urea concentrations upon ingestion of the CHO-PRO 
solutions may also help explain the observed trend towards a lower respiratory 
exchange ratio (RER) during the CHO-PRO trial than during the CHO trial (main 
effect: P = 0.06). The indirect calorimetric method used to estimate both rates of 
substrate metabolism and the RER assumes protein metabolism to be negligible. 
However, it is likely that ingestion of the CHO-PRO solution increased amino acid 
catabolism in the liver, thus simultaneously overestimating lipid metabolism (i.e. 
reducing the RER) and increasing urea production. 
Participants' reported perceptions of gut fullness were more intense when the 
CHO-PRO solution was ingested during recovery than when the CHO solution was 
ingested, possibly as a consequence of a delayed rate of gastric emptying. In general, 
intact protein is thought to empty from the stomach slower than carbohydrate 
(Thomas, 1957) and certain amino acids are known to inhibit intestinal absorption 
(van Loon et al., 2000b). In a more recent study, however, isoenergetic glucose or 
soy protein hydrolysate solutions were instilled into the stomach and similar rates 
both of gastric emptying and intestinal absorption were observed via gastric aspiration 
and deuterium oxide tracer methods, respectively (Maughan et al., 2004). 
Conversely, increased energy density has consistently been shown to delay gastric 
emptying (Vist and Maughan, 1995, 1994) and it is therefore likely that any 
impairment of gastric emptying rate following CHO-PRO ingestion in the present 
study would arise from the increased energy content of this solution rather than the 
specific macronutrient composition. It is therefore also conceivable that the slightly 
reduced peak in plasma glucose following CHO-PRO ingestion may reflect a more 
gradual appearance of exogenous glucose from the gastrointestinal tract. 
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In conclusion, consumption of the CHO-PRO solutions elicited greater serum 
insulin concentrations during recovery than consumption of CHO alone. The 
glycaemic response was not different between the CHO and CHO-PRO trials, 
possibly because the provision of 1.2 g CHO·kg· 1 h,1 alone was sufficient to stimulate 
maximal rates of glucose uptake. Ultimately, the conclusion of this study is that, 
converse to the findings of Williams et al. (2003) involving continuous cycling, 
treadmill running capacity was not improved by CHO-PRO ingestion any more 
effectively than following ingestion of CHO alone. 
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Carbohydrate-Protein Ingestion During Recovery: 
Effect of Carbohydrate Amount. 
S.l Introduction 
A previous study by Williams el al. (2003) has indicated that ingestion of a 
carbohydrate-protein supplement (CHO-PRO) during short-term recovery (i.e <8 h) 
may promote a more rapid restoration of exercise capacity than a supplement 
containing carbohydrate (CHO) with no additional protein. Since exercise capacity is 
believed to correlate positively with the magnitude of pre-exercise muscle glycogen 
stores (Ahlborg el al., 1967; Bergstrom el al., 1967), the improved time to exhaustion 
following CHO-PRO was attributed to the increased rate of glycogen resynthesis 
observed during recovery (Williams et al., 2003). However, it remains unclear 
whether the increased rate of glycogen resynthesis and concomitant ergogenic benefit 
reported by Williams et at. (2003) was the result of the additional protein or a product 
of the higher carbohydrate content of the CHO-PRO supplement. Therefore, the 
previous study of this thesis compared the effects of a CHO-PRO solution and a CHO 
solution on recovery of exercise capacity but when the solutions were matched for 
carbohydrate content (i.e. 1.2 g CHO·kg'\·h'\). 
The data recorded during this initial study revealed serum insulin 
concentrations to be higher while ingesting the CHO-PRO solution during recovery 
rather than while ingesting CHO alone. In contrast, plasma glucose responses did not 
appear to be influenced differently between trials and exercise capacity subsequent to 
recovery was also similar between the CHO-PRO and CHO treatments. There is 
currently inconsistency within the literature regarding the effect of ingesting CHO-
PRO during recovery on muscle glycogen resynthesis (Ivy el at., 2002; Jentjens et al., 
200 I) and some authors have suggested that these inconsistencies may be resolved 
through an identification of the precise quantities of carbohydrate included in CHO-
PRO supplements (Carrithers et aI., 2000; Jentjens et al., 2001; van Loon et aI., 
2000a). Specifically, it appears that the rate of muscle glycogen resynthesis has most 
commonly been accelerated following the addition of protein to ,.; 0.8 g CHO·kg'\.h'\ 
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(Ivy et aI., 2002; van Loon et al., 2000a; Zawadzki et aI., 1992) while adding protein 
to 21.2 g CHO·kg-1.h-1 has produced no such effect (Jentjens et al., 2001; Van Hall et 
al.,2000b). 
This suggestion leaves open the possibility that reducing the rate of 
carbohydrate ingestion below that applied during Study 1 might be less likely to 
maximise the rate of muscle glycogen resynthesis during recovery. Reducing the rate 
of muscle glycogen resynthesis in response to carbohydrate ingestion alone might 
therefore provide some scope for the additional protein to exert a positive influence 
on recovery. In concordance with this possibility, the study described in this chapter 
replicated the procedures of Study I exactly except that the CHO and CHO-PRO 
solutions that were ingested during recovery provided carbohydrate in amounts likely 
to be insufficient to maximise the rate of muscle glycogen resynthesis (i.e. 0.8 g 
CHO-kg-1h-1). It was therefore hypothesised that the additional protein would 
enhance the sub-optimal rate of muscle glycogen resynthesis expected in response to 
CHO ingestion alone and that this enhancement would be manifested as an increased 
capacity for physical exercise subsequent to recovery. 
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5.2 Methods 
5.2.1 Participants 
All 7 participants who volunteered to take part in this study were healthy 
males and included running as part of their habitual training. The physiological 
characteristics of these participants are presented in Table 5.1. 
Table 5.1: Participant details 
Characteristic 
Age (yr) 
Height (m) 
Mass (kg) 
VO, max (ml.kg·l·min· l) 
5.2.2 Experimental Design 
Mean + SD 
22 ± 0.5 
1.83 ± 0.1 
83.5 ± 11.8 
55 ± 4 
Each participant performed 2 main trials separated by at least I week in a 
randomised and counterbalanced design whereby interventions were applied in a 
double blind manner. Over the 48 h prior to participants' first trial a dietary record 
was completed and then the same diet was consumed prior to trial 2 (3623 ± 1630 
kcal·day"l, 49 ± 8% CHO, 30 ± 8% fat, 21 ± 3% protein: mean ± SD). Each of these 
main trials involved a 90 min run at 70% VO, max (RI) followed by a 4 h recovery, 
during which participants rested in the laboratory while consuming either CHO alone 
or a CHO-PRO mixture. Exercise capacity was then assessed as run-time to 
exhaustion at an intensity of 85% VO, max (R,). 
5.2.3 Experimental protocol 
The experimental procedures applied during this study were identical to those 
described in Chapter 4 and a schematic representation of this protocol is included on 
page 100. All participants arrived in the laboratory between 8-8.30 am following a 10 
h overnight fast and were asked to complete a pre-trial consent form (Appendix Aii). 
After providing a urine sample, each participant's post-void nude body mass was 
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recorded (Avery Ltd., UK) before a cannula was inserted into an antecubital vein and 
a 10 ml resting venous blood sample obtained. The cannula was kept patent 
throughout each trial by frequent flushing with isotonic saline. Prior to exercise, the 
Douglas bag technique was used to collect a 5 min resting expired gas sample 
(Williams and Nute, 1983). Participants were required to stand for 15 min prior to the 
collection of all resting gas and blood samples. A 5 min run at 60% \10, max was 
used as a standardised warm-up prior to running at a speed equivalent to 70% 
\lO,max for 90 min (RI)' One minute expired gas samples, heart rates (Polar 8810, 
Finland) and RPE (Borg, 1973) followed by 10 ml venous blood samples were taken 
at 30 min intervals throughout RI. Water intake was permitted ad libitum during trial 
I and matched in trial 2 (1.24 ± 0.42 I; mean ± SO). Nude body mass was recorded 
immediately following RI to assess hydration status through percentage change in 
mass. 
The first volume of prescribed solution was provided as soon as post RI nude 
body mass had been recorded. The remaining 7 volumes were provided at 30 min 
intervals during the 4 h recovery such that the last solution was ingested 30 min prior 
to R2, participants were permitted 15 min to consume each volume. Expired gas 
samples and venous blood samples, along with ratings of gut fullness and thirst (6-20 
scale; Appendicies Bii and Biii), were taken during the recovery period every hour 
prior to feedings. Nude body mass was again recorded and, after the standard warm-
up, participants began the run to exhaustion at 85% \10, max (R2) with any 
background music and verbal encouragement being standardised between trials 
(Atkinson et al., 2004). As in RI, water intake was ad libitulIl during trial I and 
matched in trial 2 (0.50 ± 0.33 I; mean ± SO). Physiological measurements were 
obtained at regular intervals (10 min) and at the point of volitional fatigue. Nude 
body mass was recorded immediately after R2, again to assess hydration status 
through changes in body mass. Ambient temperature and humidity were recorded at 
30 min intervals throughout all testing periods using a hygrometer (Zeal, UK) and 
were not different between trials. Average values recorded were 23.2 ± 1.3 °C and 
43.1 ± 5.7% (mean ± SO). Full details of all sampling and analysis are included in the 
General Methods section 3.5. 
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5.2.4 Solution Composition 
The CHO and CHO-PRO solutions ingested during this study were identical to 
those provided during Study 1 (i.e. 9.3% carbohydrate solutions: 6.2% glucose and 
3.1 % fructose). However, the total volume of solution provided relative to each 
participant's body mass was reduced in the current investigation (722 ± 102 ml·h-1) 
such that a lower quantity of carbohydrate was ingested (0.8 g CHO·kg· 1 h-1). 
Therefore, the total amount of carbohydrate provided during recovery was 267 ± 38 g 
(mean ± SD). The protein fraction was also the same as in Study 1 (l.5%) resulting in 
a lower relative quantity of protein being ingested (0.13 g PRO·kg·1·h-1) but 
maintaining the carbohydrate-protein ratio at ~6: 1. Again, including this additional 
quantity of protein (43 ± 6 g in total; mean ± SD) made approximately 16.7% more 
energy available in the CHO-PRO mixture (3.7 kcal·kg-1.h-1) than in the solution 
containing CHO alone (3.2 kcal·kg·1.h·1). As before, the CHO and CHO-PRO 
solutions were taste matched (orange and passion fruit flavour) and the amino acid 
profile of the CHO-PRO solution is included in Chapter 4 (Figure 4.2, p. 102). 
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5.2.5 Statistical Analyses 
The exercise capacity data of Williams et al. (2003) were utilised to estimate 
that a sample size of 7 has an 87% power to detect a difference in means of 11.1 min, 
assuming a SO of differences of approximately 9.4, using a paired t-test with a I sided 
significance level. The exercise capacity data recorded during R2 were found to be 
non-normally distributed and a Wilcoxon test was therefore applied to compare the 
median run times between trials, along with any other ordinal/discrete variables (i.e. 
RPE, gut fullness and thirst) requiring non-parametric statistical analysis. Paired t-
tests were used to analyse the incremental area under curve data that was calculated to 
assess the glycaemic and insulinaemic responses to each solution during recovery 
(Wolever, 2004). A 2 way general linear model for repeated measures (Drink x 
Time) was used to identify differences between experimental conditions. The 
Greenhouse-Geisser correction was utilised for epsilon <0.75, while the Huynh-Feldt 
correction was adopted for less severe asphericity. Where significant F values were 
found, the Holm-Bonferroni step-wise correction was applied to determine the 
location of variance where necessary (Atkinson, 2002; Ludbrook, 1998). Unless 
otherwise stated, all data are expressed in text as mean ± SEM and the error bars 
included on figures are confidence intervals (Cl) that have been corrected to remove 
between subject variance (Masson and Loftus, 2003). Specific details of, and 
justification for, these statistical methods are included in the General Methods section 
3.8. 
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5.3 Results 
5.3.1 Exercise Capacity 
There was no difference in exercise capacity following ingestion of the CHO 
or CHO-PRO solutions (Effect size = 0.1) and a large degree of inter-individual 
variability was apparent. Median run times to exhaustion at 85% VO 2 max (R2) were 
18 (12-52) min during the CHO trial and 19.5 (15-35) min during the CHO-PRO trial 
(Figure 5.1). 
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Figure 5.1: Run times to exhaustion for each individual during R2 following 
ingestion of either CHO or CHO-PRO during recovery (n = 7). 
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5.3.2 Serum Insulin 
Ingestion of CHO-PRO produced greater serum insulin concentrations than 
ingestion of CHO alone (F = 4.1, P = 0.02) and post hoc statistical analysis of this 
data revealed that differences reached statistical significance after 3 h of recovery (P 
= 0.03; Figure 5.2). However, this finding of higher insulin concentrations with 
CHO-PRO ingestion rather than CHO ingestion was consistent for the entire duration 
of recovery and the insulinaemic response for the 4 h period reflected this pattern (P = 
0.01; Figure 5.3). 
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Figure 5.2: Serum insulin concentrations during RI, recovery and R2. Participants (n 
= 7) received either CHO or CHO-PRO supplements during recovery. (N.B: 
insufficient degrees of freedom to construct Cl at 10 min R2, n = 4). Values are 
means ± Cl and * denotes values different between trials (P = 0.03). To convert 
from SI units into fllU·mr l divide by 6.95. 
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Figure 5.3: Insulinaemic responses during 4 h recovery (n = 7). Values are means ± 
Cl and * denotes values different between trials (P = 0.01). To convert from SI units 
into mlU·mr l divide by 6.95. 
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5.3.3 Plasma Glucose 
Glucose concentrations peaked in both trials after 1 h of recovery and 
gradually reduced over the remaining 3 h (Figure 5.4). While no significant 
differences between trials were identified at any specific sampling point, there was a 
trend for more a more rapid reduction in plasma glucose concentrations while 
ingesting the CHO·PRO rather than the CHO solutions. This trend resulted in a 
significantly lower glycaemic response with the CHO·PRO trial when expressed as 
incremental area under the glucose concentration curve for the entire recovery (P = 
0.02; Figure 5.5). After 10 min of subsequent exercise (R2), plasma glucose 
concentrations had fallen to 3.5 ± 0.3 mmoJ.r 1 in the CHO trial and 3.9 ± 0.2 mmol·r l 
in the CHO·PRO trial, although these values were not significantly different from the 
concentrations recorded at baseline. 
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Figure 5.4: Plasma glucose concentrations during RI, recovery and R2. Participants 
(n = 7) received either CHO or CHO·PRO supplements during recovery. (N.B: at 10 
min R2 n = 5). Values are means ± Cl. 
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Figure 5.5: Glycaemic responses during 4 h recovery Cn = 7). Values are means ± Cl 
and * denotes values different between trials (P = 0.02). 
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5.3.4 Plasma Urea 
During the CHO-PRO trial, plasma urea concentrations began to increase 
immediately upon ingestion of the first solution and had reached a concentration of 
6.7 ± 0.4 mmol.r i by the end of Rz. Conversely, after 1 h of ingesting the CHO 
solution, plasma urea concentrations decreased such that values were 5.6 ± 0.3 
mmoH i after Rz (Figure 5.6). Although a strongly significant interaction effect was 
identified (F = 11.6, P < 0.001), the mean effects at any given time point were not 
large enough to attain statistical significance. Notably, however, significant effects 
could be revealed at 3 h, 4 h and Post Rz (P ~ 0.02) if the data was normalised to 
remove baseline differences between treatments. 
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Figure 5.6: Plasma urea concentrations during RI, recovery and Rz. Participants (n = 
7) received either CHO or CHO-PRO supplements during recovery. (N.B: 
insufficient degrees of freedom to construct Cl at 10 min Rz, n = 5). Values are 
means ± Cl. 
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5.3.5 Plasma Free Fatty Acids and Glycerol 
Free fatty acid and glycerol concentrations increased with each exercise 
session and were reduced substantially during feeding. There were no differences in 
the concentrations of either metabolite between the CHO and CHO-PRO treatments 
(Figures 5.7 and 5.8). 
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Figure 5.7: Plasma free fatty acid concentrations during RI, recovery and R2. 
Participants (n = 7) received either CHO or CHO-PRO supplements during recovery. 
(N.B: at 10 min Rz n = 5). Values are means ± Cl. 
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Figure 5.8: Plasma glycerol concentrations during RI, recovery and R2. Participants 
(n = 7) received either CHO or CHO·PRO supplements during recovery. (N.B: at 10 
min R2 n = 5). Values are means ± Cl. 
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5.3.6 Blood Lactate 
No differences were found between the blood lactate concentrations recorded 
during the CHO and CHO-PRO trials. Concentrations increased slightly above 
baseline during RI and recovery before further increasing during R2 (Figure 5.9). 
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Figure 5.9: Blood lactate concentrations during RI, recovery and R2. Participants (n 
= 7) received either CHO or CHO-PRO supplements during recovery. (N.B: 
insufficient degrees of freedom to construct Cl at 10 min R2, n = 5). Values are 
means ± Cl. 
5.3.7 Substrate Metabolism 
The respiratory exchange ratio (RER) along with estimations of carbohydrate 
and lipid metabolism were not different between the CHO and CHO-PRO trials. 
Total metabolism of both substrates increased during RI and then decreased during 
feeding. Metabolism of lipid remained minimal during the second exercise session 
(R2) while carbohydrate metabolism again increased during exercise (Table 5.2). 
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Table 5.2: Substrate metabolism and respiratory exchange ratios during RI, recovery and R2. Participants (n = 7) received either CHO or CHO-PRO 
supplements during recovery (N.B: at 10 min R2 n = 6). Values are means ± SEM. 
Carbohydrate 
oxidation (g.min- I ) 
CHO 
CHO-PRO 
Lipid oxidation (g.min- I ) 
CHO 
CHO-PRO 
RER 
CHO 
CHO-PRO 
Pre 
0.3±0.1 
0.3±0.03 
0.1±0.02 
0.1±0.02 
30 min 
3.2±0.2 
3.0±0.2 
0.3±0.1 
0.3±0.04 
Run I 
60 min 
2.8±0.2 
2.8±0.1 
O.S±O.I 
O.S±O.I 
90 min I hr 
2.S±0.2 0.3±0.04 
2.8±0.2 0.3±0.1 
0.6±0.1 0.1±0.02 
0.S±0.04 0.1 ±0.03 
Recovery Run 2 
2 hr 
0.3±0.04 
0.4±0.1 
0.1±0.01 
0.1±0.02 
3 hr 4 hr 10 min Last min 
0.4±0.1 0.S±0.04 4.4±0.3 4.S±0.3 
0.4±0.04 O.S±O.I 4.7±0.3 4.7±0.3 
0.1±0.01 0.04±0.01 0.1±0.07 0.1±0.1 
0.1±0.02 0.04±0.02 0.04±0.03 0.03±0.03 
0.86±0.03 0.9S±0.01 0.92±0.01 0.90±0.01 0.86±0.02 0.88±0.01 0.91±0.02 0.96±0.01 1.02±0.02 1.01±0.02 
0.91±0.04 0.94±0.01 0.92±0.01 0.91±0.01 0.86±0.03 0.89±0.02 0.90±0.02 0.97±0.02 1.03±0.02 1.03±0.02 
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5.3.8 Serum Growth Hormone 
Serum concentrations of human growth hormone were very similar during 
CHO and CHO-PRO trials. The increases observed during RI were reduced to 
baseline levels upon ingestion of the first solution. Concentrations then elevated 
again when the second exercise bout (R2) was initiated (Figure 5.10). 
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Figure 5.10: Serum growth hormone concentrations during RI, recovery and R2. 
Participants (n = 7) received either CHO or CHO-PRO supplements during recovery. 
(N.B: insufficient degrees of freedom to construct Cl at 10 min R2, n = 4). Values are 
means ± Cl. 
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5.3.9 Serum Cortisol 
Serum cortisol concentrations were not different between main trials at any 
time point, concentrations elevated with increasing exercise duration in both RI and 
Rz but declined over time during recovery (Figure 5.11). 
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Figure 5.11: Serum cortisol concentrations during RI, recovery and Rz. Participants 
(n = 7) received either CHO or CHO·PRO supplements during recovery. (N.B: 
insufficient degrees of freedom to construct Cl at 10 min Rz, n = 5). Values are 
means ± Cl. 
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5.3.10 Plasma Myoglobin 
There were no differences In plasma myoglobin concentrations following 
either CHO or CHO-PRO ingestion (Figure 5.12). Concentrations reached 14.3 ± 2.8 
nmol·r l (CHO) and 18.2 ± 4.2 nmol·r l (CHO-PRO) 1 h following RI before reducing 
gradually during the remainder of recovery and finally increasing to concentrations of 
20.4 ± 5.0 nmol·r l (CHO) and 21.3 ± 6.4 nmol·r l (CHO-PRO) immediately following 
R2. 
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Figure 5.12: Plasma myoglobin concentrations during RI, recovery and R2. 
Participants (n = 7) received either CHO or CHO-PRO supplements during recovery. 
(N.B: insufficient degrees of freedom to construct Cl at 10 min R2, n = 5). Values are 
means ± Cl. 
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5.3.11 Indices of Hydration Status 
The urine osmolality measurements made prior to main trials did not reveal 
any differences between the CHO and CHO-PRO trials: 724.9 ± 331.5 mosmol·kg·1 
and 639.3 ± 83.3 mosmol·kg· 1 (mean ± SO), respectively. Changes in body mass 
(BM) during RI were -lA ± 0.2% BM in the CHO trial and -1.6 ± 0.2% BM in the 
CHO-PRO trial. During R2, a decrease of -0.8 ± 0.2% BM was recorded both in the 
CHO and CHO-PRO trials. Figure 5.13 illustrates the changes in plasma volume 
throughout each trial, there were no differences between the CHO and CHO-PRO 
treatments but an effect of time was established (F = 9.0, P = 0.001). 
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Figure 5.13: Changes in plasma volume during RI, recovery and R2. Participants (n 
= 7) received either CHO or CHO-PRO supplements during recovery. (N.B: 
insufficient degrees of freedom to construct Cl at 10 min R2, n = 5). Values are 
means ± Cl and t denotes values different from baseline (P S 0.003). 
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5.3.12 Subjective Data 
Participants' subjective ratings of perceived exertion (scale 6-20) increased 
steadily during R, to eventual values of 14.7 ± 0.6 in the CHO trial and 14.7 ± 0.5 in 
the CHO-PRO trial. The higher intensity of Rz was reflected by increased sensations 
of perceived effort, with ratings noted in the final minute of this run being 17.9 ± 0.3 
(CHO) and 17.7 ± 0.4 (CHO-PRO). There were no statistical differences between 
these scores. Neither were differences apparent between trials for any other 
subjective variables. Perceptions of thirst were found to decrease during recovery and 
increase during Rz, while gut fullness increased during recovery and decreased 
slightly during subsequent exercise (Table 5.3). 
Table 5.3: Subjective ratings of gut fullness during recovery and Rz. Participants 
(n = 7) received either CHO or CHO-PRO supplements during recovery. (N.B: at 10 
min R2 n = 6). Values are means ± SEM. 
Gut Fullness (scale 6-20) 
CHO 
CHO-PRO 
5.3.13 Control Data 
Recovery Run 2 
I h 2h 3 h 4h 10 min Last min 
10±1 II±I 12±1 II±I II±I 10 ± I 
10 ± I 9±1 9±1 II±I 10±1 10±2 
The average exercise intensities of R, (mean ± SO) were 71.1 ± 2.1 % 
VO, max and 70.5 ± 3.1% VO, max in the CHO and CHO-PRO trials, respectively. 
The exercise intensities elicited for Rz were 84.8 ± 2.7% VO 2 max in the CHO trial 
and 86.6 ± 4.4% VO, max in the CHO-PRO trial (mean ± SO). Heart rates recorded 
during these periods were almost identical between the CHO and CHO-PRO trials, 
overall averaging 164 ± 11 beats·min·' during R, and 178 ± 8 beats·min·' during R2 
(mean ± SO). 
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5.4 Discussion 
The ingestion of the CHO-PRO mixture during 4 h of recovery from 
prolonged exercise did not enhance subsequent exercise capacity any more effectively 
than ingesting a solution containing a matched quantity of carbohydrate alone. 
Insulin concentrations were higher during recovery while ingesting the solution with 
added protein and glycaemic responses during this period were lower following 
ingestion of CHO-PRO as opposed to ingestion of CHO. 
The amount of carbohydrate provided was reduced from 1.2 g CHO·kg-1h-1 
(Study I) to the amount provided in the current investigation (i.e. 0.8 g CHO·kg-l·h- l) 
in concordance with the suggestion that ingesting 1.2 g CHO·kg-l·h-1 may be 
sufficient to maximise glucose uptake even without protein (Carrithers et aI., 2000; 
Jentjens el aI., 2001; van Loon el al., 2000a). In contrast to the results of the earlier 
study, the present results revealed glycaemic responses to be lower while ingesting 
the CHO-PRO solution rather than the CHO solution. This finding is in agreement 
with the findings of other authors (Ivy el al., 2002; Van Hall el aI., 2000a; Van Hall el 
al., 2000b; van Loon el al., 2000a; Zawadzki el al., 1992) and may indicate an 
increased rate of glucose uptake, potentially stimulated by the elevated insulin 
concentrations during the CHO-PRO trial. However, this suggestion can only be 
made tentatively since blood glucose concentration actually provides a reflection of 
whole body glucose turnover and not glucose uptake per se. Indeed, Van Hall el al. 
(2000b) report that the lower glucose concentrations they observed following CHO-
PRO rather than CHO ingestion were not the product of an increased rate of glucose 
uptake, although it should be noted that the amount of carbohydrate provided in the 
above study (1.25 g CHO·kg-l·h· l) was probably sufficient to maximise glucose 
transport irrespective of the inclusion of protein (Van Hall el aI., 2000b). 
Those studies which have reported higher insulin and lower glucose 
concentrations following the addition of protein to ~0.8 g CHO·kg-l·h-1 have all found 
the rate of muscle glycogen resynthesis to be enhanced during recovery in comparison 
with ingestion of the carbohydrate fraction alone (Ivy el aI., 2002; Van Hall el al., 
2000a; van Loon el al., 2000a; Zawadzki el al., 1992). In light of these findings, it is 
possible that insulin may only represent a rate limiting factor for glycogen resynthesis 
145 
Chapter 5 Study 2 
when carbohydrate provision is insufficient to elicit maximal GLUT4 migration to the 
muscle cell membrane (Jentjens et al., 2001; Van Hall et aI., 2000b). Since the 
amount of carbohydrate provided in the present study would not be expected to 
maximise glucose uptake, the higher insulinaemic response to the additional protein 
might have accelerated the rate of glycogen resynthesis during recovery. It is 
therefore interesting that exercise capacity was similar between trials despite the 
observed differences in insulin concentrations. 
While it remains a possibility that the rate of muscle glycogen resynthesis was 
111 fact similar between treatments, another plausible interpretation would be that 
fatigue during the capacity test did not coincide with muscle glycogen depletion. 
Assuming the latter interpretation to be true, any differences between trials in the rate 
of muscle glycogen resynthesis would not necessarily be manifested as an improved 
exercise capacity during Rz. Similar to Study I, the possibility cannot be refuted that 
fatigue during R2 was actually the product of either inhibited glycolysis (Chasiotis et 
al., 1983a; Sutton et al., 1981; Trivedi and Danforth, 1966) or impaired excitation-
contraction coupling (Alien and Westerblad, 200 I; Nakamaru and Schwartz, 1972). 
Blood lactate concentrations immediately following the run to exhaustion at 85% 
VO,max were 6.6 ± 1 mmol·r l in the CHO trial and 7.1 ± 0.9 mmoIT 1 in the CHO-
PRO trial which may reflect an increased accumulation of metabolic by-products 
within active muscle fibres (i.e. hydrogen ions, lactate, inorganic phosphate and 
adenosine diphosphate). Although some evidence does support an ergogenic benefit 
of improved muscle glycogen availability even when the causes of fatigue originate 
primarily from anaerobic glycolysis (Maughan and Poole, 1981; Pizza et al., 1995; 
Stephenson et al., 1999), it has been suggested that prolonged exercise capacity tests 
(i.e. 2:90 min) at lower relative exercise intensities might provide a more valid 
reflection of pre-exercise muscle glycogen concentrations since fatigue would be 
more likely to coincide with depletion of these stores (Hawley et aI., 1997b). 
A common feature to both the current results and those presented in Chapter 4 
is the relatively low plasma glucose concentrations recorded during R2. After 10 min 
of this second exercise session, plasma glucose had fallen to concentrations of 3.5 ± 
0.3 mmol·r l and 3.9 ± 0.2 mmol-l"l in the CHO and CHO-PRO trials, respectively. 
However, this 'rebound' hypoglycaemia was a transient response to the onset of 
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exercise following feeding and would therefore not be expected to contribute to 
eventual fatigue (Jentjens et al., 2003; Moseley et aI., 2003). As discussed in Chapter 
4, the rise in plasma urea concentrations following CHO-PRO ingestion may reflect 
an increased deamination of amino acids in the liver. This would liberate a-keto 
acids for hepatic glucose production through gluconeogenesis, potentially 
supplementing plasma glucose concentrations during R2. 
Overall, the results of this study demonstrate that the addition of protein to a 
carbohydrate solution can enhance the insulinaemic effect of this solution during 
recovery from prolonged exercise. Ingestion of the CHO-PRO solution was also 
associated with lower plasma glucose concentrations during recovery than ingestion 
of CHO alone, possibly indicating an increased rate of glucose uptake into muscle. 
Exercise capacity subsequent to recovery was similar following ingestion of the CHO 
and CHO-PRO solutions, which may suggest that factors other than carbohydrate 
availability contributed to fatigue during R2• This conclusion is in agreement with the 
view that pre-exercise muscle glycogen availability may not dictate exercise capacity 
in tests lasting only ",20 min (Hawley et aI., 1997b). Furthennore, there is evidence 
that exercise capacity tests conducted at intensities in excess of ",80% VO 2 max may 
not be reliable (Krebs and Powers, 1989). This might explain the relatively large 
within subject variance in run times both in the current study and in Study 1, which 
would support the view that a full familiarisation with such high intensity capacity 
tests may be necessary to reveal a treatment effect (Hopkins et al., 2001). In addition, 
the large between subject variation in both studies might also indicate that not all of 
the participants in these investigations were exercising at the same relative exercise 
intensity during R2, possibly as a result of using a progressive incline VO, max 
protocol to detemline relative exercise intensities during level running (SI. Clair 
Gibson et al., 1999). Clearly, given that an intensity of 85% VO, max is likely to 
have been close to most participants' anaerobic threshold, even a very minor 
overestimation of VO 2 max could impact considerably upon metabolism during that 
exercise. It is therefore proposed that an exercise capacity test at a lower relative 
exercise intensity (e.g. 70% VO, max) might identify any ergogenic effect of the 
CHO-PRO solution more reliably whilst also providing a more valid reflection of 
muscle glycogen resynthesis rates during recovery. 
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Recovery of Prolonged Running Capacity 
Following Ingestion of Carbohydrate Plus Protein. 
6.1 Introduction 
Exercise capacity during exercise of moderate to high intensity is positively 
correlated with the availability of muscle glycogen and fatigue during such exercise 
often coincides with depletion of this energy source (Ahlborg et aI., 1967; Bergstrom 
et al., 1967). Given this relationship, it is therefore reasonable to assume that any 
supplement which increases the rate of muscle glycogen resynthesis during recovery 
will also restore the capacity for aerobic exercise more rapidly. Carbohydrate 
ingestion has been demonstrated to accelerate the rate of muscle glycogen resynthesis 
following prolonged exercise (Bergstrom et aI., 1967; Ivy, 1998) and to promote a 
more rapid recovery of endurance capacity (Fallowfield et aI., 1995). Furthermore, 
there is some evidence that adding protein to more moderate carbohydrate loads 
(';0.8 g CHO, kg'l. h- I ) may further enhance the glycogenic effect of such solutions 
(Fogt and Ivy, 2000; van Loon et al., 2000a; Zawadzki et aI., 1992). 
The effect of additional protein on muscle glycogen storage probably 
originates from the synergistic influence of carbohydrate and amino acids on insulin 
secretion (Floyd et al., 1970a, 1970b; Rabinowitz et al., 1966) and it appears that the 
precise quantity of protein provided will determine the extent of insulin release (van 
Loon et al., 2000e). Adding 2:0.3 g. kg'l. h- I of mixed amino acids has been 
consistently found to substantially enhance the insulinotropic effect of carbohydrate 
solutions (Jentjens et aI., 2001; Van Hall et al., 2000a; Van Hall et aI., 2000b; van 
Loon et al., 2000a; Zawadzki et aI., 1992), while studies that have added less than this 
amount of protein have reported a considerably smaller influence on insulin response 
(Carrithers et aI., 2000; Ivy et aI., 2002; Ivy et aI., 2003). In addition, it is likely that 
the magnitude of insulinaemic response to any given quantity of protein will be 
strongly dependent on the specific amino aeid profile of that protein (van Loon et aI., 
2000b). 
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Williams et al. (2003) have recently reported a 128% greater rate of muscle 
glycogen storage when their participants ingested CHO-PRO as opposed to CHO 
alone throughout a 4 h recovery. Participants in this study were then able to cycle 
55% longer during a subsequent exercise capacity test following CHO-PRO ingestion, 
although this ergogenic effect may largely be attributed to the increased amount of 
carbohydrate provided by the CHO-PRO supplement (Williams et aI., 2003). 
Similarly, Saunders et al. (2004) have reported an increased cycle time to exhaustion 
following ingestion of CHO-PRO rather than CHO during a more prolonged recovery 
period (12-15 h). However, while the solutions in this study were matched for 
carbohydrate content, the CHO-PRO solution contained 25% more energy and it 
therefore remains to be established whether the improved performance was the 
consequence of this additional energy or the presence of protein per se (Saunders et 
aI., 2004). 
The total energy content of a supplement is known to influence muscle 
glycogen synthesis regardless of the inclusion of protein (Roy and Tarnopolsky, 
1998). For example, van Loon et al. (2000a) have demonstrated increased rates of 
muscle glycogen resynthesis when protein is added to a carbohydrate solution, while 
replacing a fraction of the carbohydrate with protein (i.e. isoenergetic supplements) 
produced no such effect (van Loon et al., 2000a). In a similar study, Ivy et al. (2002) 
found CHO-PRO ingestion to produce greater rates of muscle glycogen resynthesis 
not only in comparison with a carbohydrate matched solution but also a solution 
matched for total energy content (Ivy et al., 2002). 
The aIm of the current study was to examme the effect of increasing the 
energy content of a standard CHO solution, either through adding protein or including 
further carbohydrate. This experimental design was therefore able to assess the CHO-
PRO mixture in comparison with a carbohydrate matched solution while 
simultaneously evaluating whether an isoenergetic solution would produce similar 
effects. Thus, it can be established whether the proposed effect of such supplements 
on muscle glycogen resynthesis (Ivy et al., 2002; van Loon et al., 2000a) can be 
translated into a comparable effect on exercise capacity. 
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6.2 Methods 
6.2.1 Participants 
Six healthy men volunteered for this study, all of whom included 6 ± 2 
h·weekl of endurance exercise as part of their habitual training. The physiological 
characteristics of these participants are presented in Table 6.1. 
Table 6.1: Participant details 
Characteristic 
Age (yr) 
Height (m) 
Mass (kg) 
VO, max (ml·kg,l·min'l) 
6.2.2 Experimental Design 
Mean + SO 
21 ± 2.6 
l.77±0.1 
72.6 ± 8,4 
61 + 7 
Each participant performed 3 main trials in a randomised, counterbalanced 
design that were separated by at least I week and applied in a double blind manner. A 
dietary record was completed over the 48 h prior to trial 1 and then participants were 
asked to adhere to this diet prior to subsequent trials (2497 ± 535 kcal·day'l, 53 ± 9% 
CHO, 31 ± 9% fat, 16 ± 3% protein: mean ± SO). These main trials involved a 90 
min run at 70% VO,max (RI) followed by a 4 h recovery. During recovery, 
participants rested in the laboratory while ingesting either: a carbohydrate-protein 
mixture; a solution containing a moderate amount of carbohydrate (0,8 g CHO·kg,l·h' 
I); or a solution containing a high amount of carbohydrate (l.1 g CHO·kg,l·h,I), The 
latter 2 solutions matched the former for carbohydrate and for total energy, 
respectively. Exercise capacity was subsequently assessed as run-time to exhaustion 
at an intensity of 70% VO, max (R2). 
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6.2.3 Experimental protocol 
The experimental protocol adopted for this study is illustrated graphically in 
Figure 6.1. All participants arrived in the laboratory between 8-8.30 am following a 
10 h overnight fast and were asked to complete a pre-trial consent form (Appendix 
Aii). After providing a urine sample, each participant's post-void nude body mass 
was recorded (Avery Ltd., UK) before a cannula was inserted into an antecubital vein 
and a 10 ml resting venous blood sample obtained. The cannula was kept patent 
throughout each trial by frequent flushing with isotonic saline. Prior to exercise, the 
Douglas bag technique was used to collect a 5 min resting expired gas sample 
(Williams and Nute, 1983). Participants were required to stand for 15 min prior to the 
collection of all resting gas and blood samples. A 5 min run at 60% VO, max was 
used as a standardised warm-up prior to running at a speed equivalent to 70% 
VO,max for 90 min (RI)' One minute expired gas samples, heart rates (Polar 8810, 
Finland) and RPE (Borg, 1973) followed by 10 ml venous blood samples were taken 
at 30 min intervals throughout RI. Water intake was permitted ad libitum during trial 
I and matched during ensuing trials (0.50 ± 0.38 I; mean ± SO). Nude body mass was 
recorded immediately following RI to assess hydration status through percentage 
change in mass. 
The first volume of prescribed solution was provided as soon as post RI nude 
body mass had been recorded. The remaining 7 volumes were provided at 30 min 
intervals during the 4 h recovery such that the last solution was ingested 30 min prior 
to R2, participants were pemlitted 15 min to consume each volume. Expired gas 
samples and venous blood samples, along with ratings of gut fullness and thirst (6-20 
scale; Appendices Bii and Biii), were taken during the recovery period every hour 
prior to feedings. Nude body mass was again recorded and, after the standard warm-
up, participants began the run to exhaustion at 70% VO, max (R2) with any 
background music and verbal encouragement being standardised between trials 
(Atkinson et aI., 2004). As in RI, water intake was ad libitum during trial I and 
matched in subsequent trials (0.76 ± 0.52 I; mean ± SD). Physiological measurements 
were obtained at 3 time points during the capacity test (10 min, 30 min and 60 min) 
and at the point of volitional fatigue. When participants first indicated that they could 
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no longer continue to run at the required intensity, the treadmill speed was reduced to 
4.4 km·h- I for a period of 2 min. Thereafter, the speed was increased to the previously 
applied intensity (i.e. 70% VO 2 max) and the exercise test resumed. This process was 
repeated on the second occasion that participants could not maintain the required 
exercise intensity and only on the third occasion was a final expired air collection 
made, volitional exhaustion accepted, and run time recorded. The post R2 blood 
sample was drawn immediately following the point of volitional fatigue (i.e. within 30 
s) and nude body mass was recorded within 5 min, again to assess hydration status 
through changes in body mass. Ambient temperature and humidity were recorded at 
30 min intervals throughout all testing periods using a hygrometer (Zeal, UK) and 
were not different between trials. Average values recorded were 20.5 ± 1.2 °C and 
41.5 ± 9.8% (mean ± SO). Full details of all sampling and analysis are included in the 
General Methods section 3.5. 
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Figure 6.1: A schematic representation of the experimental protocol. Key: * = 
solution provision, # = expired gas sample/blood sample & RPE, t = body mass, 
hatched area = warm-up (5 min at 60% V0 2 max), open area = RI (90 min at 70% 
V0 2 max) and closed area = R2 (70% VO, max until volitional exhaustion). 
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6.2.4 Solution Composition 
All solutions were provided in equal volumes between trials (581 ± 67 ml·h· l; 
mean ± SO) relative to each participant's body mass such that the amount of 
carbohydrate (sucrose; GlaxoSmithKline, UK) included in the CHO and CHO-PRO 
solutions was 0.8 g.kg'lh· l, a total of 232 ± 27 g CHO during recovery (mean ± SO). 
These 2 solutions were identical except for the inclusion of 3.3% (0.3 g PRO·kg·1h· l) 
whey protein isolate (Protarmor 907 LSI, Armor Proteines, France) in the CHO-PRO 
solution (i.e. ",3: I carbohydrate-protein ratio), thus providing 87 ± 10 g PRO during 
recovery (mean ± SO) and increasing the metabolisable energy content by 37.5%. To 
control for the influence of this additional energy, a third trial was introduced (CHO-
CHO) whereby the carbohydrate concentration of the CHO solution was increased 
from 10% to 13.3%. Accordingly, this third trial provided 1.1 g CHO·kg,l·h,l, 
equivalent to 320 ± 37 g CHO during recovery (mean ± SO). Therefore, the 
estimated amount of energy that each solution made available for metabolism was 3.2 
kcal.kg,l·h·1 in the CHO trial and 4.3 kcal·kg,l·h,1 in both the CHO-PRO and CHO-
CHO trials. The specific amino acid profile of the whey protein isolate is illustrated 
in Figure 6.2. All solutions were matched for flavour (orange and passion fruit), 
consistency and odour. 
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Figure 6.2: Amino acid profile of the whey protein isolate added to CHO solutions 
during CHO-PRO trials. 
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6.2.5 Statistical Analyses 
The endurance capacity data of Fallowfield et al. (1995) were utilised to 
estimate that a sample size of 6 has a 99.9% power to detect a difference in means of 
22.2 min, assuming a SO of differences of approximately 9.9, using a paired t-test 
with a I sided significance level. A 2 way general linear model for repeated measures 
(Drink x Time) was used to identify differences between experimental conditions. 
The Greenhouse-Geisser correction was utilised for epsilon <0.75, while the Huynh-
Feldt correction was adopted for less severe asphericity. Where significant F values 
were found, the Holm-Bonferroni step-wise correction was applied to detem1ine the 
location of variance where necessary (Atkinson, 2002; Ludbrook, 1998). Unless 
otherwise stated, all data are expressed in text as mean ± SEM and the error bars 
included on figures are confidence intervals (Cl) that have been corrected to remove 
between subject variance (Masson and Loftus, 2003). Where appropriate, these 
confidence intervals have been corrected for violations to sphericity through 
adjustment of the relevant degrees of freedom. With respect to the exercise capacity 
data however, it was of particular theoretical interest to illustrate the specific 
comparisons between the CHO-PRO solution and each other solution independently 
rather than to portray the general pattern between the 3 means. As such, 2 separate 
pairs of confidence intervals surround the CHO-PRO bar on Figure 6.3 (see over) 
based on the specific error terms from each contrast. Specific details of, and 
justification for, these statistical methods are included in the General Methods section 
3.8. 
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6.3 Results 
6.3.1 Exercise Capacity 
In all 6 participants, ingestion of the CHO·PRO solution resulted in a 
significantly improved recovery of exercise capacity in comparison with CHO alone 
(P = 0.02; Effect Size = 1.5). The CHO·CHO solution also restored exercise capacity 
more effectively than the CHO solution in all but 1 of the participants in this study (P 
= 0.05; Effect Size = 1.1), although no statistical difference could be detected between 
the CHO·PRO and CHO·CHO solutions (P = 0.07; Effect Size 0.7). Specifically, the 
run times to exhaustion at 70% VO, max (R2) were: 83.7 ± 6.9 min in the CHO trial; 
91.2 ± 6.5 min in the CHO·PRO trial (9% improvement versus CHO); and 99.9 ± 8.1 
min in the CHO·CHO trial (19% improvement versus CHO; Figure 6.3). 
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Figure 6.3: Run times to exhaustion recorded during R2 (n = 6). Values are means ± 
Cl and * den9tes values greater than CHO trial (P s 0.05). 
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6.3.2 Serum Insulin 
Serum insulin concentrations significantly increased in all 3 trials during 
recovery. However, this increase was most pronounced during the CHO-PRO and 
CHO-CHO trials such that statistical analysis detected an effect of treatment (main 
effect: F = 9.8, P = 0.05; Figure 6.4). Conversion of this insulin concentration data 
into an insulinaemic response for the 4 h recovery period, expressed as incremental 
area under the curve, revealed differences between the CHO-PRO and CHO trials (P 
= 0.03; Figure 6.5). 
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Figure 6.4: Serum insulin concentrations during RI, recovery and R2. Participants (n 
= 6) received either CHO, CHO-PRO or CHO-CHO supplements during recovery. 
(N.B: at 60 min R2 and Post R2 n = 5). Values are means ± Cl and are different 
between trials (P = 0.05). To convert SI units into ~IU·mrl divide by 6.95. 
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6.3.3 Plasma Glucose 
Plasma glucose concentrations peaked after 1 h of recovery in all trials and 
were lower at this point during the CHO-PRO trial than during the CHO-CHO trial (P 
= 0.01). Concentrations then decreased in both the CHO and CHO-CHO trials, while 
the CHO-PRO trials displayed stable glucose concentrations throughout recovery (F = 
3.7, P = 0.03; Figure 6.6). Upon commencement of the second exercise bout (R2), 
blood glucose concentrations in all 3 trials decreased markedly. This hypoglycaemia 
at 10 min R2 was more severe in the CHO trial than in the CHO-PRO trial (P = 0.03) 
and the difference between these 2 treatments was maintained until 30 min of this 
exercise session (P = 0.004). Conversion of these data into a glycaemic response for 
the 4 h recovery period did not expose any treatment differences (Figure 6.7). 
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Figure 6.6: Plasma glucose concentrations during RI, recovery and R2. Participants 
(n = 6) received either CHO, CHO-PRO or CHO-CHO supplements during recovery. 
(N.B: at 60 min R2 and Post R2 n = 5). Values are means ± Cl. # denotes values 
different CHO-PRO versus CHO-CHO (P = 0.01); * denotes values different CHO-
PRO versus CHO (P::; 0.03). 
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Figure 6.7: Glycaemic responses during 4 h recovery (n = 6). Values are means ± Cl. 
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6.3.4 Plasma Urea 
Concentrations of plasma urea were relatively stable during RI in under all 3 
treatments. However, circulating urea levels began to rise immediately upon 
ingestion of the first CHO-PRO solution (F = 24.6, P = 0.00 I) and became 
significantly higher than the CHO-CHO trial after 2 h of recovery and higher than the 
CHO trial after 4 h of recovery (Figure 6.8). 
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Figure 6.8: Plasma urea concentrations during RI, recovery and R2. Participants (n = 
6) received either CHO, CHO-PRO or CHO-CHO supplements during recovery. 
(N.B: at 60 min R2 and Post R2 n = 5). Values are means ± Cl. # denotes values 
different CHO-PRO versus CHO-CHO (P $ 0.04); * denotes values different CHO-
PRO versus CHO (P $ 0.01). 
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6.3.5 Plasma Free Fatty Acids and Glycerol 
Free fatty acid and glycerol concentrations responded similarly to the 
treatments during all 3 trials (Figures 6.9 and 6.10). Average values across trials 
increased gradually during RI (peak at 90 min: FFA = 1.03 ± 0.57 mmol·r l ; glycerol 
= 0.45 ± 0.18 mmol·r l ), decreased to basal levels throughout the duration of recovery 
and increased once more during R2 (peak post R2: FFA = 1.08 ± 0.49 mmol·r l ; 
glycerol = 0.39 ± 0.15 mmol·r l ). 
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Figure 6.9: Plasma free fatty acid concentrations during RI, recovery and R2. 
Participants (n = 6) received either CHO, CHO-PRO or CHO-CHO supplements 
during recovery. (N.B: at 60 min R2 and Post R2 n = 5). Values are means ± Cl. 
164 
----------- - - - - -
Chapter 6 Study 3 
0.6 
-6- cuo I 0.5 ...... ClIO-PRO 
-0- CUO·CUO 
~ 
0.4 
'0 
E g 
'0 0.3 
-~ u 
" G 
~ 0.2 
E 
~ 
~ 
0: 
0.1 
0.0 
Run I 11 Recovery Run 2 
Pre 30min 60min 90min 1 h 2. 3. 4h 10 min 30 min 60 min Post 
Figure 6.10: Plasma glycerol concentrations during RI, recovery and R2. Participants 
(n = 6) received either CHO, CHO-PRO or CHO-CHO supplements during recovery. 
(N.B: at 60 min R2 and Post R2 n = 5). Values are means ± Cl. 
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6.3.6 Blood Lactate 
Upon commencement of RI, blood lactate concentrations increased above 
resting concentrations in all 3 trials and mean values were maintained between 1.35 
and 1.67 mmoI.r 1 for the duration of this exercise session (Figure 6.11). Thereafter, 
an insignificant trend was apparent for higher lactate concentrations during recovery 
with CHO-CHO ingestion and lower lactate concentrations with CHO-PRO ingestion. 
The onset of exercise subsequent to recovery (R2) initiated a more noticeable 
accumulation of blood lactate in the CHO trial than in the other 2 trials, although this 
difference did not attain statistical significance. 
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Figure 6.11: Blood lactate concentrations during RI, recovery and R2. Participants (n 
= 6) received either CHO, CHO-PRO or CHO-CHO supplements during recovery. 
(N.B: at 60 min R2 and Post Rz n = 5). Values are means ± Cl. 
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6.3.7 Substrate Metabolism 
Estimations of lipid and carbohydrate oxidation rates via indirect calorimetry 
were not statistically different between trials (Table 6.2). Nonetheless, a trend for 
higher carbohydrate oxidation and lower lipid oxidation was evident following CHO-
CHO ingestion in comparison with ingestion of the other 2 solutions. This pattern 
was reflected in the respiratory exchange ratios (RER) recorded during recovery and 
R2 (F = 3.8, P = 0.04), with significantly lower values recorded with CHO-PRO 
ingestion than with CHO-CHO ingestion at 2 h, 3 hand 4 h of recovery (P:O; 0.05). 
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Figure 6.12: Respiratory exchange ratios during RI, recovery and R2. Participants (n 
= 6) received either CHO, CHO-PRO or CHO-CHO supplements during recovery. 
(N.B: at 60 min R2 n = 5). Values are means ± Cl and # denotes values different 
CHO-PRO versus CHO-CHO (P:O; 0.05). 
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Table 6.2: Substrate metabolism during RI, recovery and R2. Participants (n = 6) received either CHO or CHO-PRO supplements during recovery 
(N.B: at 60 min R2 n = 5). Values are means ± SEM. 
Run I Recovery Run 2 
Pre 30 min 60min 90 min I hr 2 hr 3 hr 4 hr 10 min 30 min 60 min Last min 
Carbohydrate 
oxidation (g.min-') 
CI-IO 0.2±0.1 2A±0.2 2.S±0.2 2.3±0.2 0.3±0.04 0.3±0.04 0.3±0.03 OA±O.1 2.8±0.2 2.7±0.2 2.3±0.3 2A±OA 
CHO-PRO 0.2±0.1 2.S±OA 2.5±OA 2A±OA 0.3±0.l 0.2±0.03 0.3±0.03 OA±O.l 3.l±0.3 3.l±OJ 2.6±0.3 2J±0.3 
CI-IO-CI-IO 0.2±0.04 2.7±0.3 2A±0.3 2.2±0.3 0.3±0.1 OA±0.04 OA±0.03 0.S±0.04 3.3±0.3 3A±0.3 2.9±0.3 2.1±0.3 
Lipid 
oxidation (g.min-') 
CI-IO 0.l±0.02 0.6±0.l 0.5±0.l 0.6±0.l O.l±O.Ol O.l±O.Ol O.l±O.Ol 0.l±0.02 OA±O.l O.S±O.l 0.7±0.! 0.7±0.2 
CI-IO-PRO 0.1±0.02 0.5±0.1 O.S±O.1 0.6±0.! 0.l±0.03 0.l±0.01 0.l±0.02 0.1±0.01 0.3±0.1 OJ±O.! 0.6±0.1 0.7±0.1 
CHO-CHO O.l±O.Ol 0.5±0.l 0.6±0.! 0.7±0.l 0.l±0.02 0.l±0.02 0.04±0.0! 0.02±0.0! 0.2±0.! 0.l±0.! OA±O.! O.7±O.! 
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6.3.8 Serum Growth Hormone 
The initial exercise bout of each trial (RI) increased serum concentrations of 
human growth hormone to a similar extent in all 3 trials (Figure 6.13). As 
participants began ingesting the experimental solutions during recovery, growth 
hormone concentrations returned to basal levels and remained as such until at least 10 
min into the second exercise session (R2). Growth hormone measurements taken 
immediately following R2 were higher when CHO-PRO had been ingested during 
recovery as opposed to either of the carbohydrate solutions with no additional protein 
(P:O: 0.02). 
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Figure 6.13: Serum growth hormone concentrations during RI, recovery and R2. 
Participants (n = 6) received either CHO, CHO-PRO or CHO-CHO supplements 
during recovery. (N.B: at Post R2 n = 5). Values are means ± Cl. # denotes values 
different CHO-PRO versus CHO-CHO (P = 0.02); * denotes values different CHO-
PRO versus CHO (P = 0.01). 
169 
Chapter 6 Study 3 
6.3.9 Serum Cortisol 
Concentrations of serum cortisol increased over time during RI, reduced 
below resting levels during recovery and were elevated a second time towards the end 
of R2 (Figure 6.14). While no differences could be detected between trials at any 
specific time-point (F = 2.0, P = 0.2), an overall effect of treatment was identified 
(main effect: F = 5.2, P = 0.05). In contrast to the growth hormone data, there was a 
trend for serum cortisol concentrations to be lower immediately following R2 
following CHO-PRO ingestion in comparison with the CHO and CHO-CHO 
treatments. 
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Figure 6.14: Serum cortisol concentrations during Rio recovery and R2. Participants 
(n = 6) received either CHO or CHO-PRO supplements during recovery. (N.B: at 60 
min R2 and Post R2 n = 5). Values are means ± Cl and are different between trials (P 
= 0.05). 
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6.3.10 Plasma Myoglobin 
Plasma concentrations of this ordinarily intracellular haemprotein increased 
during RI and peaked initially 1 h following this exercise bout (Figure 6.15). A 
gradual decline in myoglobin concentration was evident during recovery before a 
second more pronounced increase occurred upon commencement of Rz. This pattern 
of response was unaffected by treatment. 
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Figure 6.15: Plasma myoglobin concentrations during RI, recovery and Rz. 
Participants (n = 6) received either CHO, CHO-PRO or CHO-CHO supplements 
during recovery. (N.B: at 60 min Rz and Post Rz n = 5). Values are means ± Cl. 
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6.3.11 Indices of Hydration Status 
No participant's pre-trial urine sample was found to have an osmolality in 
excess of 900 mosmol·kg· l , with a mean value across all 3 trials of 530.3 ± 183.6 
mosmol·kg· 1 (mean ± SD). Hydration status, deternlined through changes in body 
mass (BM), was found to be reduced during RI by -2.1 ± 0.5% BM, -1.5 ± 0.3% BM 
and -1.6 ± 0.3% BM in the CHO, CHO-PRO and CHO-CHO trials, respectively. The 
second exercise session (R2) elicited similar reductions in body mass: -1.9 ± 0.7% BM 
(CHO); -2.1 ± 0.6% BM (CHO-PRO); and -1.6 ± 0.3% BM (CHO-CHO). Plasma 
volume responses were not different between treatments but deviated substantially 
from baseline measurements over the course of each trial (time effect: F = 18.4, P 
=0.001). The reduced plasma volume recorded during RI was returned to baseline 
levels after I h of recovery before declining once more and remaining significantly 
reduced from this point onwards (Figure 6.16). 
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Figure 6.16: Changes in plasma volume during RI, recovery and R2. Participants (n 
= 6) received either CHO, CHO-PRO or CH-CHO supplements during recovery. 
(N.B: at 60 min R2 and Post R2 n = 5). Values are means ± Cl and t denotes values 
different from baseline (P:O; 0.02). 
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6.3.12 Subjective Data 
The ratings of perceived exertion indicated by participants during each 
exercise bout was not influenced by experimental treatment. However, at the point of 
exhaustion during R2, there was a slight tendency for participants to report lower RPE 
scores (scale 6-20) following ingestion of the CHO-PRO mixture (16.S ± 0.5) rather 
than the CHO or CHO-CHO solutions (lS.3 ± 0.6 and IS.2 ± 1.1, respectively). 
Pmiicipants' reported sensations of thirst were not found to be different between 
trials, generally decreasing during recovery and increasing with subsequent exercise. 
The degree of gut fullness reported by participants in response to each solution was 
highly variable and, as a result, no clear pattern across the mean values was apparent 
(Table 6.3). 
Table 6.3: Subjective ratings of gut fullness during recovery and R2. Participants (n = 6) 
received either CHO, CHO-PRO or CHO-CHO supplements during recovery. 
(N.B: at 60 min R2 n = 5). Values are means ± SEM. 
Recovery Run 2 
1 h 2h 3h 4h 10 min 30min 60 min Last min 
Gut Fullness (scale 6-20) 
CHO 9 ± 0.4 10 ± 1 11 ± 1 11 ± 2 11 ± 1 10 ± 1 9 ± 1 9±1 
CHO-PRO S ± 1 11 ± 1 12 ± I 11 ± 1 12 ± 1 11 ± I 10 ± 1 10 ± 1 
CHO-CHO S ± 1 9 ± 1 11 ± 1 12 ± 2 10 ± 1 10 ± 1 8±0.4 9 ± 1 
Despite the lack of treatment differences in terms of gut fullness, it was noted 
that ingestion of the CHO-CHO solution was associated with reports of severe 
gastrointestinal discomfort in 3 of the 6 participants who completed this study. In 
addition, the data gathered from a further 2 participants who were initially recruited 
for this study was disregarded because these participants experienced such severe 
gastrointestinal distress in the CHO-CHO trial that the exercise capacity test was 
terminated before a metabolic endpoint could be established. Notably, no such 
adverse effects were reported by any participant in response to either the CHO or 
CHO-PRO solutions. 
173 
Chapter 6 Study 3 
6.3.13 Control Data 
The relative exercise intensity of each exercise seSSlOn was successfully 
standardised between experimental conditions and the heart rate data recorded during 
these periods reflected this. Table 6.4 provides an overview of this information. 
Table 6.4: Overall relative exercise intensities and heart rates recorded during RI and 
R2. Participants (n = 6) received either CHO, CHO-PRO or CHO-CHO supplements 
during recovery. Values are means ± SD. 
Run I 
Exercise Intensity (% VO, max) 
CHO 
CHO-PRO 
CHO-CHO 
Heart Rate (beats·min· l ) 
CHO 
CHO-PRO 
CHO-CHO 
70.0 ± 2.2 
70.2 ± 3.0 
69.2 ± 3.1 
170 ± 6 
169 ± 9 
166 ± 9 
174 
Run 2 
71.8 ± 2.9 
72.4 ± 3.9 
69.3 ± 3.9 
173 ± 8 
172 ± 9 
171 ± 9 
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6.4 Discussion 
The primary finding of this study was that the recovery of endurance running 
capacity following ingestion of a solution providing 0.8 g CHO· kg-I. h- I (CHO) can 
be enhanced either through the addition of 0.3 g. kg-I. h-I of protein (CHO-PRO) or 
through adding further carbohydrate (CHO-eHO). The CHO-PRO and eHO-CHO 
solutions were equally effective in achieving this benefit. 
This finding of an increased capacity to perform subsequent exercIse 
following CHO-PRO ingestion rather than ingestion of CHO alone is in agreement 
with the findings of Williams et a/. (2003). These authors reported a 55% increased 
cycle time to fatigue through the addition of protein to carbohydrate recovery 
solutions and attributed this improvement to the 128% greater rate of glycogen 
storage during recovery (Williams et al., 2003). It is therefore possible that the 
observed differences in exercise capacity in the present study were also the 
consequence of an increased rate of glycogen synthesis. While no direct 
measurement of muscle glycogen was made to assess this possibility, the higher 
insulin concentrations stimulated by the additional protein would be expected to 
increase both the uptake of blood glucose into skeletal muscle and the conversion of 
this glucose into muscle glycogen. Notably, the enhanced recovery observed in the 
present study was not as profound as that previously reported by Williams et a/. 
(2003). A likely explanation for this difference is that, in the present study, the CHO 
and eHO-PRO solutions were matched for carbohydrate content whereas in the study 
of Williams et a/. (2003) the solution with added protein included more than twice as 
much CHO (0.4 g·kg-I·h- I) as the solution containing CHO alone (0.15 g·kg"l·h- I). 
In addition, the observation in the current study of more stable plasma glucose 
concentrations during recovery and higher plasma glucose concentrations during R2 
following CHO-PRO ingestion may be indicative of an increased hepatic appearance 
of glucose. In support of this, the lower respiratory exchange ratios recorded during 
recovery in the CHO-PRO trial might reflect increased catabolism of amino acids in 
the liver rather than increased lipid metabolism, while the elevated concentrations of 
plasma urea during this trial might therefore indicate an increased availability of u-
keto acids for gluconeogenesis. Furthermore, it is likely that a substantial quantity of 
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this glucose would be stored as glycogen within the liver during recovery and recent 
evidence has demonstrated a positive correlation between liver glygogen resynthesis 
and subsequent exercise capacity (Casey et al., 2000). It is therefore possible that the 
differences in exercise capacity observed in the present study may be at least partly 
due to an increased availability of blood glucose during R2. 
Another potential benefit of adding protein to carbohydrate recovery solutions 
may be an increased rate of muscle protein synthesis. Prolonged dynamic exercise, as 
was performed in the present study, is known to produce an acute phase of negative 
protein balance in the immediate post-exercise period (Rennie and Tipton, 2000). It 
has been well established that post-exercise ingestion of amino acids encourages a 
transition from net protein degradation to net protein synthesis following resistance 
exercise (Borsheim et al., 2002; Tipton et al., 1999) and more recently a similar 
anabolic effect of amino acid ingestion has been demonstrated following endurance 
exercise (Koopman et al., 2004). The present results illustrate that the CHO-PRO 
solution elicited greater growth hormone concentrations and lower cortisol 
concentrations following R2 than either of the solutions containing carbohydrate with 
no additional protein. The wealth of available evidence certainly supports that amino 
acid ingestion can induce growth hormone release to some extent (Chromiak and 
Antonio, 2002; Jacobson, 1990), although the precise magnitude of growth hormone 
secretion is likely to be mediated by individual factors such as training status and 
gender (Mejri et al., 2005; Wideman et al., 2000b). Furthermore, it is possible that 
relatively high concentrations of certain amino acids may be necessary to impart this 
effect given that chronic oral supplementation with leucine appears to be a less 
effective stimuli than acute arginine infusion (Merimee et al., 1969; Mero et al., 
1997). 
It is also interesting to note in the present study that the treatment effects in 
terms of growth hormone concentration were apparent following R2 rather than during 
the feeding period. This is in contrast to evidence from Suminski et al. (1997) who 
have reported the stimulatory influence of amino acid ingestion on growth hormone 
release to be more potent at rest than during exercise. Similar to the present study, 
however, these authors also observed higher absolute concentrations of growth 
hormone during exercise than at rest (Suminski et al., 1997). This effect is consistent 
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with the now well recognised exercise-induced growth hormone response (Godfrey et 
al., 2003), which is thought to be regulated through the inhibitory control of 
somatostatin balanced against the stimulatory influence of growth hormone releasing-
hormone (de Vries et al., 2003). Importantly, the finding in the present study that 
growth hormone concentrations were only different between trials during exercise 
may be related to evidence that arginine stimulated growth hormone release operates 
through an inhibition of somatostatin release combined with an increased 
responsiveness of somatotropes to growth hormone releasing-hormone (Ghigo et aI., 
1991; Wideman et al., 2000a), although the elevated insulin concentrations during 
recovery could equally account for the lack of treatment differences in growth 
hormone release while feeding (Lanzi et aI., 1997). Overall, the results of the present 
study support the contention that including protein in a carbohydrate recovery 
solution may attenuate the catabolic cellular environment that occurs following 
prolonged exhaustive exercise. 
Finally, it cannot be ruled out that fatigue during R2 may have coincided not 
only with compromised substrate availability but also with a reduced motor neuron 
stimulation from the CNS. A number of neurotransmitters have been identified which 
may induce fatigue through decreased CNS activation and the synthesis of one such 
neurotransmitter (5-hydoxytryptamine) is stimulated by increases in the ratio of free 
tryptophan to other branched chain amino acids (Blomstrand, 2001). While some 
evidence does support the hypothesis that the amino acids provided in the present 
study may have offset fatigue through delaying the increase in blood tryptophan: 
BCAA ratios (Mittleman et aI., 1998), more recent evidence appears to oppose this 
contention (Watson et al., 2004a). However, it should be noted that a large inter-
individual variation was reported in this latter study and therefore the possibility 
remains that BCAA supplementation might improve the central drive for exercise in 
certain individuals. 
In conclusion, the addition of 0.3 g·kg-I·h- I of protein to a solution providing 
0.8 g CHO· kg-I h-I resulted in an improved recovery of exercise capacity 4 h 
following prolonged exercise. The insulin concentrations observed during this period 
along with muscle biopsy data reported in other studies (Ivy et al., 2002; van Loon et 
aI., 2000a; Zawadzki et aI., 1992) suggest that this improved performance might be 
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the result of an increased rate of muscle glycogen resynthesis during recovery. 
However, there are other potential mechanisms which might also account for this 
benefit and it is unlikely that the increase in exercise capacity can be entirely 
attributed to any single mechanism. Finally, the comparison of the CHO-PRO 
solution with an isoenergetic carbohydrate solution (CHO-CHO) revealed that the 
addition of protein to a carbohydrate solution is no more effective in restoring 
exercise capacity than simply adding an equal amount of carbohydrate, although an 
increased incidence of gastrointestinal discomfort was associated with the 
concentrated CHO solution. 
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Effect of Carbohydrate-Protein Ingestion on Muscle 
Glycogen Resynthesis During Recovery. 
7.1 Introduction 
The resynthesis of muscle glycogen following prolonged exercise of moderate 
to high intensity is an essential component of recovery, especially when the interval 
before a repeated performance is of short duration (i.e. <8 h). It has been 
demonstrated that carbohydrate ingestion is an effective means of enhancing the rate 
of muscle glycogen resynthesis following exercise (Bergstrom et ai., 1967; Ivy, 1998) 
and it appears that a positive correlation exists between the amount of carbohydrate 
ingested and the rate of muscle glycogen resynthesis (Jentjens and Jeukendrup, 2003). 
This relationship persists up until a carbohydrate intake of approximately 1.2 g·kg'l·h, 
I, at which point the rate of muscle glycogen synthesis plateaus slightly in excess of 
40 mmol·kg dry mass'lh'l for recovery periods of 2-6 h in duration (van Loon et ai., 
2000a). 
In comparison to the extensive literature regarding the metabolic influences of 
carbohydrate ingestion, there is relatively little published data with reference to the 
ingestion of CHO-PRO mixtures. Despite the augmented insulin response when 2':0.3 
g·kg,l·h'l of protein is ingested alongside carbohydrate during recovery, it has become 
increasingly evident that the 'maximal' rates of muscle glycogen resynthesis 
following ingestion of 1.2 g CHO·kg,l·h,1 cannot be exceeded through ingesting this 
additional protein (Jentjens et ai., 2001; Van Hall et ai., 2000b). Conversely, the 
addition of protein to smaller amounts of carbohydrate (i.e. ~0.8 g CHO·kg,l·h,l) has 
been reported to increase the sub-maximal rates of muscle glycogen resynthesis 
elicited by the carbohydrate alone (Ivy et al., 2002; van Loon et al., 2000a; Zawadzki 
et al., 1992). 
The above findings regarding CHO-PRO ingestion and muscle glycogen 
resynthesis may help explain why the recovery of exercise capacity has also been 
reported to be improved following ingestion of such supplements (Saunders et al., 
2004; Williams et al., 2003). Indeed, the rates of muscle glycogen resynthesis 
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reported by van Loon et al. (2000a) in response to either moderate carbohydrate, 
carbohydrate with protein or high carbohydrate solutions follow an identical pattern 
across treatments as does the exercise capacity data reported in the previous chapter 
of this thesis (section 6.3.1, p. 158). However, the mixture of protein hydrolysate and 
amino acids that was used by these other authors proved to be remarkably effective in 
promoting muscle glycogen resynthesis, accelerating the synthetic rate above that 
recorded in the moderate carbohydrate trial by approximately 18.8 mmol·kg dry mass-
I·h-I (van Loon et aI., 2000a). Given that certain amino acids are likely to stimulate 
muscle glycogen resynthesis more effectively than others (van Loon et aI., 2000b), it 
remains to be established whether the specific CHO-PRO mixture used in the 
previous study of this thesis provided its ergogenic benefit through facilitating muscle 
glycogen resynthesis or through some other mechanism. 
In addition, while current understanding is relatively advanced regarding the 
influence of CHO-PRO ingestion on muscle glycogen resynthesis during recovery, 
less is known about the influence of these supplements on substrate metabolism 
during exercise subsequent to recovery. Those studies attempting to maximise the 
rate of muscle glycogen resynthesis during recovery often cite evidence to support the 
contention that an elevated pre-exercise muscle glycogen content will extend the 
capacity to perform moderate to high intensity exercise (Ahlborg et aI., 1967; 
Bergstrom et al., 1967). However, it is possible that an initial bout of prolonged 
exercise may influence the metabolic response to subsequent performance such that 
muscle glycogen availability no longer dictates exercise capacity. A recent study 
assessed endurance capacity following a 4 h recovery from prolonged exercise and 
reported a moderate positive correlation (r = 0.53, P s 0.05) between pre-exercise 
liver glycogen content and exercise time to exhaustion (Casey et aI., 2000), a finding 
which may be associated to the earlier observation that an improved availability of 
blood glucose has the capacity to postpone fatigue (Coyle et aI., 1986). Taken 
together, these data raise the interesting possibility that the interaction of the initial 
exercise bout and CHO-PRO ingestion may modify the relative contributions of liver 
and muscle glycogen towards overall metabolism during subsequent exercise. 
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To this end, the present study was designed to examine the relative influences 
of CHO and CHO-PRO ingestion on the rate of muscle glycogen resynthesis during a 
4 h recovery from prolonged treadmill running were assessed in the present study. 
Subsequent to recovery, a further 60 min of treadmill running was performed to 
evaluate whether the rate of muscle glycogen utilisation for this period was different 
between experimental treatments. 
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7.2 Methods 
7.2.1 Participants 
Six male volunteers were recruited to take part in this study. These 
participants were healthy individuals who had all previously been involved with 
similar experiments and whose habitual training involved a substantial 
cardiovascular/endurance component. Physiological characteristics describing this 
cohort are presented in Table 7.1. 
Table 7.1: Participant details 
Characteristic 
Age (yr) 
Height (m) 
Mass (kg) 
VO, max (ml·kg·l·min· l) 
7.2.2 Experimental Design 
Mean + SD 
22 ± 1.3 
l.76±0.1 
73.8 ± 6.7 
61 ± 6 
In a randomised and counterbalanced design, 2 main trials were performed 
with a 2 week interval separating them. Over the 48 h leading up to the first of these 
trials, participants were asked to complete a dietary record which they were 
subsequently requested to adhere to over the same period prior to trial 2 (2772 ± 1136 
kcal·day"l, 58 ± 11% CHO, 22 ± 9% fat, 19 ± 5% protein: mean ± SD). Main trials 
involved a 90 min run at 70% VO, max (RI) followed by a 4 h recovery, during 
which participants rested in the laboratory while consuming either CHO alone or a 
CHO-PRO mixture in a double blind manner. Muscle biopsies were obtained at the 
beginning and end of recovery to assess the rate of muscle glycogen resynthesis over 
the intervening period. Furthermore, a third muscle biopsy was taken following a 
second treadmill run (R2: 60 min at 70% VO, max) to evaluate the rate of muscle 
glycogen utilisation during exercise subsequent to recovery. 
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7.2.3 Experimental protocol 
The experimental procedures applied during this study are illustrated in Figure 
7.1. Participants arrived in the laboratory between 8-9 am following a 10 h overnight 
fast and were asked to complete a pre-trial consent form (Appendix Aii). After 
providing a urine sample, each participant's post-void nude body mass was recorded 
(Avery Ltd., UK) before a cannula was inserted into an antecubital vein and a 10 ml 
resting venous blood sample obtained from 5 of the 6 participants. The cannula was 
kept patent throughout each trial by frequent flushing with isotonic saline. Prior to 
exercise, the Douglas bag technique was used to collect a 5 min resting expired gas 
sample (Williams and Nute, 1983). Participants were required to stand for 15 min 
prior to the collection of all resting gas and blood samples. A 5 min run at 60% 
VO, max was used as a standardised warm-up prior to running at a speed equivalent 
to 70% VO, max for 90 min (RI). One minute expired gas samples, heart rates (Polar 
8810, Finland) and RPE (Borg, 1973) followed by 10 ml venous blood samples were 
taken at 30 min intervals throughout RI. Water intake was permitted ad libitum 
during trial I and matched in trial 2 (0.79 ± 0.27 I; mean ± SD). Nude body mass was 
recorded immediately following RI to assess hydration status through percentage 
change in mass. Participants were then asked to rest in a supine position while a 3-5 
mm skin incision was made to the anterior portion of the thigh and a muscle biopsy 
obtained from the vastus lateralis using the percutaneous needle biopsy technique 
(Bergstrom, 1962). A more comprehensive account of muscle biopsy sampling 
procedures is included in the General Methods section 3.5. 
The first volume of prescribed solution was ingested as soon as the first 
muscle biopsy had been removed from the leg. The remaining 7 volumes were 
provided at 30 min intervals during the 4 h recovery such that the last solution was 
ingested 30 min prior to the second muscle biopsy, participants were permitted 15 min 
to consume each volume. Expired gas samples and venous blood samples, along with 
ratings of gut fullness and thirst (6-20 scale; Appendices Bii and Biii), were taken 
during the recovery period every hour prior to feedings. In addition, each 
participant's urine was collected throughout the 4 h recovery period and was stored in 
a vessel containing 5 ml of 10% thymol-iosopropanol as a preservative. 
Approximately 3 h 45 min following the initial muscle biopsy, a further 2 separate 
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skin incisions were made to the same leg and the second biopsy was sampled 
precisely 4 h following the first. Nude body mass was then recorded and, after the 
standard warm-up, participants were asked to continue running on the treadmill for a 
further 60 min at 70% VO, max (R2). As in RI, water intake was ad libitum during 
trial I and matched in trial 2 (0.39 ± 0.19 I; mean ± SD). Physiological measurements 
were obtained at 15 minute intervals during this second run. Nude body mass was 
recorded immediately after R2 and the ·remaining incision site was used to obtain a 
final muscle biopsy. The 3 muscle biopsies taken in any given trial were sampled 
from the same leg, with the use of dominant/non-dominant legs being 
counterbalanced between trials. Ambient temperature and humidity were recorded at 
30 min intervals throughout all testing periods using a hygrometer (Zeal, UK) and 
were not different between trials. Average values recorded were 20.5 ± 0.5 °C and 
55.6 ± 1.9% (mean ± SD). Full details of all sampling and analysis are included in the 
General Methods section 3.5. 
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Figure 7.1: A schematic representation of the experimental protocol. Key: * = 
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min at 70% VO, max) and closed area = R2 (60 min at 70% VO, max). 
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7.2.4 Solution Composition 
The CHO and CHO-PRO solutions used in this study were identical to those 
described in Chapter 6 (section 6.2.4). These solutions were provided in equal 
volumes between trials (590 ± 53 ml·h·!; mean ± SD) relative to each participant's 
body mass such that the amount of carbohydrate (sucrose) ingested was 0.8 g.kg·!·h·!, 
which equates to a total of236 ± 21 g CHO during recovery (mean ± SD). The CHO-
PRO mixture included 3.3% (0.3 g PRO·kg·!·h·!) whey protein isolate (i.e. ~3: 1 
carbohydrate-protein ratio), thus providing 89 ± 8 g PRO during recovery (mean ± 
SD) and increasing the metabolisable energy content by 37.5%. The estimated 
amount of energy that the CHO and CHO-PRO solutions made available for 
metabolism was therefore 3.2 kcal.kg·!·h·! and 4.3 kcal·kg·!·h·!, respectively. As in 
the previous study, the CHO and CHO-PRO solutions were matched for flavour 
(orange and passion fruit), consistency and odour. The specific amino acid profile of 
the CHO-PRO solution is included in Chapter 6 (Figure 6.2, p. 156). 
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7.2.5 Statistical Analyses 
The data of Tsintzas et al. (2003) were utilised to estimate that a sample size 
of 6 has a 63% power to detect differences in the rate of muscle glycogen resynthesis 
of 43.8 mmol glucosyl units·kg dry mass·l·h· l, assuming a SD of differences of 
approximately 45.6, using a paired t-test with a 1 sided significance level. Both the 
incremental area under curve data that was calculated to assess the insulinaemic 
response to each solution during recovery (Wolever, 2004) and the lipid oxidation 
data for R2 were found to be non-normally distributed and a Wilcoxon test was 
therefore applied to compare the median values between trials for these data sets, 
along with any other ordinal/discrete variables (i.e. RPE, gut fullness and thirst) 
requiring non-parametric statistical analysis. Paired t-tests were used to analyse any 
other results involving a single comparison of 2 means (i.e. glycaemic responses and 
rates of muscle glycogen resynthesis/utilisation) while a 2 way general linear model 
for repeated measures (Drink x Time) was used to identify overall differences 
between experimental conditions. The Greenhouse-Geisser correction was utilised for 
epsilon <0.75, while the Huynh-Feldt correction was adopted for less severe 
asphericity. Where significant F values were found, the Holm-Bonferroni step-wise 
correction was applied to determine the location of variance where necessary 
(Atkinson, 2002; Ludbrook, 1998). Unless otherwise stated, all data are expressed in 
text as mean ± SEM and the error bars included on figures are confidence intervals 
(Cl) that have been corrected to remove between subject variance (Masson and 
Loftus, 2003). Specific details of, and justification for, these statistical methods are 
included in the General Methods section 3.8. 
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7.3 Results 
7.3.1 Mixed Muscle Metabolites 
Total muscle glycogen concentrations were not different between the CHO 
and CHO-PRO treatments at any time point, although an effect of time was 
established (F = 83.3, P < 0.001). Post hoc statistical analysis confirmed that both 
treatments significantly elevated muscle glycogen storage during recovery before a 
considerable quantity of muscle glycogen was metabolised during R2 (Figure 7.2). 
This pattern is supported by the data included in Figures 7.3 and 7.4 which illustrate 
the rates of muscle glycogen resynthesis and subsequent degradation, respectively. 
All other mixed muscle metabolite data is provided in Table 7.2, which presents the 2 
sub-glycogen pools separately along with concentrations of adenosine triphosphate 
(ATP), phosphocreatine (PCr), creatine (Cr), glucose-6-phosphate (G-6-P) and muscle 
lactate. Resynthesis rates for both pro glycogen and macroglycogen exhibited large 
inter-individual variations such that the trend for greater proglycogen accumulation 
during recovery with CHO-PRO ingestion could not be detected statistically. 
Conversely, an effect of treatment was identified in terms of macroglycogen (main 
effect: F = 6.7, P = 0.05), signifying higher concentrations throughout the CHO-PRO 
trials. However, it is likely that this effect is primarily an artefact of the disparity in 
macro glycogen concentrations immediately following RI rather than a true effect of 
treatment. 
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Figure 7,2: Muscle glycogen concentrations following RI, recovery and R2. 
Participants (n = 6) received either CHO or CHO-PRO supplements during recovery. 
Values are means ± Cl. t denotes values different from Post RI (P < 0.001); tt 
denotes values different from Pre R2 (P < 0.001). 
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Figure 7.3: Rates of muscle glycogen resynthesis during 4 h recovery Cn; 6). Values 
are means ± Cr. 
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Figure 7.4: Rates of muscle glycogen degradation during R2 (n = 6). Values are 
means ± Cl. 
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Table 7.2: Mixed muscle metabolites following Rh recovery and R2. Participants (n = 6) received either CHO or CHO-PRO supplements during 
recovery. Values are means ± SEM and are given in mmol glucosyl units·kg dry mass· I for glycogen and mmol units· kg dry mass· I for all other 
metabolites. Values are different between trials for macroglycogen (P = 0.05) with no detectable free glucose present in these samples. 
CHO CHO-PRO 
Post RI PreR2 Post R2 Pre R2 
Proglycogen 189 ± 15 216 ± 12 115 ± 26 196 ± 15 234 ± 15 154 ± 19 
Macroglycogen 13.9 ± 6.7 36.1 ± 10.1 9.1 ± 5.0 39.0 ± 9.5 48.7 ± 9.9 13.2 ± 4.8 
ATP 27.3 ± l.l 27.6 ± 1.2 25.5 ± 1.5 25.8 ± 2.7 26.0 ± 1.5 29.0 ± 2.2 
PCr 79.8 ± 3.9 72.2 ± 2.5 73.5 ± 6.2 74.4 ± 4.9 65.8 ± 4.8 75.6 ± 5.2 
Cr 38.2 ± 4.7 45.8 ± 4.3 44.5 ± 7.4 43.5 ± 6.6 52.2 ± 5.2 42.4 ± 8.0 
G-6-P 1.3 ± 0.2 1.5 ± 0.2 1.3 ± 0.2 1.5 ± 0.3 1.8 ± 0.5 1.3 ± 0.4 
Lactate 6.1 ± 2.0 9.5 ± 1.8 5.3 ± 1.0 9.7 ± 3.6 11.5±3.0 7.5 ± 1.4 
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7.3.2 Serum Insulin 
The additional protein included in the CHO-PRO solution resulted in higher 
overall insulin concentrations than when the solution with no additional protein was 
ingested (main effect: F = 13.1, P = 0.02). This effect appeared to arise from the 
elevated insulin concentrations during both recovery and R2, although no specific 
effects at any particular time-point could be detected. As such, the incremental area 
under the curve for the recovery alone was calculated to assess the specific 
insulinaemic response over this period. Further to the established main effect, median 
insulin responses during recovery were different between trials (P = 0.04): CHO = 
42.8 (22.2-47.3) nmol·240 min-'·r' and CHO-PRO = 48.5 (42.9-64.1) nmol·240 min-
'.r'. 
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Figure 7.5: Serum insulin concentrations during RI, recovery and R2. Participants (n 
= 5) received either CHO or CHO-PRO supplements during recovery. Values are 
means ± Cl and are different between trials (P = 0.02). To convert from SI units into 
~IU·mr' divide by 6.95. 
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7.3.3 Plasma Glucose 
Ingestion of the eHO-PRO solution did not substantially increase plasma 
glucose concentrations at any point during recovery. In contrast, ingestion of the 
CHO solution resulted in an initial glucose peak approximately I h following the 
commencement of feeding (P = 0.08 versus CHO-PRO trial), before concentrations 
reduced gradually over the remainder of recovery (Figure 7.6). Despite this varied 
pattern of glucose turnover between trials (F = 6.5, P = 0.01), the incremental area 
under curve for the recovery period was similar with each solution (Figure 7.7). With 
the onset of exercise subsequent to recovery, plasma glucose concentrations decreased 
transientiy in both trials. However, this decrement was most pronounced in the eHO 
trial and the disparity between treatments was maintained throughout R2, with 
significant differences noted at the 30 min sampling point (P = 0.01; Figure 7.6). 
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Figure 7.6: Plasma glucose concentrations during RI, recovery and R2. Participants 
(n = 5) received either eHO or eHO-PRO supplements during recovery. Values are 
means ± Cl and * denotes values different between trials (P = 0.01). 
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Figure 7.7: Glycaemic responses during 4 h recovery (n = 5). Values are means ± Cr. 
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7.3.4 Plasma Urea 
Plasma urea concentrations did not vary substantially from basal levels at any 
time point during the CHO trial. Conversely, during the CHO-PRO trial, urea began 
to accumulate in the plasma at the start of recovery (F = 32.8, P < 0.001). This initial 
rate of increase in response to CHO-PRO ingestion was maintained until the end of 
the trial, with differences between trials recorded throughout R2 (P $ 0.02; Figure 
7.8). 
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Figure 7.8: Plasma urea concentrations during RI, recovery and R2. Participants (n = 
5) received either CHO or CHO-PRO supplements during recovery. Values are 
means ± cr and * denotes values different between trials (P $ 0.02). 
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7.3.5 Plasma Free Fatty Acids and Glycerol 
Concentrations of free fatty acids and glycerol were elevated during RI before 
rapidly decreasing with the onset of feeding. During R2, free fatty acid concentrations 
were not deemed to be statistically different between treatments (Figure 7.9). In 
contrast, glycerol concentrations were notably lower during R2 following CHO-PRO 
ingestion (F = 5.8, P = 0.02) and a specific difference between trials was identified at 
the 45 min sampling point (P = 0.04; Figure 7.10). 
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Figure 7.9: Plasma free fatty acid concentrations during RI, recovery and R2• 
Participants (n = 5) received either CHO or CHO-PRO supplements during recovery. 
Values are means ± Cl. 
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Figure 7.10: Plasma glycerol concentrations during RI, recovery and R2. Participants 
(n = 5) received either CHO or CHO-PRO supplements during recovery. Values are 
means ± Cl and * denotes values different between trials (P = 0.04). 
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7.3.6 Blood Lactate 
Blood lactate concentrations increased under both experimental treatments 
during RI and then decreased during recovery (Figure 7.11). There was a tendency in 
the latter stages of recovery for lower lactate concentrations with CHO-PRO ingestion 
than with CHO ingestion but this effect did not reach statistical significance. The 
subsequent blood lactate response to R2 was also not different between trials. 
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Figure 7_11: Blood lactate concentrations during RI, recovery and R2. Participants (n· 
= 5) received either CHO or CHO-PRO supplements during recovery. Values are 
means ± CL 
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7.3.7 Substrate Metabolism 
Protein oxidation rates were estimated from urine/plasma urea concentrations 
during recovery and revealed a greater rate of protein oxidation with ingestion of the 
CHO-PRO solution than with ingestion of the CHO solution (P = 0.01; Figure 7.12). 
Subsequent corrected estimations of RER were not different between trials and are 
presented in Table 7.3 along with the estimated contributions of lipid and 
carbohydrate towards overall metabolism. During R2, ingestion of the CHO-PRO 
solution resulted in higher rates of carbohydrate oxidation (P ~ 0.03) and lower rates 
of lipid oxidation (P = 0.01) than ingestion of the CHO solution. Figure 7.13 clearly 
illustrates that the differences between trials in terms of total carbohydrate oxidation 
were entirely attributable to variations in the contribution of carbohydrate sources 
other than muscle glycogen. Specifically, the oxidation rate of blood glucose and 
lactate during R2 was elevated from 1.1 ± 0.2 g.min·1 in the CHO trial to 1.6 ± 0.1 
g.min·1 in the CHO-PRO trial (P = 0.02). 
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Figure 7.12: Rates of protein oxidation during 4 h recovery (n = 5). Values are 
means ± Cl and * denotes values different between trials (P = 0.0 I). 
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Table 7.3: Substratc metabolism and respiratory exchange ratios during RI, recovery and Rz. Recovery data is corrected for estimated 
protein oxidation rates. Participants (n = 6) received either CHO or CHO-PRO supplements during recovery. (N.B: at Last min Rz n = 5). 
Values are means ± SEM and * denotes values different between trials (P:O; 0.03). 
Carbohydrate 
oxidation (g.min· l ) 
CHO 
CHO-PRO 
Lipid 
oxidation (g.min· l ) 
CHO 
CHO-PRO 
Pre 
O.2±O.1 
O.3±O.1 
O.I±O.03 
O.I±O.02 
Run I 
30 min 60 min 
2.S±O.2 
3.I±O.2 
O.6±O.1 
0.4±O.1 
2.7±O.1 
3.1±O.1 
0.5±O.03 
0.3±O.1 
90 min 
2.8±O.2 
2.9±O.1 
0.5±O.1 
O.S±O.1 
I hr 
O.3±O.1 
O.3±O.02 
O.I±O.03 
O.I±O.OI 
Recovery 
2 hr 
O.3±O.03 
O.3±O.03 
O.I±O.OI 
O.I±O.OI 
3 hr 
0.4±O.04 
O.3±O.1 
O.I±O.OI 
O.I±O.OI 
4 hr 
O.S±O.1 
0.4±O.1 
O.02±O.OI 
O.04±O.03 
IS min 
3.4±O.2 
3.6±O.1 
O.I±O.1 
O.2±O.1 
Run 2 
30 min 
* 
3.0±O.2 
3.7±O.2 
* 
0.4±O.1 
O.3±O.03 
45 min Last min 
3.0±O.3 
3.4±O.2 
0.4±O.1 
O.3±O.03 
* 
2.7±O.2 
3.5±O.2 
* 
O.S±O.1 
O.2±O.1 
RER 
CHO 
CHO-PRO 
Non-protein respiratory exchange ratios 
O.8S±O.OS O.90±O.OI O.91±O.OI O.92±O.OI O.87±O.03 O.91±O.02 O.92±O.OI O.97±O.02 l.02±O.04 O.93±O.OI O.93±O.02 O.91±O.OI 
O.89±O.04 O.94±O.OI O.94±O.OI O.92±O.OI O.86±O.OI O.87±O.02 O.88±O.02 O.96±O.04 O.98±O.OI O.98±O.OI O.95±O.OI 1.00±O.04 
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Figure 7.13: Rates of muscle glycogen, glucose/lactate and lipid oxidation during R2 
(n = 6). Values are means and * denotes values different between trials (P = 0.03). 
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7.3.8 Serum Cortisol 
In both trials, serum cortisol concentrations were maintained at basal levels for 
the majority of RI but increased sharply towards the end of this exercise session 
(Figure 7.14). Thereafter, concentrations declined gradually over the ensuing 3-4 h of 
recovery before increasing steadily during the second bout of exercise (Rz). This 
pattern of response was standard between trials. 
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Figure 7.14: Serum cortisol concentrations during RI, recovery and Rz. Participants 
(n = 5) received either CHO or CHO-PRO supplements during recovery. Values are 
means ± Cl. 
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7.3.9 Plasma Myoglobin 
Plasma myoglobin concentrations did not decrease substantially during 
recovery following the increases recorded during RI (Figure 7.15). Subsequently, the 
progressive myoglobin release induced by R2 appeared to supplement the already 
elevated concentrations of this haemprotein, culminating in peak values of27.5 ± 8.8 
nmol·r l (CHO) and 27.3 ± 9.1 nmol·r l (CHO-PRO) in the immediate post-exercise 
period. 
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Figure 7.15: Plasma myoglobin concentrations during RI, recovery and R2. 
Participants (n = 5) received either CHO or CHO-PRO supplements during recovery. 
Values are means ± Cl. 
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7.3.1 0 Indices of Hydration Status 
The performance of RI resulted in mean body mass (BM) losses of -2.0 ± 
0.4% BM in the CHO trial and -1.9 ± 0.3% BM in the CHO-PRO trial, with the urine 
samples taken prior to this first exercise session indicating an adequate degree of pre-
trial hydration (CHO = 612.8 ± 401.1 mosmol·kg- I; CHO-PRO = 583.1 ± 336_5 
mosmol·kg- I; mean ± SD)_ Following rehydration during recovery, similar 
decrements in body mass of -1.5 ± 0.1 % BM (CHO) and -1.3 ± 0.2% BM (CHO-
PRO) were recorded for R2. Plasma volume was reduced with each exercise session 
but increased with fluid consumption during the intervening recovery (time effect: F = 
9.0, P = 0.001). This response was uniform across the CHO and CHO'PRO 
treatments and the combined values of both trials were found to differ significantly 
from baseline at 30 min, 60 min and 90 min of RI (P::; 0.04) and at 4 h of recovery (P 
= 0.05; Figure 7.16)_ Total urine volumes passed during the 4 h recovery period were 
1204 ± 227 ml in the CHO trial and 953 ± 52 ml in the CHO-PRO trial. 
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Figure 7.16: Changes in plasma volume during RI, recovery and R2. Participants (n 
= 5) received either CHO or CHO-PRO supplements during recovery. Values are 
means ± Cl and t denotes values different from baseline (P::; 0.05). 
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7.3.l1 Subjective Data 
No statistical differences between trials could be detected in terms of the 
perceived exertion reported by participants during each exercise bout. Nonetheless, in 
the final minute of R2, participants tended to indicate a greater degree of perceived 
exertion (scale 6-20) when CHO had been ingested during recovery (16.7 ± 1.1) 
compared to when CHO-PRO had been ingested (15.3 ± 0.9). While the 2 
experimental solutions did not influence participants' reported sensations of thirst any 
differently, ingestion of the CHO-PRO solution produced higher overall ratings of gut 
fullness than ingestion ofCHO alone (P = 0.03; Table 7.4). 
Table 7.4: Subjective ratings of gut fullness during recovery and R2. Participants (n = 6) 
received either CHO or CHO-PRO supplements during recovery. 
(N.B: at Last min R2 n = 5). Values are means ± SEM and are different between trials (P = 0.03). 
Recovery Run 2 
I h 2h 3 h 4h 15 min 30 min 45 min Last min 
Gut Fullness (scale 6-20) 
CHO 9 ± I 10 ± I 11 ± 1 11 ± 1 12 ± 1 11 ± 1 11 ± 1 10 ± 1 
CHO-PRO 11 ± 1 12 ± 1 I3 ± I 14 ± I 12 ± 1 12 ± 1 11 ± 1 10 ± 1 
7.3.12 Control Data 
The treadmill speeds selected for R! were found to elicit relative exercise 
intensities of 73.7 ± 5.5% V0 2 max in the CHO trials and 74.3 ± 3.5% VO, max in 
the CHO-PRO trials (mean ± SO). Similarly, relative exercise intensities of 72.7 ± 
4.5% V0 2 max and 74.7 ± 3.2% VO, max were recorded during R2 in the CHO and 
CHO-PRO trials, respectively (mean ± SO). The heart rate responses to these 
exercise bouts were very similar, exhibiting a gradual rise with increasing exercise 
duration. Independent of trial, heart rates increased from 169 ± 9 beats·min·! to 178 ± 
8 beats·min·! during R! and from 170 ± 9 beats·min·! to 180 ± 11 beats·min·! during 
R2 (mean ± SO). 
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7.4 Discussion 
Ingesting a carbohydrate solution with an additional 0.3 g·kg·1·h·1 of whey 
protein isolate during a 4 h recovery from prolonged exercise resulted in a similar rate 
of muscle glycogen re synthesis as when a matched carbohydrate solution with no 
additional protein was ingested. In addition, the inclusion of protein in the solutions 
had no effect on muscle glycogen degradation rates during exercise subsequent to 
recovery. However, the ingestion of the CHO-PRO solution did result in improved 
maintenance of euglycaemia and an increased rate of carbohydrate oxidation during 
the second exercise session than did carbohydrate ingestion alone. 
The observation that muscle glycogen resynthesis was similar between 
treatments is not consistent with previous findings; all other research on this topic has 
reported an increase in the rate of muscle glycogen resynthesis when protein has been 
added to recovery solutions that provide :0;0.8 g CHO.kg·1.h·1 (Ivy et aI., 2002; Van 
Hall et aI., 2000a; van Loon et aI., 2000a; Zawadzki et aI., 1992). The reason for this 
discrepancy is not immediately apparent but may be related to the exercise mode that 
was selected for the present protocol. Studies using prolonged cycling to induce 
muscle glycogen depletion prior to recovery have established that adding protein to 
larger quantities of carbohydrate (i.e. 1.2 g CHO·kg-1·h·1) does not enhance muscle 
glycogen storage during recovery, possibly because such rates of carbohydrate intake 
maximise the glucose transport capacity of previously exercised muscle even without 
added protein (Jentjens et aI., 2001; Van Hall et aI., 2000b). Evidence supports the 
possibility that the treadmill running in comparison with cycling may reduce maximal 
glucose transport capacity following exercise as a consequence of the increased 
eccentric component of muscular contraction (Asp et aI., 1997b; King et al., 1993; 
Kirwan et al., 1992). If this is assumed to be true, then the maximal rate of muscle 
glycogen resynthesis might also be expected to be limited at a lower than usual rate 
(Costi1l et al., 1990; Doyle et aI., 1993; O'Reilly et al., 1987) and it would follow that 
a smaller than usual quantity of carbohydrate would be sufficient to maximise this 
process. Although speculative, this explanation would account for the virtually 
identical rates of muscle glycogen resynthesis between trials in the present study 
despite differences in serum insulin concentrations during recovery. 
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Alternatively, it may be that the treatment differences in serum insulin 
concentration in the present study were simply not of sufficient magnitude to produce 
a concomitant effect on the rate of muscle glycogen resynthesis. While even modest 
increases in circulating insulin can increase glucose uptake, it has been proposed that 
a minimum insulin concentration of ",340 pmol·r l may be necessary to shift the 
primary fate of intracellular glucose from net oxidation to net storage (Young et al., 
1988). It was certainly the case that the peak insulin concentrations which occurred 
after I h of recovery in the present study only exceeded this proposed figure in the 
CHO-PRO trial (CHO = 269 ± 26 pmoj.j'1 and CHO-PRO = 347 ± 37 pmol·r l) but by 
no means were these increments comparable with those reported in studies where the 
rate of glycogen resynthesis has been affected. For instance, the ingestion of 0.8 g 
CHO·kg·l·h·1 in the study of van Loon et al. (2000a) resulted in similar peak insulin 
concentrations to those observed in the present study, but when these authors added 
0.4 g·kg·l·h-1 of amino acids there was an 88% increase in insulinaemic response over 
5 h and peak insulin concentrations were in excess of 600 pmol·r l (van Loon et aI., 
2000a). It is not clear why the protein provided by these authors proved to be such an 
effective insulin secretagogue in comparison with solution currently under 
investigation but it may.be related either to minor variations in the amount of protein 
provided (i.e. 0.3 versus 0.4 g·kg·l·h'l) or to subtle differences in the precise amino 
acid composition of the protein that was ingested. Nonetheless, the inconsistent 
insulin concentrations between the study of van Loon et al. (2000a) and those of the 
present study are likely to be at least partially responsible for the varied rates of 
muscle glycogen resynthesis following CHO-PRO ingestion in each respective study. 
Although the insulin concentrations observed in the CHO-PRO trial of the 
present study may not have been sufficiently elevated to increase muscle glycogen 
storage overall, a trend (P = 0.15) was apparent for a greater rate of muscle 
proglycogen storage in the CHO-PRO trial (9.7 ± 2.4 mmol glucosyl units·kg dry 
mass,l·h,l) than in the CHO trial (6.8 ± 1.7 mmol glucosyl units·kg dry mass·l·h,I). Of 
the 2 forms of muscle glycogen, proglycogen is most responsive to insulin and would 
therefore be expected to account for the majority of muscle glycogen synthesis in 
response to acute nutritional intervention over 4 h (Adamo et al., 1998; Wee et al., 
2005). On the other hand, macroglycogen is known to be responsible for muscle 
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glycogen supercompensation following prior depletion, which is interesting given that 
the response of macro glycogen resynthesis to each treatment was opposite to that of 
pro glycogen in the present study. It is possible that synthesis of macroglycogen may 
have been preferentially stimulated in the CHO trial due to the lower absolute 
concentrations following RI in this trial than in the CHO-PRO trial, although this 
difference between treatments is negligible when considered as a fraction of overall 
muscle glycogen availability (Table 7.2). Nonetheless, it is interesting to note that 
macroglycogen only represented 6.8 and 16.6% of total muscle glycogen availability 
following RI in the CHO and CHO-PRO trials, respectively. These relatively low 
proportions may support the contention that macroglycogen was heavily used during 
RI since this acid soluble fraction has previously been shown to account for up to 
25% of total muscle glycogen content at rest (Jansson, 1981). This would therefore 
be consistent with the data of Adamo et al. (1998) who have reported macroglycogen 
concentrations in the region of 11-13% following exhaustive exercise. In summary, 
the distinct responses of macroglycogen and proglycogen to CHO-PRO 
supplementation are an interesting phenomenon and further research is required to 
determine the specific physiological roles of these separate pools of muscle glycogen. 
It should be noted that any gluconeogenic efflux arising from the deamination 
of amino acids during recovery will have overestimated the rate of protein oxidation 
presented in Figure 7.12. However, the NPRER that was calculated using this 
estimated protein oxidation rate remains accurate since the overall respiratory 
exchange ratio both for direct oxidation of protein and oxidation of glucose that is 
derived from protein is 0.8 (Frayn, 1983). The limitation to this method occurs if 
newly synthesised glucose is stored rather than oxidised since this process has a 
respiratory quotient of 0.4 and therefore artificially reduces the NPRER (Jequier et 
aI., 1987). It is therefore of interest that the NPRER displayed a slight tendency to be 
lower throughout recovery in the CHO-PRO trial than in the CHO trial, raising the 
possibility that the amino acids ingested in the CHO-PRO trial may have been 
de aminated and stored in the form of liver glycogen. While the lack of any significant 
differences in NPRER only allows such a conclusion to be drawn very tentatively (F 
= \.5, P = 0.15), many of the other variables measured during the present study are 
consistent with this suggestion. Firstly, it is unlikely that the reduced NPRER during 
recovery in the CHO-PRO trial was a consequence of increased lipid metabolism 
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since no trial differences in either FF A or glycerol concentrations were apparent at 
this time and the elevated insulin concentrations following CHO-PRO ingestion 
would be expected to inhibit lipolysis (Castan et al., 1999). In addition, the 
observation that plasma urea began to rise immediately upon ingestion of the CHO-
PRO solution provides evidence that the exogenously ingested amino acids were 
being deaminated and, given the relative hyperinsulinaemia during recovery, it is 
likely that a large portion of the newly generated glucose would be retained by the 
liver (Pencek et aI., 2004). Unfortunately, measurement of liver glycogen 
concentrations along with gluconeogenic hormones such as glucagon was not possible 
in the present study and the above hypothesis remains to be examined directly. 
Nonetheless, the majority of available literature attests that insulin can be expected to 
play a more central role than glucagon in the regulation of glucose metabolism and 
the current results can therefore be taken in provisional support for the suggestion that 
the protein fraction of the CHO-PRO mixture might have contributed carbon for the 
synthesis of liver glycogen during recovery. 
The above speculation regarding increased liver glycogen resynthesis during 
recovery in the CHO-PRO trial may also explain the differences between trials in 
terms of total carbohydrate oxidation during R2. Figure 7.13 neatly illustrates that 
blood glucose and lactate oxidation must have occurred at a greater rate following 
CHO-PRO ingestion since muscle glycogen utilisation during R2 was very similar 
between treatments and lipid oxidation was reduced. The hypoglycaemia which 
occurred in the early stages of R2 would be expected to stimulate endogenous glucose 
production (Coker et aI., 2002) and it is therefore conceivable that hepatic glucose 
output would be higher in the CHO-PRO treatment due to an increased availability of 
liver glycogen. While it is understood that the slightly elevated insulin concentrations 
during R2 in the CHO-PRO trial would usually oppose hepatic glucose output 
(Camacho et aI., 2004), it is thought that hypoglycaemia overrides this effect through 
reducing the action of insulin on the liver (Koyama et aI., 2002). The progressive 
increase in free fatty acids during R2 of the CHO-PRO trial lends further support for 
this contention since increments in free fatty acids are known to stimulate 
gluconeogenesis even under conditions of hyperinsulinaemia (Lam et aI., 2003). 
Therefore, the differences between trials in plasma glucose concentration during R2 
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may well reflect an improved counterregulatory response to hypoglycaemia following 
CHO-PRO ingestion. 
The finding that ingestion of the CHO-PRO solution produced more stable 
blood glucose concentrations than ingestion of the CHO solution but without 
compromising the rate of muscle glycogen resynthesis presents the interesting 
possibility that including protein in a carbohydrate solution might simultaneously 
provide the combined benefits of high and low glycaemic index (GI) carbohydrates. 
To be precise, the increased insulin response associated with ingesting high GI 
carbohydrate during recovery results in a greater rate of muscle glycogen storage than 
does ingestion of similar amounts of low GI carbohydrate (Burke et aI., 1993; Kiens 
et aI., 1990). However, the highly insulinotropic nature of high GI carbohydrates can 
also cause metabolic disturbances such as hypoglycaemia during subsequent exercise 
(Costill et aI., 1977; Foster et aI., 1979), a potential disadvantage which is less likely 
when low GI carbohydrates are ingested (Febbraio et al., 2000; Sparks et al., 1998; 
Wee et aI., 1999; Wee et al., 2005). It is therefore clear from the present results that a 
CHO-PRO mixture can provide the latter benefit oflow GI carbohydrates in terms of 
reduced metabolic disturbance while at the same time imparting the benefit of high GI 
carbohydrates through maintaining relatively high rates of muscle glycogen 
resynthesis during recovery. These combined effects of CHO-PRO ingestion on 
glucose homeostasis can clearly facilitate athletic performance but have also been 
applied as an effective nutritional intervention in clinical populations. Specifically, it 
has recently been demonstrated that the impaired insulinaemic response to 
carbohydrate ingestion in patients with type 2 diabetes can be successfully treated 
through the co ingestion of amino acids along with that carbohydrate, thus functioning 
to increase glucose disposal and reduce postprandial hyperglycaemia (Frid et al., 
2005; Manders et al., 2005; van Loon et al., 2003a). 
The reason that the peak in glucose concentrations during recovery tended to 
be lower in the CHO-PRO trial than in the CHO trial is probably related to the rate of 
glucose appearance from the GI tract under each condition. Intact protein is known to 
empty from the gut slightly slower than carbohydrate (Thomas, 1957) and has been 
found to delay gastric emptying when added to a glucose solution (Berry et al., 2002). 
While no direct evidence to verify this contention is available, participants' subjective 
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ratings of gut fullness were significantly higher when ingesting CHO-PRO than when 
ingesting CHO which may infer differences in gastric volume during recovery. 
Importantly, if it is assumed that intestinal glucose absorption was delayed with the 
CHO-PRO treatment, then it is possible that this factor might also have contributed to 
the trial differences in glucose concentration during R2. Specifically, glucose 
appearance from the GI tract may have been maintained until R2 in the CHO-PRO 
trial, thus supplementing plasma glucose concentrations more effectively than in the 
CHO trial. 
In summary, contrary to the wealth of available literature, the addition of 
protein to a carbohydrate recovery solution providing 0.8 g CHO·kg·l·h·1 did not 
further accelerate the rate of muscle glycogen resynthesis during a 4 h recovery from 
prolonged exercise. Furthermore, the rate of muscle glycogen degradation during 
exercise subsequent to recovery was also not different between the CHO and CHO-
PRO treatments despite a higher contribution of overall carbohydrate oxidation 
towards metabolism following CHO-PRO ingestion. It is concluded that the added 
protein increased the oxidation rate of other carbohydrate sources such as glucose and 
lactate during R2, possibly as a result of an elevated appearance of glucose from the 
liver and/or gastrointestinal tract during exercise. 
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General Discussion 
This series of studies has revealed that exercise capacity can be restored more 
completely within a 4 h recovery from prolonged exercise if the energy content of a 
carbohydrate solution providing 0.8 g CHO·kg-l.h- 1 is increased through the addition 
of 0.3 g·kg· 1 h- 1 of either mixed amino acids or further carbohydrate. The addition of 
amino acids was consistently found to augment the insulinaemic response to varying 
levels of carbohydrate intake, although no difference in the rate of muscle glycogen 
resynthesis during recovery was apparent between these treatments. Furthermore, the 
presence of these amino acids in the recovery solutions did not alter the rate of muscle 
glycogen degradation during exercise subsequent to recovery, instead resulting in an 
increased oxidation of alternative sources of carbohydrate. Other notable findings 
were that ingestion of CHO-PRO rather than CHO during recovery resulted in an 
immediate increase in plasma urea concentrations and also increased the 
concentrations of human growth hormone following the exercise capacity test. It is 
also noteworthy that differences in exercise capacity following recovery were only 
evident when the intensity of that exercise test did not exceed ~70% VO,max. 
The most striking of the above findings is that ingestion of a CHO-PRO 
solution during a short-term recovery can promote a more rapid restoration of exercise 
capacity than ingestion of a solution containing the carbohydrate fraction in isolation. 
More importantly, it appears that this ergogenic benefit of CHO-PRO ingestion may 
be independent of an effect on muscle glycogen resynthesis during recovery. This 
contention stems from the combined results of Studies 3 and 4 in which the addition 
of protein to a carbohydrate solution improved exercise capacity but without 
accelerating the rate of muscle glycogen resynthesis, respectively. 
However, the authority with which the above conclusion can be drawn 
depends on the degree to which Studies 3 and 4 can be assumed to reflect one another. 
In support of this assumption, the descriptive characteristics of participants recruited 
for Study 4 were almost identical to those of the participants who ran to volitional 
exhaustion during Study 3 and the experimental designs of these 2 studies were also 
identical, other than the open ended nature of the exercise test in Study 3. The overall 
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consequence of this standardisation was that virtually all of the physiological 
variables that were common to both studies displayed a very similar pattern between 
treatments. In light of this, it is reasonable to assume that the muscle glycogen 
concentrations measured in Study 4 would have followed a similar pattern during 
Study 3. This line of reasoning equally leads to the suggestion that the participants in 
Study 4 would have been able to exercise for longer during R2 had this exercise 
session required them to run to the point of exhaustion rather than being a fixed 
duration exercise task. This possibility therefore presents a number of interesting 
points of discussion regarding the potential causes of fatigue during R2 in Study 3 
along with the mechanism through which the ingestion of CHO-PRO may have 
operated to delay these processes. 
The CHO-PRO mixture did not elicit a greater rate of muscle glycogen 
resynthesis during recovery than that achieved through ingestion of a matched amount 
of carbohydrate alone. As such, the absolute amount of muscle glycogen that was 
available at the onset of R2 was not different between the CHO and CHO-PRO 
treatments and the differences in exercise capacity cannot therefore be attributed to 
differences in pre-exercise muscle glycogen status. Neither can the increased exercise 
capacity in the CHO-PRO trial of Study 3 be attributed to muscle glycogen sparing 
during R2, at least during the first 60 min of exercise, since Study 4 established that 
rates of muscle glycogen degradation were almost identical over this period between 
the CHO and CHO-PRO treatments. Once these possibilities have been eliminated, 
what remains is the prospect that some influence of the CHO-PRO solution must have 
operated to prolong physical performance in the late stages of exercise, i.e. after the 
60 min sampling point applied in Study 4. Figure 8.1 presents 2 possible mechanisms 
(a and b) through which muscle glycogen concentrations may have dissociated 
between treatments such that performance could be prolonged in the CHO-PRO trial. 
The broken lines on Figure 8.1 represent the predicted changes in muscle 
glycogen concentration following the 60 min sampling point in each trial, although it 
should be acknowledged that the suggested rates of muscle glycogen degradation 
between 60 min and the point of fatigue are probably overestimates since the rate of 
glycogen utilisation would be expected to decrease with increasing exercise duration 
(Coyle et al., 1986; Hargreaves et aI., 1995; Romijn et al., 1993). Nonetheless, given 
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the similarity of glycogen concentrations between trials at 60 min, this overestimation 
is likely to be of a similar magnitude between the 2 solutions and therefore would not 
confound interpretation of this figure. What is clearly demonstrated in Figure 8.1 is 
that muscle glycogen concentrations must have dissociated between treatments in the 
late stages of exercise, either through a reduced rate of muscle glycogen utilisation in 
the CHO-PRO trial (option a) or through lower absolute muscle glycogen 
concentrations at the point of fatigue in the CHO-PRO trial (option b). To address the 
former of these possibilities, fatigue may potentially have been postponed by an 
increased availability of liver glycogen in the latter stages of R2• According to this 
explanation, when critically low muscle glycogen concentrations occurred after 
approximately 84 min of the exercise capacity test, further performance would be 
entirely dependent on the availability of other carbohydrate sources. It is therefore 
conceivable that ingestion of CHO-PRO rather than CHO during recovery may have 
resulted in an enhanced rate of liver glycogen resynthesis, thus facilitating hepatic 
glucose output once muscle glycogen was depleted during R2. Evidence from 
Ahlborg and Felig (1982) certainly supports that, once muscle glycogen has been 
depleted, hepatic glucose output can only be sustained by an adequate supply of liver 
glycogen (Ahlborg and Felig, 1982). Furthermore, the study of Coyle et al. (1986) 
has previously demonstrated that exercise can be performed for prolonged periods 
with minimal reliance on muscle glycogen provided that an adequate supply of blood 
glucose is available to maintain carbohydrate oxidation (Coyle et al., 1986). It is 
therefore notable that blood glucose concentrations and calculated rates of 
carbohydrate oxidation were greater during R2 in the CHO-PRO trials than in the 
CHO trials both in Study 3 and Study 4. In fact, the finding that muscle glycogen 
degradation rates were almost identical between the CHO and CHO-PRO trials infers 
that the observed increase in overall carbohydrate oxidation must have arisen from an 
increased oxidation of other carbohydrate sources (i.e. blood glucose/lactate). 
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Figure 8.1: Possible dissociation of muscle glycogen concentrations between 
treatments to account for the prolonged performance in the CHO-PRO trial. The solid 
lines represent the rates of muscle glycogen degradation measured in Study 4 while 
the broken lines represent the possible changes in muscle glycogen degradation after 
the 60 min sampling point based on the run times recorded in Study 3. Option a = 
muscle glycogen sparing through oxidation of other carbohydrate sources late in 
exercise; option b = lower critical level of muscle glycogen depletion prior to the 
onset of fatigue. 
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Despite the potential similarity between the current findings and those of 
Coyle et al. (1986), in that fatigue may have been postponed with no further reliance 
on muscle glycogen (option a), it was proposed by these authors that fatigue in such 
circumstances would coincide with the development of hypoglycaemia (Coyle et aI., 
1986). However, there was no evidence of hypoglycaemia at the point of fatigue in 
any of the trials during Study 3, which would appear to conform to the more recent 
suggestion of Classen et al. (2005) that the beneficial effect of improved glucose 
availability late in exercise is unrelated either to maintenance of carbohydrate 
oxidation or avoidance of hypoglycaemia. The alternative proposal from these 
authors is that fatigue may be a consequence of combined muscle and liver glycogen 
depletion resulting in an increased cerebral sensitivity to relatively small fluctuations 
in glucose concentration (Claassen et aI., 2005), an explanation that would certainly 
be more compatible with the present results and also with data from other authors in 
relation to intermittent exercise (Foskett et al., 2004). Furthermore, this notion of 
cerebral sensitivity to overall carbohydrate status would also fit nicely with recent 
findings indicating that simply the taste of carbohydrate can impart an ergogenic 
benefit (Carter et aI., 2004). Taken in combination, all the above studies support that 
fatigue is initiated as a safety mechanism in response to compromised overall 
carbohydrate status rather than as a consequence of muscle glycogen depletion per se. 
In this sense the possibility illustrated as option b gains credibility since the CNS 
might permit muscle glycogen to reach slightly lower concentrations before 
terminating exercise in circumstances where sufficient liver glycogen is available to 
safely continue physical activity without compromising glucose homeostasis. This 
interaction between net carbohydrate status, the CNS and the onset of fatigue is 
presented graphically in Figure 8.2. 
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Figure 8.2: Proposed safety mechanism resulting from signalling between net 
carbohydrate status, the CNS and the onset of fatigue. 
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Support for the process illustrated in Figure 8.2 comes from Casey et al. 
(2000) who have described how exercise capacity may be more strongly associated 
with overall carbohydrate status than with muscle glycogen status alone (Casey et al., 
2000). Intuitively, the monitoring of liver glycogen availability by the CNS can be 
expected to play a primary role in the development of fatigue since maintenance of 
glucose homeostasis would take priority over maintaining exercise intensity in almost 
all circumstances. The implication of this model is that effective nutritional 
supplementation during a short-term recovery will need to replace both muscle and 
liver glycogen to prevent this safety mechanism being initiated prematurely during 
subsequent exercise. In relation to the present results, however, it cannot be fully 
established whether exercise capacity was enhanced as a direct result of increased 
liver glycogen storage during recovery when ingesting the solutions with added 
protein. As discussed in both Chapters 6 and 7, indirect evidence for such an effect 
might be taken from the observation of elevated urea concentrations coupled with the 
decreased RER during recovery in the CHO-PRO trials, which may reflect the storage 
of amino acids as liver glycogen. Nonetheless, while this explanation would certainly 
account for the improved maintenance of blood glucose during R2, it is clear that 
further investigation will be necessary to directly assess the impact of CHO-PRO 
ingestion on the rate of liver glycogen resynthesis during recovery. 
Just as the safety mechanism proposed in Figure 8.2 implies that muscle 
glycogen cannot be assumed to be the sole determinant of exercise capacity, it would 
be equally simplistic to suggest that compromised liver glycogen availability will be 
the primary cause of fatigue in every situation. Instead, a more adaptable system 
would involve the CNS monitoring various components of net carbohydrate status 
independently, with the relative impact of each of these signals mediated by a number 
of factors. An interesting possibility is that certain influences from a prior bout of 
exercise might carry over into the second exercise session such that the eNS will be 
more sensitive to changes in carbohydrate availability. It is apparent from this 
example that fatigue will be the overall product of a complex interaction between 
peripheral signalling of challenged carbohydrate status and the sensitivity of the CNS 
to these signals. Therefore, the differences in exercise capacity reported in Study 3 
may not only reflect differences in carbohydrate storage during recovery but also 
alterations in central drive during R2. Indeed, the central fatigue hypothesis provides 
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a clear mechanism through which the inclusion of amino acids in a recovery solution 
might offset sensations of fatigue when carbohydrate status is compromised (Davis, 
1995; Davis and Bailey, 1997). According to this hypothesis, the increase in plasma 
FF A which occurs in response to carbohydrate depletion would displace tryptophan 
from its binding site on albumin (Yamamoto et al., 1997), thus favouring the transport 
of this particular amino acid across the blood-brain barrier and facilitating the 
synthesis of certain neurotranmitters (e.g. 5-HT) that are associated with sensations of 
fatigue (Bailey et aI., 1993; Pardridge, 1983). There are therefore 2 possible 
mechanisms through which the CHO-PRO mixture used in Study 3 may have 
influenced the above process to postpone fatigue. Firstly, it is likely that circulating 
amino acid concentrations would be higher during R2 in the CHO-PRO trials than in 
the CHO trials which would competitively inhibit the transport of tryptophan across 
the blood-brain barrier. Evidence in support of this contention can be taken from 
studies which have demonstrated that ingestion of amino acids alone can both reduce 
perceived exertion and improve performance (Blomstrand et al., 1997; Blomstrand et 
al., 1991), which may also explain why participants tended to report lower RPE 
scores following CHO-PRO rather than either CHO or CHO-CHO ingestion during 
Study 3. The second mechanism through which the additional protein may have 
operated to attenuate sensations of fatigue may relate back to the findings cited earlier 
regarding carbohydrate availability. Specifically, both Studies 3 and 4 demonstrated 
that the increased glucose concentrations during exercise following ingestion of CHO-
PRO rather than CHO were also associated with slightly decreased circulating 
concentrations of FFA. According to the central fatigue hypothesis, a greater 
proportion of tryptophan would therefore remain bound to albumin in the CHO-PRO 
trials and this might reduce the synthesis of 5-HT and consequently delay the onset of 
fatigue (Blomstrand et al., 2005). In addition, given that an inhibitory influence of 
brain glucose on 5-HT synthesis has been demonstrated (Bequet et aI., 2002), it is 
also reasonable to suggest that peripheral carbohydrate status might be detected by the 
CNS at least partially through a direct assessment of blood glucose availability. 
However, it is also emerging that IL-6 release from skeletal muscle during 
exercise might provide an additional mechanism through which the CNS can detect 
critically low levels of carbohydrate availability (Nieman et al., 2005; Pedersen and 
Febbraio, 2005). Particularly since the release of this cytokine has been associated 
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with the activity of AMPK in muscle fibres that have been depleted of muscle 
glycogen (MacDonald et aI., 2003). It has been postulated that such increases in IL-6 
might contribute to the development of central fatigue as described above (Gleeson, 
2000) and, with relevance to Figure 8.2, it is also known that IL-6 serves a secondary 
purpose in stimulating hepatic glucose production (Febbriao et al., 2004). This latter 
finding is of utmost importance regarding the regulation of glucose metabolism 
during exercise because low muscle glycogen concentrations per se do not increase 
the rate of blood glucose oxidation without increases in blood glucose concentration 
(Arkinstall et aI., 2004; Weltan et aI., 1998a, 1998b). Therefore, IL-6 may represent 
the signalling mechanism through which an impending intra-muscular energy crisis is 
detected by both the brain and the liver in order to increase hepatic glucose output and 
thus sustain energy production through increasing the oxidation of blood glucose. 
Nonetheless, in light of the similarity in muscle glycogen concentrations between 
trials in Study 4, IL-6 release from muscle might also be expected to be similar 
between treatments. What would differ between trials, however, would be the ability 
of the liver to respond to this signal with an increase in glucose production, prompting 
the CNS to reduce motor unit recruitment and thus restrict further energy expenditure 
after different exercise durations following CHO or CHO-PRO ingestion. 
Further to the above discussion regarding the possible mechanisms through 
which the inclusion of protein may have prolonged exercise capacity in Study 3, this 
investigation also unearthed the interesting finding that recovery of exercise capacity 
was equally enhanced through increasing the rate of carbohydrate ingestion from 0.8 
g CHO·kg·l·h-1 to 1.1 g CHO·kg-l·h- l. Given the proposed positive correlation 
between exercise capacity and pre-exercise muscle glycogen availability (Bergstrom 
et aI., 1967), this finding is not entirely unexpected since a similar increase in 
carbohydrate intake has been previously shown to accelerate the rate of muscle 
glycogen resynthesis during a short-term recovery (van Loon et aI., 2000a). 
However, efforts from other authors to translate these differences in muscle glycogen 
resynthesis into an effect on restoration of treadmill running capacity have not been 
successful (Fallowfield and Williams, 1997; Wong and Williams, 2000). The finding 
of a similar recovery of endurance capacity following ingestion of either 0.2 g 
CHO·kg-l·h- 1 or 0.5 g CHO.kg-1.h- 1 by Wong and Williams (2000) is of particular 
interest because a subsequent investigation from Tsintzas et al. (2003) has indicated 
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that an increase in carbohydrate intake of this magnitude would be highly likely to 
increase the rate of muscle glycogen resynthesis during recovery without increasing 
the rate of muscle glycogen degradation during subsequent exercise (Tsintzas et al., 
2003). Therefore, it remains difficult to explain why effects on exercise capacity have 
not been identified in those studies in which varying amounts of carbohydrate have 
been ingested during recovery. 
One potential explanation is that the exercIse capacity tests employed by 
previous investigators may not have been sufficiently reliable to detect small but 
worthwhile differences in run time to exhaustion between treatments (Hopkins et aI., 
1999; Hopkins et al., 200 I). Indeed, the reliability of tests involving exercise to the 
point of fatigue at a fixed sub-maximal intensity have been questioned (Krebs and 
Powers, 1989; McLellan et al., 1995) and have lead other authors to promote the use 
of self-paced time-trials as a more reliable alternative (Russell et aI., 2004; Schabort 
et al., 1998a; Schabort et aI., 1998b). The concern underlying this suggestion is that 
any given exercise test will only be capable of detecting intervention effects that are 
larger than the coefficient of variation (CV) for that test (Hopkins et al., 1999). 
Therefore, while such exercise capacity tests can easily detect the large intervention 
effect which occurs when carbohydrate is compared with a placebo (Fallowfield et aI., 
1995), it is conceivable that the relatively small enhancement of exercise capacity 
which occurs in response to various rates of carbohydrate ingestion may not be 
detected (Fallowfield and Williams, 1997; Wong and Williarns, 2000). The upper 
panel of Figure 8.3 (A) illustrates that, even in the face of a large degree of error 
variance, differences in recovery of exercise capacity can be detected between a 
placebo solution and a range of carbohydrate solutions, but with no distinction 
between the varying levels of carbohydrate intake. However, it would be 
inappropriate to conclude that exercise capacity tests per se are inherently unreliable 
since the exercise capacity data gathered during Study 3 was obviously of sufficient 
sensitivity to detect not only the effect of increasing carbohydrate intake by just 0.3 
g·kg-I·h- I but also to detect the even smaller influence on exercise capacity of adding a 
matched quantity of amino acids. The capability of this increase in test-retest 
reliability to reveal small but worthwhile intervention effects is shown in the lower 
panel of Figure 8.3 (B). Overall, it seems logical to suggest that the reliability of any 
exercise test will be directly proportional to the degree of control which is exerted 
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over extraneous variables, which therefore dictates that the degree of control required 
for a given study will be inversely proportional to the magnitude of the smallest effect 
that is deemed to be worthwhile. 
The precise reason for the apparently improved reliability of the exercise 
capacity test in Study 3 in comparison with the previous studies of Fallowfield and 
Williams (1997) and Wong and Williams (2000) is not immediately obvious but may 
be related to the characteristics of the participants who were recruited for these 
respective investigations. Specifically, in both the studies cited above, the mean run 
time to exhaustion at 70% VO, max following a 4 h recovery was approximately 60 
min regardless of the amount of carbohydrate consumed during recovery (Fallowfield 
and Williams, 1997; Wong and Williams, 2000). In contrast, the participants 
recruited for Study 3 were all able to run for at least 60 min during R2, with many 
running far longer and producing mean run times to exhaustion in excess of 80 min 
for all 3 trials. It is possible, therefore, that the participants used in these earlier 
investigations may have terminated their exercise capacity tests before a true 
metabolic endpoint had been established. This is likely to be true for at least some of 
the participants recruited by Wong and Williams (2000) as evidenced by the large 
range of run times reported in this study (27.9-105.6 min). 
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Figure 8-3: Reliability of exercise capacity tests under varying degrees of control. Broken lines 
denote the 'true' exercise time to exhaustion for the target population following ingestion of each 
supplement and the solid lines denote the test-retest error variance for a given individual. The 
upper panel CA) is representative of those studies which have identified differences in recovery of 
exercise capacity between carbohydrate and placebo solutions (Fallowfield et aI., 1995) but have 
not established differences between varying rates of carbohydrate intake (Fallowfield and Williams, 
1997; Wong and Williams, 2000). The error variance for this upper figure is based a CV ranging 
between 17-27% that has been reported for similar tests (Schabort et al., 1998b). The lower panel 
(B) represents the degree of control employed in Investigation 3, which was capable of detecting 
differences between the CHO solution and the CHO-PRO and CHO-CHO solutions. 
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It is also noteworthy that no significant differences in time to fatigue were 
detectable between the CHO-PRO and CHO-CHO treatments in Study 3, this is 
despite a relatively large absolute difference between the means (i.e. 91.2 versus 99.9 
min, respectively). Given that this effect was only marginally short of attaining 
statistical significance (P = 0.07), it might be suggested that additional participants 
should have been recruited to reveal a statistical difference. However, it should be 
borne in mind that 5 of the 8 participants originally recruited for Study 3 experienced 
severe gastrointestinal distress during the exercise capacity test following ingestion of 
the CHO-CHO solution, so much so that 2 of these participants were forced to 
withdraw from the study. Therefore, it is reasonable to suggest that the reliability of 
the exercise capacity test in the CHO-CHO trial may have been compromised in that 
sensations of gastrointestinal discomfort might have precluded the establishment of a 
valid metabolic endpoint (see error variance Figure 8.38). In this sense, to recruit a 
few additional participants in order to attain statistical significance would assume that 
these new recruits would reproduce the effect observed in those participants who 
reported no gastrointenstinal distress, when in fact it is equally as likely that any 
further data collected could simply increase the degree of random error. Nonetheless, 
the tendency for longer run times following ingestion of CHO-CHO rather than CHO-
PRO indicates that it might be erroneous to conclude that these 2 solutions are equally 
effective in restoring exercise capacity. However, it would require an unrealistically 
large sample size to detect this difference given the confounding influence of the 
concentrated carbohydrate solution on the reliability of the exercise capacity test. 
Overall, even if the conclusion of Study 3 (i.e. CHO-PRO = CHO-CHO) does 
represent a type II error, it is not costly in practical terms since the negative side-
effects associated with the CHO-CHO solution would favour recommendation of the 
CHO-PRO solution regardless of any potential ergogenic differences between the 2 
treatments. 
A final issue relating to the reliability of exercIse capacity tests is the 
possibility that those conducted at 85% V02 max during Studies 1 and 2 may not 
have been sufficiently reliable to detect differences between the CHO and CHO-PRO 
solutions. Interestingly, the studies which challenge the reliability of exercise 
capacity testing by Krebs et al. (1989) and McLellan et al. (1995) acquired their CV 
(20.3% and 17.1%, respectively) from exercise tests conducted at 80% VO,max. It is 
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therefore possible that significant differences between treatments were apparent in 
Study 3 but not in Studies I and 2 entirely as a consequence of differences in the 
reliability of the capacity tests at various exercise intensities. However, this 
suggestion cannot be made with any authority because other variables relating to the 
composition of the CHO-PRO mixture were also refined prior to Study 3. Therefore 
it remains a possibility that the ergogenic benefit of including protein in a 
carbohydrate recovery solution may be dependant on the absolute amount of protein 
that is ingested during recovery. 
The insulin concentrations recorded during recovery throughout this thesis 
certainly appear to suggest that the wheat protein hydrolysate used in Study 2 may 
have been a slightly less effective insulin secretagogue than the whey protein isolate 
that was used in the latter 2 studies. Evidence from van Loon et al. (2000b) has 
previously demonstrated that the precise amino acid composition of ingested protein 
can have a profound impact on the resultant insulinaemic response. Specifically, it 
was suggested by these authors that the insulinaemic response to any given amino 
acid mixture will be strongly dependent on the quantities of leucine, phenylalanine 
and tyrosine which are included (van Loon et al., 2000b). Furthermore, despite the 
finding that glutamine may facilitate leucine evoked insulin secretion by acting as a 
fuel for pancreatic islet cells (Borel et aI., 1998; Malaisse-Lagae et aI., 1982), the 
work from van Loon et al. (2000b) concludes that enough glutamine may be present 
in humans in vivo to serve this function (van Loon et al., 2000b). Taken together, 
these findings may partially explain why the whey protein isolate was slightly more 
effective than the wheat protein hydrolysate in stimulating insulin secretion since the 
glutamine content of the former was lower, thus allowing for a greater content of the 
more insulinotropic essential amino acids. However, the augmented insulin response 
in Studies 3 and 4 cannot be exclusively attributed to the composition of protein that 
was ingested because the amount of protein included in the CHO-PRO mixtures was 
also increased following Study 2. Based on the available evidence, the increase in 
protein ingestion rate from sO.2 g PRO·kg"l·h·1 in Studies 1 and 2 to 0.3 g PRO·kg·l·h-
I in Studies 3 and 4 would be predicted to increase insulin release. This is because the 
synergistic influence of combined carbohydrate and protein ingestion on insulinaemic 
response has only been reported in those studies which have provided 20.3 g PRO· kg-
I·h- I (Jentjens et al., 2001; Van Hall et al., 2000a; Van Hall et al., 2000b; van Loon et 
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aI., 2000a; van Loon et al., 2000c; Zawadzki et aI., 1992), while CHO-PRO solutions 
containing less than this amount of protein have not produced such large increases in 
insulin concentration (Carrithers et al., 2000; Ivy et al., 2002; Ivy et aI., 2003; 
Tamopolsky et al., 1997). 
Importantly, even though the whey protein isolate was only marginally more 
effective than the wheat protein hydrolysate in augmenting the insulin response 
during recovery, the increase above that of the CHO solution was sufficient that the 
fate of intracellular glucose would be expected to shift from oxidative to non-
oxidative disposal (Young et aI., 1988). It is therefore surprising that muscle 
glycogen resynthesis was not different between treatments, although elevations in 
circulating insulin may have also contributed to non-oxidative disposal of glucose 
within the liver. First pass extraction of glucose by the liver is thought to be a highly 
efficient process irrespective of insulin concentration but an increased availability of 
insulin could possibly have increased liver glycogen storage through facilitating 
hepatic glucose retention (Wasserman and Cherrington, 1991). In this way, the CHO-
PRO solution may have enhanced liver glycogen resynthesis during recovery both 
through providing amino acids as gluconeogenic substrate and then ensuring that any 
newly formed glucose was stored rather than mobilised. 
The above possibility raises the question as to whether the CHO-CHO solution 
in Study 3 may also have increased the rate ofliver glycogen resynthesis above that of 
the CHO solution since the addition of further carbohydrate resulted in a similar 
augmentation of insulin release as did the inclusion of protein. It would therefore be 
interesting to have muscle glycogen data for the CHO-CHO solution to determine 
whether this solution improved exercise capacity through the same mechanism as the 
CHO-PRO solution or via some other mechanism. The majority of scientific 
literature seems to suggest that the rate of muscle glycogen re synthesis would be 
greater following ingestion of l.l g CHO·kg-l·h- 1 than following ingestion of 0.8 g 
CHO·kg-l·h- 1 (see Figure 2.5, p. 59), so it might be concluded that the CHO-PRO and 
CHO-CHO solutions enhanced recovery through mutually exclusive mechanisms. 
However, it should be noted that the data supporting this contention relates to 
recovery periods following prolonged cycling, which may not be entirely applicable 
to the· present results. It is particularly interesting that carbohydrate ingestion 
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following prolonged treadmill running has been reported by Tsintzas et al. (2003) to 
result in rates of muscle glycogen resynthesis that are relatively low in comparison 
with reports from other authors involving carbohydrate ingestion following prolonged 
cycling (Maehlum et al., 1978; Tamopolsky et aI., 1997; Tsintzas et aI., 2003). It is 
therefore possible that an initial bout of treadmill running may limit the rate of muscle 
glycogen resynthesis during recovery below that which is possible following 
prolonged cycling, potentially as a consequence of damage to contractile tissue as a 
result of the increased eccentric component of muscular contraction during treadmill 
running (Costill et aI., 1990; Doyle et al., 1993; O'Reilly et al., 1987; Zehnder et aI., 
2004). In concordance with this line of thought is the observation of substantial 
increases in plasma myoglobin concentrations following R, in every study of this 
thesis, thus providing clear evidence of disruption to the plasma membrane. If this 
were the case then it becomes more understandable why the glucose that could not be 
stored in damaged muscle tissue might find an alternative site of storage within the 
liver. 
In addition to the degree of muscle damage that may have been induced by RI, 
it is also likely that the rates of muscle glycogen resynthesis during recovery may 
have been restricted in the present series of studies by the fact that the exercise 
session performed prior to recovery was of fixed duration rather than to the point of 
volitional exhaustion. It has been well established that one of the most potent 
effectors of muscle glycogen synthesis is a low availability of muscle glycogen itself, 
which would explain why some of the most rapid rates of muscle glycogen 
resynthesis have been reported in those studies which have reduced muscle glycogen 
below 100 mmol glucosyl units·kg dry mass·' prior to recovery (Blom, 1989; Casey et 
aI., 1995; Van Hall et aI., 2000b). Notably, the initial exercise session used in all the 
studies cited above required participants to exercise to the point of fatigue, which 
leaves open the possibility that CHO-PRO solutions may be of greatest value 
following more prolonged periods of exercise when an effective recovery is most 
dependent on exogenous sources of carbohydrate. 
A final point of discussion which arises from this series of investigations is the 
magnitude of growth hormone response to each respective exercise session (i.e. R, 
versus R2)' In both the studies in which this variable was measured, growth hormone 
230 
Chapter 8 General Discussion 
concentrations were not vastly different between the first and second exercise sessions 
in each trial (Chapters 5 and 6). It might be expected that the growth hormone 
response to the second exercise bout should be attenuated due to an accumulation of 
hypo thalamic somatostatin during RI (Lanzi and Tannenbaum, 1992b), which would 
explain the attenuated growth hormone release which has been observed when 
repeated bouts of aerobic exercise have been performed with only 1 h of recovery 
(Sartorio et al., 2005). However, this auto-feedback mechanism is only thought to 
persist for approximately 4 h, thus explaining the relative lack of any attenuated 
growth hormone release during R2 in the current investigations (Lanzi and 
Tannenbaum, 1992a). Converse to the above hypothesis, other authors have offered 
support for the contention that repeated bouts of aerobic exercise may in fact 
progressively desensitise the growth hormone response to this auto-negative feedback 
loop, thus augmenting the degree of growth hormone secretion with each ensuing 
exercise session (Kanaley et al., 1997; Ronsen et al., 2001). The precise reasons for 
these apparently inconsistent findings remain to be fully elucidated but may be at least 
partially related to individual differences in the participants recruited for each 
investigation (Mejri et al., 2005; Wideman et aI., 2000b). Alternatively, the relative 
attenuation or augmentation of the growth hormone response to repeated exercise may 
be mediated by exercise intensity (Pritzlaff et aI., 1999), a suggestion which would 
certainly account for the marked attenuation of growth hormone response during 
repeated bouts of maximal intensity exercise (Stokes et aI., 2005). 
To summanse the mam results of this thesis in their entirety, it is firstly 
important to note that differences between recovery solutions were only recorded in 
terms of exercise capacity when the test used to assess this variable was conducted at 
running speeds equivalent to 70% VO, max. It is therefore suggested that exercise 
capacity tests at this intensity may be a more appropriate surrogate measure of 
carbohydrate status than exercise tests set at higher relative exercise intensities, such 
as were employed during Studies 1 and 2. However, future research will be necessary 
to fully confirm this suggestion since the specific composition of the CHO-PRO 
mixtures used in the current series of studies did vary slightly between the first and 
last 2 experiments. It is therefore possible that the ergogenic benefit which was 
revealed in Study 3 might be the combined product both of a more effective recovery 
solution and a more appropriate exercise test. Nonetheless, even if the mixture of 
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amino acids used in Studies 3 and 4 was superior to that used in the earlier studies, the 
wheat protein hydrolysate and the whey protein isolate were both capable of 
increasing the insulinaemic response during recovery above that elicited by a solution 
containing carbohydrate alone. Therefore, the results gathered in this thesis 
consistently support earlier evidence demonstrating a synergistic influence of 
combined carbohydrate and protein ingestion on insulin secretion (Rabinowitz et at., 
1966). 
From a practical perspective, the most prominent finding which arises from 
this sequence of experiments is that recovery of prolonged running capacity can be 
enhanced during a short-term recovery either through adding 0.3 g.kg-I.h- I of mixed 
amino acids to a moderately concentrated carbohydrate solution or through increasing 
the carbohydrate content of that solution by an amount equal to that of the additional 
protein. While other authors have previously demonstrated a similar ergogenic 
benefit of mixed carbohydrate and protein ingestion when assessed in comparison 
with a lower carbohydrate solution (Williams et at., 2003), the present data represents 
the first evidence of this effect when the CHO and CHO-PRO solutions are matched 
for carbohydrate content. In addition, the further comparison between the CHO and 
CHO-CHO solutions in Study 3 also confirms the previously uncorroborated 
hypothesis that a dose-response relationship might exist between carbohydrate 
ingestion rate and the restoration of exercise capacity following prolonged exercise. 
However, with regard to the comparison between the CHO and CHO-PRO solutions, 
a subsequent more invasive examination revealed that the rate of muscle glycogen 
resynthesis was not accelerated when amino acids were included in the carbohydrate 
solution that was ingested during recovery. It can therefore be concluded that the 
addition of protein to a carbohydrate solution can improve recovery of exercise 
capacity but that this effect is unrelated to changes in muscle glycogen availability. 
232 
REFERENCE LIST 
Reference List 
Achten J. & Jeukendrup A. E. (2003) Effects ofpre-exercise ingestion of 
carbohydrate on glycaemic and insulinaemic responses during subsequent exercise at 
differing intensities. European Journal of Applied Physiology 88, 466-471. 
Adamo K. B., Tamopolsky M. A. & Graham T. E. (1998) Dietary carbohydrate and 
postexercise synthesis of proglycogen and macroglycogen in human skeletal muscle. 
American Journal of Physiology 275, E229-234. 
Ahlborg B., Bergstrom J., Ekelund L. & Hultman E. (1967) Muscle glycogen and 
muscle electrolytes during prolonged physical exercise. Acta Physiologica 
Scandinavica 70, 129-142. 
Ahlborg G. & Felig P. (1982) Lactate and glucose exchange across the forearm, legs, 
and splanchnic bed during and after prolonged leg exercise. Journal of Clinical 
Investigation 69, 45-54. 
Ahlborg G., Felig P., Hagenfeldt L., Hendler R. & Wahren 1. (1974) Substrate 
turnover during prolonged exercise in man. Splanchnic and leg metabolism of 
glucose, free fatty acids, and amino acids. Journal of Clinical Investigation 53, 1080-
1090. 
Alessio H. M. (1993) Exercise-induced oxidative stress. Medicine and Science in 
Sports and Exercise 25, 218-224. 
Alien D. G. & Westerblad H. (2001) Role of phosphate and calcium stores in muscle 
fatigue. Journal of Physiology 536,657-665. 
Alonso M. D., Lomako J., Lomako W. M. & Whelan W. J. (1995) A new look at the 
biogenesis of glycogen. FASEB Journal 9, 1126-1137. 
Andrews M. A. W., Godt R. E. & Nosek T. M. (1996) Influence ofphysiological 
L( + )-lactate concentrations on contractility of skinned striated muscle fibres of rabbit. 
Journal of Applied Physiology 80,2060-2065. 
Angus D. J., Febbraio M. A. & Hargreaves M. (2002) Plasma glucose kinetics during 
prolonged exercise in trained humans when fed carbohydrate. American Journal of 
Physiology 283, E573-577. 
234 
Reference List 
Anthony J. c., Anthony T. G. & Layman D. K. (1999) Leucine supplementation 
enhances skeletal muscle recovery in rats following exercise. Journal of Nutrition 
129,1102-1106. 
Anthony J. C., Reiter A. K., Anthony T. G., Crozier S. J., Lang C. H., MacLean D. 
A., Kimball S. R. & Jefferson L. S. (2002) Orally administered leucine enhances 
protein synthesis in skeletal muscle of diabetic rats in the absence of increases in 4E-
BPI or S6KI phosphorylation. Diabetes 51, 928-936. 
Arkinstall M. J., Bruce C. R., Clark S. A., Rickards C. A., Burke L. M. & Hawley J. 
A. (2004) Regulation of fuel metabolism by preexercise muscle glycogen content and 
exercise intensity. Journal of Applied Physiology 97,2275-2283. 
Armstrong R. B. (1984) Mechanisms of exercise-induced delayed onset muscular 
soreness: a brief review. Medicine and Science in Sports and Exercise 16, 529-538. 
Armstrong R. B., Ogilvie R. W. & Schwane J. A. (1983) Eccentric exercise-induced 
injury to rat skeletal muscle. Journal of Applied Physiology 54, 80-93. 
Asp S., Daugaard J. R., Kristiansen S., Kiens B. & Richter E. A. (1998) Exercise 
metabolism in human skeletal muscle exposed to prior eccentric exercise. Journal of 
Physiology 509,305-313. 
Asp S. & Richter E. A. (1996) Decreased insulin action on muscle glucose transport 
after eccentric contractions in rats. Journal of Applied Physiology 81,1924-1928. 
Asp S., Rohde T. & Richter E. A. (1997a) Impaired muscle glycogen resynthesis after 
a marathon is not caused by decreased muscle GLUT-4 content. Journal of Applied 
Physiology 83,1482-1485. 
Asp S., Watkinson A., Oakes N. D. & Kraegen E. W. (1997b) Prior eccentric 
contractions impair maximal insulin action on muscle glucose uptake in the conscious 
rat. Journal of Applied Physiology 82, 1327-1332. 
Astrand P. 0., Hultman E., Juhlin-Dannfelt A. & Reynolds G. (1986) Disposal of 
lactate during and after strenuous exercise in humans. Journal of Applied Physiology 
61,338-343. 
235 
Reference List 
Atkinson G. (200 I) Analysis of repeated measurements in physical therapy research. 
Physical Therapy in Sport 2, 194-208. 
Atkinson G. (2002) Analysis of repeated measurements in physical therapy research: 
multiple comparisons amongst level means and multifactorial designs. Physical 
Therapy in Sport 3,191-203. 
Atkinson G., Wilson D. & Eubank M. (2004) Effects of music on work-rate 
distribution during a cycling time trial. International Journal of Sports Medicine 25, 
611-615. 
Azpiazu I., Manchester J., Skurat A. V., Roach P. J. & Lawrence J. C., Jr. (2000) 
Control of glycogen synthesis is shared between glucose transport and glycogen 
synthase in skeletal muscle fibres. American Journal of Physiology 278, E234-243. 
Bailey S. P., Davis J. M. & Ahlbom E. N. (1993) Neuroendocrine and substrate 
responses to altered brain 5-HT activity during prolonged exercise to fatigue. Journal 
of Applied Physiology 74,3006-3012. 
Balog E. M., Fruen B. R., Kane P. K. & Louis C. F. (2000) Mechanisms ofP; 
regulation of the skeletal muscle SR Ca2+ release channel. American Journal of 
Physiology 278, C601-611. 
Balon T. W. & Nadler J. L. (1997) Evidence that nitric oxide increases glucose 
transport in skeletal muscle. Journal of Applied Physiology 82,359-363. 
Balon T. W., Zorzano A., Treadway J. L., Goodman M. N. & Ruderman N. B. (1990) 
Effect of insulin on protein synthesis and degradation in skeletal muscle after 
exercise. American Journal of Physiology 258, E92-97. 
Bangsbo J., Madsen K., Kiens B. & Richter E. A. (1996) Effect of muscle acidity on 
muscle metabolism and fatigue during intense exercise in man. Journal of Physiology 
495, 587-596. 
Barthel A. & Schmoll D. (2003) Novel concepts in insulin regulation of hepatic 
gluconeogenesis. American Journal of Physiology 285, E685-692. 
236 
Reference List 
Bell G. 1., Burant C. F., Takeda J. & Gould G. W. (1993) Structure and function of 
mammalian facilitative sugar transporters. Journal of Biological Chemistry 268, 
19161-19164. 
Bendall J. R. & Taylor A. A. (1970) The MeyerhofQuotient and the synthesis of 
glycogen from lactate in frog and rabbit muscle. Biochemistry Journal 118, 887-893. 
Bequet F., Gomez-Merino D., Berthelot M. & Guezennec C. Y. (2002) Evidence that 
brain glucose availability influences exercise-enhanced extracellular 5-HT level in 
hippocampus: a microdialysis study in exercising rats. Acta Physiologica 
Scandinavica 176, 65-69. 
Bergman B. C. & Brooks G. A. (1999) Respiratory gas-exchange ratios during graded 
exercise in fed and fasted trained and untrained men. Journal of Applied Physiology 
86,479-487. 
Bergstrom J. (1962) Muscle electrolytes in man. Scandinavian Journal of Clinical 
and Laboratory Investigation 14, 1-100. 
Bergstrom J., Hermansen L., Hultman E. & Saltin B. (1967) Diet, muscle glycogen 
and physical performance. Acta Physiologica Scandinavica 71,140-150. 
Bergstrom J. & Hultman E. (1966) Muscle glycogen synthesis after exercise:an 
enhancing factor localized to the muscle cells in man. Nature 210, 309-310. 
Bergstrom J., Hultman E. & Roch-Norlund A. E. (1972) Muscle glycogen synthetase 
in normal subjects. Basal values, effect of glycogen depletion by exercise and of a 
carbohydrate-rich diet following exercise. Scandinavian Journal of Clinical and 
Laboratory Investigation 29, 231-236. 
Berry M. K., Russo A., Wishart J. M., Tonkin A., Horowitz M. & Jones K. L. (2002) 
Effect of solid meal on gastric emptying of, and glycemic and cardiovascular 
responses to, liquid glucose in older subjects. American Journal of Physiology 284, 
G655-662. 
Biolo G., Tipton K. D., Klein S. & Wolfe R. R. (1997) An abundant supply of amino 
acids enhances the metabolic effect of exercise on muscle protein. American Journal 
of Physiology 273, E 122-129. 
237 
Reference List 
Bird S. R., Wiles 1. & Robbins J. (199S) The effect of sodium bicarbonate ingestion 
on ISOO-m racing time. Journal of Sports Sciences 13, 399-403. 
Blair A. S., Hajduch E., Litherland G. J. & Hundal H. S. (1999) Regulation of glucose 
transport and glycogen synthesis in L6 muscle cells during oxidative stress. Journal of 
Biological Chemistry 274, 36293-36299. 
Blom C. S. (1989) Post-exercise glucose uptake and glycogen synthesis in human 
muscle during oral or i.v. glucose intake. European Journal of Applied Physiology 59, 
327-333. 
Blom C. S., Hostmark A. T., Vaage 0., Kardel K. R. & Maehlum S. (1987) Effect of 
different post-exercise sugar diets on the rate of muscle glycogen synthesis. Medicine 
and Science in Sports and Exercise 19,491-496. 
Blomstnind E. (2001) Amino acids and central fatigue. Amino Acids 20, 2S-34. 
Blomstrand E., Hassmen P., Ek S., Ekblom B. & Newsholme E. A. (1997) Influence 
of ingesting a solution of branched-chain amino acids on perceived exertion during 
exercise. Acta Physiologica Scandinavica 159, 41-49. 
Blomstrand E., Hassmen P., Ekblom B. & Newsholme E. A. (1991) Administration of 
branched-chain amino acids during sustained exercise - effects on performance and on 
plasma concentration of some amino acids. European Journal of Applied Physiology 
63, 83-88. 
Blomstrand E., Moller K., Secher N. H. & Nybo 1. (200S) Effect of carbohydrate 
ingestion on brain exchange of amino acids during sustained exercise in human 
subjects. Acta Physiologica Scandinavica 185,203-209. 
Bolster D. R., Pikosky M. A., Gaine P. C., Martin W., Wolfe R. R., Tipton K. D., 
Maclean D., Maresh C. M. & Rodriguez N. R. (2005) Dietary protein impacts human 
skeletal muscle protein fractional synthetic rates after endurance exercise. American 
Journal of Physiology 289, E678-683. 
Borel M. J., Williams P. E., Jabbour K., Levenhagen D., Kaizer E. & Flakoll P. J. 
(1998) Parenteral glutamine infusion alters insulin-mediated glucose metabolism. 
Journal of Parenteral cmd Enteral Nutrition 22, 280-28S. 
238 
Reference List 
Borg G. (1973) Perceived exertion: a note on "history" and methods. Medicine and 
Science in Sports 5, 90-93. 
Borsheim E., Tipton K. D., Wolf S. E. & Wolfe R. R. (2002) Essential amino acids 
and muscle protein recovery from resistance exercise. American Journal of 
Physiology 283, E648-657. 
Bosch A. N., Dennis S. C. & Noakes T. D. (1993) Influence of carbohydrate loading 
on fuel substrate turnover and oxidation during prolonged exercise. Journal of 
Applied Physiology 74,1921-1927. 
Bowtell J. L., Gelly K., Jackman M. L., Patel A., Simeoni M. & Rennie M. J. (2000) 
Effect of different carbohydrate drinks on whole body carbohydrate storage after 
exhaustive exercise. Journal of Applied Physiology 88, 1529-1536. 
Bowtell J. L., Gelly K., Jackman M. L., Patel A., Simeoni M. & Rennie M. J. (1999) 
Effect of oral glutamine on whole body carbohydrate storage during recovery from 
exhaustive exercise. Journal of Applied Physiology 86, 1770-1777. 
Brewer J., Williams C. & Patton A. (1988) The influence of high carbohydrate diets 
on endurance running performance. European Journal of Applied Physiology 57, 698-
706. 
Brooks G. A. (2002a) Lactate shuttle- between but not within cells? Journal of 
Physiology 541, 333-334. 
Brooks G. A. (2002b) Lactate shuttles in nature. Biochemical Society Transactions 
30,258-264. 
Brooks G. A., Dubouchaud H., Brown M., Sicurello J. P. & Butz C. E. (1999) Role of 
mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate 
shuttle. Proceedings of the National Academy of Science U.S.A 96,1129-1134. 
Brooks G. A. & Mercier J. (1994) Balance of carbohydrate and lipid utilization during 
exercise: the "crossover" concept. Journal of Applied Physiology 76, 2253-2261. 
Brozinick J. T., Jr., Etgen G. J., Jr., Yaspelkis B. B., 3rd & Ivy J. L. (1994) The 
effects of muscle contraction and insulin on glucose-transporter translocation in rat 
skeletal muscle. Biochemistry Journal 297, 539-545. 
239 
Reference List 
Burke L. M" Collier G. R" Beasley S. K., Davis P. G" Fricker p, A., Heeley p" 
Walder K, & Hargreaves M, (1995) Effect of co ingestion of fat and protein with 
carbohydrate feedings on muscle glycogen storage, Journal of Applied Physiology 78, 
2187-2192. 
Burke L. M., Collier G, R. & Hargreaves M. (1998) Glycemic Index - A new tool in 
sport nutrition? International Journal of Sport Nutrition 8,401-415, 
Burke L. M" Collier G, R. & Hargreaves M, (1993) Muscle glycogen storage after 
prolonged exercise: effect of the glycaemic index of carbohydrate feedings. Journal of 
Applied Physiology 75, 1019-1023. 
Butterfield G, Amino acids and high protein diets (1990) In: Perspectives in Exercise 
Science and Sports Medicine: Ergogenics- enhancement of performance in exercise 
and sport, edited by Lamb DR and Williams MH. Indianapolis, IN: Brown & 
Benchmark, p, 87-122. 
Camacho RC., Pencek R, R, Lacy D, B" James F, D, & Wasserman D, H. (2004) 
Suppression of endogenous glucose production by mild hyperinsulinemia during 
exercise is determined predominantly by portal venous insulin. Diabetes 53, 285-293. 
Carraro F., Kimbrough T, D, & Wolfe R. R. (1993) Urea kinetics in humans at two 
levels of exercise intensity. Journal of Applied Physiology 75,1180-1185. 
Carrithers J. A., Williamson D. L., Gallagher P. M., Godard M. P., Schulze K. E. & 
Trappe S. W, (2000) Effects of postexercise carbohydrate-protein feedings on muscle 
glycogen restoration. Journal of Applied Physiology 88, 1976-1982. 
Cartee G. D., Young D. A., Sleeper M. D., Zierath J., Wallberg-Henriksson H. & 
Holloszy J. O. (1989) Prolonged increase in insulin-stimulated glucose transport in 
muscle after exercise, American Journal of Physiology 256, E494-499, 
Carter 1. M., Jeukendrup A. E. & Jones D. A. (2004) The effect of carbohydrate 
mouth rinse on l-h cycle time trial performance. Medicine and Science in Sports and 
Exercise 36, 2107-2111. 
Casey A., Mann R., Banister K., Fox J., Morris p, G., MacDonald 1. A. & Greenhaff 
P. L. (2000) Effect of carbohydrate ingestion on glycogen resynthesis in human liver 
240 
, 
'. 
Reference List 
and skeletal muscle, measured by JJC MRS. American Journal of Physiology 278, 
E65-75. 
Casey A., Short A. H., Hultman E. & GreenhaffP. L. (1995) Glycogen resynthesis in 
human muscle fibre types following exercise-induced glycogen depletion. Journal of 
Physiology 483, 265-271. 
Castan 1., Wijkander 1., Manganiello V. & Degerman E. (1999) Mechanisms of 
inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes. 
Biochemistry Journal 339, 281-289. 
Chasiotis D., Hultman E. & Sahlin K. (1983a) Acidotic depression of cyclic AMP 
accumulation and phosphorylase b to a transformation in skeletal muscle in man. 
Journal of Physiology 335, 197-204. 
Chasiotis D., Sahlin K. & Hultman E. (1983b) Regulation of glycogenolysis in human 
muscle in response to epinephrine infusion. Journal of Applied Physiology 54, 45-50. 
Chen Z., Mitchelhill K. 1., Michell B. J., Stapleton D., Rodriguez-Crespo 1., Witters L. 
A., Power D. A., Ortiz de Montellano P. R. & Kemp B. E. (1999) AMP-activated 
protein kinase phosphorylation of endothelial NO synthase. FEBS Letters 443, 285-
289. 
Chinevere T. D., Sawyer R. D., Creer A. R., Conlee R. K. & Parcell A. C. (2002) 
Effects of L-tyrosine and carbohydrate ingestion on endurance exercise performance. 
Journal of Applied Physiology 93,1590-1597. 
Christ-Roberts C. Y., Pratipanawatr T., Pratipanawatr W., Berria R., Belfort R. & 
Mandarino L. J. (2003) Increased insulin receptor signaling and glycogen synthase 
activity contribute to the synergistic effect of exercise on insulin action. Journal of 
Applied Physiology 95, 2519-2529. 
Chromiak J. A. & Antonio J. (2002) Use of amino acids as growth hormone-releasing 
agents by athletes. Nutrition 18, 657-661. 
Chryssanthopoulos C., Hennessy L. C. M. & Williams C. (1994a) The influence of 
pre-exercise glucose ingestion on endurance running capacity. British Journal of 
Sports Medicine 28,105-109. 
241 
Reference List 
Chryssanthopoulos C., Williams c., Wilson W., Asher L. & Heame L. (l994b) 
Comparison between carbohydrate feedings before and during exercise on running 
performance during a 30-km treadmill time trial. International Journal of Sports 
Nutrition 4, 374-386. 
Claassen A., Lambert E. V., Bosch A. N., Rodger 1. M., St. Clair Gibson A. & Noakes 
T. D. (2005) Variability in exercise capacity and metabolic response during endurance 
exercise after a low carbohydrate diet. International Journal of Sport Nutrition and 
Exercise Metabolism 15, 97-116. 
Clark M. G., Wallis M. G., Barrett E. 1., Vincent M. A., Richards S. M., Clerk L. H. 
& Rattigan S. (2003) Blood flow and muscle metabolism: a focus on insulin action. 
American Journal of PhYSiology 284, E241-258. 
Cleak M. J. & Eston R. G. (1992) Muscle soreness, swelling, stiffness and strength 
loss after intense eccentric exercise. British Journal of Sports Medicine 26, 267-271. 
Coderre L., Kandror K. V., Vallega G. & Pilch P. F. (1995) Identification and 
characterization of an exercise-sensitive pool of glucose transporters in skeletal 
muscle. Journal of Biological Chemistry 270, 27584-27588. 
Coggan A. R. & Coyle E. F. (1989) Metabolism and performance following 
carbohydrate ingestion late in exercise. Medicine and Science in Sports and Exercise 
21, 59-65. 
Coggan A. R. & Coyle E. F. (1987) Reversal of fatigue during prolonged exercise by 
carbohydrate infusion or ingestion. Journal of Applied Physiology 63, 2388-2395. 
Coker R. H., Koyama Y., Denny J. C., Camacho R. c., Lacy D. B. & Wasserman D. 
H. (2002) Prevention of overt hypoglycemia during exercise. Stimulation of 
endogenous glucose production independent of hepatic catecholamine action and 
changes in pacreatic hormone concentration. Diabetes 51, 1310-1318. 
Coleman E. (1994) Update on carbohydrate: solid versus liquid. International Journal 
of Sport Nutrition 4, 80-88. 
242 
Reference List 
Conlee R. K., Hickson R. C., Winder W. W., Hagberg J. M. & Holloszy J. O. (J 978) 
Regulation of glycogen resynthesis in muscles of rats following exercise. American 
Journal of Physiology 235, RI45-150. 
Costill D. L., Bowers R., Branam G. & Sparks K. (l971a) Muscle glycogen utilization 
during prolonged exercise on successive days. Journal of Applied Physiology 31, 834-
838. 
Costill D. L., Coyle E., Dalsky G., Evans W., Fink W. & Hoopes D. (1977) Effects of 
elevated plasma FF A and insulin on muscle glycogen usage during exercise. Journal 
of Applied PhySiology 43, 695-699. 
Costill D. L., Gollnick P. D., Jansson E. D., Saltin B. & Stein E. M. (1973) Glycogen 
depletion pattern in human muscle fibres during distance running. Acta Physiologica 
Scandinavica 89, 374-383. 
Costill D. L., Jansson E., Gollnick P. D. & SaItin B. (1974) Glycogen utilization in 
leg muscles of men during level and uphill running. Acta Physiologica Scandinavica 
91,475-481. 
Costill D. L., Pascoe D. D., Fink W. J., Robergs R. A., BaIT S. 1. & Pearson D. R. 
(1990) Impaired muscle glycogen resynthesis after eccentric exercise. Journal of 
Applied Physiology 69, 46-50. 
Costill D. L. & Saltin B. (1974) Factors limiting gastric emptying during rest and 
exercise. Journal of Applied Physiology 37,679-683. 
Costill D. L., Sherrnan W. M., Fink W. J., Maresh C., Witten M. & Miller 1. M. 
(1981) The role of dietary carbohydrates in muscle glycogen resynthesis after 
strenuous running. American Journal of Clinical Nutrition 34, 1831-1836. 
Costill D. L., Sparks K., Gregor R. & Turner C. (1971 b) Muscle glycogen utilization 
during exhaustive running. Journal of Applied Physiology 31,353-356. 
Coyle E. F., Coggan A. R., Hemmer! M. K. & Ivy J. L. (1986) Muscle glycogen 
utilization during prolonged strenuous exercise when fed carbohydrate. Journal of 
Applied Physiology 61, 165-172. 
243 
Reference List 
Cross D.A: E., Watt P. W., Shaw M., van der Kaay J., Downes C. P., Holder J. C. & 
Cohen P. (I 997)-Insulin activates protein kinase B, inhibits glycogen synthase kinase-
3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal 
muscle and adipose tissue. FEBS Letters 406,211-215. 
Dahlstedt A. J., Katz A., Wieringa B. & Westerblad H. (2000) Is creatine kinase 
responsible for fatigue? Studies of isolated skeletal muscle deficient in creatine 
kinase. FASEB Journal 14, 982-990. 
Danforth W. H. (1965) Glycogen synthetase activity in skeletal muscle. 
Interconversion of two forms and control of glycogen synthesis. Journal of Biological 
Chemistry 240,588-593. 
Davis J. M. (1995) Carbohydrates, brached-chain amio acids, and endurance: the 
central fatigue hypothesis. International Journal of Sport Nutrition 5, S29-38. 
Davis J. M. & Bailey S. P. (1997) Possible mechanisms of central nervous system 
fatigue during exercise. Medicine and Science in Sports and Exercise 29, 45-57. 
Davis J. M., Bailey S. P., Woods J. A., Galiano F. J., Hamilton M. T. & Bartoli W. P. 
(1992) Effects of carbohydrate feedings on plasma free tryptophan and branched-
chain amino acids during prolonged cycling. European Journal of Applied Physiology 
65,513-519. 
Dawson K. D., Baker D. J., GreenhaffP. L. & Gibala M. J. (2005) An acute decrease 
in TCA cycle intermediates does not affect aerobic energy delivery in contracting rat 
skeletal muscle. Journal of Physiology 565,637-643. 
de Vries W. R., Schers T. J., Ait Abdesselam S., Osman-Dualeh M., Maitimu I. & 
Koppeschaar H. P. F. (2003) Involvement of endogenous growth hormone-releasing 
hormone (GHRH) in the exercise-related response of growth hormone. International 
Journal of Sports Medicine 24, 208-211. 
Decombaz J., Fleith M., Hoppeler H., Kreis R. & Boesch C. (2000) Effect of diet on 
the replenishment of intramyocellular lipids after exercise. European Journal of 
Nutrition 39, 244-247. 
244 
Reference List 
Decombaz l., Reinhardt P., Anantharaman K., von Glutz G. & Poortmans 1. R. (1979) 
Biochemical changes in a 100 km run: free amino acids, urea and creatinine. 
European Journal of Applied Physiology 41,61-72. 
Dekkers l. C., van Doomen L. l. P. & Kemper H. C. G. (1996) The role of antioxidant 
vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports 
Medicine 21, 213-238. 
Dela F., Mikines K. l., von Linstow M., Secher N. H. & Galbo H. (1992) Effect of 
training on insulin-mediated glucose uptake in human muscle. American Journal of 
Physiology 263, El 134-1143. 
Derave W., Hansen B. F., Lund S., Kristiansen S. & Richter E. A. (2000) Muscle 
glycogen content affects insulin-stimulated glucose transport and protein kinase B 
activity. A merican Journal of Physiology 279, E94 7 -955. 
Derave W., Lund S., Holman G. D., Wojtaszewski l., Pedersen O. & Richter E. A. 
(1999) Contraction-stimulated muscle glucose transport and GLUT-4 surface content 
are dependent on glycogen content. American Journal of Physiology 277, 1103-1110. 
Dill D. B. & Costill D. L. (1974) Calculation of percentage changes in volumes of 
blood, plasma and red cells in rehydration. Journal of Applied Physiology 37, 247-
248. 
Douen A. G., Ramlal T., Rastogi S., Bilan P. l., Cartee G. D., Vranic M., Holloszy l. 
O. & Klip A. (1990) Exercise induces recruitment of the "insulin responsive glucose 
transporter". Journal of Biological Chemistry 265,13427-13430. 
Doyle l. A., Sherman W. M. & Strauss R. L. (1993) Effects of eccentric and 
concentric exercise on muscle glycogen replenishment. Journal of Applied Physiology 
74,1848-1855. 
Duchman S. M., Ryan A. l., Schedl H. P., Summers R. W., Bleiler T. L. & Gisolfi C. 
V. (1997) Upper limit for intestinal absorption of a dilute glucose solution in men at 
rest. Medicine and Science in Sports and Exercise 29, 482-488. 
245 
Reference List 
Duke A. M. & Steele D. S. (2000) Characteristics of phosphate-induced Ca2+ efflux 
from th eSR in mechanically skinned rat skeletal muscle fibres. American Journal of 
Physiology 278, CI26-135. 
Eston R. G., Mickleborough J. & Baltzopoulos V. (1995) Eccentric activation and 
muscle damage: biomechanical and physiological considerations during downhill 
running. British Journal of Sports Medicine 29, 89-94. 
Fallowfield J. L. & Williams C. (1997) The influence of a high carbohydrate intake 
during recovery from prolonged, constant pace running. International Journal of 
Sports Nutrition 7, 10-25. 
Fallowfield J. L., Williams C. & Singh R. (1995) The influence of ingesting a 
carbohydrate-electrolyte beverage during 4 hours of recovery on subsequent 
endurance capacity. International Journal of Sport Nutrition 5, 285-299. 
Febbraio M. A., Keenan 1., Angus D. 1., Campbell.S, E. & Garnham A. P. (2000) 
Preexercise carbohydrate ingestion, glucose kinetics, and muscle glycogen use: effect 
of the glycemic index. Journal of Applied Physiology 89, 1845-1851. 
Febbraio M. A., Snow R. J., Stathis C. G., Hargreaves M. & Carey M. F. (1994) 
Effect of heat stress on muscle energy metabolism during exercise. Journal of Applied 
Physiology 77, 2827-2831. 
Febbriao M. A., Hiscock N., Sacchetti M., Fischer C. P. & Pedersen B. K. (2004) 
Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle 
contraction. Diabetes 53, 1643-1648. 
Felig P. & Wahren J. (1971) Amino acid metabolism in exercising man. Journal of 
ClinicaiInvestigation 50, 2703-2714. 
Fell R. D., McLane J. A., Winder W. W. & Holloszy 1. O. (1980) Preferential 
resynthesis of muscle glycogen in fasting rats after exhausting exercise. American 
Journal of Physiology 238, R328-332. 
Fell R. D., Terblanche S. E., Ivy 1. L., Young 1. C. & Holloszy J. O. (1982) Effect of 
muscle glycogen content on glucose uptake following exercise. Journal of Applied 
Physiology 52, 434-437. 
246 
Reference List 
Ferraris R. P. (2001) Dietary and developmental regulation of intestinal sugar 
transport. Biochemistry Journal 360, 26S-276. 
Fischer E. H., Heilmeyer L. M. G. J. & Haschke R. H. (1971) Phosphorylase and the 
control of glycogen degradation. Current Topics in Cellular Regulation 4, 211-2SI. 
Fisher J. S., Gao 1., Han D. H., Holloszy J. O. & Nolte L. A. (2002a) Activation of 
AMP kinase enhances sensitivity of muscle glucose transport to insulin. American 
Journal of Physiology 282, EI8-23. 
Fisher J. S., Nolte L. A., Kawanaka K., Han D. H., Jones T. E. & Holloszy J. O. 
(2002b) Glucose transport rate and glycogen syntbase activity both limit skeletal 
muscle glycogen accumulation. American Journal of Physiology 282, E 1214-1221. 
Flakoll P. J., Judy T., Flinn K., Carr C. & Flinn S. (2004) Postexercise protein 
supplementation improves health and muscle soreness during basic military training 
in marine recruits. Journal of Applied Physiology 96, 9SI-9S6. 
Floyd J. C., Jr., Fajans S. S., Conn J. W., KnopfR. F. & Rull J. (1966) Stimulation of 
insulin secretion by amino acids. Journal of Clinical Investigation 45, 1487-ISO I. 
Floyd J. c., Jr., Fajans S. S., Pek S., Thiffault C. A., KnopfR. F. & Conn 1. W. 
(1970a) Synergistic effect of certain amino acid pairs upon insulin secretion in man. 
Diabetes 19,102-108. 
Floyd J. C., Jr., Fajans S. S., Pek S., Thiffault C. A., KnopfR. F. & Conn J. W. 
(1970b) Synergistic effect of essential amino acids and glucose upon insulin secretion 
in man. Diabetes 19, 109-IIS. 
Fogt D. L. & Ivy J. L. (2000) Effects of post exercise carbohydrate-protein 
supplement on skeletal muscle glycogen storage. Medicine and Science in Sports and 
Exercise 32, S60. 
Foskett A., Tsintzas K., Williams C. & Boobis L. (2004) The effects of carbohydrate 
ingestion on muscle glycogen utilisation during exhaustive high-intensity intermittent 
running. Journal of Physiology 555, C63. 
Foster C., Costill D. L. & Fink W. (1979) Effects ofpreexercise feedings on 
endurance performance. Medicine and Science in Sports 11, I-S. 
247 
Reference List 
Foster L. J., Li D., Randhawa V. K. & Klip A. (2001) Insulin accelerates inter-
endosomal GLUT4 traffic via phosphatidylinositol 3-kinase and protein kinase B. 
Journal of Biological Chemistry 276, 44212-44221. 
Frayn K. N. (1983) Calculation of substrate oxidation rates in vivo from gaseous 
exchange. Journal of Applied Physiology 55, 628-634. 
Frid A. H., Nilsson M., Hoist J. J. & Bjork I. M. E. (2005) Effect of whey on blood 
glucose and insulin responses to composite breakfast and lunch meals in type 2 
diabetic subjects. American Journal of Clinical Nutrition 82, 69-75. 
Friden J. & Lieber R. L. (2001) Eccentric exercise-induced injuries to contractile and 
cytoskeletal muscle fibre components. Acta Physiologica Scandinavica 171, 321-326. 
Fryburg D. A., Jahn L. A., Hill S. A., Oliveras D. M. & Barrett E. J. (1995) Insulin 
and insulin-like growth factor-I enhance human skeletal muscle protein anabolism 
during hyperaminoacidemia by different mechanisms. Journal of Clinical 
Investigation 96, 1722-1729. 
Fryer L. G., Hajduch E., Rencurel F., Salt I. P., Hundal H. S., Hardie D. G. & Carling 
D. (2000) Activation of glucose transport by AMP-activated protein kinase via 
stimulation of nitric oxide synthase. Diabetes 49,1978-1985. 
Furtado L. M., Poon V. & Klip A. (2003) GLUT4 activation: thoughts on possible 
mechanisms. Acta Physiologica Scandinavica 178, 287-296. 
Fushiki T., Wells J. A., Tapscot! E. B. & Dohm G. L. (1989) Changes in glucose 
transporters in muscle in response to exercise. American Journal of Physiology 256, 
E580-587. 
Galbo H., Christensen N. J. & Hoist J. J. (1977) Glucose-induced decrease in 
glucagon and epinephrine responses to exercise in man. Journal oJ Applied 
Physiology 42, 525-530. 
Galloway S. D. R. & Maughan R. J. (1997) Effects of ambient temperature on the 
capacity to perform prolonged cycle exercise in man. Medicine and Science in Sports 
and Exercise 29,1240-1249. 
248 
Reference List 
Gannon M. C., Nuttall J. A. & Nuttall F. Q. (2002) Oral arganine does not stimulate 
an increase in insulin concentration but delays glucose disposal. American Journal of 
Clinical Nutrition 76, 1016-1022. 
Gao l., Ren l., Gulve E. A. & Holloszy l. O. (1994) Additive effect of contractions 
and insulin on GLUT -4 translocation into the sarcolemma. Journal of Applied 
Physiology 77,1597-1601. 
Ghigo E., Arvat E., Valente F., Nicolosi M., Boffano G. M., Procopio M., Bellone l., 
Maccario M., Mazza E. & Camanni F. (1991) Arginine reinstates the somatotrope 
responsiveness to intermittent growth hormone-releasing hormone administration in 
normal adults. Neuroendocrinology 54, 291-294. 
Gibala M. l. (2003) Anaplerosis of the muscle tricarboxylic acid cycle pool during 
contraction: does size matter? Journal of Physiology 548, 334. 
Gibala M. l. (2002) Dietary protein, amino acid supplements, and recovery from 
exercise. Gatorade Sports Science Insitute 15. 
Gibala M. l., MacLean D. A., Graham T. E. & Saltin B. (1998) Tricarboxylic acid 
cycle intermediate pool size and estimated cycle flux in human muscle during 
exercise. American Journal of Physiology 275, E235-242. 
Gibala M. l., Tamopolsky M. A. & Graham T. E. (1997) Tricarboxylic acid acycle 
intermediates in human muscle at rest and during prolonged cycling. American 
Journal of Physiology 272, E239-244. 
Gladden L. B. (2004) Lactate metabolism: a new paradigm for the third millenium. 
Journal of Physiology 558, 5-30. 
Gleeson M. (2000) Interleukins and exercise. Journal of Physiology 529, 1. 
Gleeson M., Nieman D. C. & Pedersen B. K. (2004) Exercise, nutrition and immune 
function. Journal of Sports Sciences 22,115-125. 
Godfrey R. l., Madgwick Z. & Whyte G. P. (2003) The exercise-induced growth 
hormone response in athletes. Sports Medicine 33,599-613. 
249 
Reference List 
Gollnick P. D., Piehl K. & Saltin B. (1974) Selective glycogen depletion pattern in 
human muscle fibres after exercise of varying intensity and at varying pedalling rates. 
Journal of Physiology 241, 45-57. 
Gollnick P. D., Piehl K., Saubert C. W., Armstrong R. B. & Saltin B. (1972) Diet, 
exercise, and glycogen changes in human muscle fibres. Journal of Applied 
Physiology 33,421-425. 
Gonzalez-Alonso J., Calbet J. A. L. & Nielsen B. (1999) Metabolic and 
thermodynamic responses to dehydration-induced reductions in muscle blood flow in 
exercising humans. Journal of Physiology 520, 577-589. 
Goodyear L. l., Hirshman M. F., King P. A., Horton E. D., Thompson C. M. & 
Horton E. S. (1990a) Skeletal muscle plasma membrane glucose transport and glucose 
transporters after exercise. Journal of Applied Physiology 68, 193-198. 
Goodyear L. J. & Kahn B. B. (1998) Exercise, glucose transport, and insulin 
sensitivity. Annual Review of Medicine 49, 235-261. 
Goodyear L. l., King P. A., Hirshman M. F., Thompson C. M., Horton E. D. & 
Horton E. S. (1990b) Contractile activity increases plasma membrane glucose 
transporters in absence of insulin. American Journal of Physiology 258, E667 -672. 
Guo Z. (2004) Muscle fat utilization during exercise: controversial only 
methodologically. Journal of Applied Physiology 96, 1569-1570. 
Halse R., Fryer L. G. D., McCormack l. G., Carling D. & Yeaman S. l. (2003) 
Regulation of glycogen synthase by glucose and glycogen. A possible role for AMP-
activated protein kinase. Diabetes 52, 9-15. 
Halseth A. E., Flakoll P. l., Reed E. K., Messina A. B., Krishna M. G., Lacy D. B., 
Williams P. E. & Wasserman D. H. (1997) Effect of physical activity and fasting on 
gut and liver proteolysis in the dog. American Journal of Physiology 273, El 073-
1082. 
Hamada K., Matsumoto K., Okamura K., Doi T., Minehira K. & Shimizu S. (1999) 
Effect of amino acids and glucose on exercise-induced gut and skeletal muscle 
proteolysis in dogs. Metabolism 48, 161-166. 
250 
Reference List 
Hamilton M. T., Gonzalez-Alonso J., Montain S. J. & Coyle E. F. (1991) Fluid 
replacement and glucose infusion during exercise to prevent cardiovascular drift. 
Journal of Applied Physiology 71, 871-877. 
Hansen B. F., Asp S., Kiens B. & Richter E. A. (1999) Glycogen concentration in 
human skeletal muscle: effect of prolonged insulin and glucose infusion. 
Scan din avian Journal of Medicine and Science ill Sports 9, 209-213. 
Hansen P. A., Nolte L. A., Chen M. M. & Holloszy 1. O. (1998) Increased GLUT-4 
translocation mediates enhanced insulin sensitivity of muscle glucose transport after 
exercise. Journal of Applied Physiology 85,1218-1222. 
Hardie D. G. (2004) AMP-activated protein kinase: A key system mediating 
metabolic responses to exercise. Medicine and Science in Sports and Exercise 36, 28-
34. 
Hargreaves M. & Briggs C. A. (1988) Effect of carbohydrate ingestion on exercise 
metabolism. Journal of Applied Physiology 65,1553-1555. 
Hargreaves M., McConell G. & Proietto 1. (1995) Influence of muscle glycogen on 
glycogenolysis and glucose uptake during exercise in humans. Journal of Applied 
Physiology 78, 288-292. 
Harris R. c., Hultman E. & Nordesjo L. O. (1974) Glycogen, glycolytic intermediates 
and high-energy phosphates determined in biopsy samples of musculus quadriceps 
femoris of man at rest: methods and variance of values. Scandinavian Journal of 
Clinical Qnd Laboratory Investigation 33, 109-120. 
Hashimoto T., Masuda S., Taguchi S. & Brooks G. A. (2005) Immunohistochemical 
analysis ofMCTl, MCT2 and MCT4 expression in rat plantaris muscle. Journal of 
Physiology 567,121-129. 
Hawley 1. A., Bosch A. N., Weltan S. M., Dennis S. C. & Noakes T. D. (1994) 
Glucose kinetics during prolonged exercise in euglycaemic and hyperglycaemic 
subjects. Pflugers Archiv 426, 378-386. 
251 
Reference List 
" 
Hawley J. A., Palmer G. S. & Noakes T. D. (1997a) Effects of 3 days of carbohydrate 
supplementation on muscle glycogen content and utilisation during a I-h cycling 
performance. European Journal of Applied Physiology 75, 407-412. 
Hawley J. A., Schabort E. J., Noakes T. D. & Dennis S. C. (1997b) Carbohydrate-
loading and exercise performance. Sports Medicine 24, 73-81. 
Hayashi T., Wojtaszewski J. F. & Goodyear 1. J. (1997) Exercise regulation of 
glucose transport in skeletal muscle. American Journal of Physiology 273, EI039-
1051. 
Helge J. W., Richter E. A. & Kiens B. (1996) Interaction of training and diet on 
metabolism and endurance during exercise in man. Journal of Physiology 492, 293-
306. 
Henriksen E. J., Bourey R. E., Rodnick K. J., Koranyi 1., Permutt M. A. & Holloszy 
J. o. (1990) Glucose transporter protein content and glucose transport capacity in rat 
skeletal muscles. American Journal of Physiology 259, E593-598. 
Hermansen 1., Hultman E. & Saltin B. (1967) Muscle glycogen during prolonged 
severe exercise. Acta Physiologica Scandinavica 71, 129-139. 
Hermansen 1. & Vaage O. (1977) Lactate disappearance and glycogen synthesis in 
human muscle after maximal exercise. American Journal of Physiology 233, E422-
429. 
Hirshman M. F., Goodyear 1. J., Wardzala 1. J., Horton E. D. & Horton E. S. (1990) 
Identification of an intracellular pool of glucose transporters from basal and insulin-
stimulated rat skeletal muscle. Journal of Biological Chemistry 265, 987-991. 
Holloszy J. O. (2005) Exercise-induced increase in muscle insulin sensitivity. Journal 
of Applied Physiology 99, 338-343. 
Holloszy J. O. (2003) A forty-yeal memoir ofresearch on the regulation of glucose 
transport into muscle. American Journal of Physiology 284, E453-467. 
Holloszy J. O. & Coyle E. F. (1984) Adaptations of skeletal muscle to endurance 
exercise and their metabolic consequences. Journal of Applied Physiology 56, 831-
838. 
252 
Reference List 
Holloszy J. O. & Narahara H. T. (1967) Enhanced permeability to sugar associated 
with muscle contraction. Studies of the role of Ca ++. Journal of General Physiology 
50, 551-562. 
Holloszy J. O. & Narahara H. T. (1965) Studies oftissue permeability. X. Changes in 
permeability to 3-methylglucose associated with contraction of isolated frog muscle. 
Journal of Biological Chemistry 240, 3493-3500. 
Holman G. D., Leggio L. L. & Cushman S. W. (1994) Insulin stimulated GLUT4 
glucose transporter recycling. Journal of Biological Chemistry 269, 17516-17524. 
Hopkins W. G., Hawley 1. A. & Burke L. M. (1999) Design and analysis of research 
on sport performance enhancement. Medicine and Science in Sports and Exercise 31, 
472-485. 
Hopkins W. G., Schabort E. J. & Hawley J. A. (2001) Reliability of power in physical 
performance tests. Sports Medicine 31,211-234. 
Horowitz J. F. & Klein S. (2000) Lipid metabolism during endurance exercise. 
American Journal of Clinical Nutrition 72, 558-563S. 
Hunt D. G. & Ivy J. L. (2002) Epinephrine inhibits insulin-stimulated muscle glucose 
transport. Journal of Applied Physiology 93,1638-1643. 
Hurley B. F., Nemeth P. M., Martin III W. H., Hagberg J. M., Dalsky G. P. & 
Holloszy J. O. (1986) Muscle triglyceride utilization during exercise: effect of 
training. Journal of Applied Physiology 60, 562-567. 
Ide K., Schmalbruch I. K., QuistorffB., Horn A. & Secher N. H. (2000) Lactate, 
glucose and O2 uptake in the human brain during recovery from maximal exercise. 
Journal of Physiology 522, 159-164. 
Ihlemann J., Galbo H. & Ploug T. (1999a) Calphostin C is an inhibitor of contraction, 
but not insulin-stimulated glucose transport, in skeletal muscle. Acta Physiologica 
Scandinavica 167, 69-75. 
Ihlemann 1., Ploug T., Hellsten Y. & Galbo H. (2000) Effect of stimulation frequency 
on contraction induced glucose transport in rat skeletal muscle. American Journal of 
Physiology 279, E862-867. 
253 
Reference List 
Ihlemann J., Ploug T., Hellsten Y. & Galbo H. (1999b) Effect of tension on 
contraction-induced glucose transport in rat skeletal muscle. American Journal of 
Physiology 277, E208-214. 
Ivy J. L. (2001) Dietary strategies to promote glycogen synthesis after exercise. 
Canadian Journal of Applied Physiology 26, S236-245. 
Ivy 1. L. (1998) Glycogen resynthesis after exercise: effect of carbohydrate intake. 
International Journal of Sports Medicine 19, SI42-145. 
Ivy J. L. (1991) Muscle glycogen synthesis before and after exercise. Sports Medicine 
11,6-19. 
Ivy J. L., Goforth H. W., Damon B. M., McCauley T. R., Parsons E. C. & Price T. B. 
(2002) Early postexercise muscle glycogen recovery is enhanced with a carbohydrate-
protein supplement. Journal of Applied Physiology 93,1337-1344. 
Ivy J. L. & Holloszy J. O. (1981) Persistent increase in glucose uptake by rat skeletal 
muscle following exercise. American Journal of Physiology 241, C200-20J 
Ivy J. L., Katz A. L., Cutler C. L., Sherman W. M. & Coyle E. F. (l988a) Muscle 
glycogen synthesis after exercise: effect of time of carbohydrate ingestion. Journal of 
Applied Physiology 64,1480-1485. 
Ivy 1. L. & Kuo C. H. (1998) Regulation ofGLUT4 protein and glycogen synthase 
during muscle glycogen synthesis after exercise. Acta Physiologica Scandinavica 162, 
295-304. 
Ivy J. L., Lee M. C., Brozinick J. T., Jr. & Reed M. J. (I 988b) Muscle glycogen 
storage after different amounts of carbohydrate ingestion. Journal of Applied 
Physiology 65, 2018-2023. 
Ivy J. L., Res P. T., Sprague R. C. & Widzer M. O. (2003) Effect of a carbohydrate-
protein supplement on endurance performance during exercise of varying intensity. 
International Journal of Sports Nutrition and Exercise Metabolism 13, 382-395. 
Jacobs K. A. & Sherman W. M. (1999) The efficacy of carbohydrate supplementation 
and chronic high-carbohydrate diets for improving endurance performance. 
International Journal of Sport Nutrition 9, 92-115. 
254 
Reference List 
Jacobson B. H. (1990) Effect of amino acids on growth hormone release. The 
Physician and Sports Medicine 18, 63-70. 
James D. E., Jenkins A. B. & Kraegen E. W. (1985) Heterogeneity of insulin action in 
individual muscles in vivo: euglycaemic clamp studies in rats. American Journal of 
Physiology 248, E567-574. 
Jansson E. (1981) Acid soluble and insoluble glycogen in human skeletal muscle. 
Acta Physiologica Scandinavica 113, 337-340. 
Jenuens R. & Jeukendrup A. E. (2003) Determinants of post-exercise glycogen 
synthesis during short-term recovery. Sports Medicine 33, 117-144. 
Jentjens R. L. & Jeukendrup A. E. (2005) High rates of exogenous carbohydrate 
oxidation from a mixture of glucose and fructose ingested during prolonged cycling 
exercise. British Journal of Nutrition 93, 485-492. 
Jentjens R. L. P. G., Cale C., Gutch C. & Jeukendrup A. E. (2003) Effects ofpre-
exercise ingestion of differing amounts of carbohydrate on subsequent metabolism 
and cycling performance. European Journal of Applied Physiology 88, 444-452. 
Jentjens R. L. P. G., Moseley L., Waring R. H., Harding L. K. & Jeukendrup A. E. 
(2004) Oxidation of combined ingestion of glucose and fructose during exercise. 
Journal of Applied Physiology 96, 1277-1284. 
Jentjens R. L. P. G., van Loon L. 1. c., Mann C. H., Wagenmakers A. J. M. & 
Jeukendrup A. E. (2001) Addition of protein and amino acids to carbohydrates does 
not enhance postexercise muscle glycogen synthesis. Journal of Applied Physiology 
91, 839-846. 
Jentjens R. L. P. G., Wagenmakers A. J. M. & Jeukendrup A. E. (2002) Heat stress 
increases muscle glycogen use but reduces the oxidation of ingested carbohydrates 
during exercise. Journal of Applied Physiology 92, 1562-1572. 
Jequier E., Acheson K. J. & Schutz Y. (1987) Assessment of energy expenditure and 
fuel utilization in man. Annual Review of Nutrition 7, 187-208. 
Jessen N. & Goodyear L. J. (2005) Contraction signaling to glucose transport in 
skeletal muscle. Journal of Applied Physiology 99, 330-337. 
255 
Reference List 
Jeukendrup A. E. & Jentjens R. (2000) Oxidation of carbohydrate feedings during 
prolonged exercise: current thoughts, guidelines and directions for future research. 
Sports Medicine 29, 407-424. 
Jeukendrup A. E., Minsink M., Saris W. H. M. & Wagenmakers A. J. M. (1997) 
Exogenous glucose oxidation during exercise in endurance-trained and untrained 
subjects. Journal of Applied Physiology 82, 835-840. 
Jeukendrup A. E., Wagenmakers A. J. M., Stegen J. H. C. H., Gijsen A. P., Brouns F. 
& Saris W. H. M. (1999) Carbohydrate ingestion can completely suppress 
endogenous glucose production during exercise. American Journal of Physiology 276, 
E672-683. 
Kanaley 1. A., Weltman 1. Y., Veldhuis J. D., Rogol A. D., Hartman M. L. & 
Weltman A. (1997) Human growth hormone response to repeated bouts of aerobic 
exercise. Journal of Applied Physiology 83, 1756-1761. 
Karlsson J. & Saltin B. (1971) Diet, muscle glycogen, and endurance performance. 
Journal of Applied Physiology 31, 203-206. 
Kasperek G. J. & Snider R. D. (1989) Total and myofibrillar protein degradation in 
isolated soleus muscles after exercise. American Journal of Physiology 257, EI-5. 
Keizer H. A., Kuipers H., van Kranenburg G. & Geurten P. (1987) Influence of liquid 
and solid meals on muscle glycogen resynthesis, plasma fuel hormone response, and 
maximal physical working capacity. International Journal of Sports Medicine 8, 99-
104. 
Kemp B. E., Mitchelhill K. 1., Stapleton D., Michell B. J., Chen Z. & Witters L. A. 
(1999) Dealing with energy demand: the AMP-activated protein kinase. Trends in 
Biochemical Sciences 24, 22-25. 
Kennedy J. W., Hirshman M. F., Gervino E. V., Ocel J. V., Forse R. A., Hoenig S. J., 
Aronson D., Goodyear L. J. & Horton E. S. (1999) Acute exercise induces GLUT4 
translocation in skeletal muscle of human subjects and subjects with type 2 diabetes. 
Diabetes 48, 1192-1197. 
256 
Reference List 
Kiens B., Raben A. B., Valeur A.-K. & Richter E. A. (1990) Benefit of dietary simple 
carbohydrates on the early postexercise muscle glycogen repletion in male runners. 
Medicine and Science in Sports and Exercise 22, S89. 
Kiens B. & Richter E. A. (1998) Utilization of skeletal muscle triacylglycerol during 
postexercise recovery in humans. American Journal of Physiology 275, E332-33 7. 
Kiens B., Roemen T. H. M. & van der Vusse G. J. (1999) Muscular long-chain fatty 
acid content during graded exercise in humans. American Journal of Physiology 276, 
352-357. 
King D. S., Feltmeyer T. L., Baldus P. 1., Sharp R. L. & Nespor J. (1993) Effects of 
eccentric eccercise on insulin secretion and action in humans. Journal of Applied 
Physiology 75,2151-2156. 
King P. A., Hirshman M. F., Horton E. D. & Horton E. S. (1989) Glucose transport in 
skeletal muscle membrane vesicles from control and exercised rats. American Journal 
of Physiology 257, CI128-1134. 
Kirwan J. P., Hickner R. c., Yarasheski K. E., kohrt W. M., Wiethop B. Y. & 
Holloszy J. O. (1992) Eccentric exercise induces transient insulin resistance in healthy 
individuals. Journal of Applied Physiology 72, 2197-2202. 
Kong J., Shepel P. N., Holden C. P., Mackiewicz M., Pack A. 1. & Geiger 1. D. (2002) 
Brain glycogen decreases with increased periods of wakefulness: implications for 
homeostatic drive to sleep. Journal of Neuroscience 22,5581-5587. 
Koopman R., Pannemans D. L. E., Jeukendrup A. E., Gijsen A. P., Senden J. M. G., 
Halliday D., Saris W. H. M., van Loon L. J. C. & Wagenmakers A. J. M. (2004) 
Combined ingestion of protein and carbohydrate improves protein balance during 
ultra-endurance exercise. American Journal of Physiology 287, E712-720. 
Koopman R., Wagenmakers A. J., Manders R. J. F., Zorenc A. H. G., Senden J. M. 
G., Gorselink M., Keizer H. A. & van Loon L. 1. C. (2005) The combined ingestion of 
protein and free leucine with carbohydrate increases post-exercise muscle protein 
synthesis in vivo in male subjects. American Journal of Physiology 288, E645-653. 
257 
Reference List 
Koyama Y., Galassetti P., Coker R. H., Pencek R. R., Lacy D. B., Davis S. N. & 
Wasserman D. H. (2002) Prior exercise and theresponse to insulin-induced 
hypo glycemia in the dog. American Journal of Physiology 282, E 1128-1138. 
Krebs P. S. & Powers S. K. (1989) Reliability of laboratory endurance tests. Medicine 
and Science in Sports and Exercise 21, S10. 
Krssak M., Petersen K. F., Bergeron R., Price T., Laurent D., Rothman D. 1., Roden 
M. & Shulman G. I. (2000) Intramuscular glycogen and intramyocellular lipid 
utilization during prolonged exercise and recovery in man: A 13C and IH nuclear 
magnetic resonance specroscopy study. Journal of Clinical Endocrinology and 
Metabolism 85, 748-753. 
Kuipers H., Keizer H. A., Brouns F. & Saris W. H. (1987) Carbohydrate feeding and 
glycogen synthesis during exercise in man. Pflugers Archiv 41, 652-656. 
Kuo C., Hunt D. G., Ding Z. & Ivy J. 1. (1999) Effect of carbohydrate 
supplementation on postexercise GLUT -4 protein expression in skeletal muscle. 
Journal of Applied Physiology 87, 2290-2295. 
Kuo C. c., Fattor J. A., Henderson G. C. & Brooks G. A. (2005) Lipid oxidation in fit 
young adults during postexercise recovery. Journal of Applied Physiology 99, 349-
356. 
Lam T. K. T., Carpentier A., Lewis G. F., van de Werve G., Fantus I. G. & Giacca A. 
(2003) Mechanisms of the free fatty acid-induced increase in hepatic glucose 
production. American Journal of Physiology 284, E863-873. 
Lanzi R., Manzoni M. F., Andreotti A. C., Malighetti M. E., Bianchi E., Sereni 1. P., 
Caumo A., Luzi 1. & Pontiroli A. E. (1997) Evidence for an inhibitory effect of 
physiological levels of insulin on the growth hormone (GH) response to GH-releasing 
hormone in healthy subjects. Journal of Clinical Endocrinology and Metabolism 82, 
2239-2243. 
Lanzi R. & Tannenbaum G. F. (1992a) Time course and mechanism of growth 
hormone's negative feedback effect on its own spontaneous release. Endocrinology 
130,780-788. 
258 
Reference List 
Lanzi R. & Tannenbaum G. F. (1992b) Time-dependent reduction and potentiation of 
growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous 
GH: Roel for somatostatin. Endocrinology 130, 1822-1828. 
Laurent D., Hundal R. S., Dresner A., Price T. B., Vogel S. M., Peters en K. F. & 
Shulman G. I. (2000) Mechansim of muscle glycogen autoregulation in humans. 
American Journal of Physiology 278, E663-668. 
Lawrence J. C., Jr. & Roach P. J. (1997) New insights into the role and mechanism of 
glycogen synthase activation by insulin. Diabetes 46, 541-547. 
Leelayuwat N., Tsintzas K., Patel K. & MacDonald I. A. (2005) Metabolic responses 
to exercise after carbohydrate loads in healthy men and women. Medicine and Science 
in Sports and Exercise 37, 1721-1727. 
Levenhagen D. K., Gresham J. D., Carlson M. G., Maron D. J., Bore! M. 1. & Flakoll 
P. J. (2001) Postexercise nutrient intake timing in humans is critical to recovery ofleg 
glucose and protein homeostasis. American Journal of Physiology 280, E982-993. 
Li D., Randhawa V. K., Patel N., Hayashi M. & Klip A. (2001) Hyperosmolarity 
reduces GLUT4 endocytosis and increases its exocytosis from a VAMP2-independent 
pool in L6 muscle cells. Journal of Biological Chemistry 276,22883-22891. 
Loftus G. R. & Masson M. E. J. (1994) Using confidence intervals in within-subject 
designs. Psychonomic Bulletin & Review 1, 476-490. 
Louard R. 1., Fryburg D. A., Gelfand R. A. & Barrett E. J. (1992) Insulin sensitivity 
of protein and glucose metabolism in human forearm skeletal muscle. Journal of 
Clinical Investigation 90, 2348-2354. 
Ludbrook J. (1998) Multiple comparison procedures updated. Clinical and 
experimental pharmacology and physiology 25, 1032-1037. 
Lund S., Holman G. D., Schmitz O. & Pedersen O. (1995) Contraction stimulates 
translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism 
distinct from that of insulin. Proceedings of the National Academy of Sciences of the 
United States of America 92, 5817-582l. 
259 
Reference List 
MacDonald C., Wojtaszewski J. F. P., Pedersen B. K., Kiens B. & Richter E. A. 
(2003) Interleukin-6 release from human skeletal muscle during exercise: relation to 
AMPK activity. Journal of Applied Physiology 95, 2273-2277. 
MacLean D. A., Bangsbo J. & Saltin B. (1999) Muscle interstitial glucose and lactate 
levels during dynamic exercise in humans determined by microdialysis. Journal of 
Applied Physiology 87,1483-1490. 
Madsen K., MacLean D. A., Kiens B. & Christens en D. (1996) Effects of glucose, 
glucose plus branched-chain amino acids, or placebo on bike performance over 100 
km. Journal of Applied Physiology 81, 2644-2650. 
Madsen K., Pedersen P. K., Rose P. & Richter E. A. (1990) Carbohydrate 
supercompensation and muscle glycogen utilization during exhaustive running in 
highly trained athletes. European Journal of Applied Physiology 61, 467-472. 
Maehlum S., Felig P. & Wahren 1. (1978) Splanchnic glucose and muscle glycogen 
metabolism after glucose feeding during postexercise recovery. American Journal of 
Physiology 235, E255-260. 
Malaisse-Lagae F., Sener A., Garcia-Morales P., Valverde 1. & Malaisse W. J. (1982) 
The stimulus-secretion coupling of amino acid-induced insulin release. Journal of 
Biological Chemistry 257,3754-3758. 
Manders R. J. F., Wagenmakers A. J. M., Koopman R., Zorenc A. H. G., Menheere P. 
P. C. A., Schaper N. c., Saris W. H. M. & van Loon L. J. C. (2005) Co-ingestion of a 
protein hydrolysate and amino acid mixture with carbohydrate improves plasma 
glucose disposal in patients with type 2 diabetes. American Journal of Clinical 
Nutrition 82, 76-83. 
Marcil M., Karelis A. D., Peronnet F. & Gardiner P. F. (2005) Glucose infusion 
attenuates fatigue without sparing glycogen in rat soleus muscle during prolonged 
electrical stimulation in situ. European Journal of Applied Physiology 93, 569-574. 
Markuns J. F., Wojtaszewski 1. F. P. & Goodyear L. J. (1999) Insulin and exercise 
decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal 
muscle. Journal of Biological Chemistry 274, 24896-24900. 
260 
Reference List 
Masson M. E. J. & Loftus G. R. (2003) Using confidence intervals for graphically 
based data interpretation. Canadian Journal of Experimental Psychology 57, 203-220. 
Maughan R. J. (1982) A simple rapid method for the determination of glucose, 
lactate, pyruvate, alanine, 3-hydroxybutarate and acetoacetate on a single 20 ul blood 
sample. Clinica Chimica Acta 13, 317-322. 
Maughan R. J., Leiper J. B. & Vist G. E. (2004) Gastric emptying and fluid 
availability after ingestion of glucose and soy protein hydrolysate solutions in man. 
Experimental Physiology 89,101-108. 
Maughan R. 1. & Poole D. C. (1981) The effects of a glycogen-loading regimen on 
the capacity to perform anaerobic exercise. European Journal of Applied Physiology 
46,211-219. 
Maxwell S. E. & Delaney H. D. (1990) Designing Experiments and Analyzing Data: 
A model comparison perspective. Belmont: Wadsworth. 
McArdle B. (1951) Myopathy due to a defect in muscle glycogen breakdown. Clinical 
Science 10, 13-33. 
McCoy M., Proietto J. & Hargreaves M. (1996) Skeletal muscle GLUT-4 and 
postexercise muscle glycogen storage in humans. Journal of Applied Physiology 80, 
411-415. 
McInerney P., Lessard S. J., Burke L. M., Coffey V. G., Lo Giudice S. L., Southgate 
R. 1. & Hawley J. A. (2005) Failure to repeatedly supercompensate muscle glycogen 
stores in highly trained men. Medicine and Science in Sports and Exercise 37, 404-
411. 
McKenzie E., Holbrook T., Williamson K., Royer C., Valberg S., HinchcliffK., Jose-
Cunilleras E., Nelson S., Willard M. & Davis M. (2005) Recovery of muscle 
glycogen concentrations in sled dogs during prolonged exercise. Medicine and 
Science in Sports and Exercise 37,1307-1312. 
McLane J. A. & Holloszy J. O. (1979) Glycogen synthesis from lactate in the three 
types of skeletal muscle. Journal of Biological Chemistry 254, 6548-6553. 
261 
Reference List 
McLellan T. M., Cheung S. S. & Jacobs 1. (1995) Variability of time to exhaustion 
during submaximal exercise. Canadian Journal of Applied Physiology 20, 39-51. 
Meeusen R., Thorre K., ChaouloffF., Sarre S., De Meirleir K., Ebinger G. & 
Michotte Y. (1996) Effects of tryptophan and/or acute running on extracellular 5-HT 
and 5-HIAA levels in the hippocampus of food-deprived rats. Brain Research 740, 
245-252. 
Mejri S., Bchir F., Rayana M. C. B., Hamida 1. B. & Slama C. B. (2005) Effect of 
training on GH and IGF-I responses to a submaximal exercise in football players. 
European Journal of Applied Physiology 95, 496-503. 
Merimee T. J., Rabinowitz D. & Fineberg S. E. (1969) Arginine-initiated release of 
human growth hormone. The New England Journal of Medicine 280, 1434-1438. 
Mero A., Pitkanen H., Oja S. S., Komi P. V., Pontinen P. & Takala T. (1997) Leucine 
supplementation and serum amino acids, testosterone, cortisol and growth hormone in 
male power athletes during training. Journal of Sports Medicine and Physical Fitness 
37,137-145. 
Metzger J. M. & Fitts R. H. (1987) Role of intracellular pH in muscle fatigue. Journal 
of Applied Physiology 62, 1392-1397. 
Mikines K. 1., Sonne B., Farrell P. A., Tronier B. & Galbo H. (1988) Effect of 
physical exercise on sensitivity and responsiveness to insulin in humans. American 
Journal of Physiology 254, E248-259. 
Mikines K. J., Sonne B., Farrell P. A., Tronier B. & Galbo H. (1989) Effect of 
training on the dose-response relationship for insulin action in men. Journal of 
Applied Physiology 66, 695-703. 
Mitchell J. B., Cosill D. L., Houmard J. A., Fink W. J., Pascoe D. D. & Pears on D. R. 
(1989) Influence of carbohydrate dosage on exercise performance and glycogen 
metabolism. Journal of Applied Physiology 67, 1843-1849. 
Mittleman K. D., Ricci M. R. & Bailey S. P. (1998) Branched-chain amino acids 
prolong exercise during heat stress in men and women. Medicine and Science in 
Sports and Exercise 30, 83-91. 
262 
Reference List 
Montain S. J. & Coyle E. F. (1992a) Fluid ingestion during exercise increases skin 
blood flow independent of increases in blood volume. Journal oJ Applied Physiology 
73,903-910. 
Montain S. J. & Coyle E. F. (I 992b) Influence of graded dehydration on hyperthermia 
and cardiovascular drift during exercise. Journal oJ Applied Physiology 73, 1340-
1350. 
Montell E., Arias A. & Gomez-Foix A. M. (1999) Glycogen depletion rather than 
glucose 6-P increments controls early glycogen recovery in human cultured muscle. 
American Journal oJ Physiology 276, RI489-1495. 
Moodley D., Noakes T. D., Bosch A. N., Hawley J. A., Schall R. & Dennis S. C. 
(1992) Oxidation of exogenous carbohydrate during prolonged exercise: the effects of 
the carbohydrate type and its concentration. European Journal oJ Applied Physiology 
64, 328-334. 
Mora J., Sakamoto K., McManus E. J. & Alessi D. R. (2005) Role of the PDKI-PKB-
GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart. FEBS 
Letters 579, 3632-3638. 
Moseley L., Lancaster G. I. & Jeukendrup A. E. (2003) Effects of timing ofpre-
exercise ingestion of carbohydrate on subsequent metabolism and cycling 
performance. European Journal oJ Applied Physiology 88, 453-458. 
Mu J., Brozinick 1. T., Jr., Valladares 0., Bucan M. & Bimbaum M. J. (2001) A role 
for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose 
transport in skeletal muscle. Molecular Cell 7, 1085-1094. 
Murray R. (1995) Fluid needs in hot and cold environments. International Journal oJ 
Sport Nutrition 5, S62-73. 
Musi N. & Goodyear L. J. (2003) AMP-activated protein kinase and muscle glucose 
uptake. Acta Physiologica Scandinavica 178, 337-345. 
Nadel E. R., Fortney S. M. & Wegner C. B. (1980) Effect of hydration state on 
circulatory and thermal regulations. Journal oJ Applied Physiology 49, 715-721. 
263 
Reference List 
Nakamaru Y. & Schwartz A. (1972) The influence of hydrogen ion concentration on 
calcium binding and release by skeletal muscle sarcoplasmic reticulum. Journal of 
General Physiology 59, 22-32. 
Narahara H. T. & Ozand P. (1963) Studies of tissue permeability. IX. The effect of 
insulin on the penetration of3-methylglucose-H3 in frog muscle. Journal oJ 
Biological Chemistry 238, 40-49. 
Nesher R., Karl 1. E. & Kipnis D. M. (1985) Dissociation of the effects of insulin and 
contraction on glucose transport in rat epitrochlearis muscle. American Journal of 
Physiology 249, C226-232. 
Nicholas C. W., Green P. A., Hawkins R. D. & Williams C. (1997) Carbohydrate 
intake and recovery of intermittent running capacity. International Journal of Sport 
Nutrition 7, 251-260. 
Nicholas C. W., Tsintzas K., Boobis L. & Williams C. (1999) Carbohydrate-
electrolyte ingestion during intermittent high-intensity running. Medicine and Science 
in Sports and Exercise 31, 1280-1286. 
Nielsen J. N. & Richter E. A. (2003) Regulation of glycogen synthase in skeletal 
muscle during exercise. Acta Physiologica Scandinavica 178, 309-319. 
Nielsen 1. N., Wojtaszewski 1. F. P., Hailer R. G., Hardie D. G., Kemp B. E., Richter 
E. A. & Vissing J. (2002) Role of 5' AMP-activated protein kinase in glycogen 
synthase activity and glucose utilization: insights from patients with McArdle's 
disease. Journal of Physiology 541, 979-989. 
Nielsen O. B., de Paoli F. & Overgaard K. (2001) Protective effects oflactic acid on 
force production in rat skeletal muscle. Journal oJ Physiology 536, 161-166. 
Nieman D. c., Davis J. M., Henson D. A., Gross S. J., Dumke C. L., Utter A. c., 
Vinci D. M., Cars on J. A., Brown A., McAnulty S. R., McAnulty L. S. & Triplett N. 
T. (2005) Muscle cytokine mRNA changes after 2.5 h of cycling: Influence of 
carbohydrate. Medicine and Science in Sports and Exercise 37,1283-1290. 
264 
Reference List 
Nilsson L. H. & Hultman E. (1974) Liver and muscle glycogen in man after glucose 
and fructose infusion. Scandinavian Journal of Clinical and Laboratory Investigation 
33,5-10. 
Noakes T. D. & SI. Clair Gibson A. (2004) Logical limitations to the "catastrophe" 
models of fatigue during exercise in humans. British Journal of Sports Medicine 38, 
1-30. 
Noakes T. D., SI. Clair Gibson A. & Lambert E. V. (2005) From catastrophe to 
complexity: a novel model of integrative central neural regulation of effort and fatigue 
• 
during exercise in humans: summary and conclusions. British Journal of Sports 
Medicine 39,120-124. 
Nybo L. (2003) CNS fatigue and prolonged exercise: effect of glucose 
supplementation. Medicine and Science in Sports and Exercise 35, 589-594. 
Olsen G. R. & Hansen B. F. (2002) AMP kinase activation ameliorates insulin 
resistance induced by free fatty acids in rat skeletal muscle. American Journal of 
Physiology 283, E965-970. 
O'Reilly K. P., Warhol M. J., Fielding R. A., Frontera W. R., Meredith C. N. & Evans 
W. J. (1987) Eccentric exercise induced muscle damage impairs muscle glycogen 
repletion. Journal of Applied Physiology 63, 252-256. 
Pardridge W. M. (1983) Brain metabolism: a perspective from the blood brain barrier. 
Physiological Reviews 63,1481-1535. 
Parkin J. A. M., Carey M. F., Martin I. K., Stojanovska L. & Febbraio M. A. (1997) 
Muscle glycogen storage following prolonged exercise: effect of timing of ingestion 
of high glycemic index food. Medicine and Science in Sports and Exercise 29,220-
224. 
Parkin J. M., Carey M. F., Zhao S. & Febbraio M. A. (1999) Effect of ambient 
temperature on human skeletal muscle metabolism during fatiguing submaximal 
exercise. Journal of Applied Physiology 86, 902-908. 
265 
Reference List 
Pedersen B. K. & Febbraio M. (2005) Muscle-derived interleukin-6 - A possible link 
between skeletal muscle, adipose tissue, liver, and brain. Brain, Behaviour and 
Immunity 19, 371-376. 
Pederson B. A., Cope C. R., Schroeder 1. M., Smith M. W., Irimia 1. M., Thurberg B. 
L., DePaoli-Roach A. A. & Roach P. 1. (2005) Exercise capacity of mice genetically 
lacking muscle glycogen synthase. In mice, muscle glycogen is not essential for 
exercise. Journal of Biological Chemistry 280, 17260-17265. 
Pencek R. R., James F. D., Lacy D. B., Jabbour K., Williams P. E., FuegerP. T. & 
Wasserman D. H. (2004) Exercise-induced changes in insulin and glucagon are not 
required for enhanced hepatic glucose uptake after exercise but influence the fate of 
glucose within the liver. Diabetes 53, 3041-3047. 
Piehl Aulin K., Soderlund K. & Hultman E. (2000) Muscle glycogen resynthesis rate 
in humans after supplementation of drinks containing carbohydrates with low and 
high molecular masses. European Journal of Applied Physiology 81, 346-351. 
Piehl K. (1974) Time course for refilling of glycogen stores in human muscle fibres 
following exercise-induced glycogen depletion. Acta Physiologica Scandinavica 90, 
297-302. 
Pimay F., Crielaard J. M., Pallikarakis N., Lacroix M., Mosora F., Krzentowski G., 
Luyckx A. S. & Lefebvre P. J. (1982) Fate of exogenous glucose during exercise of 
different intensities in humans. Journal of Applied Physiology 53,1620-1624. 
Pitcher J., Smythe C. & Cohen P. (1988) Glycogenin is the priming 
glucosyltransferase required for the initiation of glycogen biogenesis in rabbit skeletal 
muscle. European Journal of Biochemistry 176, 391-395. 
Pizza F. x., Flynn M. G., Duscha B. D., Holden J. & Kubitz E. R. (1995) A 
carbohydrate loading regimen improves high intensity, short duration exercise 
performance. International Journal of Sport Nutrition 5, 110-116. 
Ploug T., Galbo H. & Richter E. A. (1984) Increased muscle glucose uptake during 
contractions: no need for insulin. American Journal of Physiology 247, E726-73I. 
266 
Reference List 
Ploug T., Galbo H., Vinten J., Jorgensen M. & Richter E. A. (1987) Kinetics of 
glucose transport in rat muscle: effects of insulin and contractions. American Journal 
oJ Physiology 253, EI2-20. 
Ploug T., van Deurs B., Ai H., Cushman S. W. & Ralston E. (1998) Analysis of 
GLUT4 distribution in whole skeletal muscle fibres: identification of distinct storage 
compartments that are recruited by insulin and muscle contractions. Journal oJ Cell 
Biology 142,1429-1446. 
Ploug T., Wojtaszewski J. F., Kristiansen S., Hespel P., Galbo H. & Richter E. A. 
(1993) Glucose transport and transporters in muscle giant vesicles: differential effects 
of insulin and contractions. American Journal oJ Physiology 264, E270-278. 
Posterino G. S. & Fryer M. W. (2000) Effects of high myoplasmic L-Iactate 
concentration on E-C coupling in mammalian skeletal muscle. Journal oJ Applied 
Physiology 89,517-528. 
Price T. B., Laurent D., Peters en K. F., Rothman D. L. & Shulman G. 1. (2000) 
Glycogen loading alters muscle glycogen resynthesis after exercise. Journal oJ 
Applied Physiology 88, 698-704. 
Price T. B., Perseghin G., Duleba A., Chen W., Chase J., Rothman D. L., Shulman R. 
G. & Shulman G. 1. (1996) NMR studies of muscle glycogen synthesis in insulin-
resistant offspring of parents with non-insulin-dependant diabetes mellitus 
immediately after glycogen-depleting exercise. Proceedings oJ the National Academy 
oJSciences oJthe United States oJ America 93, 5329-5334. 
Price T. B., Rothman D. L., Taylor R., Avison M. J., Shulman G. 1. & Shulman R. G. 
(1994) Human muscle glycogen resynthesis after exercise: insulin-dependent and-
independent phases. Journal oJ Applied Physiology 76, 104-111. 
PritzlaffC. J., Wideman L., Weltman J. Y., Abbott R. D., Gutgesell M. E., Hartman 
M. L., Veldhuis J. D. & Weltman A. (1999) Impact of acute exercise intensity on 
pulsatile growth hormone release in men. Journal oJ Applied Physiology 87, 498-504. 
Pyne D. B. (1994) Exercise-induced muscle damage and inflammation: a review. The 
Australian Journal oJScience and Medicine in Sport 26, 49-58. 
267 
Reference List 
Rabinowitz D., Merimee T. l., Maffezzoli R. & Burgess l. A. (1966) Patterns of 
hormonal release after glucose, protein, and glucose plus protein. Lancet 2, 454-456. 
Randhawa V. K., Bilan P. 1., Khayat Z. A., Daneman N., Liu Z., Ramlal T., Volchuk 
A., Peng X., Coppola T., Regazzi R., Trimble W. S. & Klip A. (2000) VAMP2, but 
not VAMP3/cellubrevin, mediates insulin-dependent incorporation ofGLUT4 into the 
plasma membrane ofL6 myoblasts. Molecular Biology of the eel/H, 2403-2417. 
Randle P. l., Garland P. B., Hales C. N. & Newsholme E. A. (1963) The glucose 
fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of 
diabetes mellitus. Lancet 1, 785-789. 
Randle P. 1., Newsholme E. A. & Garland P. B. (1964) Effects offatly acids, ketone 
bodies and pyruvate, and of alloxan diabetes and starvation, on the uptake and 
metabolic fate of glucose in rat heart and diaphragm muscles. Biochemistry Journal 
93,652-655. 
Rasmussen B. B., Tipton K. D., Miller S. M., WolfS. E. & Wolfe R. R. (2000) An 
oral essential amino acid-carbohydrate supplement enhances muscle protein 
anabolism after resistance exercise. Journal of Applied Physiology 88, 386-392. 
Rasmussen H. N., Van Hall G. & Rasmussen U. F. (2002) Lactate dehydrogenase is 
not a mitochondrial enzyme in human and mouse vastus lateralis muscle. Journal of 
Physiology 541, 575-580. 
Ready S. L., Seifert l. G. & Burke E. (1999) The effect of two sports drink 
formulations on muscle stress and performance. Medicine and Science in Sports and 
Exercise 31, S 119. 
Reed M. 1., Brozinick l. T., lr., Lee M. C. & Ivy l. L. (1989) Muscle glycogen storage 
postexercise: effect of mode of carbohydrate administration. Journal of Applied 
Physiology 66, 720-726. 
Rehrer N. l., Wagenmakers A. l., Beckers E. l., Halliday D., Leiper l. B., Brouns F., 
Maughan R. l., Westerterp K. & Saris W. H. (1992) Gastric emptying, absorption, 
and carbohydrate oxidation during prolonged exercise. Journal of Applied Physiology 
72,468-475. 
268 
------------------- ----- - - - ----
Reference List 
Ren 1., Marshall B. A., Gulve E. A., Gao 1., 10hnson D. W., Holloszy 1. O. & 
Mueckler M. (1993) Evidence from transgenic mice that glucose transport is rate-
limiting for glycogen deposition and glycolysis in skeletal muscle. Journal of 
Biological Chemistry 268,16113-16115. 
Rennie M. 1. (2005) A role for leucine in rejuvenating the anabolic effects of food in 
old rats. Journal of Physiology 569, 357. 
Rennie M. 1. & Holloszy 1. O. (1977) Inhibition of glucose uptake and glycogenolysis 
by availability of oleate in well-oxygenated perfused skeletal muscle. Biochemistry 
Journal 168, 161-170. 
Rennie M. 1. & Tipton K. D. (2000) Protein and amino acid metabolism during and 
after exercise and the effects of nutrition. Annual Review of Nutrition 20, 457-483. 
Richter E. A., Derave W. & Wojtaszewski 1. F. P. (2001) Glucose, exercise and 
insulin: emerging concepts. Journal of Physiology 535, 313-322. 
Richter E. A., Garetto L. P., Goodman M. N. & Ruderman N. B. (1984) Enhanced 
muscle glucose metabolism after exercise: modulation by local factors. American 
Journal of Physiology 246, E476-482. 
Richter E. A., Mikines K. J., Galbo H. & Kiens B. (1989) Effect of exercise on insulin 
action in human skeletal muscle. Journal of Applied Physiology 66, 876-885. 
Richter E. A., Nielsen 1. N., 10rgensen S. B., Frosig C. & Wojtaszewski 1. F. (2003) 
Signalling to glucose transport in skeletal muscle during exercise. Acta Physiologica 
Scandinavica 178, 329-335. 
Robinson T. M., Sewell D. A. & GreenhaffP. L. (2003) L-arginine ingestion after rest 
and exercise: Effects on glucose disposal. Medicine and Science in Sports and 
Exercise 35,1309-1315. 
Rockwell M. S., Rankin 1. W. & Dixon H. (2003) Effects of muscle glycogen on 
performance of repeated sprints and mechanisms of fatigue. International Journal of 
Sport Nutrition and Exercise Metabolism 13, 1-14. 
269 
Reference List 
Rodnick K. 1., Slot J. W., Studelska D. R., Hanpeter D. E., Robinson L. J., Geuze H. 
J. & James D. E. (1992) Immunocytochemical and biochemical studies ofGLUT4 in 
rat skeletal muscle. Journal of Biological Chemistry 267, 6278-6285. 
Romijn J. A., Coyle E. F., Sidossis L. S., Gastaldelli A., Horowitz 1. F., Ender! E. & 
Wolfe R. R. (1993) Regulation of endogenous fat and carbohydrate metabolism in 
relation to exercise intensity and duration. American Journal of Physiology 265, 
E380-391. 
Romijn J. A., Coyle E. F., Sidossis L. S., Zhang X. J. & Wolfe R. R. (1995) 
Relationship between fatty acid delivery and fatty acid oxidation during strenuous 
exercise. Journal of Applied Physiology 79,1939-1945. 
Ronsen 0., Haug E., Pedersen B. K. & Bahr R. (2001) Increased neuroendocrine 
response to a repeated bout of endurance exercise. Medicine and Science in Sports 
and Exercise 33, 568-575. 
Rose A., J., Howlett K., King D. S. & Hargreaves M. (2001) Effect of prior exercise 
on glucose metabolism in trained men. American Journal of Physiology 281, E766-
771. 
Rowlands D. S., Wallis G. A., Shaw c., Jentijens R. L. P. G. & Jeukendrup A. E. 
(2005) Glucose polymer molecular weight does not affect exogenous carbohydrate 
oxidation. Medicine and Science in Sports and Exercise 37,1510-1516. 
Roy B. D. & Tamopolsky M. A. (1998) Influence of differing macronutrient intakes 
on muscle glycogen resynthesis after resistance exercise. Journal of Applied 
Physiology 84, 890-896. 
Roy B. D., Tamopolsky M. A., MacDoogall J. D., Fowles J. & Yarasheski K. E. 
(1997) Effect of glucose supplement timing on protein metabolisin after resistance 
training. Journal of Applied Physiology 82,1882-1888. 
Rudich A. & Klip A. (2003) Push/pull mechanisms of GLUT4 traffic in muscle cells. 
Acta Physiologica Scandinavica 178,297-308. 
Rudich A., Konrad D., Torok D., Ben-Romano R., Huang C., Niu W., Garg R. R., 
Wijesekara N., Germinario R. 1., Bilan P. J. & Klip A. (2003) Indinavir uncovers 
270 
----------------------
Reference List 
different contributions of GLUT4 and GLUT! towards glucose uptake in muscle and 
fat cells and tissues. Diabetologia 46, 649-658. 
Russell R. D., Redmann S. M., Ravussin E., Hunter G. R. & Larson-Meyer D. E. 
(2004) Reproducability of endurance performance on a treadmill using a preloaded 
time trial. Medicine and Science in Sports and Exercise 36,717-724. 
Ryder J. W., Kawano Y., Galuska D., Fahlman R., Wallberg-Henriksson H., Charron 
M. J. & Zierath J. R. (1999) Postexercise glucose uptake and glycogen synthesis in 
skeletal muscle from GLUT4-deficient mice. FASEB Journal 13, 2246-2256. 
Sahlin K., Femstrom M., Svensson M. & Tonkonogi M. (2002) No evidence of an 
intracellular lactate shuttle in rat skeletal muscle. Journal of Physiology 541, 569-574. 
Sahlin K., Harris R. C., Nylind B. & Hultman E. (1976) Lactate content and pH in 
muscle samples obtained after dynamic exercise. Pflugers Archiv 367, 143-149. 
Sahlin K., Katz A. & Broberg S. (1990) Tricarboxylic acid cycle intermediates in 
human muscle during prolonged exercise. American Journal of Physiology 259, 
C834-841. 
Sahlin K., Soderlund K., Tonkonogi M. & Hirakoba K. (1997) Phosphocreatine 
content in single fibres of human muscle after sustained submaximal exercise. 
American Journal of Physiology 273, CI72-178. 
Sakamoto K., Amolds D. E. W., Ekberg 1., Thorell A. & Goodyear L. J. (2004) 
Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal 
muscle. Biochemical and Biophysical Research Communications 319, 419-425. 
Sakamoto K., Hirshman M. F., Aschenbach W. G. & Goodyear L. J. (2002) 
Contraction regulation of Akt in rat skeletal muscle. Journal of Biological Chemistry 
277, 11910-11917. 
Sartorio A., Agosti F., Marinone P. G., Proietti M. & Lafortuna C. L. (2005) Growth 
hormone responses to repeated bouts of aerobic exercise with different recovery 
intervals in cyclists. Journal of Endocrinological Investigation 28, RC 11-14. 
271 
Reference List 
Saunders M. 1., Kane M. D. & Todd M. K. (2004) Effects ofa carbohydrate-protein 
beverage on cycling performance and muscle damage. Medicine and Science in Sports 
and Exercise 36,1233-1238. 
Schabort E. 1., Hawley 1. A., Hopkins W. G., Mujika I. & Noakes T. D. (1998a) A 
new reliable laboratory test of endurance performance for road cyclists. Medicine and 
Science in Sports and Exercise 30, 1744-1750. 
Schabort E. 1., Hopkins W. G. & Hawley 1. A. (I 998b) Reproducability of self-paced 
treadmill performance of trained endurance runners. International Journal of Sports 
Medicine 19,48-51. 
Seifert J. G., Kipp R. W., Amann M. & Gazal O. (2005) Muscle damage, fluid 
ingestion, and energy supplementation during recreational alpine skiing. International 
Journal of Sport Nutrition and Exercise Metabolism 15, 528-536. 
Shearer 1., Wilson R. 1., Battram D. S., Richter E. A., Robinson D. L., Bakovic M. & 
Graham T. E. (2005) Increases in glycogen in and glycogen in mRNA accompany 
glycogen resynthesis in human skeletal muscle. American Journal of Physiology 289, 
E508-514. 
Sherman W. M. (1995) Metabolism of sugars and physical performance. American 
Journal of Clinical Nutrition 62, 228-241 S. 
Sherman W. M., Costill D. L., Fink W. J. & Miller J. M. (1981) Effect of exercise diet 
manipulation on muscle glycogen and its subsequent utilization during performance. 
International Journal of Sports Medicine 2, 114-118. 
Shiota M., Galassetti P., Igawa K., Neal D. W. & Cherrington A. D. (2005) Inclusion 
oflow amounts of fructose with an intraportal glucose load increases net hepatic 
glucose uptake in the presence ofrelative insulin deficiency in dog. American Journal 
of Physiology 288, E 1160-1167. 
Shirreffs S. M., Armstrong L. E. & Cheuvront S. N. (2004) Fluid and electrolyte 
needs for preparation and recovery from training and competition. Journal of Sports 
Sciences 22, 57-63. 
272 
Reference List 
Shirreffs S. M. & Maughan R. J. (l998a) Urine osmolality and conductivity as indices 
of hydration status in athletes in the heat. Medicine and Science in Sports and 
Exercise 30,1598-1602. 
Shirreffs S. M. & Maughan R. J. (l998b) Volume repletion after exercise-induced 
volume depletion in humans: replacement of water and sodium losses. American 
journal of physiology 274, F868-875. 
Shulman R. G. (2005) Glycogen turnover forms lactate during exercise. Exercise and 
Sport Sciences Reviews 33,157-162. 
Shulman R G., Bloch G. & Rothman D. L. (1995) In vivo regulation of muscle 
glycogen synthase and the control of glycogen synthesis. Proceedings of the National 
Academy of Science U.S.A 92, 8535-8542. 
Shulman R. G. & Rothman D. L. (2001) The "glycogen shunt" in exercising muscle: a 
role for glycogen in muscle energetics and fatigue. Proceedings of the National 
Academy of Science U.S.A 98, 457-461. 
Simonsen J. c., Sherman W. M., Lamb D. R., Dernbach A. R, Doyle J. A. & Strauss 
R (1991) Dietary carbohydrate, muscle glycogen, and power output during rowing 
training. Journal of Applied Physiology 70,1500-1505. 
Siu P. M., Wong S. H. S., Morris J. G., Lam C. W., Chung P. K. & Chung S. (2004) 
Effect of frequency of carbohydrate feedings on recovery and subsequent endurance 
run. Medicine and Science in Sports and Exercise 36, 315-323. 
Smythe C. & Cohen P. (1991) The discovery of glycogen in and the priming 
mechansim for glycogen biogenesis. European Journal of Biochemistry 200, 625-631. 
Somwar R, Kim D. Y., Sweeney G., Huang C., Niu W., Lador C., Ramlal T. & Klip 
A. (2001) GLUT4 translocation precedes the stimulation of glucose uptake by insulin 
in muscle cells: potential activation ofGLUT4 via p38 mitogen-activated protein 
kinase. Biochemistry Journal 359, 639-649. 
Sparks M. J., Selig S. S. & Febbraio M. A. (1998) Pre-exercise carbohydrate 
ingestion: effect ofth eglycemic index on endurance exercise performance. Medicine 
and Science in Sports and Exercise 30, 844-849. 
273 
Reference List 
Spencer M. K., Yan Z. & Katz A. (1991) Carbohydrate supplementation attenuates 
IMP accumulation in human muscle during prolonged exercise. American Journal of 
Physiology 261, C71-76. 
Spill er G. A., Jensen C. D., Pattison T. S., Chuck C. S., Whittam J. H. & Scala J. 
(1987) Effect of protein dose on serum glucose and insulin response to sugars. 
American Journal of Clinical Nutrition 46,474-480. 
St. Clair Gibson A., Lambert M. 1., Hawley J. A., Broomhead S. A. & Noakes T. D. 
(1999) Measurement of maximal oxygen uptake from two different laboratory 
protocols in runners and squash players. Medicine and Science in Sports and Exercise 
31, 1226-1229. 
Starling R. D., Trappe T. A., Parcell A. C., Kerr C. G., Fink W. J. & Costill D. L. 
(1997) Effects of diet on muscle triglyceride and endurance performance. Journal of 
Applied Physiology 82,1185-1189. 
Stephenson D. G., Nguyen L. T. & Stephenson G. M. M. (1999) Glycogen content 
and excitation-contraction coupling in mechanically skinned muscle fibres of the cane 
toad. Journal of Physiology 519, 177-187. 
Stemlicht E., Bamard R. J. & Grimditch G. K. (1989) Exercise and insulin stimulate 
skeletal muscle glucose transport through different mechanisms. American Journal of 
Physiology 256, E227-230. 
Stokes K., Nevill M., Frystyk J., Lakomy H. & Hall G. (2005) Human growth 
hormone responses to repeated bouts of sprint exercise with different recovery periods 
between bouts. Journal of Applied Physiology 99,1254-1261. 
Suminski R. R., Robertson R. J., Goss F. L., Arslanian S., Kang J., DaSilva S., Utter 
A. C. & Metz K. F. (1997) Acute effect of amino acid ingestion and resistance 
exercise on plasma growth hormone concentration in young men. International 
Journal of Sports Nutrition 7, 48-60. 
Sutton J. R., Jones N. L. & Toews C. J. (1981) Effect of pH on muscle glycolysis 
during exercise. Clinical Science 61,331-338. 
274 
Reference List 
Suzuki Y., Lanner C., Kim J., Giuseppe Vilardo P., Zhang H., Yang J., Cooper L. D., 
Steele M., Kennedy A., Bock C. 8., Scrimgeour A., Lawrence J. c., Jr. & DePaoli-
Roach A. A. (2001) Insulin control of glycogen metabolism in knockout mice lacking 
the muscle-specific protein phosphatase PP1G/RuL. Molecular and Cellular Biology 
21,2683-2694. 
Tamopolsky L. J., MacDougall J. D., Atkinson S. A., Tamopolsky M. A. & Sutton 1. 
R. (1990) Gender differences in substrate for endurance exercise. Journal of Applied 
Physiology 68, 302-308. 
Tamopolsky M. A., Atkinson S. A., Phillips S. M. & MacDougall 1. D. (1995) 
Carbohydrate loading and metabolism during exercise in men and women. Journal of 
Applied Physiology 78, 1360-1368. 
Tamopolsky M. A., Bosman M., MacDonald J. R., Vandeputte D., Martin 1. & Roy 
B. D. (1997) Postexercise protein-carbohydrate and carbohydrate supplements 
increase muscle glycogen in men and women. Journal of Applied Physiology 83, 
1877-1883. 
Taylor H., Buskirk E. & Henschel A. (1955) Maximal oxygen uptake as an objective 
measure of cardio-respiratory performance. Journal of Applied Physiology 8, 73-80. 
Taylor P. M., Egan C. J. & Rennie M. J. (1989) Transport of glutamine across blood-
facing membranes of perfused rat jejunum. American Journal of Physiology 256, 
E550-558. 
Terjung R. L., Baldwin K. M., Winder W. W. & Holloszy J. O. (1974) Glycogen 
repletion in different types of muscle and in liver after exhausting exercise. American 
Journal of Physiology 226,1387-1391. 
Thomas D. E., Brotherhood J. R. & Brand J. C. (1991) Carbohydrate feeding before 
exercise: effect of glycaemic index. International Journal of Sports Medicine 12, 180-
186. 
Thomas J. E. (1957) Mechanics and regulation of gastric emptying. Physiological 
Reviews 37, 453-474. 
275 
Reference List 
Thorell A., Hirshman M. F., Nygren l., lorfeldt L., Wojtaszewski l. F., Dufresne S. 
D., Horton E. S., Ljungqvist O. & Goodyear L. 1. (\ 999) Exercise and insulin cause 
GLUT -4 translocation in human skeletal muscle. American Journal of Physiology 
277, E733-741. 
Tipton K. D., Elliot T. A., Cree M. G., WolfS. E., Sanford A. P. & Wolfe R. R. 
(2004) Ingestion of casein and whey proteins result in muscle anabolism after 
resistance exercise. Medicine and Science in Sports and Exercise 36, 2073-2081. 
Tipton K. D., Ferrando A. A., Phillips S. M., Doyle D. & Wolfe R. R. (\ 999) 
Postexercise net protein synthesis in human muscle from orally administered amino 
acids. American Journal of Physiology 276, E628-634. 
Tipton K. D., Rasmussen B. B., Miller S. L., Wolf S. E., Owens-Stovall S. K., Petrini 
B. E. & Wolfe R. R. (2001) Timing of amino acid-carbohydrate ingestion alters 
anabolic response of muscle to resistance exercise. American Journal of Physiology 
281, EI97-206. 
Tipton K. D. & Wolfe R. R. (2004) Protein and amino acids athletes. Journal of 
Sports Sciences 22, 65-79. 
Trivedi B. & Danforth W. H. (1966) Effect of pH on the kinetics offrog muscle 
phosphfructokinase. Journal of Biological Chemistry 241, 4110-4114. 
Tsintzas K. & Williams C. (1998) Human muscle glycogen metabolism during 
exercise: Effect of carbohydrate supplementation. Sports Medicine 25, 7-23. 
Tsintzas K., Williams C., Boobis L. & Greenhaff P. L. (\ 995) Carbohydrate ingestion' 
and glycogen utilization in different muscle fibre types in man. Journal of Physiology 
489, 243-250. 
Tsintzas K., Williams c., Boobis L. & GreenhaffP. L. (\996a) Carbohydrate 
ingestion and single muscle fibre glycogen metabolism during prolonged running in 
men. Journal of Applied Physiology 81, 801-809. 
Tsintzas K., Williams c., Boobis L., Symington S., Moorehouse l., Garcia-Roves P. 
& Nicholas C. W. (2003) Effect of carbohydrate feeding during recovery from 
276 
Reference List 
prolonged running on muscle glycogen metabolism during subsequent exercise. 
International Journal of Sports Medicine 6, 452-458. 
Tsintzas K., Williams C., Wilson W. & Burrin J. (I 996b) Influence of carbohydrate 
supplementation early in exercise on endurance running capacity. Medicine and 
Science in Sports and Exercise 28,1373-1379. 
Turcotte L. P., Richter E. A. & Kiens B. (1992) Increased plasma FFA uptake and 
oxidation during prolonged exercise in trained vs. untrained humans. American 
Journal of Physiology 262, E791-799. 
Turcotte L. P., Rovner A. S., Roark R. R. & Brooks G. A. (1990) Glucose kinetics in 
gluconeogenesis-inhibited rats during rest and exercise. American Journal of 
Physiology 258, E203-211. 
Van Hall G., Saris W. H. M., van de Schoor P. A. 1. & Wagenmakers A. J. (2000a) 
The effect of free glutamine and peptide ingestion on the rate of muscle glycogen 
resynthesis in man. International Journal of Sports Medicine 21, 25-30. 
Van Hall G., Shirreffs s. M. & Calbet J. A. (2000b) Muscle glycogen resynthesis 
during recovery from cycle exercise: no effect of additional protein ingestion. Journal 
of Applied Physiology 88, 1631-1636. 
van Loon L. J., Saris W. H., Kruijshoop M. & Wagenmakers A. J. (2000a) 
Maximizing postexercise muscle glycogen synthesis: carbohydrate supplementation 
and the application of amino acid or protein hydrolysate mixtures. American Journal 
of Clinical Nutrition 72, 106-111. 
van Loon L. J., Saris W. H., Verhagen H. & Wagenmakers A. J. (2000b) Plasma 
insulin responses after ingestion of different amino acid or protein mixtures with 
carbohydrate. American Journal of Clinical Nutrition 72, 96-105. 
van Loon L. J. C. (2004) Use of intramuscular triacylglycerol as a substrate source 
during exercise in humans. Journal of Applied Physiology 97, 1170-1187. 
van Loon L. J. c., GreenhaffP. L., Constant in-Teodosiu D., Saris W. H. M. & 
Wagenmakers A. J. M. (2001) The effects of increasing exercise intensity on muscle 
fuel utilisation in humans. Journal of Physiology 536, 295-304. 
277 
Reference List 
van Loon L. J. c., Jeukendrup A. E., Saris W. H. M. & Wagenmakers A. J. M. (1999) 
Effect of training status on fuel selection during sub maximal exercise with glucose 
ingestion. Journal of Applied Physiology 87,1413-1420. 
van Loon L. J. C., Kruijshoop M., Verhagen H., Saris W. H. M. & Wagenmakers A. 
J. M. (2000c) Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures 
increases postexercise plasma insulin responses in men. Journal of Nutrition 130, 
2508-2513. 
van Loon L. J. C., Kruishoop M., Menheere P. P. C. A., Wagenmakers A. 1. M., Saris 
W. H. M. & Keizer H. A. (2003a) Amino acid ingestion strongly enhances insulin 
secretion in patients with long-term type 2 diabetes. Diabetes Care 26, 625-630. 
van Loon L. J. C., Schrauwen-Hinderling V. B., Koopman R., Wagenmakers A. J. M., 
Hesselink M. K. C., Schaart G., Kooi M. E. & Saris W. H. M. (2003b) Influence of 
prolonged endurance cycling and recovery diet on intramuscular triglyceride content 
in trained individuals. American Journal of Physiology 285, E804-811. 
van Loon L. J. C., Thomason-Hughes M., Constantin-Teodosiu D., Koopman R., 
GreenhaffP. L., Hardie D. G., Keizer H. A., Saris W. H. M. & Wagenmakers A. J. M. 
(2005) Inhibition of adipose tissue lipolysis increases intramuscular lipid and 
glycogen use in vivo in humans. American Journal of Physiology 289, E482-493. 
Vamier M., Leese G. P., Thompson J. & Rennie M. J. (1995) Stimulatory effect of 
glutamine on glycogen accumulation in human skeletal muscle. American Journal of 
Physiology 269, E309-315. 
Vary T. c., Goodman S., Kilpatrick L. E. & Lynch C. J. (2005) Nutrient regulation of 
PKCE is mediated by leucine, not insulin, in skeletal muscle. American Journal of 
Physiology 289, E684-694. 
Vist G. E. & Maughan R. J. (1995) The effect of osmolality and carbohydrate content 
on the rate of gastric emptying of liquids in man. Journal of Physiology 486, 523-531. 
Vist G. E. & Maughan R. J. (1994) Gastric emptying of ingested solutions in man: 
effect of beverage glucose concentration. Medicine and Science in Sports and 
Exercise 26,1269-1273. 
278 
Reference List 
Wagenmakers A. J. M., Beckers E. J., Brouns F., Kuipers H., Soeters P. B., van der 
Vusse G. J. & Saris W. H. M. (1991) Carbohydrate supplementation, glycogen 
depletion, and amino acid metabolism during exercise. American Journal of 
Physiology 260, E883-890. 
Wagenmakers A. J. M., Brouns F., Saris W. H. M. & Halliday D. (1993) Oxidation 
rates of orally ingested carbohydrates during prolonged exercise in men. Journal of 
Applied Physiology 75, 2774-2780. 
Wagenmakers A. 1. M., Coakley J. H. & Edwards R. H. T. (1990) Metabolism of 
branched-chain amino acids and ammonia during exercise: clues from McArdle's 
disease. International Journal of Sports Medicine 11, SI01-113. 
Wahren J., Felig P., Ahlborg G. & Jorfeldt L. (1971) Glucose metabolism during leg 
exercise in man. Journal of Clinical Investigation 50, 2715-2725. 
Wahren J., Felig P., Hendler R. & Ahlborg G. (1973) Glucose and amino acid 
metabolism during recovery after exercise. Journal of Applied Physiology 34, 838-
845. 
Wallberg-Henriksson H., Constable S. H., Young D. A. & Holloszy J. O. (1988) 
Glucose transport into rat skeletal muscle: interaction between exercise and insulin. 
Journal of Applied Physiology 65, 909-913. 
Wallberg-Henriksson H. & Holloszy 1. O. (1984) Contractile activity increases 
glucose uptake by muscle in severely diabetic rats. Journal of Applied Physiology 57, 
1045-1049. 
Wardzala L. J. & Jeanrenaud B. (1981) Potential mechanism of insulin action on 
glucose transport in the isolated rat diaphragm. Journal of Biological Chemistry 256, 
7090-7093. 
Wasserman D. H. & Cherrington A. D. (1991) Hepatic fuel metabolism during 
muscular work: role and regulation. American Journal of Physiology 260, E811-824. 
Wasserman D. H., Williams P. E., Lacy D. B., Green D. R. & Cherrington A. D. 
(1988) Importance of intrahepatic mechanisms to gluconeogenesis from alanine 
during exercise and recovery. American Journal of Physiology 254, E518-525. 
279 
Reference List 
Watson P., Shirreffs S. M. & Maughan R. 1. (2004a) The effect of acute branched-
chain amino acid supplementation on prolonged exercise capacity in a warm 
environment. European Journal of Applied Physiology 93,306-314. 
Watson R. T., Kanzaki M. & Pes sin 1. E. (2004b) Regulated membrane trafficking of 
the insulin-responsive glucose transporter 4 in adipocytes. Endocrine Reviews 25, 
177-204. 
Watt M. 1., Heigenhauser G. 1. F., Dyck D. 1. & Spriet L. L. (2002a) Intramuscular 
triacylglycerol, glycogen and acetyl group metabolism during 4 h of moderate 
exercise in man. Journal of Physiology 541,969-978. 
Watt M. 1., Heigenhauser G. 1. F. & Spriet L. L. (2002b) Intramuscular triacylglycerol 
utilization in human skeletal muscle during exercise: is there a controversy? Journal 
of Applied Physiology 93, 1185-1195. 
Wee S. L., Williams C., Gray S. & Horabin 1. (1999) Influence of high and low 
glycaemic index meals on endurance running capacity. Medicine and Science in 
Sports and Exercise 31, 393-399. 
Wee S. L., Williams c., Tsintzas K. & Boobis L. (2005) Ingestion of a high-glycemic 
index meal increases muscle glycogen storage at rest but augments its utilization 
during subsequent exercise. Journal of Applied Physiology 99,707-714. 
Weigert C., Hennige A. M., Brodbeck K., Haring H. U. & Schleicher E. D. (2005) 
Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle 
cells by phosphorylation of Ser473 of Akt. American Journal of Physiology 289, E251-
257. 
Weir 1. B. (1949) New methods for calculating metabolic rate with special reference 
to protein metabolism. Journal of Physiology 109,1-9. 
Weltan S. M., Bosch A. N., Dennis S. C. & Noakes T. D. (1998a) Influence of muscle 
glycogen content on metabolic regulation. American Journal of Physiology 274, E72-
82. 
280 
Reference List 
Weltan S. M., Bosch A. N., Dennis S. C. & Noakes T. D. (1998b) Preexercise muscle 
glycogen content affects metabolism during exercise despite maintenance of 
hyperglycemia. American Journal of Physiology 274, E83-88. 
Westerblad H., Alien D. G. & Lannergren J. (2002) Muscle fatigue: lactid acid or 
inorganic phosphate the major cause? News in Physiological Sciences 17, 17-21. 
White T. P. & Brooks G. A. (1981) [U I4C] glucose, -alanine, and -leucine oxidation in 
rats at rest and two intensities of running. American Journal of Physiology 240, E155-
165. 
Wideman L., Weltman J. Y., Patrie J. T., Bowers C. Y., Shah N., Story S., Veldhuis J. 
D. & Weltman A. (2000a) Synergy ofL-arginine and GHRP-2 stimulation of growth 
hormone in men and women: modulation by exercise. American Journal of 
Physiology 279, RI467-1477. 
Wideman L., Weltman J. Y, Patrie J. T., Bowers C. Y., Shah N., Story S., Weltman 
A. & Veldhuis J. D. (2000b) Synergy ofL-arginine and growth hormone (GH)-
releasing peptide-2 on GH release: influence of gender. American Journal of 
Physiology 279, RI455-1466. 
Widrick J. J., Costill D. L., Fink W., Hickey M. S., McConell G. K. & Tanaka H. 
(1993) Carbohydrate feedings and exercise performance: effect of initial muscle 
glycogen concentration. Journal of Applied Physiology 74, 2998-3005. 
Wilkes D., Gledhill N. & Smyth R. (1983) Effect of acute induced metabolic alkalosis 
on 800-m racing time. Medicine and Science in Sports and Exercise 15, 277-280. 
Williams C. (2004) Carbohydrate intake and recovery from exercise. Science and 
Sports 19, 239-244. 
Williams c., Brewer J. & Walker M. (1992) Effect ofa high carbohydrate diet on 
running performance during a 30-km time trial. European Journal of Applied 
Physiology 65, 18-24. 
Williams C. & Nute M. L. (1983) Some physiological demands ofa half marathon 
race on recreational runners. British Journal of Sports Medicine 17,152-161. 
281 
Reference List 
Williams M. B., Raven P. B., Fogt D. L. & Ivy 1. L. (2003) Effects ofrecovery 
beverages on glycogen restoration and endurance exercise performance. Journal oJ 
Strength and Conditioning Research 17,12-19. 
Williams M. B., Raven P. B. & Ivy J. L. (1999) Effects of recovery drinks after 
prolonged glycogen-depletion exercise. Medicine and Science in Sports and Exercise 
31, S124. 
Wilmore J. H. & Costi1l D. L. (1973) Adequacy of the Haldane transformation in the 
computation of exercise V02 in man. Journal oJ Applied Physiology 35, 85-89. 
Wiseman R. W., Beck T. W. & Chase P. B. (1996) Effect of intracellular pH on force 
development depends on temperature in intact skeletal muscle from mouse. American 
Journal oJ Physiology 271, C878-886. 
Withers D. J., Gutierrez J. S., Towery H., Burks D. 1., Ren J. M., Previs S., Zhang Y., 
Bernal D., Pons S., Shulman G. I., Bonner-Weir S. & White M. F. (1998) Disruption 
ofIRS-2 causes type 2 diabetes in mice. Nature 391, 900-904. 
Wojcik l. R., Wallberg-Rankin l., Smith L. L. & Gwazdauskas F. C. (2001) 
Comparison of carbohydrate and milk-based beverages on muscle damage and 
glycogen following exercise. International Journal oJSport Nutrition and Exercise 
Metabolism 11,406-419. 
Wojtaszewski J. F., Jorgensen S. B., Frosig C., MacDonald C., Birk l. B. & Richter E. 
A. (2003a) Insulin signalling: effects of prior exercise. Acta Physiologica 
Scandinavica 178, 321-328. 
Wojtaszewski J. F. P., Higaki Y., Hirshman M. F., Michael M. D., Dufresne S. D., 
Kahn C. R. & Goodyear L. J. (1999) Exercise modulates postreceptor insulin 
signalling and glucose transport in muscle-specific insulin receptor knockout mice. 
Journal oJClinicalInvestigation 104,1257-1264. 
Wojtaszewski J. F. P., Jorgensen S. B., Hellsten Y., Hardie D. G. & Richter E. A. 
(2002) Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-
riboside on AMP-activated protein kinase and glycogen synthase activities in rat 
skeletal muscle. Diabetes 51, 284-292. 
282 
Reference List 
Wojtaszewski 1. F. P., MacDonald C., Nielsen J. N., Hellsten Y., Hardie D. G., Kemp 
B. E., Kiens B. & Richter E. A. (2003b) Regulation of 5' AMP-activated protein 
kinase activity and substrate utilization in exercising human skeletal muscle. 
American Journal of Physiology 284, E813-822. 
Wojtaszewski 1. F. P., Nielsen P., Kiens B. & Richter E. A. (2001) Regulation of 
glycogen synthase kinase-3 in human skeletal muscle. Diabetes 50, 265-269. 
Wolever T. M. S. (2004) Effect of sampling schedule and method of calculating the 
area under curve on validity and precision of glycaemic index values. British Journal 
of Nutrition 91, 295-300. 
Wolfe R. R., Nadel E. R., Shaw J. H. F., Stephenson L. A. & Wolfe M. H. (1986) 
Role of changes in insulin and glucagon in glucose homeostasis in exercise. Journal 
of Clinical Investigation 77, 900-907. 
Wolfe R. R., Wolfe M. H., Nadel E. R. & Shaw 1. H. F. (1984) Isotopic detennination 
of amino acid-urea interactions in exercise in humans. Journal of Applied Physiology 
56,221-229. 
Wong S. H. & Williams C. (2000) Influence of different amounts of carbohydrate on 
endurance running capacity following short tenn recovery. International Journal of 
Sports Medicine 21, 444-452. 
Wright D. A., Shennan A. & Dembach A. R. (1991) Carbohydrate feedings before, 
during, or in combination improve cycling perfonnance. Journal of Applied 
Physiology 71, 1082-1088. 
Wright D. c., Geiger P. C., Holloszy J. O. & Han D. (2005) Contraction- and 
hypoxia-stimulated glucose transport is mediated by a Ca2 -dependent mechanism in 
slow-twitch rat soleus muscle. American Journal of Physiology 288, El 062-1 066. 
Wright D. C., Hucker K. A., Holloszy J. O. & Han D. H. (2004) Ca2+ and AMPK both 
mediate stimulation of glucose transport by muscle contractions. Diabetes 53, 330-
335. 
283 
-------------~-- - - - - - ---
Reference List 
Xi X., Han J. & Zhang J. (200 I) Stimulation of glucose transport by AMP-activated 
protein kinase via activation of p38 mitogen-activated protein kinase. Journal of 
Biological Chemistry 276, 41029-41034. 
Yamamoto T., Castell L. M., Botella J., Powell H., Hall H. M., Young A. & 
Newsholme E. A. (1997) Changes in the albumin binding of tryptophan during 
postoperative recovery: a possible link with central fatigue? Brain Research Bulletin 
43,43-46. 
Yaspelkis B. B. & Ivy J. L. (1999) The effect ofa carbohydrate-arginine supplement 
on postexercise carbohydrate metabolism. International Journal of Sport Nutrition 9, 
241-250. 
Yaspelkis B. B., Patterson J. G., Anderla P. A., Ding Z. & Ivy J. L. (1993) 
Carbohydrate supplementation spares muscle glycogen during variable intensity 
exercise. Journal of Applied Physiology 75,1477-1485. 
Yawata T. (1990) Effect of potassium solution on rehydration in rats: comparison 
with sodium solution and water. Japanese Journal of Physiology 40, 369-381. 
Youn 1. H., Gulve E. A. & Holloszy 1. O. (1991) Calcium stimulates glucose transport 
in skeletal muscle by a pathway independent of contraction. American Journal of 
Physiology 260, C555-561. 
Young A. A., Bogardus C., Stone K. & Mott D. M. (1988) Insulin response of 
components of whole-body and muscle carbohydrate metabolism in humans. 
American Journal of Physiology 254, E231-236. 
Young D. A., Wallberg-Henriksson H., Sleeper M. D. & Holloszy J. O. (1987) 
Reversal of the exercise induced increase in muscle permeability to glucose. 
American Journal of Physiology 253, E331-335. 
Zachwieja J. J., Costill D. L., Pascoe D. D., Robergs R. A. & Fink W. J. (1991) 
Influence of muscle glycogen depletion on the rate of resynthesis. Medicine and 
Science in Sports and Exercise 23, 44-48. 
284 
Reference List 
Zawadzki K. M., Yaspelkis B. B., 3rd & Ivy J. L. (1992) Carbohydrate-protein 
complex increases the rate of muscle glycogen storage after exercise. Journal of 
Applied Physiology 72, 1854-1859. 
Zehnder M., lth M., Kreis R., Saris W., Boutellier U. & Boesch C. (2005) Gender-
Specific usage of intramyocellular lipids and glycogen during exercise. Medicine and 
Science in Sports and Exercise 37, 1517-1524. 
Zehnder M., Muelli M., Buchli R., Kuehne G. & Boutellier U. (2004) Further 
glycogen decrease during early recovery after eccentric exercise despite a high 
carbohydrate diet. European Journal of Nutrition 43,148-159. 
Zhang W., DePaoli-Roach A. A. & Roach P. 1. (1993) Mechanisms of multi site 
phosphorylation and inactivation of rabbit muscle glycogen synthase. Archives of 
Biochemistry and Biophysics 304, 219-225. 
Zorzano A., Balon T. W., Goodman M. N. & Ruderman N. B. (1986) Additive effects 
of prior exercise and insulin on glucose and AIB uptake by rat muscle. American 
Journal of Physiology 251, E21-26. 
Zorzano A., Palacin M. & Guma A. (2005) Mechanisms regulating GLUT4 glucose 
transporter expression and glucose transport in skeletal muscle. Acta Physiologica 
Scandinavica 183, 43-58. 
285 
APPENDICES 
Appendix A .............................. Health Questionnaires 
(i) Pre-study 
(ii) Pre-trial 
Appendix B... . ............................ Subjective Rating Scales 
(i) Rating of perceived exertion (RPE) 
(ii) Gut fullness scale 
(iii) Thirst scale 
Appendix C ..... · ............. Dietary Record Booklet 
Appendix D.... ....................... . .......................... Expired air analysis 
(i) Calculation of VO, and VCO, via the Haldane transformation 
(ii) Calculation of lipid and carbohydrate oxidation via indirect calorimetry 
(iii) Correction ofrespiratory exchange ratio for estimated protein oxidation 
Appendix E. . .. Muscle Biopsy Analysis 
Appendix F .. . ..................... Calculation ofIAUC 
Appendix G ......... . . .................. Calculation of Confidence Intervals 
286 
Appendix Ai 
HEALTH SCREEN FOR STUDY VOLUNTEERS Name or Number ................ . 
It is important that volunteers participating in research studies are currently in good health and have had no 
significant medical problems in the past. This is to ensure (i) their own continuing well-being and (ii) to 
avoid the possibility of individual health issues confounding study outcomes. 
Please complete this brief questionnaire to confirm fitness to participate: 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise .............................. Yes 0 
(b) attending your general practitioner.. ................................... Yes 0 
(c) on a hospital waiting lis!... .................................................. Yes 0 
2. In the past two years, have you had any illness which require you to: 
(a) consult your GP ................................................................ Yes 0 
(b) attend a hospital outpatient department.. ............................ Yes 0 
(c) be admitted to hospital ...................................................... Yes 0 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy .......................................................... Yes 0 
(b) Asthma ................................................................................ Yes 0 
(c) Eczema ., ...... , ... , .. , ............ ,' .. ' .. , ..... , ..... , ........ ,', ... , ....... ,',., .... Yes 0 
(d) Diabetes .............................................................................. Yes 0 
(e) A blood disorder. ............................................................... , Yes 0 
(1) Head injury ......................................................................... Yes 0 
(g) Digestive problems ............................................................. Yes 0 
(h) Heart problems ................................................................... Yes 0 
(i) Problems with bones or joints ......................................... Yes 0 
(j) Disturbance of balance/coordination .................................. Yes 0 
(k) Numbness in hands or feet ................................................. Yes 0 
(I) Disturbance of vision .......................................................... Yes 0 
(m) Ear / hearing problems ........................................................ Yes 0 
(n) Thyroid problems ............................................................... Yes 0 
(0) Kidney or liver problems .................................................... Yes 0 
(p) Allergy to nuts .................................................................... Yes 0 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after exercise? ............ Yes 0 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
If YES to any question, please describe briefly if you 'wish (eg to confirm problem was/is short-lived, 
insignificant or well controlled.) ....................................................................................................... .. 
Thank you for your co-operation! 
Appendix Aii 
Health Questionnaire 
Please complete the following brief questions to confinn your fitness to participate: 
At present do you have any health problems for which you are: 
I) On medication, prescribed or otherwise 
2) Attending your general practitioner 
YEsD NoD 
YEsD NoD 
Have you any symptoms of ill health, such as those associated with a cold or other 
common infection? YEsD NoD. 
If you have answered yes to any of the above questions please give more details 
below: 
Do you want to take part in today's experiments? YES D NO D . 
Signature: _____ _ Date: 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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Rating of Perceived Exertion 
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Very Very Light 
Very Light 
Fairly Light 
Fairly Hard 
Hard 
Very Hard 
Very Very Hard 
Maximum 
Gut Fullness Scale 
6 
Not Full 
0 
1 Fairly Full 
2 
3 
4 
5 Full 
6 
7 
8 
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9 Very Very Full 
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Thirst Scale 
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CONFIDENTIAL 
NAME AND ADDRESS 
AGE ................. yRS 
DATE OF START OF DIET ...... ..1. ....... .1 ........ . 
FOOD RECORD DIARY 
Please record everything you eat and drink during the 2 days prior to trial 1. Instructions are 
given inside. 
Information about your diet will be treated in confidence and results will be returned to you as 
soon as possible. 
Appendix C 
The most important contribution you can make as a 
participant in this study is to accurately record your dietary 
intake and replicate it precisely between trials. 
INSTRUCTION FOR USING THE FOOD DIARY 
Everything that you eat and drink over the 2 days prior to main trials should be weighed and 
the weight and type of food or drink recorded. 
For solid foods, the food should be placed on the scale on a plate or container. The plate or 
container must be weighted empty first and the scales can then be zeroed. Each item of food 
can then be added to the plate and weighted individually, returning the scales to zero 
between each item. 
ego Plate 150g zero scale. 
Roast Beef 100g zero scale. 
Potato 150g zero scale. 
Gravy 30g zero scale. 
For drinks, a cup or glass must first be weighed and then the scale can be returned to zero 
and the drink added. Please remember to record separately the weight of tea, milk and sugar 
put into a drink. 
Do not forget to weight and record second helpings and between meal snacks. 
Any leftovers (eg. apple cores) should also be weighted and recorded in the leftovers column. 
Eating Out - Most people eat foods away from home each day, please do not forget to record 
these. Take your diary and scales with you where ever it is possible. If this is too inconvenient 
just record the type of food eaten with an estimated weight - but please say when a weight 
has been estimated. 
Most snack foods will have the weight of the food on the packet so they do no need weighing 
if you eat the whole packet yourself. 
Names and descriptions of foods should be as detailed as possible, including the brand name 
and any other information available. 
Start a new page in your diary for each day, and record each item on a separate line. Record 
the time of day in the first column of each line. 
ego 10.30 am Mcvities Biscuits (2) 50g 
The space provided at the food of each page for general comments is for you to give any 
further information about your diet and your training/activity for that day. 
ego Steady run, morning 1 hour. 
Missed lunch due to stomach pains. 
Please try to be as accurate as possible and try to eat your usual diet. Try and think ahead so 
that you do not eat any foods prior to your first trial which you will not have access to prior to 
subsequent trials. 
Appendix C 
Day Month Year 
Day ............ day Date: I I IDay Order: 
Please use a separate line for each item eaten; write in weiQht of plate; leave a line between different 'plate' entries. 
A B C D E F Office Use 
Time Food eaten Brand name of Full description of each item Weight Weight of Actual 
each item including: Served Leftovers Weight 
am/pm home away (except fresh -whether fresh, frozen, dried, canned 
food) -cooked: boiled, grilled, fried, (g) (g) (g) 
roasted. 
-what typ_e of fat food fried in 
GENERAL COMMENTS: 
Expired Air 
Analysis 
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Appendix Di 
Calculation of vo, and veo, via the Haldane transformation 
The Douglas bag technique was used to measure the relative fractions of 
expired O2 and CO2 (i.e. FE0 2% and FEC02%) and the total volume 
expired per minute was corrected to the standard temperature and 
pressure for a dry gas (v E). The total volume inspired per minute (VI) 
can then be calculated as shown below: 
Concentration = Mass / Volume 
therefore; 
and· , 
Wilmore and Costill (1973) support that nitrogen can be assumed to be 
metabolically inert, which allows above equations can be combined and 
rearranged to give: 
Given that the atmospheric concentrations of O2 and CO2 are known 
(20.93% and 0.03%, respectively) and that the expired fractions of O2 and 
CO2 have been measured, FrN2% and FEN2% can therefore be determined 
as follows: 
F jN2% = 100 - (20.93 + 0.03) 
and· , 
Once VI has been determined using FrN2% and FEN2%, VO, and veo, 
can be calculated using the following equations: 
Oxygen Uptake (VO,) Carbon Dioxide Production (veO,) 
These values can then be used to determine the respiratory exchange ratio 
(RER) using the equation: 
RER= veo, / vo, 
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Calculation of lipid and carbohydrate oxidation via indirect calorimetry 
Oxidation of 1 gram of glycogen requires 0.828 litres of O2 and produces 
0.828 litres of CO2. 
RER= 1 
(N.B: only 0.746 litres of O2 and CO2 are used and produced for the oxidation of 
glucose but all equations in this thesis assume the above value for glycogen) 
Oxidation of 1 gram of lipid (e.g. palmitic acid) requires 1.989 litres of 
O2 and produces 1.419 litres of CO2. 
RER=0.7 
Therefore the below simultaneous equation can be applied to determine the oxidation 
rate oflipid (Lox) and carbohydrate (Cox) in grams per minute: 
vo,= (0.828 X Cox) + (1.989 X Lox) 
vco,= (0.828 X Cox) + (1.419 X Lox) 
Once rearranged these formulae can be expressed as: 
Lox = (VO, - VCO,) 1(1.989 - 1.419) 
Cox = (VO, - (1.989 X Lox)) I 0.828 
(N.B: If the RER for any given calculation is found to be greater than 1 then Lox can 
be assumed to be zero and Cox will be calculated simply as VO, I 0.828). 
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Correction of RER for estimated protein oxidation 
The RER values recorded during recovery in Chapter 7 were corrected 
using urinary urea excretion to estimate the rate of protein oxidation 
according to the methods described by Jequier et al. (1987). Immediately 
upon completion of RI in each trial, participants were required to empty 
their bladders before all subsequent urine that was passed during the 4 h 
recovery was collected in a vessel containing 5 ml of 10% thymol-
isopropanol as a preservative. The total volume of urine passed during 
recovery was recorded and a mixed 5 ml sample was analysed for urea 
content (mmoJ.r1). The following conversions were then applied: 
I. Divide urea concentration mrnol.r1 by 35700 to yield g·mr1 
(Urea nitrogen conversion factor mmol·r i to mg·dr i = 0.357) 
2. Multiply by 0.47 to yield nitrogen g.mr1 
(Nitrogen only comprises 47% of urea- only an approximation since urea only 
represents ",90% of urine nitrogen) 
3. Multiply by total urine volume to yield total nitrogen loss during 
recovery (g) 
4. Divide by recovery time in minutes to yield nitrogen loss g·min-1 
5. Multiply by 6.25 to yield protein oxidation rate 
(Nitrogen only comprises'" 16% of protein) 
This estimate of protein oxidation rate can now be corrected for changes 
in the bodily urea pool during recovery by incorporating the data gathered 
through plasma urea analysis. 
6. Subtract post- from pre-recovery plasma urea concentration 
(Will give a negative number ifurea concentrations increased during recovery) 
7. Multiply the difference by 60 to convert mmoJ.r 1 into g.r 1 
(mw urea = 60) 
8. Multiply by 0.47 to yield nitrogen g.r1 
(Nitrogen only comprises 47% of urea) 
9. Multiply by 57% of body mass to yield whole body nitrogen in g 
(Total body water :::-;57% of body mass) 
1 O.Divide by 1000 x recovery time in minutes to yield plasma change 
.. . -1 
III llItrogen g·mlll 
The rate of protein oxidation established in step 5 can now be corrected 
for changes in the urea pool through the addition of the result of step 10. 
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Oxidation of I gram of protein requires 0.966 litres of O2 and produces 
0.782 litres of CO2, resulting in an RER of 0.8 for protein oxidation. 
Given that only ;:::16% of protein is nitrogen, this equates to 6.04 and 4.89 
litres of O2 and CO2 per gram of nitrogen (N), respectively. This 
information can therefore be added to the equations presented earlier to 
adjust the calculated rates of lipid and carbohydrate oxidation such that 
the vo, and veo, for protein (i.e. PVO, and pveo,) are disregarded: 
vO,= (0.828 x Cox) + (1.989 x Lox) + (6.04 X N) 
veo,= (0.828 X Cox) + (1.419 X Lox) + (4.89 x N) 
Again, once solved these equations yeild: 
Lox = (1.754 X vo,) - (1.754 x veO,) - (2.017 x N) 
Cox = (4.212 X veO,) - (3.005 X vo,) - (2.449 x N) 
Basically, PVO, and PVC02 are subtracted from vo, and veo, to 
yield non-protein vo, and veo, which can then be used to establish 
corrected substrate oxidation rates and non-protein respiratory exchange 
ratios (NPRER) in the manner described in Appendices Di and Dii. 
N.B: If amino acids are used as gluconeogenic substrate during the urine 
collection period then the rate of protein oxidation will be overestimated. 
However, the NPRER that is calculated using this overestimate remains 
accurate providing that the newly synthesised glucose is oxidised (RER = 
0.8) rather than stored (RER = 0.4). 
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Appendix E 
Contents: 
Assay Reagents & Buffers ....................................................................................... 302 
Fragmentation & Freeze-Drying of Muscle Sample ............................................ 303 
Powdering of Muscle Samples ................................................................................ 304 
Muscle Extraction Sheet ......................................................................................... 305 
Metabolite Extraction from Powdered Muscle Samples ..................................... 306 
Acid Hydrolysis of Muscle Samples for Glycogen Analysis ................................ 308 
Measurement ofG-6-P, ATP & PCr ...................................................................... 309 
G-6-P/ATP/PCr Assay Sheet .................................................................................. 310 
G-6-P/ATP/PCr Calculations ................................................................................. 311 
Measurement of Creatine ....................................................................................... 312 
Creatine Assay Sheet ............................................................................................... 313 
Creatine Calculations .............................................................................................. 314 
Measurement of Lactate ......................................................................................... 315 
Lactate Assay Sheet ................................................................................................. 316 
Lactate Calculations ................................................................................................ 317 
Measurement of Prolycogen & Macroglycogen .................................................... 318 
Glycogen Assay Sheet .............................................................................................. 319 
Glycogen Calculations ............................................................................................. 320 
Correction of Muscle Metabolites for Total Creatine .......................................... 321 
Required Chemicals: 
Dithiothreitol 
Nicotinamide adenine dinucleotide phosphate 
Adenosine diphosphate 
D-glucose 
Glucose-6-phosphate 
Adenosine triphosphate 
Phosphocreatine 
Phosphoenolpyruvate 
Nicotinamide adenine dinucleotide (Reduced) 
Creatine 
Nicotinamide adenine dinucleotide 
Lactic Acid 
Required Enzymes: 
Glucose-6-phosphate dehydrogenase 
Hexokinase 
Creatinephosphokinase 
Lactate dehydrogenase 
Pyruvate kinase 
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(DTT) 
(NADP) 
(ADP) 
(Glu) 
(G-6-P) 
(ATP) 
(PCr) 
(PEP) 
(NADH) 
(Cr) 
(NAD) 
(LA) 
(G-6-PDH) 
(HK) 
(CPK) 
(LDH) 
(PK) 
Appendix E 
Assay Reagents & Buffers 
Metabolite Extraction Reagents 
• 0.5 M perchloric acid (HCl04) + I Mm ethylenediaminetetraacetic acid (EDTA) 
10.062 ml of70% HCI04 
+ 74.44 mg EDTA in 200 ml dw 
• 2.2 M potassium hydrogen carbonate (KHCO]) 
22.026 g ofKHCO] in 100ml dw 
Muscle Hydrolysis Reagents 
• I M hydrolchloric acid (HCl) 
9.S23 ml of 10.IS HCl in lOO ml dw 
• 6 M sodium hydroxide (NaOH) 
24 g NaOH in lOO ml dw 
Assay Buffers 
• Gl (glycogen) pH = S.2 (KOH) 
7 g triethanolamine (TEA) 
+O.S g potassium hydroxide (KOH) 
+2.4 g magnesium acetate (Mg(AChAH20) 
+0.14 g EDTA·Na2·2H20 in lOO ml dw 
• Dl (G-6-P, ATP, PCr) pH = 7.5-7.6 (KOH) 
IS.6 g TEA 
+2.2 g Mg(AC)2AH20 
+0.4 g disodium ethylenediaminetetraacetic acid (EDTA·Na2·2H20) in lOO ml dw 
• D2 (lactate) pH = 9.5 
6.5 ml ofhydrazine hydrate (N2H4·H20) 
+7.5 g of glycine (Gly) 
+0.2 g ofEDTA·Na2·2H20 in lOO ml dw 
• D3 ( creatine) 
15 g potassium chloride (KCl) in 100 ml dw 
• D4 (creatine)- pH = 9.0-9.1 (KOH or NaOH) 
2.4 g glycine 
+0.4 g Mg(AC)2AH20 in lOO ml dw 
• DS (G-6-P, ATP, PCr, creatine) 
0.5 gKHCO] 
+50 mg bovine serum albumin (BSA) in 100ml dw 
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Fragmentation & Freeze-Drying of Muscle Sample 
Required equipment: 
-Kidney dish 
-Scalpels 
-Tweezers 
-Liquid nitrogen 
-Freeze-drier 
-Petroleum ether (1 ml.sample'l) 
-Pipette (,.,5 J-lI) 
Appendix E 
The standard muscle metabolite assay (i.e. glycogen, creatine, lactate, ATP, PCr 
& G-6-P) can be conducted on ,.,2 mg of powdered muscle and approximately 8 mg of 
frozen muscle will yield this amount. Therefore, 16-20 mg (extra 2 mg for additional 
assays) should be removed from the initial muscle biopsy using scalpels and tweezers to 
fragment the sample. This procedure should be performed in a kidney dish with the 
sample submerged in a small volume of liquid nitrogen. Both fragments can then be 
stored in separate eppendorfs in liquid nitrogen. 
The powder fragments are then freeze-dried over 24 h at -50°C and between -
101 and _102 mmHg. Ensure that all eppendorfs have 4-5 holes in the top to ensure that 
all moisture can escape and include a small volume of liquid nitrogen to keep samples 
cool while the freeze-drier reaches the desired temperature & pressure. 
Remove samples from freeze-drier and check each individual sample to ensure 
that they have freeze-dried effectively (they should be white & brittle rather than red and 
sticky). Remove pierced lids and add approximately I ml of petroleum ether; this will 
remove any fat to facilitate powdering but also reduces the quantity of blood metabolites 
in each sample since blood cells will stay in suspension longer than muscle cells 
(corrections for total creatine account for any further blood metabolites which remain in 
the sample). Attach new lids with no holes and vortex thoroughly. Remove as much 
ether as possible using a pipette and then leave the eppendorfs open in the fume cupboard 
for ,.,30 min to allow the last few J-lI to evaporate. These samples must now be stored at -
80°C in a bag containing silica gel. 
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Required equipment: 
-Pestle and mortar 
-Scalpel 
-Tweezers 
-Scales 
Powdering of Muscle Samples 
-70% methylated spirit 
Appendix E 
Prepare the bench with the pestle and mortar on a cloth to ensure a clear work 
area (ideally, spotlights and a magnifier will be used). All powdering tools should be 
cleaned in 70% methylated spirit and dry in the air. Remove cleaned, freeze-dried 
samples from -80°C and allow to reach room temperature (approximately 20 min) before 
emptying each one into the mortar. Initially the scalpel should be used to remove any 
obvious connective tissue (there will be very little in human samples) and to scrape off 
any dried on blood (will have retained its red colour- again, non-essential since later 
creatine corrections will account for any blood metabolites). Slice the sample into pieces 
using the scalpel and then use 2 sets of tweezers to grind up these slices into a rough 
powder. Collect this rough powder into the centre of the mortar and grid up with the 
pestle (any remaining connective tissue will be revealed at this stage as it will not reduce 
to powder). Repeat the process using scalpel, tweezers then pestle until a very fine 
powder results (usually takes 5-10 min). 
Label 2 (P+A) eppendorfs and then de-static both, along with any spatulas to be 
used in transferring pOWder. Calibrate scales and then zero using the tube labelled P. 
Transfer >2 mg of powder into the eppendorf into the tube and record the weight (see 
muscle extraction sheet). Re-zero scales using tube labelled A and record the weight of 
the remaining powder. The first tube (P) will be used for metabolites and requires in 
excess of 2 mg while the second tube (A) requires slightly more powder for additional 
analyses (e.g. phosphorylase). Most biopsies will provide sufficient powder for both 
tubes but if <2 mg is available for any additional analyses then use all of it for 
metabolites. 
Following powdering, samples are again stored at -80°C in a bag containing silica 
gel. Powdering tools should now be cleaned in 70% methylated spirit and left to dry in 
the air before powdering the next sample. It will take approximately 15-20 min to 
complete each sample. 
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Muscle Extraction Sheet 
100 I Il··mg ·1 250/, o extract remove d 
Sample Mass HCI04 added (Ill) Extract KHC03 added (Ill) 
Extract + Final 
(mg) removed (Ill) KHC03 (Ill) Volume (Ill) 
e.g. 3.00 mg 300 III 285 III 71.25 J.!I 356.25 J.!I 325 III 
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Metabolite Extraction from Powdered Muscle Samples 
Required equipment: 
-Ice tray 
-Eppendorf centrifuge 
-0.5 M perchloric acid (HCl04) + I Mm ethylenediaminetetraacetic acid (EDTA) 
-2.2 M potassium hydrogen carbonate (KHCO)2 
-Pipettes (",5 J.!l & z200 J.!l) 
-Litmus paper 
Label 2 new eppendorfs (X & E) for each sample to be extracted. Only attempt to 
extract ",6 samples at a time to allow frequent vortexing later. These 6 samples should be 
removed from -80DC and allowed to reach room temperature (z20 min) in a bag 
containing silica gel. An ice tray can be prepared and samples will be stored on ice for 
the remainder of this procedure. Centrifuges should also be pre-cooled while samples 
defrost. 
Spin all tubes at 14,000 rpm for 1 min and tap down gently to dislodge pellet 
without dispersing loose powder. Using the powder masses recorded on muscle 
extraction sheet, add 100 III of HCI04/EDTA mixture per mg of powdered muscle (the 
volume added can also be recorded on this sheet). Start a timer immediately and begin 
gently vortexing all samples for 5 seconds each, keeping them on ice in between mixes. 
It is important to ensure that pellets remain submerged in HCI04/EDT A throughout this 
stage. After 10 min of regular vortexing, centrifuge the tubes at 14,000 rpm for 3 min at 
0-4DC (if centrifuge is not yet cooled then the vortexing stage can be extended). 
Transfer samples back to ice and use a pipette to remove as much extract as 
possible (usually'" 15 J.!l less than volume added). This extract should be stored in the 
eppendorf labelled X and the volume recorded on muscle extraction sheet. 
-note: it is best to leave a small quantity of extract around the pellet rather than risk touching the pellet 
since the extract only holds ~15% of glycogen (i.e. macroglycogen) while the pel1et contains :::::85% (i.e. 
proglycogen). Therefore it is best if any contamination occurs due to extract being left on the pellet. Often 
the last 2-5 ~I to be removed should be discarded. 
Both fractions are then stored on ice. 
As quickly as possible, KHCO) must be added to stop the reaction initiated by 
HCI04 (thus preventing any further reductions in metabolites). Using the volumes 
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recorded in the previous step, 25% of the volume already in the tube should be added (i.e. 
285 /-11 of extract will require 71.25 /-11 of KHCO)). Add these figures together and 
include on muscle extraction sheet for later reference. The addition of KHCO) will 
liberate CO2 and a white salt will form. Each tube should be vortexed quickly upon the 
introduction of KHCO) and then be left on ice with lids loosely fitted for approximately 5 
min (litmus paper can be used to check that the reaction is complete). 
Once the reaction is over, screw on lids and tubes can be spun for 3 min at 14,000 
rpm. The clear supematant can now be transferred to the final eppendorf (E) using the 
previous recording on muscle extraction sheet as a guide for how much will be available 
(usually ~30 /-11 less than total volume). The final volume in tube E can now be recorded 
on muscle extraction sheet simply as a guideline for how many assays will be possible 
(>150 /-11 will typically be required for the standard array of metabolites). Tube X 
containing the salt pellet can be discarded and the products should be our original tube 
(P) containing the pellet for proglycogen analysis and the final tube (E) containing our 
extract for all other metabolites. 
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Acid Hydrolysis of Muscle Samples for Glycogen Analysis 
Required equipment: 
-Ice tray 
-Dry bath (up to 100°C) 
-I M hydrolchloric acid (HCn 
-6 M sodium hydroxide (NaOHl 
-Pipette (",200 fll) 
-Eppendorf centrifuge 
Pre-heat dry bath to 100°C and defrost all pellets and extracted samples quickly in 
hot water (i.e. tubes P & E) before storing on ice. Label' a new tube (H) for each extract 
(E) and transfer 20 fll of each extract into its corresponding tube (H). 100 fll of HCI can 
now be added to every 20 fll of extract (H) and 100 fll of HCI per mg of muscle powder 
can be added to each pellet (P); refer to muscle extraction sheet to detennine the mass of 
each pellet (i.e. 2.71mg of muscle powder will require 271 fllofHCI). 
Ensure that the lids of all eppendorfs are tightly screwed before mixing both 
samples (P & H) gently (avoid leaving any sample in the lid) and then incubate in the dry 
bath for 2 h at 100°C. Following incubation, all tubes should be centrifuged for I min at 
14,000 rpm before being left at room temperature for 5-10 min to cool. The acid 
hydrolysed extract (H) is now neatralised with 15 fll ofNaOH (do not add any NaOH to 
the pellet). 
In addition to the hydrolysis procedures, 20 fll of the hydrolysed pellet (P) can be 
transferred to a new eppendorf labelled (D) and 180 fll of dw added to give a 10: I 
dilution. Similarly, 40 fll of the master extract (E) can be transferred into another newly 
labelled eppendorf (S) and 200 fll of dw added to give a 6: I dilution. 
The end result is 5 labelled eppendorfs for each muscle biopsy originally taken: 
E= Undiluted (Master) Extract -Lactate 
P= Hydrolysed Pellet -n/a 
H= Hydrolysed Extract -Macroglycogen 
D= 10 x diluted hydrolysed pellet -Proglycogen 
S= 6 x diluted hydrolysed extract -Creatine, PCr, ATP & G-6-P 
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Measurement ofG-6-P, ATP & per 
Principle: 
G-6-P +NADP _---'Ge::-6e:.-P'-'D"'H'---_+~ P -gl u co n olacta te + N AD PH 
ATP + Glucose __ --,oHK~ __ +~ ADP + G-6-P 
PCr+ADP __ --'C"-P:.:.K ___ ~ Cr + ATP 
Method: 
• Weigh and dilute all components of reagent mixture, enzymes and standards according to 
G-6-P/ A TP/PCr Assay Sheet. All should be thoroughly vortexed and stored on ice. 
• Once reagent mixture, enzymes and standards are prepared, samples (S) can be defrosted 
quickly in hot water, vortexed and spun for 3 min at 14,000 rpm. 
• Before pipetting, the spectrophotometer (plate reader) should be switched on to allow the 
internal temperature to reach >20°C. All samples should be read at 340 nm. 
• Pipette 20 I.d of Si gm a RNAse free H20 for blanks into wells AI-A5. 
• Pipette 20 III of 6: 1 diluted samples into wells B 1 onwards. 
• Pipette 200 III of reagent mixture into all wells. 
• Add 7 III of each standard into wells A6-A8 (total 21 III in each well). 
• Mix and read AI. 
• Add 3 III of G-6-PDH, mix well and incubate in the plate reader (>20°C). 
• Mix again and read A2 at 5 minute intervals beginning at 10 minutes to establish plateau 
(reaction should be complete by 20 min). 
• Add 5 III ofHK, mix well and incubate in the plate reader (>20°C). 
• Mix again and read A3 at 5 minute intervals beginning at 15 minutes to establish plateau 
(reaction should be complete by 20 min). 
• Add 3 III of CPK, mix well and incubate in the plate reader (>20°C). 
• Mix again and read A4 at 5 minute intervals beginning at 30 minutes to establish plateau 
(reaction should be complete by 40 min). 
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G-6-P/ATP/PCr Assay Sheet 
Cat. no# Reaction Volume per x total wells +10% Required concentration 
mixture well (Il-I) (Tot.) added (RC) 
- DI buffer 22.2 r 1 -
(Boeh. 19777) DTT 4.4 r 1 7.8 mg.mr 
(Boeh. 128058) NADP 8.9 r 1 20.9 mg.mr' 
(Boeh. 236675) ADP 0.9 r 1 5.1 mg.mr' 
(Fisons 05003) Glu 8.9 r 1 22.5 mg.mr' 
(Sigma) RNAse free H2O 154.7 r 1 -
L 200 -
Enzvmes 
(Sigma G5885) G-6-PDH 3 -
(Sigma H113!) HK 5 
.' -(Sigma S3755) CPK 3 .D 15 mg.ml D5 buffer" 
Standards mw lOmM Weighed amount 
(Boeh. 121027) G-6-P 304.2 3.042 mg.mr' 
(Boeh. 127523) ATP 605.2 6.052 mg.mr' 
(Boeh. 127574) PCr 327.2 3.272 mg.mr' 
.' Hexokinase is diluted I part enzyme to I part dw (so transfer to eppendorf 50% ofrequired enzyme) . 
• b Creatinephosphokinase is diluted 2 parts enzyme to 1 part dw (so weigh for 67% of required enzyme). 
Volume requires Weighed amount Volume to add 
(>mg) (WA) (Il-I) 
. . . 
> 
> 
> 
> 
- - -
Tot. x RC WAx 1000 
-1000 RC 
- - -
- - -
> 
Volume to add (Ill) Dilution 
IOOl·i1 10 mM + 900 III H20 = 1 
mM 
Where: 
G-6-P/ATP/PCr Calculations 
G-6-P (mmoI. kg dm-I): 
Vol. oost-enzyme x (A2-BLKA2) - Vol. ore-enzyme x (AI-BLKAl) x Extraction factor x Dilution factor 
Extinction coefficient x Sample Vol. 
Excel Formula = «(223*(A2-BLKA2»-(220*(AI-BLKAl»)*(125*6»/(6.22*20) 
ATP (mmoI. kg dm-I): 
Vol. oost-enzyme x (A3-BLKA3) - Vol. ore-enzyme x (A2-BLKA2) x Extraction factor x Dilution factor 
Extinction coeffIcient x Sample Vol. 
Excel Formula = «(228*(A3-BLKA3»-(223*(A2-BLKA2»)*(125*6»)I(6.22*20) 
PCr (mmoI. kg dm-I): 
Vol. oost-enzyme x (A4-BLKA4) - Vol. ore-enzyme x (A3-BLKA3) x Extraction factor x Dilution factor 
Extinction coefficient x Sample Vol. 
Excel Formula = «(231 *(A4-BLKA4»-(228*(A3-BLKA3»)*(125*6»/(6.22*20) 
Extraction factor = 125 (i.e 100 Ill.mg-I of HC104/EDTA mixture + 25% KHC03 for extraction). 
Dilution factor = 6 (i.e. tube S = 200 III H20 + 40 III master extract). 
Extinction coefficient =6.22 (i.e. 6.22 cm2 Ilmol is the absorbency ofNADH when read at 340 nm- note: 3.44 cm21lmol at 366 nm). 
Note: Standard calculations include no extraction or dilution factors and the standard volume will be 7 Ill. 
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Measurement of Creatine 
Principle: 
Pyruvate + NADH ___ ---"LD"'H"----____ Lactate + NAD 
ADP+PEP ___ ---'P-=.;K'--___ -._ ATP + Pyruvate 
Cr+ATP ___ ---"C:..:PK-'----____ PCr + ADP 
Method: 
• Weigh and dilute all components of reagent mixture, enzyme and standard according to 
Creatine Assay Sheet. All should be thoroughly vortexed and stored on ice. 
• Once reagent mixture, enzyme and standard are prepared, samples (S) can be 
defrosted quickly in hot water, vortexed and spun for 3 min at 14,000 rpm. 
• Before pipetting, the spectrophotometer (plate reader) should be switched on to allow 
the internal temperature to reach >20°C. All samples should be read at 340 nm. 
• Pipette 15 fll of Si gm a RNAse free H20 for blanks into wells AI-A5. 
• Pipette 15 fll of standard into wells A6-A8. 
• Pipette 15 fll of 6: 1 diluted samples into wells B 1 onwards. 
• Pipette 225 fll of reagent mixture into all wells (viscous, pipette onto side of well). 
• Mix and read A!. 
• Add 5 fll of CPK, mix well and incubate in the plate reader (>20°C). 
• Mix again and read A2 at 5 minute intervals beginning at 20 minutes to establish 
plateau (reaction should be complete by 30 min). 
Note: The reaction in this assay converts NADH into NAD. Therefore our 
absorbencies will reflect the disappearance ofNADH (i.e. decrease until plateau). 
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Creatine Assay Sheet 
Cat. no# Reaction mixture 
Volume per x total wells + 1 0% Required concentration Volume requires Weighed amount Volume to add 
well (ILl) (Tot.) added (RC) (>mg) (WA) (ILl) 
-
04 buffer 75 [ 1 - - - -
- 03 buffer 3.75 [ 1 - - - -
(Sigma A2383) ATP 15 [ 1 15.4 mg.mr' > 
(Sigma P7252) PEP 11.25 [ 1 11.6 mg.mr' > 
(Boch. 107735) NAOH 3.75 [ 1 9 mg.mr' > 
(Boch. 107085) LOH 0.375 [ 1 - - - -
(Boch. 128155) PK 0.375 [ 1 - - - - I 
(Sigma) RNAse free H2O 115.5 r 1 - - - -
I 
~ 225 Tot. x RC WAx 1000 - - RC 1000 
SeDarate Enzvme 
(Sigma S3755) CPK 5 15 mg.ml 05 buffe(' > 
Standard mw 30mM Weighed amount Volume to add (Ill) Dilution 
(Sigma C0780) Creatine Anhydrous 131.1 3.933 mg.mr' 50 III 30 mM + 950 III H20 = 1.5 mM 
Creatine Calculations 
Creatine (m mol. kg dm- I ): 
Where: 
Vol. pre-enzyme x CA l-BLKAl) - Vol. post-enzyme x CA2-BLKA2) x Extraction factor x Dilution factor 
Extinction coefficient x Sample Vol. 
Excel Fonnula = «(240*(A l-BLKA1))-(24S*(A2-BLKA2)))*(l2S*6))/(6.22* IS) 
Extraction factor = 12S (i.e 100 fil.mg-' of HC104/EDTA mixture + 2S% KHC03 for extraction). 
Dilution factor = 6 (i.e. tube S = 200 fil H20 + 40 fil master extract). 
Extinction coefficient =6.22 (i.e. 6.22 cm2 fimol is the absorbency ofNADH when read at 340 nm- note: 3.44 cm2 fimol at 366 nm). 
Note: Standard calculations include no extraction or dilution factors and the standard volume will also be IS fil. 
Appendix E 
Measurement of Lactate 
Principle: 
Lactate + NAD, __ --'L:=D-'-'H _____ Pyruvate + NADH 
Method: 
• Weigh and dilute all components of reagent mixture, enzyme and standard according to 
Lactate Assay Sheet. All should be thoroughly vortexed and stored on ice. 
• Once reagent mixture, enzyme and standard are prepared, samples (E) can be 
defrosted quickly in hot water, vortexed and spun for 3 min at 14,000 rpm. 
• Before pipetting, the spectrophotometer (plate reader) should be switched on to allow 
the internal temperature to reach >20°C. All samples should be read at 340 nm. 
• Pipette 10 III of Sigma RNAse free H20 for blanks into wells A I-AS. 
• Pipette 10 III of standard into wells A6-A8. 
• Pipette 10 III of samples into wells B I onwards. 
• Pipette 200 III of reagent mixture into all wells. 
• Mix and read AI. 
• Add 3 fll of LDH (must be from pig heart), mix well and incubate in the plate reader 
• Mix again and read A2 at 5 miilUte intervals beginning at 15 minutes to establish 
plateau (reaction should be complete by 30 min but can be checked up to 1 h). 
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Lactate Assay Sheet 
Reaction Volume per x total wells +10% Required concentration Volume requires Weighed amount Volume to add Cat. no# 
mixture well (~l) (Tot.) (RC) (>mg) (WA) (~l) added 
- 02 buffer 75 r 1 - - - -
(Boeh. 127965) NAO 25 [ 1 16.6 mg.mr' > 
(Sigma) RNAse free H2O 100 [ 1 - - - -
L 200 Tot. x RC WA x 1000 - 1000 - RC 
Enzyme 
(Boeh. 107069) LOH 3 - - - -
Standards mw 20 mM Weighed amount Volume to add (~l) Dilution 
(Sigma L6402) Lactic acid (98%) 90.08 1.8376 mg.mr 1 50 Jll 20 mM + 950 Jll H20 = I mM 
Where: 
Lactate Calculations 
Lactate (mmol. kg dm-I): 
Vol. post-enzyme x CA2-BLK(2) - Vol. pre-enzyme x CAI-BLKA]) x Extraction factor 
Extinction coefficient x Sample Vol. 
Excel Formula = «(2 13*(A2-BLKA2))-(2 I O*(AI-BLKA 1)))* 125)/(6.22* 10) 
Extraction factor = 125 (i.e 100 fll.mg·1 of HCI04/EDTA mixture + 25% KHC03 for extraction). 
Extinction coefficient =6.22 (i.e. 6.22 cm2 flmol is the absorbency ofNADH when read at 340 nm- note: 3.44 cm2 flmol at 366 nm). 
Note: Standard calculations include no extraction factor and the standard volume will also be 10 fll. 
Appendix E 
Measurement of Prolycogen & Macroglycogen 
Principle: 
Glucose + ATP __ ----'H.::;K~ ___ •• G-6-P + ADP 
G-6-P + NAD __ --'G:..:.6:..:.P'-"D::.:H'--__ ~ 6-phosphogluconate + NADH + H 
Method: 
• Weigh and dilute all components of reagent mixture, enzyme and standard according to 
Glycogen Assay Sheet. All should be thoroughly vortexed and stored on ice. 
• Once reagent mixture, enzyme and standard are prepared, samples (D & H) can be 
defrosted quickly in hot water, vortexed and spun for 3 min at 14,000 rpm. 
• Before pipetting, the spectrophotometer (plate reader) should be switched on to allow 
the internal temperature to reach >20°C. All samples should be read at 340 nm. 
• Pipette 20 fil of Si gm a RNAse free H20 for blanks into wells AI-AS. 
• Pipette 20 fil of standard into wells A6-A8. 
Note: A set of blanks and standards is required on each new plate. 
• Pipette 20 fil of samples into wells B I onwards. 
• Pipette 200 fil of reagent mixture into all wells. 
• Mix and read A I . 
• Add 2 fil of G-6-PDHIHK mixture, mix well and incubate in the plate reader (>20°C). 
• Mix again and read A2 at 5 minute intervals beginning at 10 minutes to establish 
plateau (reaction should be complete by 20 min). 
Note: During high intensity exercise (i.e. >85% VO, max), it may be necessary to 
conduct an assay for free glucose on the muscle extract (E) since some free glucose may 
contribute to the recorded concentration of soluble glucose in this fraction (i.e. 
macroglycogen). 
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Glycogen Assay Sheet 
Cat. no# Reaction mixture 
Volume per x total wells +1 0% Required concentration Volume requires Weighed amount Volume to add 
well (,.d) (Tot.) added (RC) (>mg) (WA) (~I) 
- G I buffer 64 1J - - - -
(Sigma A2383) ATP 4 [ 1 27.72 mg.mr' > 
(Boeh. 197777) OTT 4 ( 1 9J6mg.mr' > 
I (Boeh. 127965) NAO 8 [ 1 19.92 mg.mr' > 
(Sigma) RNAse free H2O 120 ( 1 - - - -
1: 200 Tot. x RC WA x 1000 - 1000 - RC 
Enzymes 
I (Sigma G5885) G-6-POH 1 * - - - -
I (Sigma H 1131) HK 1 * - - - -
Standards mw 15mM Weighed amount Volume to add (Ill' Dilution 
(Fisons 05003) Glu 180.16 2.7 mg.mr! 100 III 15 mM + 900 III H20 = 1.5 mM 
* The enzyme mixture is I part G-6-POH to 1 part hexokinase (i.e. 2 ~I of mixture added to each well). 
Glycogen Calculations 
Proglycogen (rnrnol. kg drn-I): 
r(A2 x Vol. post-enzyme) - (AI x Vol. pre-enzyme))- r(BLKA2 x Vol. post-enzyme) - (BLKAI x Vol. pre-enzyme)) x Hydrolysis factor (D) x Dilution factor 
Extinction coefficient x Sample Vol. 
Excel Formula = ««A2*222)-(AI *220))-«BLKA2*222)-(BLKA 1 *220)))* 100* 1 0/(6.22*20) 
Macroglycogen (rnrnol. kg drn-I): 
t(A2 x Vol. post-enzyme) - (AI x Vol. pre-enzyme)) - [(BLKA2 x Vol. post-enzyme) - (BLKAI x Vol. pre-enzyme)] x Hydrolysis factor CH) x Extraction factor 
Extinction coefficient x Sample Vol. 
Excel Formula = ««A2*222)-(AI *220))-«BLKA2*222)-(BLKAI *220)))*6.75* 125/(6.22*20) 
Where: 
Hydrolysis factor (D) = lOO (i.e. lOO fll mg- I ofHCI for pellet hydrolysis). 
Hydrolysis factor CH) = 6.75 (i.e. lOO fll HCI + 15 fll NaOH + 20 fll for extract hydrolysis). 
Dilution factor = 10 (i.e. tube 0 = 180 fll H20 + 200 fll hydrolysed pellet). 
Extraction factor = 125 (i.e 100 fll.mg-I of HCI04/EDTA mixture + 25% KHC03 for extraction). 
Extinction coefficient =6.22 (i.e. 6.22 cm2 flmol is the absorbency ofNADH when read at 340 nm- note: 3.44 cm2 flmol at 366 nm). 
Note: Standard calculations include no hydrolysis, extraction or dilution factors and the standard volume will also be 20 fll. 
Appendix E 
Correction of Muscle Metabolites for Total Creatine 
G-6-P, ATP, PCr, creatine and glycogen concentrations must be corrected for 
the total concentration of creatine (i.e. PCr + Cr) recorded in each sample (n.b. per & 
er are therefore self-correcting). Based on the assumption that there will be little 
variability in total creatine concentrations for a given individual over a short period of 
time, a single value can be established for each participant. This value can either be 
taken as the highest value recorded for that participant or as the average total creatine 
recorded over all sampling-points ('" 124 mmol.kg dm- I .). The equation below can 
then be used to correct muscle metabolite results for the influence of any 
contaminating blood metabolites: 
where: 
Uncorrected Result x TCr Corrected Result = -========:....:..= 
tCr 
TCr = Total creatine for that participant. 
tCr = Total creatine at the corresponding sampling-point. 
Note: Muscle lactate concentrations are not corrected for total creatine. 
Typical Resting Concentrations of Muscle Metabolites 
MetaboIite Mean (mmol. kg dm-') ±SD 
AMP 0.1 0.05 
ADP 3.2 0.5 
ATP 24 2.6 
G-6-P 1.7 0.7 
PCr 75.5 7.6 
Cr 49 6.7 
per + Cr 124.4' 11.2 
Glucose 1.7 0.7 
Glycogen 349 69.0 
Pyruvate 0.4 0.21 
Lactate 5.1 2.5 
Mean metabohte contents of the quadnceps femons at rest usmg 4 different methods of analysIS. 
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Calculation oflncremental Area Under Curve 
The incremental area under curve (IAUC) was calculated throughout this 
thesis is accordance with the method recommended by Wolever (2004), 
as described below: 
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The total IAUC for the above example will be the sum of periods A+B+C+D+E 
Triangle A = (start cone. + end cone.) x Yz time (m in) - baseline area 
= (5 + 7) x 30 - (5 x 60) 
= 60 mmol·60 min·r l 
Trapezoid B= (7 + 6.5) x 30 - (5 x 60) 
= 105 mmol·60 min·r! 
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Triangle C = (start conc. - baseline conc.) X t / 2 
= (6.5 - 5) X 42.9 / 2 
= 32.2 mmo\·60 min·r! 
Appendix F 
where t = (start conc. - baseline conc.) / (start conc. + end conc.) x time (min) 
= (6.5 - 5) / (6.5 - 4.4) X 60 
= 42.9 min 
Period D the concentrations both at the start end the end of this period are 
below baseline so IAUe = 0 mmo\·60 min·r! 
Triangle E = (end conc. - baseline conc.) X t / 2 
=(5.5-5)x37.5/2 
= 9.4 mmo\·60 min·r! 
where t = (end conc. - baseline conc.) / (end conc. + start conc.) X time (min) 
= (5.5 - 5) / (5.5 - 4.7) x 60 
= 37.5 min 
Therefore the total IAUe for the 5 h period = 
60 mmol·60 minTl 
+ 105 mmol·60 minT! 
+ 32.2mmol·60 minT! 
+ 0 mmol·60 minT! 
+ 9.4 mmol·60 minTl 
206.6 mmol·300 min·r! 
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Calculation of Confidence Intervals 
The error bars displayed on all figures in this thesis are confidence 
intervals (Cl) that have been corrected to remove between subject 
variance according to the methods described by Loftus and Masson 
(1994). These Cl can be calculated using commercially available 
statistical software (SPSS 11.0, USA) as shown below: 
• Begin with data set to be compared, if you are comparing multiple 
points over time then take the data from a given time point in each trial, 
e.g. 
Trial! Tria12 Trial 3 
10 13 13 
6 8 8 
11 14 14 
22 23 25 
16 18 20 
IS 17 17 
I I 4 
12 IS 17 
9 12 12 
8 9 12 
• Paste these data into SPSS in columns as shown above and perform a 
general linear model (GLM): 
Tests of Within-Subjects Effects 
Measure' MEASURE 1 
Type III Sum 
Source 01 SJlUares dl Mean Square F Sjg. 
DRINK Sphericity Assumed 52.267 2 26.133 42.506 .000 
Greenhouse-Geisser 52.267 1.690 30.928 42.506 .000 
Huynh-Feldt 52.267 2.000 26.133 42.506 .000 
Lower-bound 52.267 1.000 52.267 42.506 .000 
Error(DRINK) Sphericity Assumed 11.067 18 .615 
Greenhouse-Geisser 11.067 15.209 .728 
Huynh-Feldt 11.067 18.000 .615 
Lower -bau nd 11.067 9.000 1.230 
• Note the Mean Square for error and the corresponding degrees of 
freedom (df): 0.615 & 18, respectively. 
• Use a t Distribution table to determine a t value using the df. 
For the above example df= 18 so t = 2.101. 
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• A normalised confidence interval can now be created using the formula: 
Cl = Mj + 
where: MSsxc = mean squared error 
n = number of subjects in each trial 
criterion t = t distribution value 
So for the present example this formula will be: 
= ~O.615110 x 2.101 
= 0.52 
• Therefore the overall Cl that will be plotted about each mean will be: 
Trial! Trial 2 Trial 3 
Mean ±CI 11 ± 0.52 13 ± 0.52 14 ± 0.52 
• Interpretation of these Cl is not entirely objective and is not intended to 
correspond with traditional null hypothesis testing techniques. In 
general, however, plotted means whose confidence intervals overlap by 
no more than half the distance of 1 side of an interval are likely to be 
deemed statistically different via t-test. 
• Confidence intervals calculated for within-subjects designs in this way 
do not infer that there is a 95% probability that the mean of the general 
population lies within that interval (as do conventional Cl). Instead, 
what is illustrated by these Cl is the probability that the pattern of 
recorded means is reflective of the general population (i.e. statistical 
significance). The reason that this relationship does not always 
correspond with standard statistical methods is that these Cl also 
provide additional information regarding the statistical power of each 
companson. 
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Additional Issue: Violations of Sphericity 
• When 3 or more treatments are to be compared, the F ratio calculated 
using a general linear model will only be accurate when sphericity can 
be assumed. The degree of sphericity can be assessed through referring 
to the Greenhouse-Geisser epsilon. If this value is <0.75 then, similar 
to hypothesis testing, the Greenhouse-Geisser corrected MSsxc and df 
should be used. If the Greenhouse-Geisser epsilon is >0.75 then the 
Huynh-Feldt corrected MSsxc and df are used, as was the case in the 
example on the previous page. 
• However, the table below presents the severe violation of sphericity that 
was observed in relation to the exercise capacity data recorded in Study 
3 (Chapter 6): 
Greenhouse-Geisser Huynh-Feldt 
I Epsilon .557 .604 
• The Greenhouse-Geisser epsilon of 0.557 is therefore applied to the 
GLM output below to increase the MSsxc and reduce the df: 
Tests of Within-Subjects Effects 
Measure' MEASURE 1 
Type III Sum 
Source 01 Squares dl Mean Square F Sig. 
FACTOR1 Sphericity Assumed 793.750 2 396.875 6.082 
Greenhouse-Geisser 793.750 1.115 711.928 6.082 
Huynh-Feldt 793.750 1.207 657.580 6.082 
Lower-bound 793.750 1.000 793.750 6.082 
Error(FACTOR1 ) Sphericity Assumed 652.583 10 65.258 
I 
Greenhouse-Geisser 652.583 5.575 117.063 
Huynh-Feldt 652.583 6.035 108.126 
Lower-bound 652.583 5.000 130.517 
• Therefore the confidence intervals to be plotted around each mean can 
now be calculated using this corrected omnibus error term as 
previously: 
• 
Cl = .J117.1/6 x 2.447 
= 10.8 
S D h d 3 h' o or t e run tImes III stu ly t IS wou Id I equa: 
CHO CHO-PRO 
Mean ±CI 83.7 ± 10.8 91.2 ± 10.8 
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• This correction of the omnibus error term maintains an accurate 
illustration of the pattern across all treatments and is therefore more 
useful on a line graph where the comparisons of interest can vary over 
time . 
• However, when constructing a bar graph, the specific differences 
between each pair of means are more important and it would therefore 
be inappropriate to use a corrected omnibus error term when sphericity 
has been violated severely (i.e. Greenhouse-Geisser epsilon <0.75) . 
• In such situations it will be more appropriate to compute a separate 
GLM for each comparison of interest and then use their respective 
MSsxc and df to construct distinct pair of Cl for each contrast. For 
example, in Study 3 it was of interest to illustrate the specific 
comparisons between the CHO-PRO trial and each other trial 
separately. Therefore the Cl were constructed and plotted as follows: 
CHO-PRO versus CHO 
MSsxc = 12.6 
df = 5 
t = 2.571 
n=6 
Cl = .jfC":12=-.67":/-:::6 X 2.571 
= 3.7 
CHO = 83.7 ± 3.7 
CHO-PRO= 91.2 - 3.7 
120 
_CHO 
100 c::::::::J CH 0-PR 0 
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.: 80 
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CHO-PRO versus CHO-CHO 
MSsxc = 70.2 
df = 5 
t = 2.571 
n =6 
Cl = .j'-'-70"'--. 2--'/-:-6 X 2.571 
= 8.8 
CHO-CHO = 99.9 ± 8.8 
CHO-PRO = 91.2 + 8.8 


